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ABSTRACT 
EPIGENETIC REGULATION OF GENOMIC IMPRINTING DURING EARLY 
MAMMALIAN EMBRYONIC DEVELOPMMENT 
 
SEPTEMBER 2018 
 
CHELSEA MARCHO, B.S., UNIVERSITY OF PITTSBURGH BRADFORD 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Jesse Mager 
 
Mammalian development involves remarkable changes, starting from a single-cell, 
totipotent zygote and ending with a developed organism comprised of diverse cells types with 
distinct morphologies, structures, and functions. Within three days of murine development, the 
two parental genomes merge into a single nucleus, begin zygotic gene expression, undergo 
epigenetic remodeling, and make the first lineage decisions. Diversity in cell-types is possible 
even though cells share the same genome. This diversity is achieved by the tight regulation of 
differential transcriptional programs. There are many ways these transcriptional programs can be 
initiated. Epigenetic alterations to the genome can drive transcriptional changes. 
Epigenetic changes can influence expression for any gene across the whole genome; 
however, one epigenetic phenomenon that only affects a small subset of loci is genomic 
imprinting. Defined as mono-allelic gene expression in a parent-of-origin manner, imprinting is 
interesting because 1) epigenetic marks at imprinted sites differ between the two parental haploid 
genomes, 2) the epigenetic marks persist past fertilization, following the merger of the two 
parental genomes, 3) imprinted epigenetic marks escape epigenetic reprogramming during 
development, and 4) when misregulated, can lead to disease states.  
At the most basic level, imprinting makes an excellent system for studying epigenetic 
phenomenon in general; having both an active and repressed allele in the same nuclear 
environment allows for examination of the epigenetic requirement to maintain those states. 
Studying imprinting has highlighted the role DNA methylation can play in regulating genes in 
	  ix	  
cis, how long non-coding RNAs function in the genome, and how long-range, chromatin looping 
can regulate expression. Imprinting is also medically relevant; there are multiple human disorders 
linked to aberrant imprinted expression. Additionally, imprinting can be used as an epigenetic 
readout to improve reprogramming techniques including induced pluripotent stem cell (iPCs) and 
somatic cell nuclear transfer (SCNT), as well as assessing the quality of embryos created by 
artificial reproductive technology (ART). 
The goal of this thesis is to characterize imprinted expression during early embryonic 
development. Here, I will define a novel spectrum of imprinted expression and epigenetic 
dynamics, which should inform both basic biology and applied technologies. 
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CHAPTER 1 
 
INTRODUCTION 
1.1 Abstract 
Decisions drive development. Starting with fertilization of the egg, development unfolds 
as a series of lineage decisions. The first lineage decisions occur early, leading to the formation of 
the blastocyst.  Following implantation of the blastocyst into the uterine wall, the second major 
lineage decisions are made. The pluripotent epiblast gives rise to the three main germ layers: the 
endoderm, ectoderm, and mesoderm. These lineage decisions are morphologically dynamic. The 
single cell divides; cells move and change. These changes are caused, in part, by transcriptional 
programs setting the course for lineage decisions to come. In turn, these early embryonic lineage 
allocations are epigenetically dynamic as well. In concert, these morphological, transcriptional, 
and epigenetic changes can transform a single cell into a complex, dynamic organism. 
In this chapter, I will outline these early developmental decisions in the context of the 
murine embryo. This will all be framed around one specific epigenetic phenomenon: genomic 
imprinting. 
1.2 From fertilization to gastrulation 
In order to understand lineage-specific epigenetic phenomena, it is first important to 
understand where distinct lineages are derived. I will first detail the preimplantation lineages that 
lead to the formation of the blastocyst. Following blastocyst formation, the embryo implants into 
the uterine wall. From there, the cells undergo morphological changes and differentiate, leading 
to the gastrulating embryo. 
1.2.1 Preimplantation development and the first lineage decisions 
Development begins once a mature oocyte is fertilized, creating a single-celled zygote. 
Fertilization sets into motion highly regulated proliferation and differentiation events that 
1
	  	  
ultimately lead to an adult organism. The first morphological decision is simple: divide. The first 
division, or cleavage event, occurs one day post-fertilization (E1.5). During this time, one of the 
first major developmental events occurs: the maternal-to-zygotic transition (MZT) takes place. 
The MZT functions to activate the newly formed zygotic genome, as well as degrade oocyte-
specific transcripts (Schultz 2002; Walser and Lipshitz 2011; Li et al. 2013; Lee et al. 2014). 
Following the first division, there are 2 subsequent cell cleavage steps, leading to the 
formation of an 8-cell embryo. These divisions are relatively slow; the embryo doesn’t reach this 
stage until approximately 2.5 days post fertilization. At this point, the 8 individual blastomeres 
appear morphologically similar. The embryo then undergoes the process of compaction. The 
cellular membrane changes, becomes polarized, and compacts (Fleming et al. 2001). At this 
stage, both E-cadherin and β-catenin are involved in the regulation of compaction (Larue et al. 
1994; Fleming et al. 2001; Fierro-Gonzalez et al. 2013). Formation of cell-cell contacts and 
mechanical forces change cell shape, forming a compacted 8-cell embryo. Additional regulation 
drives cell polarity. Together, this process of compaction and subsequent cell divisions generates 
cells with a newly established apical-basal polarity; the cells have distinct asymmetry (Biggins et 
al. 2015).  
Now the cells can divide both symmetrically (maintaining the apical-basal polarity) or 
asymmetrically (where one cell retains the apical domain and the other cell becomes apolar). 
Individual embryos have variability in the divisions that they make at this step; a subset of 
embryos will only divide symmetrically or asymmetrically at this stage (Fleming 1987; Ajduk et 
al. 2014; Anani et al. 2014). There is flexibility in this development and often the next cell cycle 
adjusts for variation in divisions (Anani et al. 2014). Additionally, cells on the outside can be 
internalized (Sutherland et al. 1990; McDole et al. 2011). This all suggest that development at 
these stages is flexible and context aware, rather than predetermined. 
After compaction, the cells have an obvious distinction, inner cells versus outer cells, 
which leads to the first lineage decision. The outer cells will primarily give rise to the 2
	  	  
trophectoderm (TE), while the inner cells will primarily give rise to the inner cell mass (ICM) 
(Ralston and Rossant 2008; Stephenson et al. 2010). Molecularly, the positional information of 
the cells leads to differential regulation of signaling pathways. Specifically, cell-cell contacts 
drive differential hippo pathway signaling (Anani et al. 2014). In polarized outside cells, hippo 
signaling is repressed. This allows Yap/Taz to interact with Tead4, which activated TE-specific 
genes including Cdx2 (Nishioka et al. 2009). This directs the outside cells of the morula to 
assume a TE cell fate. Internalized cells, which are apolar, have active hippo signaling that acts to 
prevent Yap from entering the nucleus. This leads to inactivation of Tead4 and, in turn, no 
activation of Cdx2 or other TE-specific programs (Nishioka et al. 2009). Without these signals, 
there is continued expression of ICM gene programs including Oct3/4 and Nanog, which are 
initially expressed in all cells of the morula. Oct3/4 and Cdx2 act to further repress each other, 
progressively confining expression of both to distinct differentiated populations: TE and inner 
cells mass (ICM). 
It might appear as though positional information is the primary driver of expression 
differences; however, positional information following compaction alone does not drive this 
initial lineage decision. In fact, there is evidence that, even though the early blastomeres appear 
identical, there is already heterogeneity between the early blastomeres. The first molecular 
differences between blastomeres are evident by the 4-cell stage. Additionally, there might even be 
lineage distinctions following the first cell division (Gardner 2001; Piotrowska et al. 2001); 
however, this has been disputed (Motosugi et al. 2005; Kurotaki et al. 2007).  
At the 4-cell stage, the blastomeres distinction is relatively robust, which includes 
differences in an histone modification enrichment (detailed in Section 1.3). For example, global 
levels of H3R17/26me are not the same between blastomeres at the 4-cell stage. This 
heterogeneity leads to a bias in cell-fate specification; cells with lower global H3R17/26me are 
biased to become TE (Torres-Padilla et al. 2007). Experiments injecting exogenous Carm1, a 
methyltransferase that methylates H3 arginine, leads to enrichment H3R17/26me, an up-3
	  	  
regulation in ICM-specific genes, and ultimately an ICM fate (Torres-Padilla et al. 2007; Parfitt 
and Zernicka-Goetz 2010).  
Additionally, there are molecular differences with regards to Oct3/4 kinetics with in 4-
cell blastomeres (Plachta et al. 2011). Specifically, there are differences in Oct3/4 mobility within 
the cell. Highly mobile Oct3/4 (presumably not bound) generate outside cells during compaction, 
which leads to a TE fate. Lower mobility (less nuclear import/export; likely bound) generates 
inside cells and, in turn, ICM (Plachta et al. 2011). 
There is also heterogeneity in global gene expression at these early stages. One example 
is differential expression of Prdm14, an epigenetic modifier that becomes enriched in the ICM. 
PRDM14 can interact with Carm1 (Burton et al. 2013). Together, they might act to increase 
H3R17/26me; cells with Prdm14 expression go on to form ICM. Single-cell RNA sequencing 
(RNA-seq) has highlighted this global heterogeneity (Biase et al. 2014; Huang et al. 2014; 
Blakeley et al. 2015; Shi et al. 2015). Transcriptional differences, together with epigenetic and 
kinetic differences, might drive cells specific cells fates. It is clear that subtle differences at the 2- 
and 4-cell stage can be amplified, guiding cells towards a lineage.  
Following the differentiation of TE (outside cells) and ICM (inner cells), the blastocyst 
forms. Facilitated by the TE, the blastocoel cavity develops, generating the first major embryonic 
axis: the embryonic and abembryonic axis. At this point, the second lineage decisions are made. 
The ICM will differentiate into the inner epiblast (EPI) and the surface primitive endoderm (PrE). 
This distinction between cells is clear by E4.5, but the lineages are established earlier. This is 
evident by a “salt and pepper” pattern of lineage markers among ICM cells at E3.5 (Chazaud et 
al. 2006; Plusa et al. 2008; Yamanaka et al. 2010; Grabarek et al. 2012). 
In the same way that earlier lineage history might bias TE versus ICM fates, so too can it 
drive EPI versus PrE fates. For example, cells internalized earlier have been shown to be biased 
to become epiblast. Conversely, cells internalized in the subsequent cell divisions are biased 
towards the PrE fate (Morris et al. 2010; Morris et al. 2013). This has been controversial; other 4
	  	  
groups have disputed these findings (Yamanaka et al. 2010). Still, context likely plays a role in 
this cell-fate decision as well. 
Molecularly, the cell fates are determined, in part, by the functional interplay of Nanog 
and Gata6, as well as FGF signaling (Chazaud et al. 2006; Yamanaka et al. 2010; Schrode et al. 
2014). In 8- to 16-cell embryos, Nanog and Gata6 are heterogeneously expressed. This expression 
becomes restricted and eventually mutually exclusive in the EPI and PrE. In the epiblast, Nanog 
represses Gata6, as well as activates Fgf4. The segregated Fgf4 acts as a paracrine signal to 
adjacent Fgfr2-positive cells, activating Gata4 and Sox17. Together with Gata6, this drives a PrE 
cell fate.  
At this point, the first three lineages that make up the blastocyst are specified: the TE, 
EPI, and PrE. In order to continue development, the blastocyst now must hatch and implant. 
1.2.2 Implantation 
 One checkpoint during development is the blastocysts ability to hatch from the zona 
pellucida and implant into the uterine wall. Receptivity involves a short window of hormonal 
regulation that alters the lumen and uterine lining to allow for implantation (Ma et al. 2003). The 
free-floating blastocyst makes contact with the uterine luminal epithelium via the mural 
trophectoderm (Aplin and Kimber 2004; Aplin 2006; Wallingford et al. 2013). Following contact, 
the trophectoderm invades, triggering stromal cells to undergo decidualization. The formation of 
the decidua allows for embryo support, including early gas and nutrient exchange (Simmons and 
Cross 2005; Simmons et al. 2007). Additionally, this is the first interaction between the embryo 
and the maternal tissue, which serves as an important immunological checkpoint. This short but 
critical window leads to a major morphological remodeling: gastrulation. 
1.2.3 Post-implantation through gastrulation 
 Following implantation into the uterus, rapid cell proliferation and morphological 
changes occur. The trophectorderm opposite of the epiblast, the mular trophectoderm, grows and 
5
	  	  
differentiates into the cells of the parietal yolk sac. This includes the polytene trophoblast giant 
cells. The polar trophectoderm, which is in association with the epiblast, differentiates into the 
ectoplacental cone and the extra-embryonic ectoderm, as well as placenta, chorion, and some 
trophoblast cells. The primitive endoderm will give rise to the parietal endoderm, which becomes 
the parietal yolk sac. The primitive endoderm also forms the visceral endoderm. This tissue 
becomes the endodermal component of the visceral yolk sac, which is the first site of gas, 
nutrient, and waste exchange between the maternal and embryonic tissues. The epiblast cells 
become polarized and form a rosette-like structure. By either cellular remodeling and/or apotosis, 
the epiblast then forms the proamnion cavity. At approximately E5.0, the embryo takes on an egg 
cylinder morphology characteristic of gastrulation. 
 At the egg cylinder stage, there is tissue heterogeneity that directs cell fate decisions. The 
extra-embryonic ectoderm contains at least 2 distinct populations of cells. For example, there is 
wide expression of Elf5, Eomes, and Wnts in the extra-embryonic ectoderm (Chazaud and 
Rossant 2006; Kemp et al. 2007). These markers are often required for appropriate signaling to 
the epiblast, allowing for gastrulation. Loss of Elf5 in the extra-embryonic ectoderm leads 
embryos to fail to undergo gastrulation (Donnison et al. 2005). This highlights the signaling 
interactions required between tissues. Additionally, there is enrichment of Bmp4 and Brachyury 
in the distal region of the extra-embryonic ectoderm, associated with the epiblast (Lu et al. 2001; 
Perea-Gomez et al. 2004; Rivera-Perez and Magnuson 2005). Bmp4 is thought to provide 
signaling necessary for primordial germ cell specification (Lawson et al. 1999). Additionally, 
Nodal signaling from the epiblast regulates Bmp4 expression in the distal extra-embryonic 
ectoderm, and in turn, activate primitive streak markers like Wnt3 and Brachyury.  
 In addition to the extra-embryonic ectoderm, the visceral endoderm also plays an 
important role in patterning the gastrulation embryo.  The visceral endoderm at this stage is 
comprised of distinct populations as well. This distal visceral endoderm (DVE) is 
morphologically and transcriptionally distinct. The distal visceral endoderm begins as cuboidal 6
	  	  
cell that become columnar and migrate towards what will eventually become the anterior side of 
the embryo. Molecularly, these cells express Hex, along with Dkk1, Cerl1, and Lefty1 (Pfister et 
al. 2007). The posterior visceral endoderm contains cells that are Wnt3 and Mixl1 positive, which 
contributes to the specification of the primitive streak (Liu et al. 1999; Pearce and Evans 1999; 
Robb et al. 2000; Rivera-Perez and Magnuson 2005). Additionally, there is visceral endoderm 
that overlays the extra-embryonic ectoderm, which is also distinct. The cells are columnar, similar 
to the distal visceral endoderm, and express Sox7, Sox17, and Gata4 (Kanai-Azuma et al. 2002; 
Pfister et al. 2007). 
 The critical step in gastrulation is the formation of the anterior-posterior axis. This occurs 
when the distal visceral endoderm migrates towards the proximal axis at approximately E5.75. As 
cells of the distal visceral endoderm migrate, the visceral endoderm cells move as well; these 
visceral endoderm cells will become the anterior visceral endoderm, forming the anterior axis. 
Importantly, the distal visceral endoderm and the future anterior visceral endoderm are two 
distinct populations of cells (Takaoka et al. 2011). The cells continue to migrate until they reach 
the extra-embryonic ectoderm. By E6.5, the anterior visceral endoderm is fully established and is 
restricted to what is now the anterior side of the embryo. While the migration of the anterior 
visceral endoderm requires distal visceral endoderm, the specification of the anterior visceral 
endoderm does not. Removing or genetically ablating distal visceral endoderm prevents anterior 
visceral endoderm migration, even thought the anterior visceral endoderm forms (Miura and 
Mishina 2007; Takaoka et al. 2011). Migration of the anterior visceral endoderm is critical for 
further lineage specification. Underlying epiblast will give rise to the head and brain. Opposite 
the anterior visceral endoderm and away from the anterior visceral endoderm, the posterior 
epiblast will go on to form the primitive streak. 
 The onset of gastrulation is marked by the formation of the primitive streak. This is the 
site where the epiblast cells undergo epithelial-to-mesechymal transition (EMT) and differentiate 
into mesoderm and endoderm lineages. By E6.5, a morphologically distinct streak is present on 7
	  	  
the posterior side of the embryo. Molecularly, these cells appear primed by E5.75 via expression 
of Wnt3 and Brachyury (Rivera-Perez and Magnuson 2005). This is at the same time that the 
distal visceral endoderm migration is occurring on the opposite side of the embryo. The formation 
of the streak is regulated by the remodeling of epiblast basement membranes at the interface of 
the epiblast and visceral endoderm. Cells then ingress, followed by elongation of the streak 
towards the dorsal tip of the embryo (Williams et al. 2012). Elongation is driven, in part, by the 
high rate of proliferation in the epiblast near the streak.  
 The timing of cells entering the streak is thought to determine lineage specification. This 
is likely due to the time spent in specific cellular environments and duration cells are exposed to 
certain signals. Cells that enter the streak first go on to give rise to extra-embryonic mesoderm, 
including yolk sac mesoderm, amnion, and chorion. This is thought to be a consequence of Bmp4 
signaling coming from the extra-embryonic ectoderm. Next derived are the cardiac mesoderm, 
lateral plate mesoderm, and paraxial mesoderm, followed by the axial mesoderm and definitive 
endoderm (Tam et al. 2003). It is thought that Nodal signaling drives these later lineage 
commitments; lower Nodal levels lead to the loss of endoderm, but not mesoderm (Lowe et al. 
2001; Vincent et al. 2003). While this model for timing is how the majority of cells become 
specified, it appears that cells are more dynamic. Genetic fate mapping suggests that germ layers 
can desegregate simultaneously. As cells leave the streak, they need to migrate and undergo 
morphological changes again. For example, the definitive endoderm needs to intercalate into the 
visceral endoderm and displace those cells. This requires that the definitive endoderm undergo 
mesenchymal-to-epithelial transition (Kwon et al. 2008; Kwon and Hadjantonakis 2009; Viotti et 
al. 2011).  
 While symmetry breaking and streak formation appear tied to the direction of distal 
visceral endoderm migration at around E5.75, this lineage is specified much earlier, around the 
blastocyst stage (Takaoka et al. 2006; Takaoka et al. 2011). At E3.75-E4.0, the primitive 
endoderm of the blastocyst asymmetrically expresses Lefty1 and will contribute to the Lefty1-8
	  	  
positive distal visceral endoderm. This asymmetry is found in cultured preimplantation embryos. 
When in vitro cultured embryos are returned to pseudo-pregnant females, the Lefty1-positive cells 
still give rise to the distal visceral endoderm, suggesting that the specification of the anterior-
posterior axis can occur without maternal input (Takaoka et al. 2006; Takaoka et al. 2011). 
Additional asymmetries are found at the blastocyst stage, including Nodal expression and β-
catenin localization (Chazaud et al. 2006; Granier et al. 2011). 
Continued efforts using sequencing and lineage tracing will aid in a better understanding 
of the requirements of the earliest lineages decisions. This includes characterizing the earliest 
heterogeneities in 2- and 4-cell embryos, as well as in the blastocyst, and identifying what signals 
are necessary and sufficient to drive lineage decisions.  
Additionally, understanding these early stages of development has important implications 
in improving preprogramming technologies, including stem cell differentiation, induced 
pluripotent stem cell (iPSCs) generation, and cloning. The molecular and morphological changes 
are critical, but the characterization of epigenetic dynamics during these developmental windows 
is also required. Above I illustrated how specific histone modifications can bias early cell fate 
decisions. In the next section, I will outline how a single cell zygote with two distinct haploid 
genomes undergoes epigenetic remodeling.  
1.3 Epigenetic dynamics during early development 
Just as early development is morphologically dynamic (as illustrated in Section 1.2), so 
too is it epigenetically dynamic. These dynamics help to drive lineage specification. This early 
window of development involves two main epigenetic events: the erasure of germ cell-specific 
epigenetic marks and the reprogramming of the newly formed diploid genome. 
1.3.1 Preimplantation epigenetic reprogramming 
In mammalian cells, the predominant form of DNA methylation occurs at CpG 
dinucleotides.  Throughout the genome, non-promoter associated CpGs are generally found 
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methylated. However, the majority of protein coding genes have regions of high density CpG 
dinucleotides termed CpG islands.  In most cell types the methylation status at these promoter 
associated CpG islands correlate with the transcriptional activity of the locus; actively transcribed 
genes generally are not methylated, while silenced genes are often found to be heavily methylated 
in the promoter island.  Additionally, there is growing evidence that CpG islands found outside of 
transcription start sites play functional roles (Saxonov et al. 2006; Illingworth et al. 2010; 
Maunakea et al. 2010).  While DNA methylation at gene promoters is traditionally thought to act 
as a binary switch (methylated is silent, unmethylated is active), it appears that CpG density, not 
presence of methylation alone, contributes to regulation of expression. For example, methylation 
at low CpG dense promoters still allows for transcriptional activity (Fouse et al. 2008).  
Furthermore, there are numerous examples, particularly of non-coding RNAs, that are transcribed 
although the allele is heavily methylated (Bartolomei et al. 1993; Takada et al. 2002; Sleutels et 
al. 2003). These examples highlight that while there are general correlations of methylation status 
and gene activity; individual loci vary greatly.  
The molecular machinery responsible for adding a methyl group to cytosine residues, 
resulting in 5-methylcystosine (5mC), has been identified as a family of DNA methyltransferases 
(Dnmt1, Dnmt3a, Dnmt3b, and Dnmt3l). Dnmt3a and Dnmt3b are responsible for de novo 
methylation and play partially redundant but independently essential roles during early 
development. This includes methylation of repeat regions, imprinted loci, as well as genes 
involved in lineage decisions (Okano et al. 1999; Bourc'his et al. 2001; Kaneda et al. 2004). More 
specifically, Dnmt3a and Dnmt3b help to establish de novo methylation in the blastocyst, 
allowing global 5mC levels to increase to that of somatic cells following implantation (Smith et 
al. 2012).  Dnmt3a is maternally loaded in the oocyte and is the predominate methyltransferase in 
the oocyte and zygote (Kaneda et al. 2004; Kato et al. 2007), whereas Dnmt3b is transcribed upon 
zygotic genome activation (Watanabe et al. 2002). Knockout studies in mice show that each of 
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the Dnmts are required for viability (Li et al. 1992; Okano et al. 1999), highlighting the essential 
nature of de novo and maintenance methylation during development. 
Dnmt1 has two functional transcripts that are expressed during development; Dnmt1s is 
expressed in somatic cells, while Dnmt1o is expressed as an oocyte specific form (Rouleau et al. 
1992; Gaudet et al. 1998; Mertineit et al. 1998). Unlike Dnmt3a and Dnmt3b, Dnmt1 maintains 
CpG methylation by recognizing hemimethylated DNA and methlyating the unmethlyated strand 
ensuring 5mC is maintained through DNA synthesis (Leonhardt et al. 1992; Arand et al. 2012). 
Targeting of Dnmt1 to replication foci occurs in most proliferating cells (Kishikawa et al. 2003; 
Bostick et al. 2007); however, Dnmt1o/s is largely excluded from the nucleus during early 
preimplantation stages (Howell et al. 2001), likely to allow for the global demethylation that 
occurs to both haploid genomes (Figure 1.2, Figure 1.3). 
Both sperm and oocytes contain distinct 5mC patterns. At the time of fertilization, the 
two haploid genomes form a zygote with parent-of-origin specific epigenomic signatures.  Both 
the parental pronuclei undergo dramatic global demethylation, presumably to ensure similar 
epigenetic information at the two parental alleles for the majority of genes, excluding imprinted 
loci, as well as to allow the newly formed zygote to reach a totipotent state. The male haploid 
genome is heavily methylated in sperm, where between 80-90 percent of all CpG dinucleotides 
are methylated (Mayer et al. 2000; Oswald et al. 2000; Santos et al. 2002). Global DNA 
methylation levels in the maternal haploid genome are approximately half that of the sperm 
(Howlett and Reik 1991; Smallwood et al. 2011; Peat et al. 2014). Shortly after fertilization, the 
two parental genomes undergo distinct but equally dramatic waves of DNA demethylation. The 
paternal genome undergoes active, replication-independent demethylation within the first several 
hours post-fertilization. In contrast, the maternal genome largely undergoes passive, cell division-
dependent diffusion of methylation, resulting in demethylation over the course of preimplantation 
development. 
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Demethylation begins immediately in the newly formed embryo, prior to the first cell 
division. By the time the embryo reaches the morula stage, the genome is almost completely 
devoid of DNA methylation (Santos et al. 2002).  Despite wide-spread global demethylation, a 
few regions of the genome are protected, including imprinted loci and active retrotransposons like 
intracisternal A Particle (IAP) elements (Lane et al. 2003). The large-scale demethylation begins 
with the rapid, active demethylation of the paternal haploid genome. 
The differences between demethylation dynamics within the maternal and paternal 
pronuclei are thought to arise from distinct epigenetic architecture. The paternal genome is 
packed mostly around protamines, which are disassembled after fertilization and re-organized 
with histone containing nucleosomes (Braun 2001; Balhorn 2007). The maternal genome is 
largely assembled around H3K9me2-rich histones. These structural distinctions between the two 
haploid genomes at pronuclear stage 0 (PN0) is thought to influence the timing of bulk genome-
wide demethylation (Santos et al. 2005), kinetics of which are different between the maternal and 
paternal pronuclei (Figure 1.2). Examination of global DNA methylation by immunofluorescence 
showed that the paternal pronucleus undergoes division-independent demethylation (Santos et al. 
2002). When the zygote reaches the PN3 stage (approximately 4 hours after fertilization), there is 
already a dramatic loss of 5mC observed in the paternal pronucleus but little change in the 
maternal pronucleus (Mayer et al. 2000; Oswald et al. 2000). By the time of the first cell division 
(24 hours after fertilization), there is no 5mC signal detected in the paternal pronucleus, 
indicating near-complete loss of 5mC methylation. Even though the two parental genomes 
occupy the same nucleus after pronuclear fusion, the differences in 5mC levels are apparent 
beyond the 4-cell stage (Santos et al. 2002).   
Early studies of demethylation dynamics based on immunofluorescence conflicted 
somewhat with bisulfite DNA sequencing data sets, which did not show as dramatic a loss of 
5mC (Oswald et al. 2000).  It was not until the realization that the 5mC oxidation product 5-
hydroxymethylcytosine (5hmC) is present in vivo that this discrepancy was resolved.  Traditional 12
	  	  
bisulfite treatment does not distinguish between 5mC and 5hmC (Huang et al. 2010), while the 
antibodies used for immunofluorescence specifically detect 5mC. It has been subsequently shown 
that TET enzymes mediate the oxidation of 5mC to 5hmC (as well as 5fC and 5caC) in vivo and 
that TET proteins are expressed and differentially localized during preimplantation development 
(Gu et al. 2011; He et al. 2011; Iqbal et al. 2011; Wossidlo et al. 2011). Specifically, TET3 
primarily localizes to the paternal pronucleus (Figure 1.2) and is thought to be responsible for the 
observed rapid demethylation.  Importantly, Gu et al showed that the loss of 5mC corresponds 
with a concomitant gain in 5hmC (Gu et al. 2011). In both pronuclei, 5mC is present until PN3, 
and by late PN3, there is a detectable decrease in 5mC and an increase in 5hmC (Figure 1.2, (Gu 
et al. 2011; Iqbal et al. 2011; Wossidlo et al. 2011).  It was also shown Tet proteins convert 5mC 
to 5fC and 5caC as well, suggesting that Tet-mediated oxidation results in three oxidative forms 
for cytosine in vivo (Inoue et al. 2011; Inoue and Zhang 2011), ultimately resulting in 
replacement of the oxidized base with unmethylated cytosine by base excision repair or 
replication-dependent diffusion. Additionally, oxidation of 5mC occurs in other mammalian 
zygotes indicating a conserved mechanism of demethylation (Wossidlo et al. 2011). 
Surprisingly, deletion of Tet3 activity results in retention of 5mC in the paternal 
pronucleus and inappropriate gene activation at many loci, but only mild global phenotype 
(reduced viability (Gu et al. 2011)).  Tet3 mediated hydrolysis of 5mC also occurs during 
reprogramming after SCNT cloning; Tet3 localizes to the pseudo-pronucleus in recombined 
zygotes. In SCNT embryos made with Tet3-null host oocytes, there is no 5hmC present in the 
pseudo-pronucleus, further indicating the role of Tet3 in active demethylation. (Wossidlo 2011, 
Gu 2011).   
These recent studies offered the prevailing idea that demethylation during 
preimplantation development occurrs via active DNA demethylation of the paternal pronuclei 
mediated by Tet3 and thymine DNA glycosylase (TDG)-mediated base excision repair (Kohli and 
13
	  	  
Zhang 2013) and passive, replication dependent dilution loss of methylation of the maternal 
genome due to lack of Dnmt1 in the nucleus (Howell et al. 2001).   
However, recent work is shifting the hypotheses about the mechanisms responsible in 
vivo. Using whole genome approaches to assess cytosine methylation patterns, it has been shown 
that Tet3-mediated demethylation is only partially responsible for paternal demethylation and that 
active demethylation also occurs in the maternal pronucleus (Guo et al. 2014a; Shen et al. 2014a). 
Furthermore, although Tet3 mediated oxidation is required for active demethylation, TDG-
mediated base excision repair is not (Guo et al. 2014a). Additionally, it appears that there is 
conflicting evidence regarding the role that replication dependent demethylation plays in 
removing methylation from the paternal genome. By blocking replication of the paternal 
pronucleus, Shen et. al showed diminished demethylation in the paternal pronucleus even though 
Tet3 is active, indicating that replication is also involved in the demethylation of the paternal 
pronucleus (Shen et al. 2014a). Adding additional ambiguity is the fact that Tet3-mediated 
demethylation is largely dispensable for successful development (Peat et al. 2014; Shen et al. 
2014a; Inoue et al. 2015). 
Taken together, the mechanisms that reprogram sperm and oocyte specific DNA 
methylation are not mutually exclusive as once predicted, and these recent stories indicate that 
there are likely unknown mechanisms also contributing to DNA methylation dynamics during 
preimplantation. With these advances, there are 3 main modes of DNA demethylation: 1) active 
Tet3-mediated oxidation, predominantly in the paternal pronucleus, 2) replication dependent 
dilution of Tet3-oxidative products, which plays a major role in demethylation the paternal 
pronucleus, and 3) replication dependent (Tet3-independent) dilution of 5mC, predominantly in 
the maternal pronucleus.  As our technical abilities evolve it will be interesting to determine the 
interplay of these mechanisms within the same cells in vivo, define the specific loci at which each 
occurs, and identify if there are differing roles influencing cell fate decisions.  
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If Tet3 is present in the oocyte but only acts primarily on the paternal genome, there must 
be a protective mechanism to prevent conversion of maternal 5mC. One candidate for this 
maternal genome protection is PGC7/Stella, a DNA binding protein expressed during germ cell 
specification, gonad, and in oocytes (Saitou et al. 2002; Sato et al. 2002).  PGC7 null embryos fail 
to complete preimplantation and there is a loss of 5mC in both pronuclei, indicating a protective 
role in the maternal pronucleus. Additionally, PGC7/Stella is targeted to differentially methylated 
regions (DMRs) of imprinted genes in the early embryo (Nakamura et al. 2007), supporting a 
functional role in blocking Tet3 mediated demethylation.  
PGC7/Stella is able to protect the maternal pronucleus by binding to H3K9me2, which is 
a distinguishing feature of the maternal pronucleus. Loss of H3K9me2 by ectopic Jndm2a, a 
H3K9 methylation/dimethylation-specific demethylase, leads to loss of 5mC in both the maternal 
and parental pronuclei.  PGC7/Stella also binds to H3K9me2 regions of the paternal pronucleus, 
including DMRs, which are not subject to protamine replacement. Tet3 is inhibited by 
PGC7/Stella thus offering protection from active demethylation (Nakamura et al. 2012). 
While most of the genome undergoes global DNA demethylation, imprinted loci are 
protected and retain parent of origin differentially methylated regions (Branco et al. 2008; Cirio et 
al. 2008; Hirasawa et al. 2008).  It is clear that Dnmt1 is required for the maintenance of these 
imprinted sites (Bourc'his et al. 2001), even though it is largely excluded from the nucleus 
(Hirasawa et al. 2008).  Stella is also known to protect these loci, including some imprinted sites 
of the paternal genome.  Additionally, Zfp57, a KRAB zinc finger protein, and Trim28 have also 
been shown to be required for integrity of DNA methylation imprinting control regions (ICRs) in 
the early embryo.  Trim28 interacts with Zfp57 to target it to specific imprinted sites resulting in 
recruitment of repressive complexes including NuRD, SETDB1, and DMNTs (Iyengar et al. 
2011; Quenneville et al. 2011; Zuo et al. 2012). While loss of maternal Zfp57 can be rescued by 
paternal expression, loss of maternal Trim28 is lethal (Li et al. 2008; Messerschmidt et al. 2012), 
due in part to the variation in loss of imprinted expression (Messerschmidt et al. 2012). 15
	  	  
Sequencing efforts, including reduced representation bisulfite sequencing (RRBS) and 
whole-genome bisulfite sequencing (WGBS), now allow assessment of global DNA methylation 
reprogramming with high resolution even from limited numbers of cells. Confirming earlier 
work, methylation across the genome is observed at relatively low levels in oocytes and early 
preimplantation stages, while sperm and post-implantation embryos have methylation similar to 
that of somatic cells (Smith et al. 2012; Guo et al. 2014a; Guo et al. 2014b; Peat et al. 2014).  
These technologies have allowed for refined assessment of methylation changes across the 
genome during precise developmental stages, examination of specific classes of DNA sequence 
elements and comparison of mouse and human preimplantation embryos.   
In addition to characterizing epigenetic dynamics in mouse, two groups recently 
examined genome-wide DNA methylation changes in human oocyte, sperm, zygote, pre- and 
post-implantation stages, using reduced representation bisulfite sequencing (RRBS) and whole-
genome bisulfite sequencing (WGBS) (Smith et al. 2012; Guo et al. 2014a). Similar to mouse, 
both groups found that human sperm is highly methylated, although less than mouse sperm, and 
human oocytes have intermediate levels of methylation. The post-fertilization demethylation 
kinetics are also similar in the human zygote (Smith et al. 2012). Guo et al. note that the greatest 
loss of DNA methylation occurred between the 1- to 2-cell stage in human embryos, rather than 
during pronuclear stages, as is the case in the mouse. This could indicate that differences in the 
rate of active demethylation and also correlates with the timing of zygotic genome activation, 
which occurs later in humans (Beaujean et al. 2004). Because bisulfite sequencing used in these 
studies did not distinguish between 5mC and the oxidative products of Tet-mediated 
demethylation, the distinct timing in mouse and human embryos may reflect a difference in the 
oxidation rates of 5mC or Tet activity between species. Paternal genome demethylation in human 
is similar to observations in mouse zygotes in that the majority of methylation is rapidly lost and 
only low levels of methylation remain during preimplantation. Levels of methylation in the 
maternal pronucleus are similar to mouse, but the genomic regions that are demethylated are 16
	  	  
divergent.  Additionally, unlike in mouse, the majority of sperm and oocyte specific differentially 
methylated regions regain their full methylation following implantation (Smith et al. 2012; Guo et 
al. 2014a). 
Comparison of genome-wide methylation with single-cell RNA sequencing data (Yan et 
al. 2013) confirmed previously observed negative correlation between promoter methylation and 
gene expression and highlighted that this inverse relationship strengthens after the maternal to 
zygotic transition in human embryos (Smith et al. 2012; Guo et al. 2014b). Genes that had 
increased promoter methylation after the blastocyst stage showed a predicted decrease in 
expression in post-implantation stage embryos (Guo et al. 2014b). Also as expected, changes in 
DNA methylation during preimplantation influence the repression of transposable elements. 
SINE/variable number of tandem repeat/Alu elements (SVAs) expression increases after the 2-
cell stage, when rapid demethylation occurs. This expression is maintained until the morula stage, 
when expression decreases, presumably as the genome is re-methylated; a trend which continues 
post-implantation (Smith et al. 2012; Guo et al. 2014b). 
While many repeat elements undergo loss of DNA methylation and increased expression, 
the evolutionary age of the transposable element appears to influence the retention of methylation 
during preimplantation development. Evolutionarily younger elements, which are still capable of 
transposition are relatively resistant to demethylation while their evolutionarily older counterparts 
which have lost the ability to jump are readily demethylated along with coding genes. This might 
hint at the evolutionary origins of methylation/demethylation dynamics in mammalian 
preimplantation development (Wang et al. 2014). 
While global DNA methylation differences stand out as the apparent difference between 
the maternal and paternal genome, chromatin structure and histone modifications also differ at the 
time of fertilization and these differences need to be resolved.  Additionally, differential histone 
modifications help to drive lineage-specification (Section 1.2.1). Chromatin is comprised of 
histones and additional proteins, which help to organize and package the large amount of genetic 17
	  	  
material contained in each cell.  The primary unit in which DNA is packaged is the nucleosome 
made of histone subunits. The individual histones form an octomer comprised of H2A, H2B, H3, 
and H4 doublets. There are also additional histone variants that can affect transcriptions, 
chromatin packaging, and DNA repair (reviewed in (Talbert and Henikoff 2017)).  The 
nucleosomes are spaced closely across the DNA (approximately 200 bp apart) and form the 
“beads on a string” structure with the wrapped DNA (Oudet et al. 1975).  
The state of the chromatin is regulated, in part, by post-translational modifications to the 
nucleosome protein tails. These include methylation, acetylation, phosphorylation, and 
ubiquitination, as well as other modifications. Post-translational modifications made to histone 
tails correlate with regulation and structure of the chromatin. Marks can be added by histone 
acetyltransferases, methyltransferases, and kinases and removed by histone deacetylases 
(HDACs) and demethylases (HDMs), allowing for dynamic regulation. In general, histone 
acetylation is associated with open chromatin structure that promotes accessibility for 
transcriptions factors and other proteins to the DNA. This allows for active transcription at 
acetylation-rich regions. Conversely, histone methylation can act to either activate (via 
H3K4me3, H3K36me3) or repress genomic regions (via H3K9me3, H3K27me3) (Talbert and 
Henikoff 2017).   
As mentioned earlier, both the oocyte and sperm have distinct chromatin landscapes 
(Figure 1.4). The sperm DNA is largely packaged with protamine, which is thought to aid in the 
compaction. Regions that retain histones are thought to be developmentally relevant; they are also 
known sites of genomic imprinting. The paternal pronucleus also has histone modifications that 
are distinct from the maternal pronucleus, including H3K27ac, H4K5ac and H4K16ac (Adenot et 
al. 1997; Stein et al. 1997; Hayashi-Takanaka et al. 2011). The oocyte more closely resembles 
somatic cells. It is enriched for H3K4 and H3K9 methylation, as well as H3K9me3S10P, 
H3K36me3 and H4K20me3 (Lepikhov and Walter 2004; Santenard et al. 2010) (Lepikhov and 
Walter 2004; Wongtawan et al. 2011; Beaujean 2014). Additionally, while H3K27me1 is present 18
	  	  
in both pronuclei, H3K27me2 and H3K27me3 occur extensively in the maternal pronucleus 
(Erhardt et al. ; Santos et al. 2005; Santenard et al. 2010) (Figure 1.4).  
In the same way that whole genome sequencing allowed for global DNA methylation 
dynamics to be defined, sequencing also provided global information on the enrichment of 
histones and chromatin structure. Multiple groups have analyzed the global enrichment of 
specific histone marks (H3K4me3, H4K27me3, and H3K27ac), as well as the general 
accessibility of the DNA (Dahl et al. 2016; Liu et al. 2016; Lu et al. 2016; Wu et al. 2016; Zhang 
et al. 2016; Zheng et al. 2016). In all cases, there is distinct histone enrichment that is unique to 
the germ cells and the preimplantation embryo.  
For example, the oocyte and zygote were found to have broad H3K4me3 domains 
(termed non-canonical H3K4me3) that shift to the normal sharp peaks around promoters during 
the 2-cell stage. This shift in enrichment appears to be critical for the maternal-to-zygotic 
transition (Dahl et al. 2016; Liu et al. 2016; Zhang et al. 2016). Actively preventing the broad 
H3K4me3 reduction in at the 2-cell stage by depleting the demethylases (KDM5A/B) leads to 
downregulation in zygotic gene expression (Dahl et al. 2016; Zhang et al. 2016). It appears that 
the broad, non-canonical H3K4me3 might silence zygotic genes and that the shift to a canonical 
enrichment state is required for normal zygotic expression. The enrichment of H3K4me3 also 
differs between the two alleles; even in the ICM, the enrichment of H3K4me3 is lower on the 
paternal allele. Interestingly, while there is lower level of enrichment on the paternal allele, it 
retains a broad domain pattern (Zhang et al. 2016). This indicated reprogramming of H3K4me3 is 
different between the two alleles. 
The repressive mark H3K27me3 also has a distinct enrichment pattern in the 
preimplantation embryo. There is broad enrichment during earlier stages, with a clear lack of 
enrichment at promoter regions. During development, there is a widespread loss of enrichment of 
H3K27me3 at developmental genes on the paternal allele; the maternal allele undergoes site-
specific loss of enrichment. Even though there is loss of the repressive mark, many of the 19
	  	  
developmentally relevant genes remain inactive until later in development, indicating additional 
silencing mechanisms. There is also deposition of broad domains of H3K27me3 in regions 
without active transcription (Zheng et al. 2016). While there is some disagreement about the 
bivalent state (both H3K4me3 and H3K27me3) of genes during preimplantation, it appears that 
there is initially unstable bivalent histone states that are quickly lost (Liu et al. 2016; Zheng et al. 
2016). Bivalent states that persist are generally not found until after implantation (Zheng et al. 
2016). 
To what degree histone difference between alleles, as well as different histone variants, 
during preimplantation development influence expression still needs additional work. Functional 
studies of specific histone modification at this time aid in the role each histone modification plays 
in development. For example, knockdown of HDAC1, which leads to hyperacetylation of histone 
H4, can cause delays in development and decrease in developmental potential. Fewer embryos 
make it to the blastocyst stage when HDAC1 is knocked down compared to control (Ma and 
Schultz 2008). HDAC1 plays a critical role in regulating the state of histone acetylation, which 
likely has a global effect on transcription, leading to the developmental phenotype. Additionally, 
knockdown of other histone modifiers lead to morula arrest and embryonic lethality (Oda et al. 
2009; Zhang et al. 2013b; Ooga et al. 2015; Zhou et al. 2015; Dahl et al. 2016; Zhang et al. 2016). 
It is clear that appropriate histone modifications are required for successful development due to 
the regulatory functions of histone marks. 
The accessibility of the DNA during preimplantation development has also been 
analyzed. It has been shown that there is broad accessibility of the DNA at the 2-cell stage, and 
that accessibility increases as development continues (Lu et al. 2016; Wu et al. 2016). Even 
though the two parental alleles differ in terms of DNA methylation and histone enrichment, both 
alleles are remarkably similar in terms of accessibility. Reprogramming of the paternal allele 
happens quickly, so that by the 2-cell stage, both alleles are equally accessible (Lu et al. 2016; 
Wu et al. 2016). Sites of accessibility shift during development, and this is tied to function (Lu et 20
	  	  
al. 2016). Comparing open regions to known gene enhancers allows for the establishment of 
regulatory networks during development. For example, early regions of open DNA are involved 
in chromatin regulation. In later stages, open regions are associated with developmentally 
relevant genes, including Sox2, Tead4, Oct4, Gata4, and Nanog. Comparing ICM to ESCs 
highlights lineage-specific accessibility; ICM, which has the potential to give rise to epiblast and 
primitive endoderm cells, has characterizes of both cell types, whereas ESCs have an epiblast-like 
state (Wu et al. 2016). This indicates that the primary structure of the chromatin could confer 
lineage-specific fate. 
Like the histone landscape, the global 3-dimentional architecture of the preimplantation 
chromatin is also unique. Upon fertilization, the chromatin is relatively dispersed as 10nm 
chromatin fibers. Following the first cell division, the organization of the genome shifts; 
association with the nuclear envelope increases and compartments begin to form. At the 1- and 2-
cell stage, there are blocks of compact chromatin. Surprisingly, this organization shifts again. The 
8-cell embryo chromatin is highly dispersed and compartments are less defined (Ahmed et al. 
2010). It is hypothesized that this highly dispersed, open chromatin state allows for 
transcriptional flexibility and, ultimately, pluripotency. This is supported by data indicating that 
the TE and PrE, both lineage-committed cell types, have higher levels of chromatin compaction 
compared to the EPI. Additionally, when pluripotency marker Oct4 is lost, the epiblast chromatin 
resemble that of the TE and PrE (Ahmed et al. 2010).   
Sequencing has also been used to better understand the higher order chromatin states. In 
general, sequencing corroborated earlier work using microscopy techniques (Ahmed et al. 2010). 
As mentioned above, the chromatin state during preimplantation is relatively open, lacking higher 
order chromatin structures when compared to adult interphase cells (Lieberman-Aiden et al. 
2009; Dixon et al. 2012; Dixon et al. 2015). The genome is usually partitioned into megabase-
sized topological domains, as well as smaller domains called topologically associating domains. 
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order compartments- Compartment A and Compartment B. Compartment A is associated with an 
open, accessible, and actively transcribed state compared to Compartment B, which is associated 
with a closed, repressed state (Lieberman-Aiden et al. 2009). 
The oocyte has uniform, dispersed chromatin lacking both topologically associating 
domains or compartments. Fertilization leads to a differential state where the paternal genome has 
weak topologically associating domains (Du et al. 2017; Flyamer et al. 2017). This is likely due 
to the differences in genome packaging. Following fertilization, the chromatin relax and then 
slowly form higher order structures in a step-wise manner. This restructuring of the genome can 
occur in the absence of transcription in mouse, as well as in drosophila (Du et al. 2017; Hug et al. 
2017). Importantly, sequencing has been able to demonstrate that the two parental genomes are 
spatially segregated during preimplantation development; there is limited interactions between the 
two genomes until the 8-cell stage and specific loci can remain segregated for longer (Du et al. 
2017). 
These data highlight the fundamental differences in chromatin state present in the early 
mouse embryo compared to other, more differentiated cell types. Together with the DNA 
methylation landscape, this might hint at the requirements of a totipotent cell state.  
1.3.2 Gastrulation lineage differences 
Understanding epigenetic dynamics during post-implantation development is more 
challeneging than preimplantation development. As lineage decisions are being made, there is 
more heterogenetiy in the epigenetic state of the embryo. Collecting embryos and separating 
tissues for global anaylsis involves overcoming multiple technical hurdles. As a result, there is 
less information on the epigenetic state of the gastrulating embryo compared to preimplantation 
and post-gastrulation stage tissues. Recent work using whole genome sequencing methods, 
including data presented in Chapter 4, have improved the resolution of epiegentic dymanics 
during and after implantation allowing for a global perspective of epigenetic reprogramming 
during gastrulation. 22
	  	  
Following global epigenetic programming during preimplantation development, the 
blastocyst is largely devoid of DNA methylation (Figure 1.3). After implantation, methylation 
levels increase as development proceeds and lineage decisions are made (Auclair et al. 2014; 
Zhang et al. 2018). The acquisition of new methylation occurs in a lineage-specific manner; the 
epiblast lineage gains more methylation between E5.5 and E6.5 compared to the visceral 
endoderm. This is associated with higher overall levels of Dnmta3, Dmnt3b, and Dmnt3l in the 
epiblast compared to the extra-embryonic tissue. While the methylation is largely found in a CpG 
context, CH-context methylation also preferentially increases in the embryonic lineage 
(Ramsahoye et al. 2000; Lee et al. 2017; Zhang et al. 2018). Compared to the three lineages of the 
blastocyst, the gastrulation lineages are more distinct in terms of methylation pattern (Zhang et al. 
2018). This suggests that clear lineage differences began just prior to gastrulation.  
The embryonic and extra-embryonic lineages also have differences in DNA methylation 
levels at both promoters and large regions of hypomethylation refered to as DNA methylation 
valleys (Xie et al. 2013; Jeong et al. 2014; Zhang et al. 2018). There is more promoter 
methylation in the E6.5 epiblast compared to the visceral endoderm, which correlates with the 
higher overall methylation levels in the embryonic lineage. Some lineage-specific promoter 
methylation is associated with lineage-specific expression programs; epiblast-specific 
hypermethylation is found at many visceral endoderm-specific genes and visceral endoderm-
specific hypermethylation is found at genes like Oct4, Nanong, and Tdgf1 (Zhang et al. 2018). 
Additionally, visceral endoderm-specific hypermethylation is associated with developmentally 
relevant genes like Hox family menmbers, Nkx2-5, Nkx2-6, Prdm14, and Hand1. The visceral 
endoderm hypermethylated regions appear to be DNA methylation valleys and are distinct from 
the epiblast (Zhang et al. 2018). 
It is important to note that the hypomethylation found at DNA methylation valleys in the 
epiblast is established via Tet-mediated demethylation. In Tet1/Tet2 knockout embryos, there is 
an increase in methylation levels at the DNA methylation valleys (Zhang et al. 2018). CG island 23
	  	  
methylation is also enriched in the extra-embryonic lineage compared to the epiblast. In the 
epiblast, methylation levels at CG islands remain in a hypomethylated state, potentially also being 
driven by active demethylation (Auclair et al. 2014; Zhang et al. 2018). This suggests that the 
active demethylation at these regions might allow for transcriptional plasticity for the 
developmentally relevant genes in the epiblast.  
While the majority of allele-specific reprogramming occurs during preimplantation 
development, there are still differences between the maternal and paternal genome at the 
blastocyst stage. For example, the maternal genome still has oocyte-like methylation levels in 
gene bodies when compared to the paternal allele. Globally, the two genomes reconcile these 
differences by E5.5 (Zhang et al. 2018).  
In addition to DNA methylation differences between the embryonic and extra-
emebryonic lineages, there are also higher order chromatin structure differences that can regulate 
lineage specification. In fact, the lineage-specific methylation patterns between the two tissues is 
associated with different chromatin states. In general, higher order chromatin structures are 
established by E3.5 and are maintained until at least E7.5 (Ahmed et al. 2010). In the visceral 
endoderm, open chromatin domains are associated with partially methylated regions and closed 
chromatin domains are associated with highly methylated regions. In contrast, the epiblast does 
not appear to have compartment-specific methylation patterns (Zhang et al. 2018). This might be 
due to the increased levels of DNMTs in the epiblast; an abundance of protein might allow 
methylation to occur in more restricted, closed regions of the genome. The higher order 
chromatin structure appears to also regulate lineage specific expression programs (Lu et al. 2016; 
Wu et al. 2016). There is distinct accessiblity and histone modificaiton in the lineages of the 
blastocyst that likely persist during gastrulation (Dahl et al. 2016; Liu et al. 2016; Lu et al. 2016; 
Wu et al. 2016; Zhang et al. 2016; Zheng et al. 2016). Remodeling the chromatin is one way to 
regulate cell fates when going from a pluripotent state to a more differentiated state. 
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Future work detailing histone enrichment, DNA accessiblity, and 3-dimension structure 
of the geneome in specific cell lineages will provide a panoramic view of the epigenetic 
landscape during gastulation. Coupled with functional studies and transcriptional profiling, this 
should improve our understanding of global epigenetic dynamics during this developmental 
window and provide a resoultion of the genome comparable to preimplantation development. 
1.4 Genomic imprinting: an epigenetic phenomenon 
In the following section, I will detail the history leading up to the identification of the 
first imprinted genes. I will also highlight the epigenetic mechanisms at canonical imprinted sites. 
Lastly, I will describe recent allele-specific sequencing efforts that have increased the number of 
imprinted genes, as well as challenged the mechanisms by which imprinting can occur.  
1.4.1 History of genomic imprinting 
Genomic imprinting is the epigenetic phenomenon where one allele is silenced in a 
parent-of-origin manner. The first suggestions of parent-of-origin expression in mammals arose 
from early work with chromosome complementation studies (Searle and Beechey 1978), as well 
as assessment of gynogenetic and androgenetic embryos which showed disparate phenotypes 
(Barton et al. 1984; McGrath and Solter 1984a; Surani et al. 1984). For example, embryos 
containing two maternal pronuclei (gynogenetic) or two paternal pronuclei (androgenetic) failed 
to develop. Additionally, knockout mouse studies revealed parent-of-origin phenotypes. For 
example, the “hair-pin tail” mutant allele, when inherited from the maternal genome, caused 
overgrowth that is embryonic lethal (Johnson 1974). Injecting “hair-pin tail” mutant pronuceli 
into a wild-type oocyte was unable to rescue the phenotype. This indicated that it was not a factor 
in the maternal oocyte that caused the phenotype; rather, it was something inherited within the 
pronuclei itself (McGrath and Solter 1984b). These studies provided evidence that the two 
mammalian haploid pronuclei (oocyte and sperm) are not equivalent at the time of fertilization 
and zygote formation. Additionally, it demonstrated that uniparental mammalian development 
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was not possible, unlike previously thought (Hoppe and Illmensee 1982).  Both parental genomes 
are required for successful embryogenesis. 
Uniparental disomy mapping continued to add evidence of imprinting. Multiple 
independent translocations showed parent-of origin effects, but the entire genome did not have 
the same potential, indicating specific regions of the genome conferred the parent-of-origin 
effects (Cattanach and Kirk 1985). Additionally, some human diseases, like Prader-Willi 
syndrome that only arose when paternally inherited, did not follow normal Mendelian inheritance 
(Nicholls et al. 1989; Reik 1989; Hall 1990). Together, these supporting data ultimately lead to 
the identification of the first imprinted loci. 
In 1991, multiple groups identified and characterized specific imprinted genes exhibiting 
parent-of-origin phenotypes (Barlow et al. 1991; Bartolomei et al. 1991; DeChiara et al. 1991; 
Ferguson-Smith et al. 1991). One of the first identified imprinted loci was the maternally 
expressed insulin-like growth factor type 2 receptor (Igf2r) (Barlow et al. 1991), which is the 
receptor that brings the growth hormone insulin-like growth factor type 2 (Igf2) into cells to be 
degraded. It turned out the “hair-pin tail” overgrowth phenotype was caused by disruption to 
Igf2r (Barlow et al. 1991). Around the same time, Igf2 was also identified as being paternally 
expressed (DeChiara et al. 1991; Ferguson-Smith et al. 1991). Additionally, the long non-coding 
RNA (lncRNA) H19 was identified to map closely to Igf2 and is maternally expressed 
(Bartolomei et al. 1991). Early evidence from Igf2/H19 suggested that imprinted genes could be 
clustered and reciprocally imprinted. Also, the reciprocal imprinting of Igf2 and its receptor Igf2r 
was interesting because it suggested imprinted expression could be a result of different 
developmental goals of the maternal and paternal genome. Many of the early identified imprinted 
genes played a role in embryonic growth. For example, paternally expressed genes were found to 
play a role as promoters of growth, such as Igf2, Dlk1 Peg1, Peg3, and Rasgrf1. Conversely, 
maternally expressed genes, including Igf2r Cdkn1c, Gnas, Grb10, and H19, repressed growth 
(reviewed in (Plasschaert and Bartolomei 2014) 26
	  	  
Following the identification of imprinted loci, the next step was to identify a mechanism. 
The mechanism clearly was not genetic; imprinting still occurred in inbred mouse lines with 
identical alleles. This meant that the mechanism was epigenetic. The epigenetic mark, or 
“imprint”, would need to be 1) stable following fertilization, 2) maintained during development, 
and, 3) erased during germ-line specification. It was soon discovered the primary epigenetic mark 
at these loci was differential DNA methylation established during gametogenesis and maintained 
after fertilization (Bartolomei et al. 1993; Stoger et al. 1993; Tremblay et al. 1995). These 
gametic-derived differentially methylated regions (DMRs) are referred to as imprinting control 
regions (ICRs). Subsequent studies have shown that the majority of known imprinted genes occur 
in large gene clusters that are coordinately regulated.  
The common theme of imprinted clusters is that they contain multiple protein coding 
mRNAs, along with at least one non-coding RNA. In general, the protein coding genes are 
expressed from one parental allele; the non-coding RNAs are expressed from the opposite allele. 
Additionally, clusters that have non-imprinted genes that manage to escape silencing (reviewed in 
(Bartolomei and Ferguson-Smith 2011)). 
These fundamental studies have provided the basic cannon of epigenetic regulation at 
imprinted loci, where DNA methylation is the primary driver of allele-specific expression, with 
allele-specific histone modifications, secondary DMRs and allele-specific chromatin alterations 
as additional layers of epigenetic modification that occur post-fertilization (in response to the 
ICR). For these canonical imprinted genes, once established, the epigenetic marks and 
corresponding imprinted expression are generally maintained throughout development and in all 
somatic tissues (Babak et al. 2015). Prior to genome-wide expression profiling, approximately 
120 genes had been identified and characterized as imprinted genes, most with robust and 
consistent parent-of-origin allele-specific expression in most tissues and developmental stages.  
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1.4.2 Epigenetic regulation at imprinted loci 
Differential DNA methylation was the first identified allele-specific mark that could 
confer imprinted expression (Bartolomei et al. 1993; Stoger et al. 1993; Tremblay et al. 1995). At 
the Igf2r/Airn imprinted cluster, a gametic DMR was identified within the second intron of Igf2r, 
overlapping the promoter of the non-coding RNA Airn (Stoger et al. 1993). The methylation was 
established in the female germline and maintained in the oocyte and embryo. This allowed for the 
silencing of the non-coding RNA Airn on the maternal allele (detailed further in Chapter 3). At 
the same time, the gametic DMR at the Igf2/H19 locus was identified (Bartolomei et al. 1993; 
Tremblay et al. 1995; Tremblay et al. 1997). Similar to Igf2r/Airn, the Igf2/H19 DMR was 
located within the promoter of the H19 non-coding RNA on the silent paternal allele. Because 
these gametic DMRs regulated the expression of the entire imprinted cluster, they were referred 
to as imprinting control regions, or ICRs. Interestingly, ICRs generally act by silencing the non-
coding RNA within the cluster; this is the case for multiple other clusters including Dlk1, Gnas, 
Kcnq1, Snrpn (Shemer et al. 1997; Liu et al. 2000; Takada et al. 2002; Yatsuki et al. 2002; 
Williamson et al. 2006). 
In addition to ICRs, there are also secondary DMRs that are established following 
fertilization and are thought to act to maintain imprinting. Secondary, or somatic, DMRs can 
allow for tissue-specific imprinting, like that seen at Igf2r/Airn in the brain (Hu et al. 1998; 
Yamasaki et al. 2005). It is often the case where deletion of secondary DMRs leads to altered 
expression of nearby genes (Sleutels et al. 2003), whereas deletion of ICRs leads to misregulation 
of the entire imprinted locus (Wutz et al. 1997; Fitzpatrick et al. 2002; Sleutels et al. 2002; 
Sleutels et al. 2003; Williamson et al. 2006). This can be due to the fact that non-coding RNAs 
are often regulated by ICRs and that ICRs can also act to inhibit insulator binding. 
As mentioned, non-coding RNAs, many of which are long non-coding RNAs (lncRNAs), 
can regulate imprinted loci in cis. Non-coding RNAs can function by transcriptionally 
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activity. For example, Airn, which is 108 kb long, is required to inhibit Igf2r, along with Slc22a2 
and Slc22a3; when Airn is truncated, there is loss of imprinting for all three genes (Sleutels et al. 
2003). Importantly, the truncated Airn still retains imprinted expression and DNA methylation is 
not altered. Similar mechanisms are found at the Kcnq1 and Gnas clusters (Kcnq1ot1 and Nespas 
lncRNAs) (Shin et al. 2008; Williamson et al. 2011). In the case of Airn, it functions both by 
transcriptional overlap with Igf2r and in cis by recruiting repressive complexes (Nagano et al. 
2008; Latos et al. 2012). Both Airn and Kcnq1ot1 can form localized RNA clouds, similar to Xist. 
The RNA can directly recruit and interact with repressive complexes (Nagano et al. 2008; Pandey 
et al. 2008; Terranova et al. 2008; Redrup et al. 2009). Interestingly, the recruitment can be 
tissue-specific. Airn acts in cis only in the extra-embryonic lineage (Nagano et al. 2008). 
Together, these data illustrate how ICRs can regulate non-coding RNAs, and in turn, regulate 
imprinted expression across a cluster. 
ICRs can also regulate clusters by differential insulator activity. Imprinting at Igf2/H19 is 
regulated, in part, by insulator activity at its ICR. The maternal ICR is unmethylated, which 
allows for the insulator protein CTCF to bind. CTCF has been shown to insulate genes through 
chromatin looping (Nativio et al. 2009). Binding of CTCF inhibits downstream enhancer 
interaction for Igf2 and allows H19 interaction instead. On the opposite allele, paternal ICR 
methylation inhibits CTCF binding, allowing for activation of Igf2 by interactions with the shared 
enhancer (Schoenherr et al. 2003; Kurukuti et al. 2006). CTCF has also been shown to be 
involved at other imprinting sites, suggesting ICR/insulator interactions are also a common 
mechanism regulating imprinting (Hikichi et al. 2003; Fitzpatrick et al. 2007; Prickett et al. 2013; 
Schultz et al. 2015).   
Differential histone enrichment also influences imprinted expression. For example, 
H3K4me3 and H3K27me3 are often found together at transcriptional start sites. Due to technical 
limitations of early sequencing (not being able to distinguish alleles), this enrichment appears to 
be a bivalent state that is found at some developmental genes (Mikkelsen et al. 2007; Pan et al. 29
	  	  
2007; Zhao et al. 2007); however, this overlapping signal is differential enrichment of the two 
alleles. H3K4me3 is enriched on the active allele and H3K27me3 enriched on the repressed 
allele. In addition, ICRs have distinct histone profiles. The methylated allele lacks H3K4me3 and 
is enriched for K3K9me3, H3K27me3, and H4K20me3 (Gregory et al. 2001; Fournier et al. 2002; 
Delaval et al. 2007). Some lineage-specific imprinted expression is regulated, in part, by 
differential histone modification enrichment (Yamasaki et al. 2005; Carr et al. 2007). 
Additionally, recent sequencing has demonstrated the allele-specific enrichment of H3K27me3 
can be the primary driver of imprinted expression for some imprinted genes during 
preimplantation development (Inoue et al. 2017).  
1.4.3 Genome-wide approaches to identify imprinted genes 
Historically, imprinted genes were identified based on genetic techniques including 
uniparental disomy mapping, parent-of-origin phenotypes, and proximity to previously identified 
imprinted clusters or DMRs. Microarray-based expression analysis provided larger scale 
examination of imprinted loci, but the technology came with technical limitations (Lo et al. 2003; 
Nikaido et al. 2003; Pant et al. 2006; Bjornsson et al. 2008). The most important limitations 
include the biased nature of microarrays and the risk of cross hybridization of the two alleles.  
With the increase in accessibility to sequencing technologies, researches began using allele-
specific sequencing techniques to identify and characterize imprinted phenomena. The 
experimental design for allele-specific sequencing is simple; F1 hybrid tissue of interest is 
sequenced, providing unbiased means to examine imprinting across the entire genome. F1 hybrids 
have polymorphisms between the parental strains, allowing maternal and paternal alleles to be 
distinguished. Both the forward and reciprocal crosses are usually performed in order to 
differentiate between imprinted expression and strain-specific expression.  
The first allele-specific RNA sequencing to study imprinted expression was performed in 
2008 (Babak et al. 2008; Wang et al. 2008). At this point, there were approximately 120 
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imprinted genes ranged from 100 to over 2,000, with most estimating that 1% of the mouse 
genome was imprinted (Nikaido et al. 2003; Luedi et al. 2005). Following the initial sequencing 
efforts, the number of imprinted genes still hovered around 120. Both groups only added a few 
novel imprinted loci to the count (Babak et al. 2008; Wang et al. 2008). This suggested that most 
of the imprinted loci had already been identified and any new imprinted genes would be tissue-
specific, expressed at low levels, or would have a parent-of-origin bias, rather than full imprinted 
expression. 
Two years later, two papers were published claiming that imprinted expression levels 
were much higher than previously reported. The group examined allele-specific expression in 
E15 brains and in two adult brain regions (medial prefrontal cortex and preoptic area). They 
found more than 1,300 imprinted loci, which would have represented a 10-fold increase in the 
total number of imprinted genes in the mouse genome (Gregg et al. 2010a; Gregg et al. 2010b). It 
was suggested that improved sequencing techniques, including higher detection sensitivity, lead 
to the increase in identification of novel imprinted genes; however, reanalysis of the data found 
that almost all of the novel imprinted genes were false positives. In fact, only 11 genes were 
potentially imprinted following reanalysis. Of those 11, only 6 could be validated and only one 
had strong mono-allelic expression (DeVeale et al. 2012). 
Following the re-evaluation of the 2010 papers, there has been a push for more stringent 
bioinformatics. Groups have continued to characterize imprinted genes and are still identifying 
novel imprinting phenomenon, and the number of imprinted genes in the mouse genome now 
hovers at around 300 genes. Importantly, many of the novel imprinted genes that have been 
identified are tissue-specific or transient (DeVeale et al. 2012; Goncalves et al. 2012; Babak et al. 
2015; Baran et al. 2015; Bonthuis et al. 2015; Crowley et al. 2015; Pinter et al. 2015; 
Andergassen et al. 2017; Inoue et al. 2017). This highlights the need for continued analysis of 
different stages and tissues to fully understand the degree of imprinted expression. Additionally, 
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gene expression (Bonthuis et al. 2015; Crowley et al. 2015; Inoue et al. 2017), so future work will 
involve defining the mechanisms for non-canonical imprinted expression (Chapter 4, Chapter5). 
1.5 History of work presented 
 The overall goal of this thesis is to better understand genomic imprinting and epigenetic 
phenomenon during the early stages of mammalian development. This covers work on three main 
projects focusing on characterizing the expression and epigenetic regulation of imprinted loci 
during mouse preimplantation and gastrulation development.  
 Chapter 2 investigates whether the transcription factor Sox4 plays a role in maintaining 
imprinted expression during embryo development. We used a dsRNA knockdown approach to 
characterize the role of Sox4 in preimplantation development and found loss of imprinted 
expression in the absence of Sox4. To follow up on these results, we examined Sox4 in a 
knockout mouse model. Surprisingly, we were not able to recapitulate the knockdown phenotype. 
This indicates that there are likely differences in sensitivity to the loss of Sox4 in an in vitro 
versus in vivo developmental context. These data highlight the importance of different 
environmental contexts during development, which is especially important from in vitro 
reprogramming efforts. 
 In Chapter 3, we characterize the imprinted expression and epigenetic changes that occur 
at the Igf2r/Airn locus during mouse gastrulation. The Igf2r/Airn cluster is a known imprinted 
cluster that was identified more than 20 years ago. Still, the expression dynamics in vivo had not 
been carefully studied. Here we show the lineage- and temporal-specific regulation of both DNA 
methylation and histone modifications at the Igf2r/Airn locus. This correlates with the differential 
establishment of imprinted expression during gastrulation. This works demonstrates the tissue-
specific imprinted expression at this locus during gastrulation. It illustrates the fact that known 
imprinted clusters can have dynamic expression and epigenetic marks (Marcho et al. 2015). 
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 In order to have a global perspective of the imprinted landscape across gastrulation, 
Chapter 4 presents allele-specific RNA-sequencing (RNA-seq), which we used to identify and 
characterize imprinted expression across the entire genome. We coupled the expression data with 
whole genome bisulfite sequencing (WGBS) to begin to understand the epigenetic mechanism 
involved in the imprinted expression. By examining known imprinted genes, as well as all 
expressed genes, we have a compiled a list of genes with imprinted expression during 
development, including additional novel imprinted genes. This work adds to the growing list of 
imprinted genes. Additionally, it helps to define canonical versus non-canonical imprinted genes, 
specifically DMR-independent imprinting (Marcho et al. in preparation).  
Chapter 6 will discuss the impacts of this work, as well as the future for this research. 
This includes defining the spectrum of imprinted gene expression and how it relates to the 
evolution of genomic imprinting, reprogramming, and epigenetics. 
 The appendix contains data for discussion, including preliminary data to be pursued in 
the future by the lab. This includes gastrulation embryo culture experiments (Section A.2) and 
cis-regulatory, strain-specific expression during gastrulation (Section A.3). I will discuss 
supplemental information pertaining to protocols I modified during my thesis work, including the 
troubleshooting of the WGBS libraries (Section B). The appendix also contains supplemental 
tables and reprints of work I contributed to during my graduate career. 
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Figure 1.1 Schematic outlining mouse preimplantation development. Upon fertilization, the 
second polar body is extruded and the two haploid genomes begin the process of reprograming 
and development. By the 4-cell stage, the embryo already has heterogenetic in expression and 
epigenetic marks that will direct lineage decisions later. Compaction of the cells then occurs. This 
event leads to the formation of cells with distinct polarity and localization. At the morula stage, 
cells begin to take on an inner cell mass (ICM) or trophectoderm (TE) cell fate. The next cell fate 
decision occurs in the blastocyst, when the ICM differentiates into epiblast (EPI) or primitive 
endoderm (PrE) and those cells sort.  
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Figure 1.2. Active demethylation in the zygote. Distinct demethylation dynamics occur in the 
maternal (pink) and paternal (blue) pronuclei prior to fusion. At fertilization, the maternal haploid 
genome has approximately 40% methylation compared to nearly 90% methylation in the paternal 
haploid genome. Upon fertilization and continuing through pronuclear stage PN2, the paternal 
genome undergoes Tet3-dependent demethylation. PGC7, which preferentially binds to 
H3K9me2-rich chromatin, protects the maternal genome from Tet3 activity during pronuclear 
stages. By PN5 stage, the bulk of paternal 5mC is gone and little change has occurred to maternal 
methylation. PPN- paternal pronucleus, MPN- maternal pronucleus. 
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Figure 1.3. Global DNA methylation dynamics from fertilization to gastrulation. The three 
main phases of methylation change are illustrated. During zygotic stages the paternal genome 
undergoes active demethylation (blue line). This active demethylation is evident by sharply 
increased levels of oxidative products  (5mC to 5hmC, 5fC, and 5caC) in the paternal pronucleus. 
Passive replication dependent demethylation (predominantly in the maternal pronucleus) occurs 
though exclusion of DNMTs from the nucleus during early preimplantation (red line). Lowest 
levels of methylation are reached between the morula to blastocyst stage, when methylation levels 
begin to rise. During blastocyst formation and gastrulation, the genome becomes re-methylated to 
levels consistent with somatic cells (black line).  
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Figure 1.4. Differential histone enrichment during preimplantation development. After 
fertilization the parental pronuclei are differentially enriched with many distinct histone 
modifications (left side, list of post-translational modifications).  Little data is available regarding 
the timing and mechanisms resulting after pronuclear fusion that result in largely homogenous 
post-translational modifications during cleavage stages (indicated by question mark).  By the time 
ICM and TE begin to differentiate, these cell lineages have acquired distinct epigenetic signatures 
and gene expression patterns (right side). 
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CHAPTER 2 
 
THE ROLE OF SOX4 IN REGULATING IMPRINTED EXPRESSION DURING 
DEVELOPMENT 
 
2.1 Abstract 
Now that we have annotated the mouse and human genomes, one of the current goals in 
genetics is to understand the role and function of all the genes. This is especially interesting 
during the earliest states of development.  Preimplantation development is when many 
pregnancies fail. Additionally, many pregnancies begin in a dish; assisted reproduction 
technologies allow for fertilization and development of preimplantation embryos to aid people 
dealing with infertility. To understand the functions of expressed genes during preimplantation 
development, the lab has undertaken a large reverse genetic RNAi screen. One result from the 
initial screen was that when Sox4 is knocked down, imprinted expression at Glt2 (Meg3), 
Kcnq1ot1 (Lit1), and Mest (Peg1) was lost. To validate loss of imprinting and to characterize the 
epigenetic mechanisms responsible for the biallelic expression, we assessed imprinted expression 
in a Sox4 knockout mouse model. Surprisingly, we found normal imprinted expression in Sox4 
knockout mice. These results suggest the different environments of development (in vitro 
compared to in vivo) lead to distinct phenotypes. 
2.2 Introduction 
One of the greatest genetic undertakings has been sequencing entire genomes (Lander et 
al. 2001; Mouse Genome Sequencing et al. 2002). When the first genomes were being sequenced, 
both the cost and time required were challenges. Now it is quicker, easier, and cheaper, but there 
still are difficulties. Once an organism is sequenced, the next challenge is annotating the genome. 
To date, there is still debate on the total number of genes and functional units in the human 
genome, which highlights the difficulties with annotation. Still, the next question following 
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annotation of a genome is simple: How does the genome function? Coordinated efforts have been 
established to address this question. The goal is to understand the function of all genes, as well as 
the structure and regulation of the genome. These efforts include the Encyclopedia of DNA 
Elements (ENCODE), International HapMap Project, Roadmap Epigenomics Mapping, 
International Mouse Phenotyping Consortium (IMPC), and the Knockout Mouse Project (KOMP) 
(Daly et al. 2001; Sachidanandam et al. 2001; Austin et al. 2004; Bernstein et al. 2010; 
Consortium 2012). 
One of the ongoing goals of the lab is to aid in these efforts by characterizing the function 
of genes during early mouse development. This has included preimplantation screens (Maserati et 
al. 2011; Zhang et al. 2013a; Zhang et al. 2013b; Maserati et al. 2014; Cui et al. 2016a; Cui et al. 
2016b), as well as the current work for the Knock-Out Mouse Project (KOMP). One interesting 
candidate gene that came out of our lab’s preimplantation screen was Sox4. Sox4 is a member of 
the Sry-like HMG box family of transcription factors that is known to play a critical role in 
development (van de Wetering et al. 1993; Wotton et al. 1995). For example, complete loss of 
Sox4 in developing mice is embryonic lethal by E14.5 (Schilham et al. 1996; Ya et al. 1998). This 
lethality is due to improper formation of endocardial cushions and ridges, leading to truncus 
arteriosis (common trunk). Additionally, Sox4 is involved in hematopoiesis, pancreas formation, 
nervous system development, as well as tumorigenesis (Schilham et al. 1997; Graham et al. 1999; 
Cheung et al. 2000; Lund et al. 2002; Suzuki et al. 2002; Wilson et al. 2005). 
At the same time as our screen, Sox4 was found to directly regulates histone 
methyltransferase Ezh2 (Enhancer of Zeste homolog 2), the catalytic subunit of the Polycomb 
(PcG) repressive complex 2 (PRC2) (Tiwari et al. 2013). Ezh2 functions by adding methyl groups 
to histone 2 lysine 27 (H3K27me) and is responsible for gene silencing (Cao et al. 2002). 
Importantly, Ezh2/PRC2 is involved in silencing imprinted alleles (Mager et al. 2003; Lewis et al. 
2004; Umlauf et al. 2004; Lindroth et al. 2008). Together with the knockout mouse data, this 
makes Sox4 both a developmentally and epigenetically interesting candidate.  39
	  	  
When Sox4 was knocked down in preimplantation embryos, we found loss of imprinting 
at three loci. Surprising, we could not recapitulate these result in a knockout embryo system. 
These data suggest that Sox4 can lead to loss of imprinting, potentially via regulation of 
Ezh2/PRC2, in vitro, but not in vivo. This is likely due to the differences in developmental 
environments, which highlights the importance of understanding in vitro versus in vivo 
phenotypes.  
2.3 Materials and Methods 
2.3.1 Tissues 
The University of Massachusetts Amherst Institutional Animal Care and Use Committee 
approved all procedures. Embryos were derived from B6D2F1/J (JAX100006) and PWD/PhJ 
(JAX004660) following superovulation. 8-10 week old females received intra-peritoneal 
injections of pregnant mare serum gonadotrophin (PMSG; 5IU/female, Sigma G4877), followed 
48 hours by injection of human chorionic gonadotrophin (hCG; 5IU/female, Sigma CG10). Mice 
were then mated with PWD/PhJ studs. Zygotes (E0.5) were collected into M2 media with phenol 
red (Millipore MR-015-D). The conditional Sox4fl/+ was provided by the Lefebre lab (Penzo-
Mendez et al. 2007). B6.C-Tg(CMV-cre)1Cgn/J (CMV-cre) mice were supplied from the Jackson 
Laborabory (JAX006054). 
2.3.2 Microinjections of B6D2F1xPWD/PhJ embryos and in vitro culture 
Microinjections were performed using a Piezo-driven injector (PrimeTech) and 
Transferman NK2 microinjector (Eppedorf). Injection and holding micropipettes were pulled 
from borosilicate capillary tubes using a micropipette puller (Sutter Instrument Co. Model P-95, 
settings: 712, 60, 70, 190). Individual embryos were injected with approximately 5pL double-
stranded RNA (dsRNA). Following injections, embryos were held in M2 to recover and then 
transferred to KSOM +AA with D-glucose (Millipore MR-106-D) for culture. 
Injected 1-cell embryos were cultures in 35mm culture dishes (Falcon 353001) in 50uL 
drops of KSOM under tissue-culture grade mineral oil (Millipore ES-005-C). Incubation was 40
	  	  
carried out at 37°C in 5% CO2/5% 02 balance in N2. Embryos remained in culture until the 
blastocyst stage. 
2.3.3 Double-stranded RNA (dsRNA) and control mRNA synthesis 
T7-RNA polymerase mediated double-stranded RNA (dsRNA) synthesis (MegaScript 
T7, Invitrogen AM1333) was performed using genomic DNA and gene-specific primers 
containing T7 binding sequences. Primers used are provided in Appendix C. 
2.3.4 Imprinting expression analysis 
Total RNA was isolated using the Roche High Pure RNA Isolation Kit (Roche 
11828665001). cDNA synthesis was performed using Bio-Rad iScript cDNA synthesis kit (170-
8891). RT-PCR was performed on E0.5 embryo equivalents using imprinted gene specific 
primers in Appendix C. TaqMan assays used were Ezh2 (Mn00468464_m1) and Sox4 
(Mn00486317_s1). 
2.4 Results 
2.4.1 Double-stranded RNA knockdown of Sox4 leads to loss of imprinting in 
preimplantation embryos 
 In order to characterize the function of genes during preimplantation development, the 
lab conducted a RNA interference (RNAi) screen using double-stranded RNA (dsRNA) for gene-
specific knockdown. To start, pooled dsRNAs were injected into zygotes and were allowed to 
develop in culture to the blastocyst stage (Figure 2.1A). If embryos were able to develop 
normally, they were assessed for general morphology, proper lineage specification, appropriate 
imprinted expression, and the ability to hatch from the zona pellucida and outgrow (Figure 2.1B). 
If the pooled dsRNA injected embryos failed to develop or failed any of the blastocyst-staged 
phenotypying, the genes within that pool were further assessed individually. 
 One candidate gene from the pooled injection screen was Sox4. When Sox4 was knocked 
down, the normally repressed allele of known imprinted genes become reactivated; there was loss 
of imprinting. Specifically, reduction of Sox4 leads to the loss of imprinted expression of Glt2 41
	  	  
(Meg3), Kcnq1ot1 (Lit1), and Mest (Peg1) compared to dsGFP-injected control (Figure 2.2). In 
all cases, the normally repressed allele becomes reactivated. Reactivation of the maternal Lit1 and 
Peg1 are weak, but detectable by restriction fragment length polymorphism (RFLP) assay. Meg3 
has a more robust phenotype and is biallelicly expressed following Sox4 knockdown. Importantly, 
overall development and gross morphology of Sox4 knockdown embryos was not effected. This is 
not surprising; Sox4 is not embryonic lethal until E14.5 (Schilham et al. 1996).  
 In order to better understand the dynamics of Sox4 during preimplantation development, 
we assessed the expression in wild-type embryos. Both RT-PCR and qPCR show that Sox4 
expression is primarily restricted to the 2-cell stage during preimplantation development (Figure 
2.3A,B). The more sensitive qPCR assay is able to detect low levels of Sox4 in the oocyte, as well 
as the 1-, 4-, and 8-cell embryo (Figure 2.3B); however, Sox4 was not detected at any level at the 
morula or blastocyst stage (Figure 2.3A,B). Importantly, in adult spleen and thymus, we see 
expected expression of Sox4. This suggests that during preimplantation development, Sox4 is 
largely restricted to the maternal-to-zygotic transition (MZT). During this window, zygotic 
genome activation occurs. The burst of Sox4 expression at this time might aid in the activation of 
Ezh2 (Figure 2.5A)(Tiwari et al. 2013). In turn, Ezh2/PRC2 can act at imprinting loci during 
epigenetic remodeling, protecting the sites from reprogramming, maintaining allele-specific 
marks (see Chapter 1, Section 1.3.1).  Our hypothesis was that in the absence of Sox4, Ezh2 levels 
are decreased, leading to loss of repression at specific imprinted loci (Figure 2.5B).  
 To test this hypothesis, we first measured the efficacy of the Sox4 knockdown. We 
injected dsSox4 and dsGfp into zygotes and then collected embryos at the 2-cell stage when Sox4 
is endogenously expressed. We found robust reduction in Sox4 transcripts at the 2-cell stage 
compared to injection control (Figure 2.4A).  Next, we examined Ezh2 expression in response to 
Sox4 knockdown. Compared injected controls, we found a slight decrease in the overall 
expression of Ezh2 at the 2-cell stage (Figure 2.4B). The small but appreciable reduction in Ezh2 
expression might be a consequence of incomplete knockdown at this stage (Figure 2.4A). 42
	  	  
Although minor, this indicates Sox4 can regulate Ezh2 during preimplantation development and 
might be responsible for the reactivation of the repressed imprinted allele at imprinted loci 
(Figure 2.2).  
 Taken together, these preimplantation data suggest Sox4 can regulate Ezh2, which in turn 
regulates imprinted repression by H3K27me3. To further characterize the role of Sox4 in 
imprinting and how it might interact with Ezh2, we next examined a knockout mouse model. 
2.4.2 Sox4 knockout does not recapitulate the preimplantation knockdown phenotype 
 To further assess the loss of imprinting phenotype identified during preimplantation 
development, we used a Sox4 knockout mouse model. We received Sox4 conditional mice from 
the Lefebre lab at the Cleveland Clinic. These mice have loxP sites in the 5’ and 3’ untranslated 
regions of the endogenous Sox4. Cre-mediated recombination leads to removal of the entire 
coding region, resulting in a Sox4 null allele (Penzo-Mendez et al. 2007). In order to produce 
mice with ubiquitous deletion of Sox4, we used a CMV-cre line for recombination (Schwenk et 
al. 1995). Once we generated Sox4+/- mice, we crossed heterozygous mice back into either a 
C57Bl/6J or PWD/PhJ background. This allowed us to have the necessary strain alleles required 
for imprinted analysis. B6- Sox4+/- females were mated with PWD- Sox4+/- studs to produce  
Sox4-/--F1 embryos.  
 We collected Sox4-/--F1 embryos at E12.5 to identify whether loss of Sox4 in vivo lead to 
changes in imprinted expression. Sox4 null mutation leads to embryonic lethality at 
approximately E14.5 due to heart defects (Schilham et al. 1996; Ya et al. 1998). Neither group 
cites gross morphological defects in Sox4 null embryos. In our background, we find normal 
overall external morphology of Sox4+/+ and Sox4+/- embryos (Figure 2.6A,B). Sox4-/- embryos have 
variable gross morphology (Figure 2.6C,C’). In the more severe cases, Sox4-/- has more signs of 
hemorrhaging, as well hindbrain malformation (Figure 2.6C’). Even still, embryo genotype was 
not obvious by morphological examination alone. E12.5 Sox4-/- -F1 embryos and their 
heterozygous littermates were used for imprinting analysis. 43
	  	  
 Before expression analysis could be performed, we first needed to insure the correct 
parental alleles were present at imprinting loci. We genotyped embryos from two litters at Meg3, 
Lit1, and Peg1, as well as Airn. We identified 2 embryos with useful alleles at Lit1 and 6 embryos 
with useful alleles at Meg3 (Figure 2.7A). The rest of the embryos from the two litters only had 
C57Bl/6J alleles were not useful for imprinting analysis.  
 We performed RT-PCR for Lit1 and Meg3 on Sox4+/- and Sox4-/- embryonic tissue where 
both B6 and PWD alleles were present (Figure 2.7A,B). For Lit1, we had 2 useful embryos (1 
Sox4+/- and 1 Sox4-/-). In both genetic conditions, we found normal, paternal expression of Lit1. 
We also had 6 useful embryos for Meg3 (2 Sox4+/- and 4 Sox4-/-). In all cases, we also found 
normal, maternal expression of Meg3 (Figure 2.7B). These results do not match the 
preimplantation knockdown phenotypes, where we saw loss of imprinting. This is even true for 
Meg3, where we saw biallelic expression after preimplantation knockdown.  
2.5 Discussion 
 Even though Sox4 knockdown leads to loss of imprinting in preimplantation embryos, we 
were not able to recapitulate the phenotype in a knockout model. It is still reasonable to believe 
that Sox4 regulates imprinting via its activation of Ezh2. Not only has it been shown that Sox4 
can directly regulate Ezh2, but it has also been demonstrated that Sox4 is often misexpressed in 
cancer cells with aberrant epigenetic profiles (Tiwari et al. 2013). So, why were we not able to 
identify loss of imprinting following total loss of Sox4 in vivo?  
 One possibility is that the act of injection and in vitro culture, combined with the 
knockdown of Sox4, made the preimplantation embryos more susceptible to loss of imprinting. It 
has been well documented that in vitro culture conditions can lead to variable loss of imprinted 
expression. For example, specific culture media can lead to biallelic expression at some loci, 
while leaving other imprinting loci unaltered (Doherty et al. 2000; Market-Velker et al. 2010; 
Market Velker et al. 2012; Huntriss et al. 2013). These affects can also be tissue-specific (Mann 
et al. 2004). It is important to note that our microinjection and in vitro culture system alone does 44
	  	  
not lead to loss of imprinting, as is evident by the dsGFP controls. In the same say that certain 
culture media can lead to loss of imprinting in vitro, so can knockdown of Sox4.  
 It is also a possibility that Sox4 knockout does lead to loss of imprinting during 
preimplantation development, but that this loss is corrected during reprograming of the 
epigenome. We did not examine preimplantation knockout embryos due to technical limitation at 
the time. In vivo development might be more resilient and, in turn, correct for the loss of 
imprinting. The loss of imprinting might also be tissue-specific (Mann et al. 2004); it is 
potentially restricted to the extra-embryonic tissue or a subset of embryonic tissues.  
 Taken together, these data suggest that Sox4 can lead to loss of imprinting under certain 
conditions. It highlights the differences between in vivo and in vitro development. These 
distinctions are especially important for in vitro fertilization (IVF) techniques and other artificial 
reproduction technologies, where aberrant expression can lead to clinical outcomes. It is also a 
reminder of the importance of doing in vivo developmental biology experiments that complement 
in vitro work.   
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Figure 2.1. Preimplantation RNAi screen overview. Double-stranded RNA specific to genes of 
interest is injected into 1-cell zygotes. These embryos are allowed to development in vitro to the 
blastocyst stage. During development, the embryos are assessed for developmental potential, i.e. 
can they form a morphologically normal blastocyst. Knockdown embryos that make it to the 
blastocyst stage are assessed for multiple phenotypic outputs, including appropriate lineage 
specification, imprinted expression, and embryonic stem (ES) cell derivation.  
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Figure 2.2. Preimplantation RNAi screen results indicate loss of imprinting following 
dsSox4 knockdown. Restriction fragment length polymorphism (RFLP) assays for the imprinted 
genes Gtl2 (Meg3), Kcnq1ot1 (Lit1), and Mest (Peg1). B6D2F1 maternal and PWD/PhJ paternal 
parental controls are used to distinguish allele-specific expression. Double-stranded Gfp (dsGfp) 
serves as an injection control. Loss of imprinting is evident in dsSox4 blastocysts (compare to 
dsGfp). + and – restriction enzyme (RE) is indicated above each lane. NTC- no template control. 
Data provided courtesy of J. Mager.  
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Figure 2.3. Developmental panel for Sox4 expression in wild-type embryos. A). RT-PCR for 
Sox4 expression in preimplantation embryos and in adult spleen and thymus. ActB serves as a 
loading control. B). Relative expression of Sox4 compared to Gapdh by qPCR in preimplantation 
embryos. ICM- inner cell mass.  
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Figure 2.4. Expression of Sox4 and Ezh2 in 2-cell embryos following dsSox4 knockdown. A). 
Relative expression of Sox4 in pooled 2-cell embryos following knockdown compared to 
injection control. B). Relative expression of Ezh2 in pooled 2-cell embryos following knockdown 
compared to injection control. 
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Figure 2.5. Hypothesis for Sox4 regulating imprinted expression via Ezh2/PRC2. A). In 
wild-type tissue, Sox4 directly regulates the transcription of Ezh2. This, in turn, regulates 
Polycomb Repressive Complex 2 (PRC2) mediated H3K27me3 silencing on imprinted alleles. 
B). When levels of Sox4 are reduced, Ezh2 levels also decrease. This leads to disruption of PRC2 
mediated silencing. The phenotypic output is reactivation of the normally repressed allele; the 
target imprinted gene is now biallelic. 
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Figure 2.6. Gross anatomy of embryos from C57Bl/6J- Sox4+/- x Sox4+/--PWD/PhJ cross. A). 
Sox4+/+ -F1 Wild-type littermate control. B). Sox4+/--F1 heterozygous  littermate control. C,C’). 
Sox4-/- -F1 mutant embryos. Note the variation in morphology between the mutant embryos.  
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Figure 2.7. Imprinting analysis of E12.5 embryos reveals no loss of imprinting in Sox4-/- 
mice. A). Restiction fragment length polymorphis (RFLP) allele-typing of genomic DNA at Lit1 
and Meg3. Red boxes indicate embryos that have both C57Bl/6J and PWD/PhJ alleles at the loci 
of interest. B). RT-PCR followed by RFLP used to identify allele-specific expression at Lit1 and 
Meg3. C57Bl/6J is the maternal allele and PWD/PhJ is the paternal allele. In all embryos, we see 
normal imprinted expression. + and – restriction enzyme (RE) is indicated above each lane.  
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CHAPTER 3 
 
TISSUE-SPECIFIC IMPRINTING OF IGF2R/AIRN DURING GASTRULATION 
3.1 Abstract 
In the previous chapter, we used known imprinted genes as a readout to assess the 
epigenetic landscape of the preimplantation embryos. In order to use imprinted genes in this 
fashion, it is required that there be detailed expression data for those genes. In the mouse, many 
known imprinted genes occur in clusters across the genome, which are epigenetically regulated 
together. One imprinted cluster on chromosome 17 includes the maternally expressed Igf2r, 
Slc22a2, Slc22a3 genes and the paternally expressed long non-coding RNA (lncRNA) Airn. 
Although it is known that Igf2r and Airn are reciprocally imprinted, the timing of imprinted 
expression and accompanying epigenetic changes have not been well characterized in vivo.  
Here we show lineage- and temporal-specific regulation of DNA methylation and histone 
modifications at the Igf2r/Airn locus correlating with differential establishment of imprinted 
expression during gastrulation. Our results show that Igf2r is expressed from both alleles in the 
E6.5 epiblast. After gastrulation commences, the locus becomes imprinted in the embryonic 
lineage, with the lncRNA Airn expressed from the paternal allele and Igf2r restricted to maternal 
allele expression.  
We also document for the first time allele-specific spreading of DNA methylation during 
gastrulation concurrent with establishment of imprinted expression of Igf2r. We also identify 
differentially enriched allele-specific histone modifications in extra-embryonic and embryonic 
tissues.  Importantly, we show that imprinted expression does not change in extra-embryonic cells 
even though maternal DMR2 methylation spreading does occur, suggesting distinct mechanisms 
at play in embryonic and extra-embryonic lineages. These results indicate that similar to 
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preimplantation development, gastrulation represents a window of dynamic lineage-specific 
epigenetic regulation in vivo.  
3.2 Introduction 
As introduced in Chapter 1, genomic imprinting is an epigenetic phenomenon that results 
in mono-allelic gene expression in a parent of origin manner. Many well characterized imprinted 
occur in clusters containing multiple imprinted transcripts (Bartolomei 2009; Barlow 2011). 
Expression of these genes is thought to be established in cis by allele-specific DNA methylation 
established at imprinting control regions (ICRs) in the gametes; the differential methylation 
arrives in the zygote as maternal and paternal specific information. A regulatory theme has 
emerged at many imprinted clusters in which a single long non-coding RNA (lncRNA) is thought 
to repressively regulate genes in cis through direct transcriptional blocking and/or recruitment of 
repressive chromatin remodeling complexes such as G9a and PRC2, resulting in differential 
allele-specific histone modifications (Lindroth et al. 2008; Nagano et al. 2008). Together, these 
regulatory features make up the canonical mechanisms driving imprinted expression. 
One imprinted cluster on mouse chromosome 17 includes the maternally expressed Igf2r, 
Slc22a2, Slc22a3 mRNAs and the paternally expressed lncRNA Airn, as well as several non-
imprinted genes (Slc22a1, Mas, and Plg). The Airn promoter lies in the second intron of Igf2r and 
Airn transcription occurs from the opposite strand overlapping Igf2r exons 1 and 2.  Paternal Airn 
expression may participate in imprinting of the maternally expressed Igf2r by blocking access of 
the transcriptional machinery to the Igf2r start site (Latos et al. 2012). Paternal allele silencing of 
the other maternally expressed genes in the cluster only occurs in extra-embryonic lineages as a 
result of Airn recruitment of repressive complexes such as G9a to their promoters (Nagano et al. 
2008).   
Biallelic expression of Igf2r is observed in ES cells and only becomes imprinted upon 
differentiation in vitro (Nagano et al. 2008). Although the expression of Igf2r and Airn has been 
documented in preimplantation and late stage embryos (Szabo and Mann 1995; Lerchner and 54
	  	  
Barlow 1997; Yamasaki et al. 2005), lineage-specific expression dynamics have not been 
observed during gastrulation.  Recent studies have focused on mechanisms in ES cell models 
(Nagano et al. 2008; Latos et al. 2009; Latos et al. 2012), but the precise timing and mechanisms 
responsible for imprinting at Igf2r/Airn in vivo remains unknown. Here we characterize tissue-
specific dynamics of expression and epigenetic modifications that occur at Igf2r/Airn during 
normal gastrulation. We show that significant epigenetic regulation occurs at imprinted loci 
during epiblast differentiation in vivo.  
3.3 Materials and Methods 
3.3.1 Tissues  
The University of Massachusetts Amherst Institutional Animal Care and Use Committee 
approved all procedures. Embryos were derived from C57BL/6J (JAX 000664) and PWD/PhJ 
(JAX004660). Reciprocal F1 embryos were derived from female C75BL6/J Chr17PWD/PhJ/ForeJ (JAX 
005267) and C57BL/6J (JAX 000664) males. Embryos were microdissected for DNA and mRNA 
extraction. MII oocytes were collect from superovulated B6D2F1 females to confirm ICR 
methylation. 
3.3.2 Imprinted expression analysis 
Total RNA was isolated using the Roche High Pure RNA Isolation Kit (Roche 
11828665001). cDNA synthesis was performed using Bio-Rad iScript cDNA synthesis kit (170-
8891). Primers for allele-specific expression and full-length Airn RT-PCR are shown in Table 
C.1.  Airn restriction fragment length polymorphism (RFLP) was performed with AvaI (NEB 
R01525).  Single strand confirmation polymorphism (SSCP) was performed on Igf2r PCR 
products with MDE polyacrylamide gel electrophoresis (Lonza 50620). PCR products were 
visualized by ethidium bromide illumination and imaging. 
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3.3.3 Bisulfite PCR sequencing  
Bisulfite sequencing was performed using DNA extracted by phenol/chloroform followed 
by ethanol precipitation. Purified DNA was denatured using 3N freshly prepared 3N NaOH to a 
final concentration of 0.3N for 30 minutes at 42°C. Following denaturation, DNA was then 
treated with freshly prepared, house-made bisulfite conversion solution (340 uL 3.6M sodium 
bisulfite, 20 uL hydroquinone, 70 uL denatured DNA/water) for 4 hours at 55°C under a layer of 
mineral oil. Following conversion, samples were cleaned using the GeneClean Turbo kit (MP Bio 
111102-400). Samples were desulfinated with 3N NaOH to a final concentration of 0.3N for 15 
minutes at 37°C. The samples were precipitated again to a final volume of 10 uL in TE. Bisulfite 
converted samples were amplified using bisulfite-specific primers provided in Table C.1. PCR 
products were cloned into DHα cells using TOPO TA cloning (Invitrogen 450030). Cells were 
plated on ampicillin selection plates and incubated overnight at 37°C. Individual colonies were 
selected and PCR amplified. PCR products were sent for sequencing to Eton Biosciences 
(Charlestown, MA). Base-calling and sequencing alignment was performed using Codon Code 
Aligner Software (Centerville, MA). Conversion efficiency was calculated by examining non-
CpG cytosine conversion rates.  
3.3.4 Chromatin immunoprecipitation (ChIP) 
E8.5 C75BL/6J x PWD/PhJ-F1 embryos were dissected and embryonic and extra-
embryonic tissues were separated and immediately processed using instructions in either ChIP-IT 
High Sensitivity kit (Active Motif 53040) or Zymo-Spin ChIP kit (Zymo D5210). Samples were 
kept on ice and either sonicated twice for 20 seconds with the Heat Systems Sonicator/Ultra 
Processor (output 3) or sonicated for 30 seconds on/20 seconds off for 3 minutes using a cup horn 
adaptor for the QSonica A500 . After sonication, 1% of each sample was removed for input 
control. Immunoprecipitation was carried out using Active Motif Protein G agarose beads or 
magnetic Protein A Dynabeads (10001D) and either anti-CTCF (Santa Cruz sc-28198), anti-
H3K4me3 (Abcam ab8580), anti-H3K9me3 (Abcam ab8898), or H3K27me3 (Millipore 07-449) 56
	  	  
along with normal rabbit IgG. After antibody incubation, beads were washed and DNA was 
collected using manufacturer’s protocol. ChIP-PCR primers found in Table C.1. 
3.3.5 Immunofluorescence 
Decidua containing embryos were collected in cold PBS and were prepared for histology 
by fixation in 4% paraformaldyhe (PFA) for 1 hour at room temperature. Embryo within decidua 
were dehydrated through a series of ethanol washes for 15 minutes in 70%, 80%, 90% ethanol 
diluted in phosphate buffered saline (PBS), followed by three washes of 100% ethanol. Samples 
were infiltrated for 90 minutes in xylene at room temperature, then in 50% xylene/ 50% paraplast 
for 1 hour. They were then transferred to 100% paraplast (Fisher 23-021-400) and incubated 
overnight at 65°C. The samples were then embedded in plastic molds (Ted Pella 27147-2, Fisher 
B33978156) and cooled to room temperature.  Using a microtome, 7 micrometer sections were 
cut and floated in water, collected on Superfrost Plus slides (Fisher 12-550-15) and dried 
overnight at 42°C.  Sections were deparafinized with three 5-minutes washes in xylene and 
rehydrated with three 5-minute washed in 100% ethanol, followed by 2-minute washes in 90%, 
80%, and 70% ethanol. Antigen retrieval was performed by boiling for 4 minutes in 0.01M Tris 
Base pH10. Once the slides cooled to room temperature, they were washed twice in phosphate 
buffered saline with 0.01% Tween-20 (PBT) for 2-minutes blocked with 0.5% milk in PBT for 
two hours at room temperature in a humidified chamber. Primary antibody was applied in 0.05% 
milk/PBT overnight at 4°C in a humid chamber. Three 15-minute PBT washes preceded a 1-hour 
secondary antibody treatment in 0.05% milk/PBT in a humid chamber at room temperature. 
Slides were washed in in PBS three times for 15 minutes. Nuclei were countered stained with 
Dapi (Roche or Molecular Probes) in PBS (1:10,000) for 2 minutes and then rinsed with PBS. 
Slides were sealed and coverslipped with Prolong Gold (Invitrogen P36934). 
Preimplantation immunofluorescence was performed on blastocysts collected from 
superovulated B6D2F1 females. Embryos were flushed from the uteri with PBS and fixed in 4% 
PFA/PBS for 30 minutes at room temperature. Samples were washed in PBS/0.1% Triton-X100 3 57
	  	  
times, then permeabilized with PBS/0.5% Triton-X100 for 15 minutes at room temperature, and 
then washed in PBS/0.1% Triton-X100 3 times. Blocking was carried out for 1 hour at room 
temperature using PBS/10% FBS with 0.1% Triton-X100. Primary antibody was applied in 
PBS/10% FBS with 0.1% Triton-X100 at 4°C overnight. Samples were washed 3 times with 
PBS/0.1% Triton-X100 followed by 1-hour secondary antibody treatment in PBS/0.1% Triton-
X100. After secondary antibody staining, samples were washed 3 times with PBS/0.1% Triton-
X100 followed by counterstaining with DAPI and mounted on slides with 90% glycerin/PBS. 
Primary antibody used was CTCF (Santa Cruz, sc28198) and secondary antibody used 
was Alexa Fluor-488 donkey anti-rabbit IgG (Invitrogen, A21206). Both antibodies were used at 
1:500 dilutions. 
3.4 Results 
3.4.1 Imprinted expression of Igf2r and Airn during gastrulation 
The Igf2r/Airn imprinted cluster contains the maternally expressed Igf2r, Slc22a2, and 
Slc22a3, the paternally expressed Airn and the non-imprinted Plg, Slc22a1, and Mas1 genes 
(Figure 3.1A). In order to characterize the expression of this cluster during gastrulation, we 
performed RT-PCR on embryonic and extra-embryonic tissues from C57BL/6JxPWD/PhJ-F1 
embryos at embryonic days E6.5 and E7.5 (Figure 3.1B). Of the genes in the cluster, Igf2r is 
expressed in both the epiblast (EPI) and visceral endoderm (VE) at E6.5 and the embryonic (EM) 
and extra-embryonic (EX) tissues of E7.5 embryos (Figure 3.1B).  Airn is expressed in the VE at 
E6.5 and in both tissues at E7.5; however, no Airn was detected in the epiblast at E6.5 (Figure 
3.1B).  
To further understand the imprinted expression of Igf2r and Airn during gastrulation, we 
carried out allele-specific expression analysis of C57BL/6JxPWD/PhJ-F1 and C57BL/6JChr 
17PWD/Ph/ForeJxC57BL/6J-F1 embryos (referred to as BxP and PxB F1 embryos, respectively). 
Single-strand confirmation polymorphism (SSCP) revealed that Igf2r is expressed from both 
alleles in the EPI of E6.5 embryos (Figure 3.2A, red box). In E6.5 VE, Igf2r is maternally 58
	  	  
expressed (paternally imprinted) (Figure 3.2A). At E7.5, Igf2r is imprinted in both tissues (Figure 
3.2A). This maternal expression is what has previously been characterized at this locus. Our 
results show that in the multipotent epiblast, Igf2r is expressed from both alleles. It is not until 
embryonic cells have adopted defined lineages at E7.5 that Igf2r expression becomes imprinted.  
This correlation suggests a relationship between relative differentiation state in vivo and 
imprinted expression at the locus and is consistent with ES cell models.    
Since Airn is thought to establish imprinting of Igf2r via transcription overlap (Latos et 
al. 2012), we also examined allele-specific Airn expression. In E6.5 EPI, Airn is not expressed 
(Figure 3.2B,C, red box), corresponding with biallelic Igf2r expression (Figure 3.2A). In the VE 
at E6.5, where Igf2r is imprinted, we observe reciprocal imprinting (paternal expression) of Airn 
(Figure 3.2C). At E7.5, Igf2r and Airn are imprinted in both embryonic and extra-embryonic 
tissue (Figure 3.2C). This change in imprinted expression between EPI and EM also occurs in the 
reciprocal cross (PxB, Figure 3.2), ruling out strain-specific genetic differences. Although Airn 
has also been shown to regulate imprinting of Slc22a2 and Slc22a3 in extra-embryonic lineages 
(Zwart et al. 2001), we could not detect these transcripts at appreciable levels during gastrulation 
(Figure 3.1B).  The change in Igf2r and Airn expression indicate a lineage- and stage-specific 
establishment of imprinted expression during normal in vivo development.  To understand the 
mechanisms driving the dynamic imprinted expression, we next examined allele-specific 
epigenetic modifications at the locus. 
3.4.2 DNA methylation spreads at DMR2  
Allele-specific DNA methylation at imprinting control regions (ICRs) or differentially 
methylated regions (DMRs) is required for imprinted expression at many loci (Li et al. 1993; 
Wutz et al. 1997; Thorvaldsen et al. 1998). The Igf2r/Airn locus has two known differentially 
methylated regions (Figure 3.3A, Figure 3.4A, (Wutz et al. 1997)). Methylation at DMR1 has 
been shown to occur late in development in a tissue-specific manner after imprinting is 
established and is thought to be a consequence of Airn expression (Stoger et al. 1993). 59
	  	  
Additionally, methylation levels vary between tissues. In the adult brain, where Igf2r imprinting 
is relaxed, we see low levels of differential methylation (Figure 3.3B (Hu et al. 1998; Yamasaki 
et al. 2005)). We identified differential methylation at DMR1 in the liver, where imprinted 
expression is maintained (Figure 3.3B, (Hu et al. 1998)). In all gastrulation tissues examined, 
DNA methylation at DMR1 is not significantly different than methylation in the adult brain 
(Figure 3.3), suggesting that DMR1 DNA methylation does not regulate the silencing of the 
paternal Igf2r allele that we observe at E7.5 and is likely a secondary silencing mark in tissues 
with maintained imprinted Igf2r expression. 
DMR2 methylation has been shown to be present in oocytes (Stoger et al. 1993), defining 
DMR2 as an ICR. Previous reports documented DMR2 by methylation sensitive restriction 
enzymes, presenting the analysis of two specific CpG dinucleotides (Stoger et al. 1993; Latos et 
al. 2009).  To gain a more comprehensive understanding of the methylation status, we designed 
two overlapping PCR amplicons for bisulfite sequencing at DMR2 (Figure 3.4). With this 
approach, we fortuitously identified the precise 3’ boundary of ICR methylation present in 
oocytes (CpG at chr17:12,742,488-12,742,489 (Figure 3.4A, red asterisk)).  In E6.5 EPI and VE, 
the precise ICR border was maintained on the maternal allele (Figure 3.4B); however, by E7.5 
DNA methylation had spread in the 3’ direction in both embryonic and extra-embryonic tissues 
(Figure 3.4B). These results indicate that although ICR methylation at DMR2 is established in the 
female germline (Stoger et al. 1993), maternal allele-specific methylation increases and spreads in 
cells of all lineages coincident with the onset of gastrulation.  It is particularly intriguing that the 
methylation spreading occurs in the extra-embryonic tissue given that reciprocal imprinting of 
Igf2r and Airn is already established. It is also evident that the increase in DNA methylation is 
coincident with initiation of Airn expression in the epiblast, suggesting a tissue-specific 
mechanistic relationship.  It may be of interest in the future to determine how far DNA 
methylation continues, if the spreading also occurs in the 5’ direction, and if the spreading is 
required for paternal silencing of Igf2r and activation of Airn.  60
	  	  
3.4.3 Airn is progressively expressed during development. 
To more closely examine the timing of Airn expression, paternal Igf2r silencing, and the 
spread of DNA methylation at DMR2, we carefully assessed litters of late-streak stage embryos at 
approximately E7.0. Variable staging within litters allowed us to assess developmentally varied 
embryos during the mid-streak stage (Figure 3.5A, 4 staged embryos from one litter). The 
spreading of maternal methylation at DMR2 had already occurred in all embryos examined at 
E7.0 (Figure 3.5D) Surprisingly, Igf2r is expressed from both alleles in all embryos (Figure 3.5B) 
even though Airn is expressed in older staged embryos (3 and 4 (Figure 3.5C)). Hypermethylation 
of maternal DMR2 (Figure 3.5D) clearly precedes paternal Airn expression in embryos 1 and 2.  
Hypermethlyation of maternal DMR2 also precedes silencing of paternal Igf2r in embryonic 
lineages (embryos 3 and 4). Importantly, the epiblast of embryos 3 and 4 express both alleles of 
Igf2r and paternal Airn, suggesting heterogeneity on silencing at these stages. It is also possible 
that transcription from both loci can occur on opposite strands of the same paternal chromosome. 
Analysis with single cell-resolution will be important to support this finding.  
Since the Airn transcript is 108kb, we designed amplicons along is length to assess if the 
entire lncRNA is detectable in embryonic lineages at various developmental stages (Figure 3.6A). 
Qualitative RT-PCR indicates that Airn transcripts increase in length with developmental 
progress (Figure 3.6B). At E7.0, only the 5’-most amplicons are detected while the 3’-most 
amplicons are detected in older embryos (Figure 3.6B).  By E9.5, all but the very 3’-most 
amplicon is detected, and the entire lncRNA is detectable in adult tissue (Figure 3.6B, +). 
Although qualitative, these results also suggest that total levels of Airn transcripts increases as 
development proceeds (Figure 3.6B, compare to ActB control).  
These findings raise the possibility that maternal DNA methylation spreading is required 
to inhibit maternal Airn transcription. This could explain activation of only the paternal 
unmethylated allele in the embryo.  Furthermore, the difference in Igf2r and Airn expression 
between EPI (biallelic Igf2r and no Airn) and VE (reciprocal imprinting) indicate a distinct 61
	  	  
mechanism during EPI differentiation that activates Airn (since Airn is already expressed in VE 
but the methylation dynamics are the same in EPI-EM and VE-EX). Alternatively, there may be 
regulation on the paternal allele that initially inhibits Airn transcription in epiblast. Either scenario 
indicates that neither DNA methylation nor Airn expression is responsible for silencing paternal 
Igf2r in the epiblast. Taken together, the observation that DNA methylation dynamics are the 
same in embryonic and extra-embryonic tissues, but that allelic expression patterns are different, 
requiring an embryonic lineage-specific mechanism responsible for establishment of imprinted 
expression.  
3.4.4 CTCF binding at DMR2 
The methylation sensitive insulator CTCF participates in chromatin looping at imprinted 
loci (Murrell et al. 2004; Engel et al. 2006; Zhang et al. 2011). At Igf2/H19, CTCF binds to the 
unmethylated maternal ICR preventing Igf2–enhancer interactions (Pant et al. 2003; Engel et al. 
2006). We therefore examined CTCF expression and binding to DMR2 to determine if it may be 
involved in regulation of Igf2r/Airn. At E6.5, very little Ctcf transcript is detectable in EPI or VE, 
but expression is evident at E7.5 in both lineages (Figure 3.7A). Consistent with the absence of 
transcripts, immunofluorescence showed no/trace nuclear signal at E6.5, while robust nuclear 
CTCF is observed at E7.5 (Figure 3.7B). We confirmed earlier reports of Ctcf expression in 
blastocysts (both mRNA and protein, Figure 3.7 D,D’), indicating that the locus undergoes 
differential transcriptional regulation during normal development.  This dramatic change is Ctcf 
expression and localization was unexpected, and may reflect the important role that the protein 
plays in maintaining epigenetic regulatory domains. Perhaps CTCF is required during 
preimplantation to establish and/or maintain chromatin dynamics established during the first cell 
lineage decisions (ICM/TE), but is dispensable until the next major lineage decisions are made 
during gastrulation. This possibility supports the idea that genome-wide epigenetic alterations are 
required during gastrulation lineage decisions, similar to preimplantation. In the future, 
62
	  	  
conditional deletion strategies may make it feasible to functionally test the requirement of CTCF 
in specific tissues during gastrulation.  
CTCF chromatin immunoprecipitation (ChIP) indicates CTCF binds to DMR2 in both 
embryonic and extra-embryonic E8.5 tissues (Figure 3.8A). Sequencing of ChIP-PCR products 
clearly shows allele-specific binding of CTCF at DMR2 to the unmethylated paternal allele in 
extra-embryonic tissues (Figure 3.8B). Surprisingly, both alleles are bound by CTCF in 
embryonic lineage, although there is a detectable shift toward the paternal allele (compare input 
and ChIP, Figure 3.8).  Together, the lack of Ctcf in the epiblast at E6.5 and the biallelic binding 
of CTCF at E8.5 suggest that while CTCF may play a role in maintaining imprinted expression at 
later stages, it is not involved in the initiation of paternal Igf2r silencing or Airn activation in the 
embryonic lineage during gastrulation.   
3.4.5 Differential histone enrichment at DMR2 
  Allele-specific histone modifications (HMODs) have been shown to correlate with Igf2r 
imprinting in the central nervous system (Fournier et al. 2002; Yamasaki et al. 2005). We 
therefore performed ChIP to examine enrichment of H3K4me3, H3K9me3, and H3K27me3 at 
DMR1 and DMR2 (Figure 3.9A). In the embryonic tissue at DMR1, we observe maternal allele-
specific enrichment of H3K4me3, as well as paternally biased H3K9me3 and H3K27me3. In the 
extra-embryonic tissues, there is no allele-specific enrichment of H3K4me3, and a weak paternal 
bias of H3K9me3 and H3K27me3 (Figure 3.9B,B’).  
  Similar to binding of CTCF, we observe allele-specific enrichment of HMODs at DMR2 
in extra-embryonic tissues but not in chromatin derived from the embryo (Figure 3.9 C,C’). In 
extra-embryonic tissues, the active H3K4me3 mark is enriched on the paternal allele, which 
expresses Airn, and H3K9me3 is enriched on the maternal allele, where Airn is silent (Figure 3.9 
C,C’). Surprisingly, PRC2-mediated H3K27me3, which has been shown to be required for 
imprinting at other loci (Mager et al. 2003), is not enriched on the silent Igf2r allele, suggesting 
that PRC2 does not participate in regulation of the Airn locus in extra-embryonic cells.  In the 63
	  	  
embryonic tissue, however, we find maternal bias of repressive H3K9me3 and H3K27me3, 
although not as highly enriched as extra-embryonic cells.  
 Together these data indicate distinct lineage- and allele-specific enrichment of HMODs 
occur at DMR1 and DMR2.  Strikingly, there is limited allele-specific enrichment in the extra-
embryonic tissue at DMR1 at E8.5, even though Igf2r is imprinted at least 2 days prior. This 
indicates differential methylation (Figure 3.3) and HMODs at DMR1 (Figure 3.9) may play a 
secondary role in the imprinting of Igf2r. 
Dramatic allele-specific enrichment of CTCF, H3K4me3 and H3K9me3 is present at 
DMR2 in extra-embryonic tissues, suggesting that these chromatin modifications are established 
at an earlier stage.  Although biased, DMR2 allele-specific chromatin modifications are not fully 
established in embryonic lineages by E8.5.  While it is possible that multiple cell types of the 
E8.5 embryo contain distinct allele-specific enrichment, it is more likely that the allele-specific 
modifications are not yet fully established, particularly since imprinted expression of Igf2r and 
Airn is initiated only 24 hours prior at E7.5.     
3.5 Discussion 
Our results indicate lineage-specific regulation of Igf2r/Airn imprinted expression during 
gastrulation. We identify the precise ICR boundary, as well as spreading of DNA methylation at 
Igf2r DMR2 during gastrulation (Summarized in Figure 3.10). At E6.5, both EPI and VE lineages 
maintain oocyte-derived maternal ICR methylation; however, in the EPI, Igf2r is biallelic and 
Airn is not expressed. In contrast, both genes are imprinted in VE of the same embryos.  
Therefore, there must exist mechanistic distinctions that result in imprinted expression in VE but 
not in EPI at E6.5; possibly lineage-specific expression of chromatin binding/modifying genes 
established during preimplantation inner cell mass/trophectoderm differentiation.  Our data also 
show locus specific methylation spreading occurs during gastrulation in both lineages. While 
spreading of ICR methylation is known to occur during preimplantation, it has not been 
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previously shown during gastrulation at imprinted loci, indicating that DNMTs are targeted to the 
locus specifically during these stages. 
The lineage differences in imprinted expression documented here are remarkably similar 
to patterns of X-inactivation. Imprinted X-inactivation is established in extra-embryonic cells 
during preimplantation, while stochastic X-inactivation occurs in the embryo only after 
gastrulation commences. Furthermore, non-coding RNAs help induce silencing in cis of the 
inactive X chromosome (reviewed in (Yang et al. 2014)), suggesting that Airn may function in a 
similar fashion at the Igf2r locus. The results presented here support the possibility that regulation 
of Igf2r/Airn (and other imprinted loci) and X-inactivation may utilize a common mechanism.  
Identification of the lineage-specific machinery that enables epigenetic changes specifically in the 
embryo will lead to a more complete understanding of the events underlying normal gastrulation 
and epigenetic reprogramming. 
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Figure 3.1. Expression of the Igf2r/Airn cluster.  A). Schematic of the Igf2r/Airn locus. The 
locus contains the maternally expressed Igf2r, Slc22a2, and Igf2r (red) and the paternally 
expressed long non-coding RNA (lcRNA) Airn (blue). Transcription start sites are annotated as 
bent arrows.  Genes expressed during gastrulation are in grey. B). RT-PCR analysis of the genes 
in the cluster show expression of Igf2r at E6.5 and E7.5, as well as Airn expression in the E6.5 
visceral endoderm and at E7.5. The other genes in the cluster are not expressed at appreciable 
levels during gastrulation. EPI- epiblast, VE- visceral endoderm, EM- embryonic tissue,  EX- 
extra-embryonic tissue. Positive control tissue (+) is pooled adult kidney, liver, brain, and heart 
cDNA. 
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Figure 3.2. Allele-specific expression analysis of Igf2r and Airn during gastrulation. A). 
SSCP analysis of Igf2r expression shows biallelic expression in the E6.5 epiblast, while the 
paternal allele is silent (imprinted) in all other tissues and stages examined. B). RT-PCR confirms 
that Airn is not expressed in epiblast but is paternally expressed (C) in all other samples. Two 
individual embryos (1 per lane) are shown for each tissue/stage for each assay. EPI- epiblast, VE- 
visceral endoderm, EM- embryonic tissue at E7.5, EX- extra-embryonic tissue at E7.5.  Red box 
highlights the non-imprinted status of Igf2r and lack of Airn expression in the E6.5 epiblast. B- 
B6 allele, P-PWD allele. 
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Figure 3.3. DNA methylation at DMR1. A). Schematic of the mouse Igf2r/Airn locus: 
transcription start sites (bent arrows), Igf2r exons (boxes), and location for DMR1 and DMR2. 
One amplicon spanning 12 CpG dinucleotides was analyzed. B). Methylation of adult F1 brain 
and liver. Note DMR1 methylation levels are variable in a tissue specific context. C). DMR1 
methylation in the embryonic lineage at E6.5, E7.0, and E7.5. D). DMR1 mehytlation in the 
extra-embryonic lineage at E6.5, E7.0, and E7.5. Note that levels of DMR1 methylation during 
gastrulation are comparable to the adult brain. Maternal- A, Paternal- G. 
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Figure 3.4. DNA methylation at DMR2. A). Schematic of the mouse Igf2r/Airn locus: 
transcription start sites (bent arrows), Igf2r exons (solid boxes) and location of DMR1 and 
DMR2. Two amplicons (F2R2 and F4R4) spanning 20 CpG dinucleotides were analyzed. 
Methylation in oocytes confirmed that DMR2 is an imprinting control region (ICR) and defined 
the methylation boundary (red asterisk in A).  B). ICR methylation is maintained in epiblast (EPI) 
and visceral endoderm (VE). Spreading of maternal DMR2 methylation occurs in embryonic 
(EM) and extra-embryonic (EX) (compare EPI to EM, and VE to EX). Filled circles- methylated 
cytosine, Open circles- unmethylated cytosine. Red asterisk denotes the ICR border 
(chr17:12,742,488-12,742,489).  Arrows indicate bisulfite-sequencing primer locations in A. The 
parental SNP used to distinguish alleles is located between CpG site 6 and 7 (G/A 
polymorphism).  
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Figure 3.5. Mid-gastrulation expression and DNA methylation. A. Four ~E7.0 embryos from 
a single litter shown in age order - analyzed for Igf2r (B), Airn and ActB (C) expression, as well 
as DMR2 DNA methylation (D). Igf2r is expressed from both alleles in all 4 embryos but Airn is 
detected only in the two older embryos (3 and 4). DNA methylation has already spread across 
DMR2 (D) independent of Airn expression. Filled circles- methylated cytosine, Open circles- 
unmethylated cytosine. F4R4 amplicon is shown. The parental SNP used to distinguish alleles is 
located between CpG site 6 and 7 (G/A polymorphism). Pat- Paternal, Mat- Maternal. 
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Figure 3.6. Progressive expression of Airn during gastrulation. A). Schematic of Airn loci, 
illustrating Airn and Igf2r start sites and locations of primer pairs used in (B). B). RT-PCR 
expression analysis from E7.0 embryos 1, 3, and 4, as well as other stages and adult kidney RNA 
(+) highlight progressive expression of Airn coordinated with development.  
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Figure 3.7. Expression of insulator protein CTCF. A. Ctcf RT-PCR indicates no/trace 
expression of Ctcf in both epiblast (EPI) and visceral endoderm (VE) at E6.5. Ctcf is expressed in 
both lineages at E7.5. B, B’). No/trace nuclear CTCF signal is detectable in EPI or VE in E6.5 
embryos. Decidual cells show robust nuclear CTCF (FITC) serving as a positive control. C, C’). 
Robust nuclear CTCF is observed at E7.5 in all cells. D, D’). Nuclear staining is observed in the 
blastocyst at E3.5. CTCF shown in FITC/green, nuclear counterstain DAPI shown in blue. Scale 
= 100 µm.   
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Figure 3.8. Allele-specific CTCF binding analysis. A). CTCF ChIP at DMR2 with E8.5 
chromatin shows binding in both embryonic and extra-embryonic tissues. B). Sequencing of 
ChIP-PCR products indicates allele-specific CTCF enrichment of the paternal allele in the extra-
embryonic tissue (red asterisks), but both alleles are bound in embryonic tissue (although biased 
towards the paternal allele). C). Parental input for B6, PWD, and BxP-F1 adult controls.  
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Figure 3.9. Allele-specific histone enrichment at DMR1 and DMR2. A). Illustration of DMR1 
and DMR2 in relation to the start sites of Igf2r and Airn. B,C).  H3K4me3, H3K9me3 and 
H3K27me3 ChIP-PCR of DMR1 and DMR2 on E8.5 chromatin. B’,C’). Sequencing of ChIP-
PCR products shows allele-specific enrichment in embryonic tissues at DMR1 and extra-
embryonic tissue at DMR2. The position of the polymorphism is boxed in red on each 
electropherogram. DMR1 (Maternal=A Paternal=G). DMR2 (Maternal B6=G, Paternal PWD=C). 
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Figure 3.10. Summary of Igf2r/Airn regulation during mouse gastrulation. Schematic 
depiction showing dynamic regulation of Igf2r and Airn in the embryonic lineage. In the epiblast, 
Igf2r is biallelic and Airn is not expressed. During gastrulation, maternal methylation at DMR2 
spreads, followed by initiation of paternal Airn expression and then silencing of paternal Igf2r. In 
the extra-embryonic lineage (right side), reciprocal imprinting of Igf2r and Airn is already 
established in visceral endoderm at E6.5.  DMR2 methylation spreads but does not correlate with 
changes in allelic expression in extra-embryonic lineage. Paternal specific binding of CTCF 
occurs at DMR2 in the extra-embryonic lineage, but not in the embryo. Additionally, lineage- and 
allele-specific histone modifications are present at DMR1 and DMR2 suggesting an epiblast 
specific mechanism required to establish imprinted expression.  
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CHAPTER 4 
CHARACTERIZATION OF GLOBAL IMPRINTED EXPRESSION DURING 
MAMMALIAN GASTRULATION 
4.1 Abstract 
Chapter 1 outlined how normal development is regulated by the careful coordination of 
gene expression during both lineage allocation and tissue differentiation, which is accomplished 
in part through epigenetic mechanisms. Chapter 3 demonstrated that during the dynamic window 
of gastrulation development, imprinted expression and epigenetic regulation could be established 
in a lineage-specific manner. Based on this previous identification of lineage-specific imprinted 
expression and epigenetic modifications during gastrulation, we performed allele-specific RNA 
sequencing on micro-dissected mouse gastrulation stage tissues to identify known and novel 
imprinted events. We also performed whole genome bisulfite sequencing (WGBS) to attempt to 
identify corresponding differentially methylated regions with imprinted expression.  These 
experiments have identified a novel set of imprinted genes that exhibit tissue-specific and 
temporally transient allele-specific expression.  Importantly, we do not find any differential DNA 
methylation at or near these loci, suggesting there must be an alternate epigenetic mechanism 
responsible for the parent-of-origin expression. Taken together, these data begin to define a novel 
paradigm of epigenetic regulation during mammalian gastrulation and provide additional 
evidence for DNA methylation independent imprinting. 
 
4.2 Introduction 
The adoption of RNA sequencing (RNA-seq) approaches has led to an increase in the 
number of imprinted genes described in the mouse and other organisms including humans. Using 
RNA-seq to identify and characterize imprinted gene expression has many advantages; 
sequencing of F1-hybrid tissue allows for the analysis of all expressed transcripts in an unbiased, 
allele-specific manner. While this method is powerful, it is not without pitfalls. Early work using 77
	  	  
allele-specific RNA-seq identified greater than 1,300 novel imprinted genes, which would have 
increased the number of imprinted genes 10-fold (Gregg et al. 2010a; Gregg et al. 2010b); 
however, further analysis found that most of these were false-positives (DeVeale et al. 2012).  
Subsequently, there has been a push for appropriately stringent bioinformatic analysis 
and validation of novel imprinted sites. With these more robust assessment methods, the list of 
potential imprinted genes still hovers around 300 genes (Babak et al. 2008; Babak et al. 2015; 
Bonthuis et al. 2015; Crowley et al. 2015).  Remarkably, unlike the initially described imprinted 
genes, many of these newly discovered imprinted genes have tissue-specific and time-dependent 
expression and appear mechanistically distinct from the earlier identified, canonical imprinted 
gene clusters (Babak et al. 2015; Bonthuis et al. 2015; Crowley et al. 2015; Inoue et al. 2017). 
Importantly, although some instances of non-ICR regulated imprinting rely on histone 
H3K27me3 as the maternal imprint (Inoue et al. 2017), a consensus of mechanisms for this 
alternative route to parent-of-origin expression has yet to be identified.  
In order to further elucidate the landscape of parent-of-origin expression during 
development, we present allele-specific expression accompanied by genome-wide DNA 
methylation analysis during mouse gastrulation.  We assessed the parent-of-origin status of all 
transcripts in the genome, including all previously documented and suspected imprinted genes, 
using a stringent definition of imprinted expression.  In addition to finding that a large number of 
previously reported imprinted genes are either biallelic or genetic background dependent, we 
have also identified a set of novel imprinted loci that are transiently imprinted during gastrulation 
and organogenesis stages. These imprinted sites add to the growing list of non-canonical 
imprinted genes and appear to have an ICR-independent mechanism driving parent-of-origin 
expression. 
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4.3 Materials and Methods 
4.3.1 Tissues  
The University of Massachusetts Amherst Institutional Animal Care and Use Committee 
approved all procedures. Post-implantation embryos were derived from C57BL/6J (JAX 000664), 
PWD/PhJ (JAX 004660), and DBA/J2 (JAX 000671) F1 crosses via natural timed mating. 
Embryos from individual litters were staged and microdissected in PBS. Appropriately staged 
embryos were then pooled for DNA and RNA extraction. Gastrulation tissues were dissected and 
collected at E6.5 through E8.5. For E6.5 embryos, the visceral endoderm was peeled from the 
epiblast using pulled glass capillaries. E7.5 and E8.5 embryonic and extra-embryonic tissues were 
carefully dissected and pooled. 
E13.5 yolk sac separations were performed by first removing the yolk sac from the 
embryo proper and transferring yolk sacs to 4°C Pancreatin/Trypsin/Ca++,Mg++-free Tyrode 
Ringer’s Saline Buffer. Whole yolk sacs were incubated for 30 minutes to 1 hour, while being 
checked periodically for yolk sac separation. Following incubation, yolk sac visceral endoderm 
and mesoderm were carefully peeled apart, washed in PBS, and transferred to lysis buffer (Roche 
11828665001, lysis binding buffer).  
Adult tissues were collected from 8-week-old male and female F1-hybrid crosses. Gross 
dissections of tissues (brain, eye, heart, intestine, kidney, liver, lung, skeletal muscle, spleen, 
stomach, thymus, tongue, uterus, ovary, testis) were collected and washed in PBS before being 
processed for RNA extraction. 
4.3.2 Generation and sequencing of RNA-seq libraries 
Total RNA was isolated using the Roche High Pure RNA Isolation Kit (Roche 
11828665001) and was either sent to the Broad Institute (Cambridge, MA) for sequencing or 
processed for library preparation in house. RNA quality and quantity was assessed with an 
Agilent 2100 BioAnalyzer using RNA 6000 Nano Chips (Agilent 5067-1511) and NanoDrop 
1000, respectively. Between 2-3ug total RNA was used to generate libraries following the 79
	  	  
Illumina TruSeq Stranded mRNA LT Sample Prep Kit protocol (Illumina RS-122-2101). 
Libraries were assessed using Agilent DNA 1000 Kit (Agilent 5067-1504) and Qubit dsDNA HS 
Assay Kit (Q32851). The Illumina HiSeq2500 (Broad Institute, Cambridge, MA) or NextSeq500 
(University of Massachusetts, Amherst, MA) was used to generate 76-bp paired-end reads.  
4.3.3 RNA-seq analysis 
In order to decrease the bias in mapping to one reference genome, we masked 
polymorphic bases on the C57Bl/6J (mm10) genome compared to the PWK/PhJ genome. Reads 
were mapped to the masked C57Bl/6J mouse genome (mm10) using tophat (v.2.1.1, -N 2, --mate-
inner-distance 150, --mate-std-dev 50). SNP calling was performed with samtools (v1.3.1) 
mpileup. The mpileup output was compared to high quality SNPs in the PWK/PhJ genome 
(Sanger Institute, PWK/PhJ.mgp.vs.snps.dbSNP142.vcf). Polymorphic bases between the two 
genomes were binned by transcript and allele ratio was calculated across the transcript. SNP reads 
were normalized by calculating the total number of SNP reads divided by the total SNPs per 
transcript divided by the total number of SNP reads per sample.  We applied the following 
cutoffs: coverage= greater than 2 reads/SNP average across transcript, reads/transcript 
SNPs/million SNPs= greater than 0.1. The maternal and paternal alleles of biological replicated 
were average and the mean normalized SNP count was used to determine allelic expression.  
Known imprinted gene values were extracted from the whole genome and the allele ratio 
was plotted on a scale from 0-1, with 0 being 100% paternally expressed and 1 being 100% 
maternally expressed.  Genes were imprinted if the log2(FC) between the maternal and paternal 
alleles was greater than 2 (approximately greater than 80% one allele expressed) and the forward 
and reciprocal cross had parent-of-origin agreement.  Genes where the forward and reciprocal 
cross were not in agreement were categorized as strain-specific expression. Genes where the 
log2(FC) was less than 2 and the allele ratio was less than 80% one allele expressed were 
characterized as biallelicly expressed. Strain-specific bias (a subcategory of biallelic expression) 
was defined as genes with greater than 60% one allele expressed, which was not in parent-of-80
	  	  
origin agreement. Changes in imprinted expression during gastrulation were calculated using an 
unpaired t-test. 
4.3.4 Sanger sequencing validation 
Total RNA was isolated using the Roche High Pure RNA Isolation Kit (Roche 
11828665001). cDNA synthesis was performed using Superscript II (ThermoFisher 18064014) 
with oligo(dT) primers (Promega C1101). Novel imprinted gene expression was validated by 
performing RT-PCR against genes of interest using primers that span informative polymorphic 
sites (Appendix C). PCR amplification for expression panels and Sanger sequencing validation 
was run using RubyTaq (Affymetrix 71191) for 35 cycles. PCR products were visualized by 
ethidium bromide illumination and imaging and then sent to either Eton Bioscience (Charlestown, 
MA) or Macrogen (Boston, MA) for PCR cleanup and sequencing. Base calling and sequence 
alignment was performed using CodonCode Aligner software (Centerville, MA). 
4.3.6 Generation and sequencing of WGBS libraries 
Pooled E7.5 embryonic tissue was lysed in Roche High Pure lysis/binding buffer in PBS 
(Roche 11828665001) and purified using standard phenol/chloroform extraction and ethanol 
precipitation. Bisulfite conversion was performed on 100ng total DNA using the Zymo EZ DNA 
methylation-lightning kit (Zymo D5030) with modifications to the manufactures protocol. 
Specifically, starting reaction volumes were halved. This was due to incomplete bisulfite 
conversion using the recommended 150ul volume. Following binding of converted DNA to the 
column, the protocol was followed, with the exception of eluting with 9ul total. Libraries were 
prepared from bisulfite converted DNA using TruSeq DNA methylation kit (Illumina 
EGMK81312) and assessed using Agilent High Sensitivity DNA Kit (Agilent 5067-4626) and 
Qubit dsDNA HS Assay Kit (Q32851).  Illumina NextSeq500 (University of Massachusetts, 
Amherst, MA) was used to generate 76-bp paired-end reads.  
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4.3.6 WGBS mapping and analysis 
Reads were mapped on Illumina Basespace using the MethylSeq pipeline (v2.0.0) to 
either strand of the mm9 mouse reference genome (E7.5 replicate 1 aligned 251,894,012 unique 
reads and E7.5 replicate 2 aligned 267,627,884 unique reads). Cytosine methylation was called 
using bismark_methylation_extractor. Levels of individual CpG sites were calculated by the 
number of reads mapped as cytosine, divided by the total number of cytosine and thymine at the 
individual CpG position.  
To identify potential DMR windows, we used a modified sliding window approach as 
described by Court et. al. (2014). Briefly, methylation levels of 25 consecutive CpGs with read 
coverage greater than 5 were averaged. Intervals were considered differentially methylated if the 
average methylation of the window was 0.25 < mean ± 1.5SD <0.75. Following DMR window 
identification, we applied a window filter to extract intermediately methylated windows with 
specific CpG content thresholds (CpG>10/window; CpG/100bps>1).  Enrichment of known 
imprinted genes on DMR windows list was calculated using Fisher’s Exact Test. Chromosome 
positioning was converted to from mm9 to mm10 coordinates with USCS liftover. Overlap 
between known DMRs and our methylation and imprinted gene datasets were analyzed by 
comparing regions with published mouse DMRs (Xie et al. 2012) using bedtools (v2.26.0). DMR 
distance from known/novel imprinted genes and random genes were calculated using bedtools 
(v2.26.0). Control genes were randomly selected from non-imprinted, expressed genes in our 
E7.5 embryonic dataset.  
4.3.7 Data Access  
All RNA-seq and WGBS datasets generated in this study are summarized in Table 4.1 
and will be deposited in the Gene Expression Omnibus. In house Perl scripts are available upon 
request.  
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4.4 Results 
4.4.1 Determining allele-specific expression during mouse gastrulation by RNA-seq 
Gastrulation is a morphologically dynamic developmental window when the pluripotent 
epiblast differentiates the three main germ layers of the embryo: the endoderm, ectoderm, and 
mesoderm.  These lineage allocation decisions are driven, in part, by epigenetic alterations, 
suggesting gastrulation is also epigenetically dynamic. As detailed in Chapter 3, we identified a 
lineage-specific switch from biallelic to imprinted expression of Igf2r during the onset of 
gastrulation that was accompanied by allele-specific changes to the epigenetic state of the locus, 
including spreading of DNA methylation at the imprinting control region (ICR) (Marcho et al. 
2015). To better understand the global regulation of epigenetic phenomenon occurring during this 
dynamic developmental window, we performed allele-specific RNA sequencing (RNA-seq) on 
F1-hybrid embryonic tissues during mouse gastrulation. To identify expression in a parent-of-
origin manner, we generated F1-hybrid embryos by crossing the divergent C57BL/6J (B) and 
PWD/PhJ (P) mouse strains and performed RNA-seq on micro-dissected tissues from embryos 
derived by reciprocal crosses (BxP-F1 and PxB-F1, Figure 4.1A,B; Figure 4.2). We produced 76 
base pair, strand-specific, paired-end reads on micro-dissected pooled tissue from E6.5 through 
E8.5 to generate a transcriptome-wide, allele-specific gastrulation panel (Table 4.1).  Specifically, 
we collected the embryonic epiblast and visceral endoderm at E6.5, the embryonic and extra-
embryonic tissues at E7.5, and embryonic tissue at E8.5 (Figure 4.2, Bold).  
To characterize imprinted expression during gastrulation, we compiled a list of 303 
previously reported imprinted genes to determine the status of allele-specific expression for 
putative and known imprinted genes during gastrulation (see Appendix C for complete gene list).  
Importantly, we included genes that have been reported with tissue-specific imprinting, as well as 
genes whose allele-specific expression has been debated in the literature. It is important to note 
that our sequencing only includes polyadenylated transcripts due to poly-A selection during the 
initial library preparation; however, we included all known imprinted genes, including non-83
	  	  
polyadenylated transcripts. This newly complied reference of imprinted genes provides a clear 
picture of imprinted during gastrulation, as well as identifies several genes with strain-specific 
expression. We also show that many reported tissue-specific imprinted loci are biallelic at these 
stages (Figure 4.3). 
To identify imprinted expression, we mapped reads to a polymorphism-masked mm10 
reference genome and extracted read counts at all known polymorphic bases between the two 
reference strains. Differential allelic expression at all polymorphic bases for each individual gene 
was calculated. Genes were considered imprinted only if reciprocal cross data each showed 
parent-of-origin expression with a log2(FC) > 2 between alleles (80% expression from one 
allele).  
Of the 303 imprinted genes analyzed, 227 genes were expressed at detectable levels in at 
least one tissue examined. Of these, 189 were expressed in at least one gastrulation tissue and met 
the minimum depth of coverage requirement for parent-of-origin analysis at polymorphic bases. 
These genes were further analyzed for allele-specific expression. Surprisingly, only 79 of these 
189 previously reported genes are imprinted during gastrulation (Figure 4.3A). These 79 
imprinted genes are comprised of 45 maternally expressed and 35 paternally expressed alleles, 
and nearly all reside in the originally identified ICR regulated imprinted clusters. 
 We also find numerous instances of previously reported imprinted genes that display 
strain-specific expression (Figure 4.3A,B). This includes Lin28a, Rbp2, Atp5e, Tspan32, Slc38a1, 
Slc38a2, Ptms, Tle3, Pkm Ifitm10, Tnfrsf22, Hnrnpk, Gpr1, Camk2n1, Foxl1, and Ajap1 (Hiura et 
al. 2010; Crowley et al. 2015; Inoue et al. 2017). If we reduce the allele-bias threshold, we 
identify additional strain-specific bias (Figure 4.3A,B). In agreement with previous studies, we 
also observe a substantial background-specific, cis-regulatory effect across the genome (Crowley 
et al. 2015). These results highlight the essential requirement for stringent analysis of reciprocal 
cross data to identify both parent-of-origin and background-specific expression. 
Additionally, many of the 189 known imprinted genes expressed during gastrulation are 84
	  	  
either show biallelic expression or strain-specific bias (Figure 4.3). These results are likely 
explained due to tissue- and/or temporal-specific imprinting. These genes are not imprinted 
during gastrulation but parent-of-origin expression is present in specific tissues at other stages of 
development. For example, one study recently identified genes that are imprinted during 
preimplantation development and are regulated by maternal H3K27me3. This imprinted 
expression is largely lost post-implantation (Inoue et al. 2017). Of these genes we observe 
continued parent of origin expression for a few H3K27me3-dependent genes during gastrulation 
(Slc38a4, Gab1, and Stmbt2) (Figure 4.3). However, we observe a strain-specific bias, rather than 
parent-of-origin expression, for Smoc1, which was also identified as an H3K27me3-dependent 
imprinted gene (Inoue et al. 2017).   
Additionally we identify a subset of genes with a parent-of-origin bias, rather than 
imprinted, mono-allelic expression. Other groups have considered these genes to be imprinted or 
defined them as a subset of imprinted genes (Bonthuis et al. 2015; Crowley et al. 2015), but we 
are confining our definition of imprinting to genes with greater than approximately 80% mono-
allelic expression and have classified these genes as biallelic during gastrulation (Figure 4.3).  
For some reported imprinted loci, the allelic tissue-specific expression has been disputed. 
For example, Gatm was found be maternally expressed in embryonic placenta (Sandell et al. 
2003), which was later thought to be maternal contamination (Okae et al. 2012); however, we 
find maternal specific expression of Gatm in all gastrulation tissues except E8.5. Surprisingly, we 
also identified a set of genes with specific expression from the opposite parental allele that has 
been reported, including Dio3, Rtl1, Wt1 Otog, and Tshz2. This was unexpected since Dio3 and 
Rlt1 are part of the well-characterized Dlk1/Dio3 imprinted cluster (da Rocha et al. 2008). We 
observe maternal Dio3 and Rlt1 expression at early gastrulation stages, which flips following the 
start of gastrulation (Figure 4.4A,B). One likely explanation is that the paternal allele at these loci 
are not yet actively transcribed, resulting in low levels of maternal-only transcripts we observe 
(Yevtodiyenko et al. 2002). Supporting this possibility is the relative abundance of total 85
	  	  
transcripts at later stages, indicating stronger activation of the Dio3 and Rtl1, resulting in 
paternal-specific expression as expected (Figure 4.4A,B) This highlights the need for detailed 
tissue-specific imprinted expression analysis across multiple tissues and developmental time 
points to fully understand molecular regulation of imprinted loci.  
Others have reported global imprinting distinction between the embryonic and extra-
embryonic lineages, suggesting that imprinted expression is often maintained in the extra-
embryonic tissues but lost in the embryo proper (Babak et al. 2015; Inoue et al. 2017); however, 
we find no statistically significant difference in the overall number of imprinted genes when 
comparing E7.5 embryonic and extra-embryonic tissues, indicating that imprinting in the epiblast 
is maintained through gastrulation and may be lost or relaxed sometime later during 
differentiation and development. This hypothesis is supported by the fact that we do observe a 
significant decrease in the total number of genes imprinted in the embryonic tissue at E8.5 when 
compared with E7.5 (p=0.0101), indicating a loss of imprinting following gastrulation (Figure 
3.3A). These results provide the first comprehensive characterization of known imprinted genes 
during mouse gastrulation.  
4.4.2 Identification of novel imprinted genes  
To identify novel imprinted loci, we analyzed all expressed genes for parent-of-origin 
expression. From our allele-specific sequencing data, we have identified and validated 6 novel 
imprinted genes during gastrulation: Alpha-2-Macroglobulin (A2m), Collagen, type III, alpha 1 
(Col3a1), Desmin (Des), Dermokine (Dmkn), Regulator of G-protein signaling 2 (Rgs2), and 
Suprabasin (Sbsn). (Figure 4.3A asterisks, Table 4.2). We find these genes are maternally 
expressed at E6.5 and E7.5 in both embryonic and extra-embryonic tissues. By E8.5, the paternal 
alleles become active, with the exception of Dmkn, which does not meet the coverage cutoff at 
E8.5.  Specifically, Col3a1, Des, and Rgs2 become completely biallelic, while A2m and Sbsn 
become biallelic at E8.5 in one cross (Figure 4.3), but maintain a maternal bias in the opposite 
cross. Even with careful morphological staging of embryos, the reciprocal cross expression 86
	  	  
suggests a slight delay in developmental progression, which might lead to slightly different 
timing of this loss of imprinting (Figure 4.5A,B). Still, this suggests these 6 genes have a 
developmentally restricted window of imprinted expression. We observe similar activation of 
imprinted alleles at several other known imprinted loci during gastrulation including Ano1, Tshz2, 
Aqp1, Gatm, Dcn, Dio3, and Epas1 (Figure 4.3B, dynamic), suggesting a category of genes 
whose imprinted status correlates precisely with pre- and post-gastrulation stages.  This likely 
reflects epigenetic programming of specific lineages as they adopt differentiated fates post-
gastrulation. 
To validate these novel imprinted expression patterns, we designed RT-PCR assays 
overlapping useful polymorphisms in order to distinguish parental alleles via Sanger sequencing 
(Figure 4.5A).  These RT-PCR results are consistent with the RNA-seq expression results. While 
we do see amplification of Dmkn at E8.5, it is dramatically reduced. We also see weaker 
expression of A2m, Col3a1, Des, and Dmkn in both E6.5 tissues. Following RT-PCR, we 
confirmed the parent-of-origin expression of each of these genes (Figure 4.6B).  These results 
validate that each of these genes has a developmentally restricted window of imprinted 
expression and hint at an alternative mechanism for imprinted expression at these loci (Bonthuis 
et al. 2015; Inoue et al. 2017). 
Because we used widely divergent strains for our RNA-seq experiments, we also 
generated embryos from C57BL/6J (B) and DBA/2J (D) reciprocal crosses (BxD-F1 and DxB-
F1, Figure 4.7) to ensure that the novel imprinting was present in other genetic backgrounds. This 
cross provided informative polymorphisms for Col3a1, Dmkn, and Sbsn. Again, we performed 
RT-PCR followed by Sanger sequencing in order to validate the novel imprinted expression in the 
inbred-strain derived crosses (Figure 4.7). Although we do observe some differences in the 
expression of Col3a1, Dmkn, and Sbsn, sequencing confirmed the switch from imprinted 
expression to biallelic expression between E7.5 and E8.5 in both embryonic and extra-embryonic 
tissues from DxB and BxD reciprocal embryos (Figure 4.7, DxB shown). These experiments 87
	  	  
confirm the stage specific imprinted expression of these genes and indicate that the transient 
imprinting is not a specific feature of the divergent genomes initially analyzed.  
Several groups have sought to identify the locations of all gametic imprinting control 
regions (ICRs) and differentially methylated regions (DMRs) in mouse gametes (see Appendix C 
for ICR and DMR locations).  We find that these newly identified imprinted genes are not near 
any known ICRs or DMRs. This suggests that these genes represent a non-canonical class of 
parent-or-origin epigenetic regulation and as such will be referred to as ICR-independent 
imprinting. 
4.4.3 Allele-specific expression of novel imprinted genes is maintained in distinct 
developmental lineages 
 As mentioned above, other studies have shown sites of transient imprinted expression in 
the embryonic lineage are sometimes maintained in extra-embryonic cell types. Therefore, we 
also sequenced E13.5 extra-embryonic tissues, including the spongiotrophoblast placenta, yolk 
sac visceral endoderm, and yolk sac mesoderm (Figure 4.2B, bold), which are derived from 
distinct populations during development (Simmons and Cross 2005; El-Hashash et al. 2010; 
Hudson et al. 2010). The spongiotrophic placenta and the yolk sac visceral endoderm are derived 
from early allocation of extra-embryonic tissues at approximately E4.0 from the trophectoderm 
and primitive endoderm, respectively. In contrast, the yolk sac mesoderm is derived from the 
epiblast during gastrulation (Theiler 1989). The distinct origins of these three tissues allow for the 
inference of epigenetic differences between them, potentially highlighting differences in 
epigenetic states between early and late allocated extra-embryonic tissues. Other studies have 
suggested that extra-embryonic specific maintenance of imprinted expression only occurs 
derivatives of trophectoderm and primitive endoderm, but not from epiblast derived extra-
embryonic tissues (Hudson et al. 2010; Hudson et al. 2011).  
 The risk of maternal tissue contamination when working with extra-embryonic tissues 
has been well characterized (Hudson et al. 2010; Proudhon and Bourc'his 2010; Hudson et al. 88
	  	  
2011), so we first validated tissue isolation by performing RT-PCR for ActB, followed by Sanger 
sequencing (Figure 4.8).  In all tissues used for RNA-seq, ActB was biallelicly expressed.  
Maternal contamination would result in a skewing towards the maternal allele, which we did not 
observe in the spongiotrophic placenta, yolk sac visceral endoderm, or yolk sac mesoderm, 
indicating clean embryonic cell isolation. (Figure 4.8, compare to trophoblast placenta). Similar 
to the gastrulation tissues, we performed 76 base pair, strand-specific paired-end RNA-seq on 
these BxP-F1 extra-embryonic tissues (Table 4.1).  
 Out of the 309 genes assessed (303 known and 6 novel imprinted genes), 198 genes met 
our coverage cutoff in at least one tissue in the E13.5 extra-embryonic tissues analyzed; however, 
we removed all of the strain-specific genes identified during the gastrulation analysis (Figure 
4.3), leaving a total of 172 genes analyzed at E13.5 (Figure 4.9). This includes the 6 novel 
imprinted genes identified during our gastrulation screen. Out of the 172 total genes analyzed at 
E13.5, 74 genes show imprinted expression in at least one of the tissues.  
When we compare the 74 imprinted genes at E13.5 to the 85 (79 known, 6 novel) genes 
with imprinted expression during gastrulation, we find that 53 are maintained in at least one of 
the E13.5 extra-embryonic tissues Additionally, 21 genes that have imprinted expression in all 
lineages and time-points during gastrulation (Fkbp6, Grb10, H19, Igf2, Igf2os, Magel2, Meg3, 
Mirg, Ndn, Nnat, Peg10, Peg13, Peg3, Phlda2, Rian, Sgce, Slc22a18, Snhg14, Snrpn, Zdbf2, and 
Zrsr1) are imprinted in at least one tissue at E13.5, and 13 are imprinted in all E13.5 lineages. 
The other genes are either not expressed one lineage (Fkbp6, Magel2, Snhg14, and Ndn) or are 
biased towards the imprinted allele  (Grb10, Zdbf2, Nnat, and Zrsr1). This list of 21 widely 
imprinted genes is enriched for loci that are regulated by ICR/DMRs and fit the currently 
accepted model of regulation and establishment of imprinted expression.  
4.4.4 ICR-independent imprinting is lost in embryonic lineages 
 The novel imprinted expression that we identified during gastrulation is maintained in the 
spongiotrophic placenta for A2m, Col3a1, Des, and Rgs2. In the yolk sac visceral endoderm, only 89
	  	  
Des is imprinted. Interestingly, we found that all six newly identified imprinted genes are 
expressed from both alleles the embryo at E8.5 as well as the E13.5 yolk sac mesoderm (Figure 
4.3B, Figure 4.9B, asterisk). E13.5 imprinted expression was validated by RT-PCR and Sanger 
sequencing in the same manner as the gastrulation tissues (Figure 4.10). These results indicate 
that imprinted expression is not maintained in embryonically derived extra-embryonic mesoderm 
and that the paternal allele is activated by E8.5. This suggests a novel mechanism responsible for 
paternal repression in pre-E8.5 stages in embryonic cells, which may or may not be the same 
mechanism maintaining imprinting in the yolk sac endoderm and spongiotrophic placenta.   
We also analyzed allelic expression in a panel of 19 adult tissues from reciprocal crosses 
(BxP-F1 and PxB-F1). Although each novel imprinted gene showed individual tissue-specific 
expression across the 19 adult tissues (Figure 4.11), we observe all biallelic expression except for 
Dmkn, which remains maternally expressed in the eye. Together, these results indicate that 
although the ICR-independent imprinted expression observed during gastrulation is transient, 
there must be epigenetic information at these loci maintained into adulthood, which facilitates 
paternal repression of Dmkn specifically in the eye (Figure 4.11). Further evaluation of cell type 
specific expression in the eye will be required to explore the mechanism regulating Dmkn. 
4.4.5 No differential DNA methylation at ICR-independent imprinted loci. 
As mentioned earlier, other groups have identified the location of all ICRs and DMRS in 
gametes  (see Appendix C), providing a genome-wide map of potential imprinted loci. 
Surprisingly, there are no ICRs or DMRs located near any of the 6 novel imprinted loci that we 
identified and validated.  These new genes are between 12-80 megabases away from the nearest 
ICRs or DMRs, making it unlikely and unprecedented that these distant sites regulate the 
imprinted expression. This suggests that these genes represent a non-canonical class of parent-of-
origin epigenetic regulation that is ICR-independent. 
To examine mechanisms that contribute to the gastrulation-specific imprinted expression 
and to assess the presence of post-fertilization DMRs near the novel imprinted loci, we performed 90
	  	  
whole genome bisulfite sequencing on E7.5 embryos, a stage at which all 6 genes are robustly 
expressed and imprinted. We used a genome-wide approach in order to examine both global and 
locus-specific evidence of DMRs in a non-biased manner. Following mapping and methylation 
calling, we screened for regions of the genome that had a level of DNA methylation predictive of 
an allele-specific pattern (i.e. an intermediate methylation level between 25% and 75%).  To 
identify potential DMRs, we used a sliding window approach similar to previously published 
reports (Court et al. 2014). Briefly, for each CpG dinucleotide, the number of cytosine reads was 
divided by the total number of cytosines and thymines at that base. If the total number of reads at 
an individual base was greater than or equal to 5 reads, that individual site was used for further 
sliding window analysis. For the sliding window, 25 consecutive CpG sites passing the coverage 
filter were considered for each window and averaged (0.25 < mean ± 1.5SD <0.75) to give a 
percent methylation for that window. We then filtered the windows by CpG number and ratio 
(total CpG > 10; CpGs/100bps >1).  
Using this approach, we identified 134 regions of intermediate methylation across the 
genome that were present in both biological replicates. Of these, 61 were associated with genes, 
18 of which are known imprinted genes with differentially methylation regions (Table 4.3). This 
approach resulted in identification of nearly all ICRs, as well as several documented DMRs 
(Figure 4.12A, red box).  Additionally, this approach discovered many potential novel DMRs that 
require further allele-specific validation (Figure 4.12A). Importantly, the resulting list of 
intermediate methylation sites was significantly enriched for known imprinted genes (p<0.0001); 
however, we did not identify any DMRs associated with any of our novel imprinted genes (Figure 
4.12B, red dots, Table 4.3). In fact, the majority of potential imprinted genes are distal to DMRs 
(Figure 4.12B). This suggests an ICR-independent mechanism for imprinted expression at many 
known imprinted sites. These data strongly support a conclusion that the 6 novel imprinted loci 
are not regulated or maintained by differential DNA methylation; neither in the gamete nor in the 
embryo.  91
	  	  
4.5 Discussion 
 Here we present the status of parent-of-origin expression of all expressed genes across 
distinct tissues during mouse gastrulation and in E13.5 extra-embryonic lineages. These data 
contribute to the growing body of allele-specific gene express work and add essential 
developmental stages during a critical lineage allocation window (the “mouse imprinting atlas” 
(Babak et al. 2015), WAMIDEX (Schulz et al. 2008)). Additionally a current table of all 
documented imprinted genes will be of use to the community for future studies (see Appendix). 
 From a genome-wide perspective, we observe that the number of imprinted loci tends to 
decrease in the embryonic lineages as development progresses, which is consistent with previous 
work (Barlow and Bartolomei 2014; Babak et al. 2015). We observe that the number of imprinted 
genes is higher in the epiblast and embryonic tissue at E7.5, but drops significantly in the 
embryonic tissue at E8.5 (Figure 4.3A). The novel imprinted genes that we identified also lose 
imprinted expression in embryonic derived tissues and in most adult tissues, suggesting a 
correlation of imprinted expression and undifferentiated states during development. Additionally, 
of the 303 previously documented genes with imprinted expression, 105 are imprinted in at least 
one tissue analyzed here, despite many being previously described as tissue-specific, indicating 
the importance of examining disparate developmental stages and lineages. 
These data also highlight the difference between the historic ideas of imprinting: that 
genes are often regulated in clusters controlled by DMRs/ICRs and non-coding RNAs. The 
imprinting status of these genes is generally stable during development and is maintained in adult 
tissues. Consistent with the work of many others, genes that are imprinted in all gastrulation 
tissues are all associated with DMRs. Additionally, many of these canonical genes are conserved 
between mouse and humans (Babak et al. 2015; Baran et al. 2015). In contrast, recently identified 
imprinted genes, including those discovered here, do not fit this canonical imprinting model. In 
contrast, here we show that the novel imprinted genes that we have found, as well as the majority 
of recently identified imprinted genes, are not associated with differential DNA methylation 92
	  	  
(Bonthuis et al. 2015; Inoue et al. 2017). Additionally, they are not associated with non-coding 
RNAs or part of an imprinted cluster. 
Likely, these novel imprinted genes are not regulated in cis by DNA methylation. This 
does not exclude the potential that 3-dimensional confirmation of the allele allows for interactions 
with other imprinted loci, but we do not have evidence for such trans-regulation. One obvious 
potential mechanism for ICR/DMR independent imprinting is allele-specific histone 
modifications. Differential histone modifications have been shown to play an important, but often 
secondary role in regulating imprinted expression (Carr et al. 2007; Delaval et al. 2007; McEwen 
and Ferguson-Smith 2010). Recently, H3K27me3 has been shown to control some sites of 
imprinted expression in a DNA methylation-independent manner, suggesting that like DNA 
methylation, specific histone mark from the gametes can also drive imprinted expression (Inoue 
et al. 2017).  As we do not know the specific regulatory regions at these loci, future experiments 
will explore allele specific histone marks across the genome.  
In total, this work adds to the growing list of imprinted phenomenon and highlights the 
importance of examining epigenetic dynamics during early development towards elucidating the 
mechanisms regulating allele-specific expression across the genome.  
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Figure 4.1. Summary of experimental design for detection of allele-specific expression using 
RNA-seq. A-B). Divergent strains (C57Bl/6J and PWD/PhJ) produce F1 hybrid embryos that 
allow for determination of maternal and paternal expression specific expression based on single 
nucleotide polymorphisms (SNPs) (schematic yellow and blue chromosomes with SNPs). 
Biallelic expression results in equal number of reads mapping to both alleles. Imprinted genes 
will only have transcripts originating from one allele (either maternal or paternal). B). The 
reciprocal cross (PWD/PhJ x C57Bl/6J) allows for us to differentiate strain-specific (cis-
regulated) expression and imprinted gene expression. Strain-specific expression would result in 
mono-allelic expression irrespective of parent-of-origin. This is in contrast to imprinted parent-of-
origin expression.  
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Figure 4.2. Illustration of tissues used for RNA-seq. A). Gastrulation RNA-seq was performed 
on E6.5 epiblast (EPI), E6.5 visceral endoderm (VE), E7.5 embryonic (EM), E7.5 extra-
embryonic tissue (EX), E8.5 embryonic tissue (EX). B). E13.5 extra-embryonic lineage RNA-seq 
was performed on E13.5 yolk sac mesoderm (YME), E13.5 yolk sac visceral endoderm (YVE), 
and E13.5 spongiotrophic placenta (SP) (bold text). 
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Table 4.1. Sequencing information for data generated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample'Name Seq'Location Cross Tissue Library'Kit Seq'Model
E65EPI1 The*Broad*Institue B6*x*PWD E6.5*Epiblast TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E65EPI3 Umass*Genomics*Core B6*x*PWD E6.5*Epiblast TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E65EPI4 Umass*Genomics*Core B6*x*PWD E6.5*Epiblast TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E65VE1 The*Broad*Institue B6*x*PWD E6.5*Visceral*Endoderm TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E65VE2 The*Broad*Institue B6*x*PWD E6.5*Visceral*Endoderm TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EM1 The*Broad*Institue B6*x*PWD E7.5*Embryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EM1_REC The*Broad*Institue PWD*x*B6 E7.5*Embryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EM2 The*Broad*Institue B6*x*PWD E7.5*Embryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EM2_REC The*Broad*Institue PWD*x*B6 E7.5*Embryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EM3 Umass*Genomics*Core B6*x*PWD E7.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E75EM3_REC Umass*Genomics*Core PWD*x*B6 E7.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E75EX1 The*Broad*Institue B6*x*PWD E7.5*ExtraNembryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EX1_REC The*Broad*Institue PWD*x*B6 E7.5*ExtraNembryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EX2 The*Broad*Institue B6*x*PWD E7.5*ExtraNembryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EX2_REC The*Broad*Institue PWD*x*B6 E7.5*ExtraNembryonic TruSeq*Strand*Specific*mRNA*Pipeline HighSeq*2500
E75EX3 Umass*Genomics*Core B6*x*PWD E7.5*ExtraNembryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E75EX3_REC Umass*Genomics*Core PWD*x*B6 E7.5*ExtraNembryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E85EM1 Umass*Genomics*Core B6*x*PWD E8.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E85EM1_REC Umass*Genomics*Core PWD*x*B6 E8.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E85EM2 Umass*Genomics*Core B6*x*PWD E8.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E85EM2_REC Umass*Genomics*Core PWD*x*B6 E8.5*Embryonic TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135SP1 Umass*Genomics*Core B6*x*PWD E13.5*Spongiotrophic*placenta TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135SP2 Umass*Genomics*Core B6*x*PWD E13.5*Spongiotrophic*placenta TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135VE1 Umass*Genomics*Core B6*x*PWD E13.5*YolkSac*Visceral*Endoderm TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135VE2 Umass*Genomics*Core B6*x*PWD E13.5*YolkSac*Visceral*Endoderm TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135ME1 Umass*Genomics*Core B6*x*PWD E13.5*Yolk*Sac*Mesoderm TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E135ME2 Umass*Genomics*Core B6*x*PWD E13.5*Yolk*Sac*Mesoderm TruSeq*LT*mRNA*Strand*Specific*(RSN122N2101) NextSeq*500
E75EMme1 Umass*Genomics*Core B6*x*PWD E7.5*Embryonic TruSeq*DNA*methylation*(EGMK81312) NextSeq*500
E75EMme2 Umass*Genomics*Core B6*x*PWD E7.5*Embryonic TruSeq*DNA*methylation*(EGMK81312) NextSeq*500
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Figure 4.3. Imprinted expression during mouse gastrulation. Analysis of 189 imprinted genes 
assembled from literature and 6 novel loci. A) Proportion of imprinted, strain-specific, and 
biallelic genes in E6.5 epiblast and visceral endoderm, E7.5 embryonic and extra-embryonic 
tissue, and E8.5 embryonic tissue. Imprinted expression was classified as genes with log2 (fold 
change) greater than 2 (greater than 80%) for one parental allele.  Strain-specific expression has a 
log2(FC) greater than 2 for one allele, but in the reciprocal cross the same allele is still expressed. 
Biallelic expression are those genes that do not meet the log2(FC) criteria. We also define genes 
with a strain-specific bias; that is expression greater than 60% one allele that is not due to parent-
of-origin. B). Heat map of allele-specific expression of known and novel imprinted genes that are 
expressed during gastrulation (n=195). The y-axis is clustered based on allelic expression bias. 
Genes fall into the following categories: Biallelic/biased expression (including strain-specific 
bias), maternal expression, dynamic maternal expression, strain-specific expression, and paternal 
expression. Heat map is colored for allelic bias rather than expression level (Red= Maternal, 
Blue= Paternal, Black= Biallelic). Red asterisks indicate novel imprinted genes identified during 
this study.  
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Figure 4.4. Validation of Dlk1/Dio3 cluster gastrulation expression. 
A). RT-PCR expression panel of Dlk1/Dio3 cluster genes in gastrulation tissues, with ActB 
serving as a loading control. B). Sanger sequencing traces of gastrulation expression for Dio3, 
Dlk1, Meg3 and Rian in BxP-F1 gastrulation tissues (E6.5 epiblast (EPI) and visceral endoderm 
(VE), E7.5 embryonic (EM) and extra-embryonic (EX), and E8.5 embryonic (EM) and extra-
embryonic (EX)). Blue line indicates polymorphic base.  
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Table 4.2 Novel imprinted genes identified and validated in this project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symbol Name Feature.Type Expression Chr Strand Start End Ensembl.ID
Col3a1 collagen,)type)III,)alpha)1 protein)coding)gene Maternal 1 + 45311538 45349706 ENSMUSG00000026043
Des desmin protein)coding)gene Maternal 1 + 75360329 75368579 ENSMUSG00000026208
Rgs2 regulator)of)GGprotein)signaling)2 protein)coding)gene Maternal 1 G 143999338 144004161 ENSMUSG00000026360
A2m alphaG2Gmacroglobulin protein)coding)gene Maternal 6 + 121635376 121679227 ENSMUSG00000030111
Dmkn dermokine protein)coding)gene Maternal 7 + 30763756 30781063 ENSMUSG00000060962
Sbsn suprabasin protein)coding)gene Maternal 7 + 30751471 30756134 ENSMUSG00000046056
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Figure 4.5. Tissue validation and developmental profiling of the embryonic gastrulation 
lineage. A). Plot of FPKM values for genes with higher expression in the E6.5 epiblast compared 
to the E8.5 embryonic tissue. B). Plot of FPKM values for genes with lower expression in the 
E6.5 epiblast compared to the E8.5 embryonic tissue. Note that the E7.5 and E8.5 PxB-F1 cross 
(REC) stages younger relative to the comparable BxP-F1 cross of those stages.  
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Figure 4.6. Validation of novel imprinted genes during gastrulation. A). RT-PCR expression 
of novel imprinted genes in gastrulation tissues. B). Electropherograms allow for assessment of 
allelic expression in BxP-F1 gastrulation tissues (E6.5 epiblast (EPI) and visceral endoderm (VE), 
E7.5 embryonic (EM) and extra-embryonic (EX), and E8.5 embryonic (EM) and extra-embryonic 
(EX)). Blue line indicates polymorphic base. Parental alleles are labeled. 
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Figure 4.7. Validation of novel gastrulation imprinting using inbred laboratory strains. A). 
Closely related strains (C57Bl/6J and DBA/2J) were bred to produce F1-hybrid embryos. B). RT-
PCR expression panel of novel imprinted genes in gastrulation tissues, with ActB serving as a 
loading control. C). Sanger sequencing validation of gastrulation tissues of inbred laboratory 
strains DBA/2J and C57Bl/6J (DxB-F1) (E6.5 epiblast (EPI) and visceral endoderm (VE), E7.5 
embryonic (EM) and extra-embryonic (EX), and E8.5 embryonic (EM) and extra-embryonic 
(EX)). Blue line indicates polymorphic base. Parental alleles are as labeled. Note that there are no 
useable polymorphisms between DBA/2J and C57Bl/6J in A2m, Des, or Rgs2.  
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Figure 4.8. Validation of E13.5 extra-embryonic lineage tissues. ActB validation for maternal 
tissue contamination. Note the trophoblast placenta was not used for sequencing because of high 
maternal (C>T) tissue contamination. The spongiotrophic placenta (SP), yolk sac visceral 
endoderm (YVE), and yolk sac mesoderm (YME) all have equal allelic (C=T) contribution, 
suggesting clean dissection. 
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Figure 4.9. Imprinted expression in E13.5 extra-embryonic tissues. A). Proportion of 
imprinted and biallelic genes in E13.5 spongiotrophoblast, yolk sac visceral endoderm, and yolk 
sac mesoderm. Imprinted expression was classified as genes with log2 (fold change) greater than 
2 (greater than 80%) for one parental allele.  Strain-specific expression has a log2(FC) greater 
than 2 for one allele, but in the reciprocal cross the same allele is still expressed. Biallelic 
expression are those genes that do not meet the log2(FC) criteria. We also define genes with a 
strain-specific bias; that is expression greater than 60% one allele that is not due to parent-of-
origin. Strain-specific genes identified in Figure 2 were removed from this analysis.  B). Heat 
map of allele-specific expression of known and novel imprinted genes that are expressed in E13.5 
tissues. The y-axis is clustered based on allelic expression bias. Genes fall into the following 
categories: Biallelic/biased expression (including strain-specific bias), maternal expression, 
dynamic maternal expression, and paternal expression. Heat map is colored for allelic bias rather 
than expression level (red= maternal, blue= paternal, black= biallelic). Red asterisks indicate 
novel imprinted genes identified during this study.  
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Figure 4.10. Validation of novel imprinted genes in E13.5 extra-embryonic lineage tissues. 
A). RT-PCR of novel imprinted genes in the trophoblast placenta (TP), spongiotrophic placenta 
(SP), yolk sac visceral endoderm (YVE), and yolk sac mesoderm (YME) showing differential 
expression of novel imprinted genes. B). Sanger sequencing validation of BxP-F1 tissue 
differential maintenance of imprinted expression for Col3a1 and Sbsn.  
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Figure 4.11. Validation of novel imprinted genes in adult tissues. A). RT-PCR of novel 
imprinted genes in adult PxB-F1 tissues including brain (female), eye, heart, intestine, kidney, 
liver, lung, skeletal muscle, spleen, stomach, thymus, tongue, uterus, ovary, and testis. B). Sanger 
sequencing validation of adult expression. Blue line indicates polymorphic base. Parental alleles 
are labled. Red box- imprinted expression of Dmkn in the adult eye.  
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Table 4.3. Location of E7.5 embryonic intermediate DNA methylation sites identified via 
WGBS. Asterisks indicate known imprinted genes containing previously identified DMRs/ICRs. 
 
 
 
 
 
 
 
 
 
 
 
Gene$Locus Chr Start End Window$Length #$CpG CpG/100bp Gene$Locus Chr Start End Window$Length #$CpG CpG/100bp
A830018L16Rik chr1 11620559 11622982 2423 25 1.03177879 ! chr8 27317969 27319429 1460 23 1.57534247
! chr1 16762196 16763867 1671 26 1.55595452 ! chr8 30711487 30711765 278 22 7.91366906
Adgrb3 chr1 25526016 25527180 1164 22 1.89003436 ! chr8 66596807 66597845 1038 12 1.15606936
! chr1 26899957 26900873 916 12 1.31004367 ! chr8 73494198 73496548 2350 24 1.0212766
! chr1 27179410 27180519 1109 25 2.25428314 ! chr8 80365014 80365742 728 17 2.33516484
Zdbf2* chr1 63249419 63251488 2069 21 1.01498308 Cdh9 chr8 90886879 90887623 744 49 6.58602151
Zbdf2* chr1 63261379 63262564 1185 25 2.10970464 A330008L17Rik chr8 99421497 99422670 1173 18 1.53452685
Zranb3 chr1 128038574 128039152 578 31 5.3633218 ! chr8 107940525 107942276 1751 21 1.19931468
Brinp3 chr1 146817496 146820213 2717 28 1.0305484 ! chr8 107945590 107947101 1511 24 1.58835208
Dnm3 chr1 162120280 162120623 343 25 7.28862974 = chr8 123537378 123538003 625 29 4.64
! chr1 185155421 185155858 437 24 5.49199085 = chr8 123538062 123538609 547 17 3.10786106
Camk1d chr2 5483400 5484251 851 24 2.82021152 = chr9 44767845 44768780 935 25 2.67379679
Malrd1 chr2 16027296 16028396 1100 48 4.36363636 ! chr9 48518675 48520586 1911 24 1.25588697
! chr2 144156379 144157835 1456 25 1.71703297 Smad6 chr9 63953811 63954247 436 26 5.96330275
! chr2 150526118 150526758 640 25 3.90625 Myo6 chr9 80173787 80174913 1126 17 1.50976909
H13* chr2 152686735 152687077 342 29 8.47953216 Tgdf1 chr9 110945457 110946002 545 26 4.7706422
Mcts2*/H13* chr2 152687136 152687224 88 14 15.9090909 Sash1 chr10 8877860 8878925 1065 25 2.34741784
a chr2 155016995 155018372 1377 25 1.81554103 Camk2b chr11 6007342 6007450 108 17 15.7407407
Blcap*/Nnat* chr2 157560791 157561802 1011 38 3.7586548 Grb10* chr11 12026454 12026782 328 29 8.84146341
Nespas* chr2 164507631 164507789 158 14 8.86075949 ! chr11 40990349 40991749 1400 16 1.14285714
Nespas* chr2 174283765 174284283 518 22 4.24710425 Hs3st3b1 chr11 63889236 63889417 181 17 9.39226519
Nespas/Gnas* chr2 174284494 174285192 698 56 8.02292264 Srcin1 chr11 97552533 97553850 1317 25 1.89825361
Nespas/Gnas* chr2 174286218 174286718 500 21 4.2 Rara chr11 98968864 98969623 759 25 3.29380764
Gnas* chr2 174295453 174295848 395 19 4.81012658 ! chr11 101937437 101938157 720 25 3.47222222
Gnas* chr2 174298551 174298699 148 19 12.8378378 ! chr12 14494609 14494787 178 11 6.17977528
Gnas* chr2 174298833 174299202 369 24 6.50406504 Meg3* chr12 109541867 109542949 1082 29 2.68022181
Gnas* chr2 174299223 174299637 414 28 6.76328502 Rian* chr12 109612894 109613111 217 17 7.83410138
Gnas* chr2 174300257 174300620 363 30 8.26446281 ! chr12 117807757 117808563 806 25 3.10173697
Gnas* chr2 174327908 174328544 636 34 5.34591195 Ero1lb chr13 12603031 12604026 995 11 1.10552764
! chr3 21689040 21690082 1042 24 2.30326296 4930586N03Rik chr13 23325463 23326270 807 16 1.9826518
! chr3 97144482 97145522 1040 11 1.05769231 ! chr13 45010820 45011525 705 25 3.54609929
! chr3 124384544 124385636 1092 20 1.83150183 2410141K09Rik chr13 66418639 66419393 754 26 3.44827586
! chr3 137600308 137600773 465 24 5.16129032 ! chr13 87327735 87329834 2099 25 1.19104335
! chr4 7355341 7356380 1039 23 2.21366699 ! chr13 91339614 91340301 687 24 3.49344978
! chr4 8394253 8396312 2059 34 1.65128703 ! chr13 104883445 104883912 467 17 3.64025696
! chr4 41781763 41782611 848 24 2.83018868 ! chr14 6425611 6426476 865 25 2.89017341
Hivep3 chr4 120110768 120111313 545 14 2.56880734 Lats2 chr14 57732654 57734261 1607 24 1.49346609
! chr4 124358300 124358575 275 19 6.90909091 Gm5088 chr14 89898843 89898984 141 17 12.0567376
Abcd1a chr5 8711650 8712074 424 25 5.89622642 ! chr14 114205437 114208793 3356 48 1.43027414
Actr3b chr5 25768874 25768991 117 18 15.3846154 Itgbl1 chr14 123723238 123723625 387 23 5.94315245
! chr5 40718202 40719226 1024 13 1.26953125 ! chr15 12631790 12632160 370 21 5.67567568
Gm7056 chr5 89620522 89621574 1052 28 2.66159696 ! chr15 36573569 36573940 371 25 6.73854447
! chr5 132729108 132729988 880 24 2.72727273 Trsp1 chr15 50869707 50870671 964 27 2.80082988
Mest* chr6 30732821 30733535 714 25 3.50140056 Peg13*,TTrappc9* chr15 72809183 72810037 854 50 5.85480094
Mest* chr6 30737996 30738325 329 37 11.2462006 Slc38a4* chr15 97054291 97054891 600 39 6.5
! chr6 47759610 47761294 1684 21 1.24703088 ! chr15 99665201 99666094 893 25 2.79955207
Zfp777 chr6 48024761 48025234 473 34 7.18816068 ! chr16 8769390 8770889 1499 25 1.66777852
Nap1l5*,THerc3* chr6 58906508 58906928 420 32 7.61904762 ! chr16 51093908 51094447 539 21 3.8961039
! chr6 66875601 66876863 1262 25 1.98098257 ! chr16 70175373 70177778 2405 25 1.03950104
Lrrtm4 chr6 80019442 80019828 386 12 3.10880829 Tmprss15 chr16 78972476 78973844 1368 17 1.24269006
! chr6 89835552 89835834 282 23 8.15602837 ! chr16 90514707 90515276 569 25 4.39367311
! chr6 90233642 90235950 2308 24 1.03986135 Igf2r*,Airn* chr17 12742376 12742949 573 24 4.18848168
! chr6 114548999 114550085 1086 17 1.56537753 ! chr17 27855636 27856473 837 27 3.22580645
! chr6 114556445 114557533 1088 19 1.74632353 ! chr18 30267066 30267804 738 54 7.31707317
March8 chr6 116354243 116356731 2488 25 1.00482315 ! chr19 5406384 5406721 337 22 6.52818991
Prp2 chr6 132599636 132600514 878 18 2.0501139 ! chr19 9836241 9836861 620 24 3.87096774
Peg3* chr7 6729900 6730099 199 11 5.52763819 Slc5a3 chr19 10842710 10843399 689 29 4.20899855
! chr7 10325435 10325908 473 25 5.28541226 ! chr19 21737029 21737925 896 24 2.67857143
! chr7 18464429 18464756 327 25 7.64525994 1700028P14Rik chr19 23619438 23620064 626 27 4.31309904
Apoe* chr7 19696771 19697186 415 27 6.5060241 ! chr19 40761551 40762420 869 26 2.99194476
! chr7 23476932 23477160 228 11 4.8245614 Slit1 chr19 41743708 41744633 925 27 2.91891892
Nphs1 chr7 30459545 30460359 814 17 2.08845209 ! chr19 44649941 44650238 297 14 4.71380471
! chr7 33829726 33830627 901 25 2.77469478
! chr7 39587302 39588640 1338 24 1.79372197
! chr7 47795159 47796155 996 17 1.70682731
! chr7 53776123 53778688 2565 26 1.01364522
Gabrg3* chr7 57374040 57374404 364 25 6.86813187
! chr7 102622438 102624760 2322 25 1.07665805
! chr7 103487565 103488678 1113 16 1.43755615
! chr7 104118662 104120476 1814 26 1.43329658
Inpp5f* chr7 128687970 128688483 513 43 8.38206628
H19* chr7 142580201 142581794 1593 47 2.95040804
DMR$Window DMR$Window
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Figure 4.12. Identification of potential DMRs in the E7.5 embryonic mouse genome. We 
identified 134 regions of intermediate DNA methylation at E7.5 A) Violin plot of 134 E7.5 
DMRs relative to the distance from literature identified DMRs (Table 4.2). The red box highlights 
overlapping regions. B) Violin plot of known and novel imprinted genes that are imprinted in 
E7.5 embryonic tissue, and control biallelic expressed genes plotted against distance to 134 
DMRs. This highlights 2 categories of imprinted genes: genes that are associated with DMRs and 
genes that are not. 
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CHAPTER 5 
DISCUSSION: EXPLORING THE BIGGER PICTURE 
5.1 Forward 	   The goal of this work has been to better understand the imprinted expression and 
epigenetic regulation that occurs during the early stages of mammalian development. 
Specifically, I’ve aimed to identify the often subtle, but important lineage-specific and time-
dependent expression of known and novel imprinted genes. This work raises additional questions 
about the regulation of imprinted expression and how imprinting might have evolved in placental 
mammals. Additionally, the dynamics of imprinted expression are critical for reprogramming 
efforts including cloning and induced pluripotency. In this chapter, I will frame the work 
presented above in the context of our larger understanding of imprinted expression and epigenetic 
reprogramming. 
5.2 Summary and impact of the work presented in this dissertation 
 This thesis began with the characterization of the role of Sox4 in preimplantation 
development. Our goal was to understand how reduction of Sox4 leads to loss of imprinting. The 
loss of imprinted expression associated with Sox4 knockdown was robust. Surprisingly, when we 
looked at imprinted expression in a Sox4 knockout model, we found normal imprinted expression. 
This work has highlighted how in vitro and in vivo imprinting dynamics can differ and how in 
vitro culture of embryos can lead to loss of imprinted expression (Chapter 2, Appendix A). Other 
groups have also characterized loss of imprinting under certain conditions; this loss can occur in a 
locus-specific and tissue-specific manner. This hints at the differences in epigenetic silencing 
between known imprinted genes as well as the same imprinted loci between tissues (Doherty et 
al. 2000; Mann et al. 2004; Market-Velker et al. 2010; Market Velker et al. 2012; Huntriss et al. 
2013).  
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 Even though there are discrepancies between the knockdown and knockout models, it is 
still important to consider the role Sox4 plays in imprinted expression regulation. Additionally, 
this system can be used to identify differences in epigenetic mechanisms at both canonical and 
non-canonical imprinted sites in in vivo and in vitro contexts. It would be interesting to determine 
if Sox4 knockdown alters imprinted expression of non-canonical imprinted genes. It will also be 
valuable to determine if Sox4 knockout embryos also undergo loss of imprinting when cultured in 
vitro.  
 Following the Sox4 work, I transitioned to identifying the lineage-specific expression 
dynamics of the well-characterized Igf2r/Airn locus during gastrulation (Szabo and Mann 1995; 
Lerchner and Barlow 1997; Yamasaki et al. 2005; Latos et al. 2009; Latos et al. 2012; Marcho et 
al. 2015). Even though the Igf2r/Airn cluster was one of the first identified imprinted cluster in 
the mouse genome, the detailed expression dynamics during gastrulation was not well-
characterized. The expression during this window was largely assumed based on in vitro work on 
ES cells (Latos et al. 2009). Given the fact that in vitro imprinting dynamics can be altered 
compared to in vivo, we felt is was imperative to closely examine expression during gastrulation. 
We were able to show that the pluripotent epiblast displays biallelic expression of Igf2r, while the 
non-coding RNA Airn is not expressed. In the differentiated extra-embryonic tissue, imprinted 
expression is already established. As gastrulation lineage decisions are made in the epiblast, 
imprinted expression is established for both Igf2r and Airn (Marcho et al. 2015).  This indicated 
that there are distinct mechanisms between the two lineages and that imprinted expression 
appears to be linked to the developmental potential of the cell type; differentiation leads to 
imprinted expression of the Igf2r and Airn.  
 The dynamic imprinted expression of Igf2r and Airn during gastrulation lead us to 
characterize imprinted expression across the entire genome at this time. When we started this 
project, there were approximately 150 known imprinted genes in the mouse genome. Using the 
same site-specific characterization approach would be laborious and resource intensive. Instead, 112
	  	  
we chose to perform allele-specific RNA sequencing (RNA-seq) during gastrulation and in E13.5 
tissues. This allowed us to identify imprinted expression across the entire genome in an unbiased 
manner. In addition to characterizing imprinted expression of known imprinted genes (the 
number of which has grown to over 300 genes since starting this project), we were also able to 
discover novel imprinted expression. The novel imprinted genes identified as part of this thesis, 
as well as the additional imprinted genes identified in other RNA-seq screens, appear to be 
regulated by an alternative mechanism and not by differential DNA methylation (Babak et al. 
2015; Bonthuis et al. 2015; Crowley et al. 2015). Both the Igf2r/Airn and allele-specific RNA 
sequencing projects highlight the need for detailed characterization of gene expression, even for 
relatively well-characterized imprinted clusters.  
Taken together, this thesis begins to define the additional, overlooked imprinted 
phenomenon during early mouse development. Below, I will outline some of the major 
implications for this work, as well as propose hypotheses for how the recently identified novel 
imprinted expression might be regulated and function within the genome. 
5.2.1 Defining canonical and non-canonical imprinted expression 
 As detailed in Chapter 1.4, genomic imprinting is mono-allelic expression that is 
regulated by layers of epigenetic modifications. The canonical mechanism for imprinted 
expression is differential DNA methylation (DMRs) that is derived for the gametes (known as the 
imprinting control region (ICR)) and persists during reprogramming. Imprinted expression was 
initially thought to largely occur in imprinted clusters, often with a non-coding RNA that is 
regulated by the ICR and, in turn, regulates the rest of the genes in the cluster. Differential protein 
binding and histone modification, along with secondary DMRs, add additional layers of 
regulation. Together, this makes up the mechanism by which imprinting is thought to occur; 
however, there have recently been challenges to this canonical imprinting mechanism.  
Many newly identified imprinted genes, including those identified in this thesis, do not fit 
this model for imprinted expression. In this work, I have referred to these genes as ICR-113
	  	  
independent imprinted genes, a subset of non-canonical imprinted phenomenon. Non-canonical 
imprinting, as I have defined it, is imprinted expression that does not appear to be controlled by 
ICR methylation. Likely, they are regulated by differential histone enrichment, alternative protein 
binding, or differences in the local and global 3-dimension structure of the chromosome (Inoue et 
al. 2017). These non-canonical imprinted genes are often singletons, not associated with other 
imprinted genes or non-coding RNAs as part of a larger imprinted cluster. Additionally, they 
appear to have tissue-specific or transient imprinted expression. Recently sequencing efforts, 
including our work here, have identified multiple genes that fall within this category of imprinted 
expression (Babak et al. 2015; Bonthuis et al. 2015; Crowley et al. 2015; Inoue et al. 2017). To 
date, these genes do not appear to be regulated by differential methylation. 
 This means that there are alternative mechanisms that can serve as the “imprint” marking 
the two parental alleles. Recent work shows that histone modifications enriched on the maternal 
allele can be serve as the mark. Oocyte-specific H3K27me3 restricts imprinted expression of a 
subset of genes on the maternal allele during preimplantation development, leading to paternal 
expression during this time (Inoue et al. 2017). We found that the novel H3K27me3-regulated 
imprinted genes are largely biallelic during gastrulation. This indicates that the differential 
epigenetic mark is not maintained during preimplantation reprogramming; however, there is one 
gene from this study that maintains imprinted expression in our dataset, which shows that 
differential histone marks arriving in the gametes can persist past implantation.  Currently, there 
has not been identification of any additional histone mark that can serve as the primary driver of 
imprinted expression, but it is likely that there are others that can function as the imprinting mark. 
Evaluating gastrulation stages when there is a high level of overall imprinted expression, 
including non-canonical imprinted expression, may help elucidate alternative mechanisms for 
imprinted expression; there are more loci to examine, which may provide consistency of 
epigenetic signatures such as specific histone modifications. 
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 Importantly, it is becoming clear that imprinted expression occurs on a spectrum from 
strict mono-allelic expression to allele-specific preference (Figure 5.1). Many imprinted genes 
have variable imprinted expression depending on the developmental stage or tissue type. In fact, 
the number of canonically regulated, ubiquitously imprinted genes is relatively low (Babak et al. 
2015). Most imprinted genes that have been identified have some degree of tissue specificity. 
Chapter 3 outlines imprinted expression that is canonically regulated but that has tissue-specific 
and time-dependent establishment. We found that imprinted expression of the Igf2r/Airn cluster is 
linked to a more differentiated state (Marcho et al. 2015). This expression is more dynamic than 
the strict mono-allelic expression that has been identified for only a limited number of imprinted 
genes. 
 On the other end of the spectrum is non-canonical imprinting and allele-specific 
preference. In both cases, imprinted expression does not appear to be regulated by ICRs/DMRs. 
The non-canonical imprinted genes that we have identified have strong, but transient, mono-
allelic expression.  Recently identified imprinted genes also have similar expression; they are 
either highly tissue specific (i.e. only in subpopulation of brain cells) or are transient (i.e. only 
during preimplantation development) (Babak et al. 2015; Bonthuis et al. 2015; Inoue et al. 2017). 
In Chapter 4, I identified and characterized additional non-canonical imprinted genes that have 
imprinted expression largely restricted to gastrulation development and some extra-embryonic 
lineages. These genes are bona fide imprinted genes. When imprinted, they are expressed solely 
from one allele in a parent-of-origin manner. 
 Additionally, groups have identified genes that have a parent-of-origin preference (Babak 
et al. 2015; Crowley et al. 2015). Crowley and colleagues claimed to have identified additional 
novel imprinted genes; however, many of the novel imprinted genes identified are only biased in 
their parent-of-origin expression. The novel imprinted loci the group identified only have a 1-5% 
bias towards one parental allele. In fact, they call genes with 50.6% expression from one allele 
imprinted (Crowley et al. 2015). For our work, we required expression to be strongly mono-115
	  	  
allelic (approximately >80% one allele) in order to be called imprinted. It is important to note that 
while these genes would not be imprinted by our definition, the allele-specific bias is consistent in 
all of the 3x3 diallelic crosses examined, suggesting the allele-specific bias is a parent-of-origin 
phenomenon (Crowley et al. 2015). Still, parent-of-origin bias is distinct from mono-allelic 
expression found at imprinted loci. 
Bonthuis and colleagues also identified genes that had maternal or paternal biases. This 
group defied this expression as non-canonical imprinting effects. They found hundreds of genes 
with a parent-of-origin bias. This expression was highly tissue specific; while the parent-of origin 
effect was prevalent in specific regions of the brain, it was rare in the liver and skeletal muscle. 
Interestingly, these genes also have allele-specific enrichment of histone modifications (Bonthuis 
et al. 2015). This suggests that the epigenetic modifications are not equivalent at sites with allele-
specific biases and that this can occur in a tissue-specific manner. 
This newly defined spectrum of parent-of-origin expression should be the lens by which 
imprinted expression is viewed. Imprinted genes regulated by canonical mechanisms will benefit 
from a through examination, similar to our work with Igf2r and Airn. In fact, there is still work to 
be pursued at the Igf2r/Airn cluster. We would like to be able to identify the requirements of 
DNA methylation spreading at the locus during gastrulation, determine what drives tissue-
specific DNA methylation acquisition at DMR1, characterize the tissue-specific role of Airn, and 
identify a potential function for CTCF at the locus. Additionally, examination of non-canonical 
imprinted genes will further our understanding of allele-specific regulation and the epigenetic 
landscape during development and in terminally differentiated lineages.  
By comparing and contrasting the different forms of parent-of-origin expression, we 
might be able to better understanding of how genomic imprinting evolved and how imprinting 
can be used to improve reprogramming efforts. Below I will describe how canonical and non-
canonical imprinting can be used to further understand those points, as well as describe the future 
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5.2.2 Evolution of imprinting in the context of novel imprinted expression 
The general characteristics of imprinted expression suggest potential evolutionary 
explanations for how imprinted evolved. Imprinting itself seems to be at odds with fitness; 
diploid organisms forgo the benefits of having two functional copies of a gene in favor of 
silencing one copy. Importantly, imprinted expression is found for a small number of genes in 
therian mammals and angiosperms. Even though therian mammals and angiosperms are from 
divergent phylogenies, they share common features, including the development of extra-
embryonic support tissues. For both groups, incidence of imprinted expression is higher in the 
extra-embryonic tissue compared to the embryo proper. This suggests a relationship between the 
accessory tissues, the parental tissues, and the evolution of genomic imprinting. There is also 
evidence, although less compelling, that social insects might also undergo genomic imprinting.  
Additionally, imprinted expression is conserved within a species, but often not across 
species. While there are overlaps in imprinted expression between mouse and humans, the two 
species also have distinct imprinted genes as well (Babak et al. 2015; Baran et al. 2015). Also, 
there is often variable imprinted expression between tissues of individual organisms (Babak et al. 
2015; Bonthuis et al. 2015; Crowley et al. 2015; Marcho et al. 2015).  The presence of both 
conserved and divergent imprinted genes between species raises the question of how imprinted 
expression evolved. The most frequently cited hypothesis for how imprinted expression arose is 
the parental conflict hypothesis (also known as kinship hypothesis) described by David Haig 
(Haig 2000a; Haig 2000b).  
The parental conflict hypothesis suggests that imprinted expression was selected for 
based on differing benefits between the maternal and paternal genomes. In this way, canonically 
imprinted genes often function to regulate neonatal growth and post-natal care behaviors (Barlow 
and Bartolomei 2014). The idea is that paternally expressed genes function to maximize maternal 
resources to the embryo, regardless of the detriment to fitness of the mother. To counteract this, 
the maternally expressed genes repress growth and balance nutrient acquisition between all 117
	  	  
embryos. Imprinted genes involved in behavior are often associated with maternal care and 
suckling behavior; both behaviors influence growth, development, and ultimately fitness of the 
litter.  
A clear example used to illustrate this hypothesis is the reciprocal imprinting of Igf2 and 
its receptor Igf2r. Igf2 is paternally expressed and functions as a growth factor during embryo 
development. On the other hand, Igf2r is a receptor that removes Igf2 from circulation, degrading 
it within the cell. This acts to restrict growth. Together, the genes balance the growth of the 
embryo; the paternal genome would benefit from the largest amount of growth and resources, 
whereas the maternal genome needs to balance resource between all of the embryos. 
Misexpression of either gene leads to growth phenotypes.  
Many tissue-specific, non-canonically imprinted genes are not involved with either 
growth or post-natal behavior, challenging the parental conflict hypothesis. The novel imprinted 
genes we identified in Chapter 4 do not have characterized functions for growth of maternal care 
behaviors (Milner et al. 1996; Liu et al. 1997; Umans et al. 1999; Oliveira-Dos-Santos et al. 2000; 
Bazzi et al. 2007; Cooper et al. 2010; Tsang et al. 2010; Smith et al. 2011; Leclerc et al. 2014); 
Rgs2 is involved with behavior phenotypes, but not any that fit the parental conflict hypothesis; it 
is suggested to be involved with male aggression and anxiety in mice (Oliveira-Dos-Santos et al. 
2000)). Additionally, all but Sbsn have been knocked out in mice and none show overt growth 
phenotypes. In addition to the novel imprinted genes identified in this thesis, recently identified 
imprinted loci from other groups also do not fit the parental conflict hypothesis. The novel 
imprinted genes might, instead, support an alternative hypothesis for the function of imprinted 
genes (Spencer and Clark 2014). 
It is important to note that while the parental conflict hypothesis is frequently cited (and 
often times sounds like the most clear and compelling hypothesis), there are multiple hypotheses 
for how imprinting might have evolved (Haig 2014; Patten et al. 2014; Spencer and Clark 2014; 
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pressures and multiple hypotheses are likely necessary to describe the spectrum of imprinted 
phenomena as described in Section 5.2.1.   
 Evolution of imprinted expression can be informed by the fact that we have defined a 
spectrum of imprinted phenomena. It is easy to imagine how imprinting likely arose from parent-
of-origin expression preferences resulting from incomplete reprogramming of the epigenomes 
during development and gametogenesis or differences between local and global architecture of 
both alleles. Selective pressures potentially drive maintenance of the allele-specific bias. 
Advantageous expression biases (driven by one or more of the potential hypotheses for imprinted 
expression evolution) and the acquisition of additional silencing epigenetics marks ultimately 
lead to canonical imprinted expression. This has occurred for a small fraction of the total number 
of transcripts in genomes that undergo genomic imprinting. Even the number of genes with 
parental preference expression, which is greater than the number of imprinted genes (both 
canonical and non-canonical), indicates parent-of-origin expression is rare (Bonthuis et al. 2015; 
Crowley et al. 2015). Comparing the mechanism of canonical and non-canonical imprinted 
expression to genes with a parent-of-origin bias might help to better understand the potential 
earlier evolutionary steps of imprinted expression. Additionally, while there have been no 
documented instances of imprinted expression in monotremes (egg laying mammals), it would be 
interesting to see if there is the presence of parent-of-origin preferences in genes expression by 
which selection could act upon (Renfree et al. 2009) 
 It is also interesting to speculate on the ancestral and derived states of imprinted genes 
between species. It might seem be the case, as eluded to earlier, that non-canonical imprinted 
expression is the more ancestral state of imprinted expression; however, it is important to 
remember that non-canonical imprinted expression is generally not concerned between species 
and likely arose independently in individual lineages. Additionally, canonically imprinted genes 
are more likely to be conserved, there are still differences between species. More empirical work 
is needed in order to characterize imprinted expression across multiple species. Even still, there 119
	  	  
are compelling examples of the potential ancestral and derived states of some imprinted genes 
based on comparisons between mouse and human. For example, Igf2r imprinted expression arose 
following the divergence of monotremes and therian mammals, suggesting imprinted expression 
is the derived state in mammals. In mice, Igf2r is imprinted in most tissues. The tissue-specific 
dynamics during gastrulation have been characterized in this thesis (Marcho et al. 2015). 
Additionally, Igf2r imprinting is relaxed in the mouse brain (Yamasaki et al. 2005). In humans 
and other euarchonta, imprinted expression of Igf2r is lost. This suggests that Igf2r become 
imprinted upon the divergences monotremes and therian mammals and then lost upon the 
divergences of euarchonta from other placental mammals. The loss of Igf2r imprinting might be 
correlated with the a decrease in litter size; mammals that can have larger litters and multiple 
paternities within a litter might have selective pressure to maintain imprinted Igf2r expression. 
Applying the same logic of comparing expression, function, and regulation of imprinted 
genes across species might aid in elucidating and differentiating the selective pressures that lead 
to the evolution of genomic imprinting events. Just like imprinting aided in our understanding of 
epigenetic regulation in general, it can also inform our understanding of the evolution of 
genomes, including regulatory elements, transposable elements, and the structure of the genome. 
5.2.3 Imprinting and reprogramming 
Since the discovery of imprinted phenomenon, imprinted expression has been a useful 
tool for understanding the epigenetic regulation of the genome at large. For example, studying 
imprinted mechanisms has provided evidence for how gene expression, in general, is regulated, 
how non-coding RNAs can function to regulate expression, and what epigenetic modification can 
control active and repressive states of the genome (Barlow 2011; Bartolomei and Ferguson-Smith 
2011). Specifically, appropriate imprinted expression has proven to be a critical component for 
understanding and improving reprogramming efforts; misregulation of imprinted expression often 
leads to reprogramming failure. Understanding the mechanisms of transient, developmentally 
restricted, non-canonical imprinted genes may help in reprogramming efforts (such as induced 120
	  	  
pluripotent stem cells (iPSCs) and somatic cell nuclear transfer (SCNT)) by providing an 
important epigenetic read-out of reprogramming fidelity.  
Historically, imprinted expression has demonstrated to be a challenge for reprogramming 
efforts. While we know cloning is possible now, it had seemed for a while that the mammalian 
genome was not amenable to cloning techniques. During the 1980’s through the late-1990’s, 
groups pushed to successfully achieve nuclear transfer, which had been demonstrate in frogs 
decades before (Gurdon and Byrne 2003; Gurdon et al. 2003). It was identified that nuclear 
transfer was possible in mouse, but this was followed by details of its limitations (McGrath and 
Solter 1983). The first big success came in 1996, when Campbell and colleagues successfully 
cloned sheep from cultured embryonic cells (Campbell et al. 1996). The cloning of “Dolly” the 
sheep quickly followed (Wilmut et al. 1997). This breakthrough was remarkable because it 
showed that an adult, terminally differentiated nucleus could be used to generate a clone.  Still, 
both cloning successes, and all those that have followed, have proven to be extremely ineffective. 
This is largely due to incomplete epigenetic reprogramming, which is clear when imprinted genes 
and DNA methylation are analyzed in cloned embryos (Dean et al. 2001; Gurdon and Byrne 
2003; Matoba et al. 2018). 
Currently, canonical imprinted genes are used to assess the efficacy and quality of 
reprogramming by assessing appropriate imprinted expression and differential DNA methylation 
marks (Okita et al. 2007; Plasschaert and Bartolomei 2014). For example, the first descriptions of 
induced pluripotent stem cells derived from terminally differentiated adult cell types involved the 
assessment of the methylation status of important pluripotency related genes, like Oct4, Nanog, 
and Fbx15, as well as the imprinted genes Igf2r and H19 (Okita et al. 2007). This demonstrates 
that in vitro reprogramming can reverse some of the epigenetic changes that occur during 
development as cell are directed to a terminally differentiated state.  
Once additional mechanisms for tissue-specific and ICR-independent imprinting are 
identified, these loci will provide additional, and perhaps more sensitive, measures of epigenetic 121
	  	  
regulation during development and induced pluripotency. It is also important to understand the 
mechanism and function of lineage-specific imprinting when directing differentiation toward 
specific cell fates in vitro.  
Reprogramming technologies can feedback into our understanding of the biology of 
imprinting in different cell types. It would be interesting to see if in vitro differentiated cells 
maintain appropriate non-canonical imprinted expression or parental-specific biases. Using in 
vitro systems in concert with in vivo development can help to inform us on the requirements of 
non-canonical imprinted genes in specific cell types. For example, it would be interesting to see if 
parent-of-origin biases seen in the brain are established and maintained in iPSC-derived neurons. 
It would also be interesting to compare those induced neurons to iPSC-derived hepatocysts, 
which would be expected to have a limited bias (Bonthuis et al. 2015). For our novel imprinted 
genes, would in vitro differentiation of pluripotent cells lead to biallelic expression? Can inducing 
pluripotency lead to imprinted expression? Characterizing non-canonical imprinted expression 
and allele-specific preferences and identifying mechanisms will likely lead to improved 
differentiation technologies. 
5.3 Looking ahead 
 There needs to be continued efforts for detailing imprinting expression across 
mammalian genomes. This includes detailed tissue- and stage-specific expression analysis in 
mouse and humans, as well as other species. It is important to remember that non-canonical 
imprinted expression is often not conserved between mouse and humans (Babak et al. 2015; 
Baran et al. 2015). Work in mice will still provide useful information about the ICR-independent 
mechanisms for imprinted expression, which can hopefully be applied to imprinted loci of other 
species. Comparing species might allow for identification of a common regulatory theme, even if 
the loci are different. If the mechanisms were distinct, that would suggest divergent biology 
regulating imprinting and reprogramming. Both possibilities are exciting. 
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 The top candidate for ICR-independent mechanisms is differential histone enrichment 
coming from the sperm or the oocyte, which has already been demonstrated for some imprinted 
genes (Inoue et al. 2017). It will be interesting to see if additional histone marks can direct 
imprinted expression. While the paternal genome is largely wrapped around protamine, there are 
regions that retain histones, often at canonical imprinted loci. These histone-enriched regions may 
also regulate non-canonical imprinting as a germline inherited mark. Careful analysis of the 
structure and packaging of the paternal genome will be needed.  
Additionally, there might be differences during repackaging the paternal genome 
following fertilization that can persist during reprogramming. Establishment of histone marks, as 
well as global histone dynamics, during preimplantation development are distinct between the 
two parental alleles (Dahl et al. 2016; Liu et al. 2016; Lu et al. 2016; Wu et al. 2016; Zhang et al. 
2016; Zheng et al. 2016; Du et al. 2017) (Chapter 1.3.1).  It is possible that different histone 
marks are established during development in an allele-specific manner. That would mean that the 
primary epigenetic mark driving imprinted expression was not directly inherited from the oocyte 
or sperm; a mechanism that has yet to be demonstrated.   
 The 3-dimensional architecture of the genome might also play a role in non-canonical 
imprinting. Recent work looking at the topography of the genome in undifferentiated and 
differentiated cells indicated that the genome is localized into specific domains (Dixon et al. 
2012; Dixon et al. 2015; Du et al. 2017; Flyamer et al. 2017). It has also been shown that the two 
parental alleles are often not associated with each other in the nucleus (Du et al. 2017; Reichmann 
et al. 2018). It is possible the topography of the higher order chromatin structures, as well as the 
localization of the two alleles within the nucleus, lead to imprinted expression. For example, the 
paternally repressed alleles we identified might be sequestered in regions of nuclear repression. 
 These higher order structures are also reprogrammed during development. Unlike DNA 
methylation or histone modification enrichment, the 3-dimenstional structures and chromatin 
accessibility is largely the same between alleles (Lu et al. 2016; Wu et al. 2016). Still, the two 123
	  	  
alleles remain physically separated during preimplantation development and have been show to 
occupy different nuclear spaces in later stages (Ahmed et al. 2010). 
 It is also possible that the transient imprinted expression we see is due to the timing of 
activation of the two alleles. We identified genes that go from being maternally expressed to 
biallelic during gastrulation. The maternal allele might be posed for expression of these genes 
earlier that the paternal allele. This could potentially due to the different requirements for 
reprogramming between the two alleles or the difference in the chromatin structure of the two 
alleles, as mentioned above.  
 In addition to the tissue-specific, transient imprinted expression identified here, there are 
also other varieties of non-canonical imprinted expression that have been characterized. This 
includes allele-specific alternative polyadenylation and alternative allele splicing and mRNA 
processing (Wood et al. 2008; Cowley et al. 2012; Li et al. 2012; MacIsaac et al. 2012). These 
phenomena can occur in an allele-specific fashion, although this appears to be rare. Still, it is 
important to consider these mechanisms when characterizing imprinted expression.  
 Continued sequencing efforts, including expression, histone modification enrichment, 
DNA accessibility, and chromatin structure analysis will hopefully aid in the discovery of novel 
mechanisms for non-canonical imprinted expression, as well as provide additional information 
about the mammalian genome. Combined with functional studies, future work will increase our 
understanding of the spectrum of imprinted gene expression. 
5.4 Concluding remarks 
 It is likely that all of the canonically imprinted, ICR-dependent imprinted genes have 
been identified in mouse; however, that does not mean that we have a full understanding of the 
expression dynamics of these genes, as illustrated by the work presented in Chapter 3. Even still, 
identifying novel genes based on canonical characteristics like DMRs/ICRs will be unlikely. Now 
we can detail the subtle imprinting effects and epigenetic regulation that occur. New technologies 
will allow us to characterize imprinted expression and embryonic development in higher 124
	  	  
resolution, paving the way for better understanding novel, dynamic regulation of the mammalian 
genome. 
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Figure 5.1. Spectrum of imprinted expression phenomena. Allele-specific expression can be 
divided into canonical and non-canonical imprinting categories based on the mechanism and 
characteristics of expression.  	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APPENDIX A 
TO BE PURSUED 
A.1 Forward  
There is an extensive body of work that I contributed to during my tenure as a graduate 
student, including work on collaborations, which will not be including in this thesis.  
Additionally, there is data that I’ve generated that have the potential to jumpstart additional 
projects within the lab, but do not warrant an independent chapter. Below, I will highlight 
interesting data for future exploration and discussion.  
A.2 Embryonic gastrulation in vitro culture  
 In order to better understand the epigenetic mechanisms at play influencing imprinted 
expression of the novel imprinted genes identified in Chapter 4, we employed a gastrulation 
embryo culture system. This would allow us to inhibit or activate components of the epigenetic 
machinery during gastrulation, starting at E6.5 and allowing development in vitro for up to 48 
hours. Our goal was to identify a mechanism or pathway by which imprinting was occurring at 
these novel sites. To this end, we used 5-aza-2’deoxycytidine (5’aza) and Trichostatin A (TSA); 
5’aza alters the DNA methylation state by incorporating into the DNA and preventing 
maintenance methylation leading to a hypomethylated state, whereas TSA functions as an HDAC 
inhibitor. If DNA methylation regulated imprinted expression, culturing with 5’aza would lead to 
loss of methylation and then possibly the reactivation of the repressed allele and biallelic 
expression. Using TSA would allow us to potentially identify the role histone modifications play 
in regulating the imprinted loci. Together, drug treatment would potentially elucidate a potential 
mechanism driving novel, non-canonical imprinted expression. 
A.2.1 Methods 
A.2.1.1 Tissues 
The University of Massachusetts Amherst Institutional Animal Care and Use Committee 
approved all procedures. Troubleshooting culture conditions was performed using ICR embryos. 127
	  	  
Experimental embryos were derived from C57BL/6J (JAX 000664) and PWD/PhJ (JAX 004660) 
crosses. Embryos were collected at E6.5 in pre-warmed dissection media. The embryos were 
removed from their decidua and the Reichert's membrane was carefully removed using sharpened 
forceps. Care was taken to not remove the ectoplacental cone.  
A.2.1.2 Culture media and drug preparation 
Embryos were transferred into holding wells (4-well culture plate, Thermo Scientific 
144444) containing culture media made of 1:1 DMEM (high glucose w/o L-glutamine, 12-614) 
and normal rat serum (Valley Biomedical AS3061). They were then placed into temporary 
incubation at 37°C in 5% CO2/5% 02 balance in N2. Culture media with either dimethyl sulfoxide 
(DMSO, Sigma 34869), 5-aza-2’deoxycytidine (5’aza, Sigma A3656), or Trichostatin A (TSA, 
Sigma T8552) was prepared. Then embryos were transferred into culture tubes (VWR 60818-
667) containing 1 mL prepared culture media and incubated with rotation for time specified at 
37°C in 5% CO2/0.5% 02. Following incubation, embryos were transferred into 4-well plates 
(Thermo Scientific 144444), imaged, washed in PBS, and then transferred to lysis/binding buffer 
(Roche 11828665001).  
The 5-aza-2’deoxycytidine stock was prepared fresh in PBS and then was diluted to final 
concentration in culture media. Trichostatin A stock was prepared in DMSO and frozen. Frozen 
aliquots were diluted in culture media just prior to embryo culture. Final concentration is 
annotated in figures. 
A.2.1.3 Analysis of allele-specific expression 
Total RNA was isolated using the Roche High Pure RNA Isolation Kit (Roche 
11828665001). cDNA synthesis was performed using Superscript II (ThermoFisher 18064014) 
with oligo(dT) primers (Promega C1101). RT-PCR was performed against imprinted genes of 
interest using primers that span informative polymorphic sites (Table C.1). PCR amplification for 
expression panels and Sanger sequencing validation was run using RubyTaq (Affymetrix 71191) 
for 35 cycles. PCR products were visualized by ethidium bromide illumination and imaging and 128
	  	  
then sent to Macrogen (Boston, MA) for PCR cleanup and sequencing. Base calling and sequence 
alignment was performed using CodonCode Aligner software (Centerville, MA). 
A.2.2 Results and summary 
A.2.2.1 Culture conditions allow for in vitro development 
Before using F1 embryos, we wanted to test culture conditions using ICR embryos. The 
Tremblay lab uses ICR embryos in their embryo culture system; the embryos develop well in 
culture and litter size is higher than inbred lines, making them amenable to troubleshooting 
culture conditions. 
The first culture experiment was run for 48 hours, the longest time that we would need to 
culture. Our goal was to be able to culture to approximately E8.5 staging. This is when we see 
biallelic expression of the novel genes identified in Chapter 4. Figure 5.1 shows the results of the 
first culture experiment using ICR embryos in culture for 48 hours. The embryos were visually 
assessed during culture, but no augmentation of the media was performed. Morphological 
development was acceptable (Figure 5.1). Control embryos had head folds and somites (Figure 
5.1A,C). The DMSO control and the drug treated embryos were less developed and were not 
morphologically normal (Figure 5.1A,B). Note that embryos without their ectoplacental cones 
failed to develop (Figure 5.1B, first embryo in 5 nM 5’aza and TSA).  
A follow-up experiment was run with ICR embryos to try and improve development of 
control embryos. Unlike the first experiment, we removed embryos from their media at 20 hours 
in culture, imaged them, and then returned them to freshly prepared culture media. Embryos at 
this time display varied morphology (Figure 5.2).  Culture was carried out for an additional 22 
hours, for a total of 42 hours in culture (Figure 5.3). General morphology of the control embryos 
was improved with media replacement (Figure 5.3A,C). Note that the drug treated embryos have 
collapsed yolk sacs due to changes in media viscosity, rather than disruption in development 
(Figure 5.3B). The controls do not have this because the imaging media was adjusted for those 
embryos. Like the first round of experiments, the drug treated embryos are morphologically 129
	  	  
delayed (Figure 5.3). These new culture conditions were sufficient to begin troubleshooting in 
BxP-F1 embryos (Figure 5.4). 
The first BxP litter only had one embryo, which was still cultured to help with 
troubleshooting (Figure 5.4A). The embryo was imaged at 26 and 46 hours. Development by 46 
hours was not as effective compared to the ICR controls (Figure 5.4A). We decided we would 
assess imprinted expression at 16-20 hours.  
A.2.2.2 Control culture conditions leads to loss of imprinting for novel imprinted genes 
Once the culture conditions for the BxP embryos was established, we collected and 
processed embryos for imprinted expression analysis. Embryos were imaged and collected after 
16 hours in culture (Figure 5.4B). The ectoplacental cones were removed and individual embryos 
were transfer to lysis buffer. A control embryo without its ectoplacental cone, which attached to 
another embryos cone and continued to develop, was not included.  
In order to identify if either 5’aza or TSA treatment lead to loss of imprinted expression 
of novel imprinted genes identified in Chapter 4, we performed RT-PCR followed by Sanger 
sequencing. We expected to see maintenance of imprinted expression in the culture controls. 
Depending on the mechanism driving imprinted expression, we might expect to see loss of 
imprinting following drug treatment. Surprisingly, we saw loss of imprinting in all conditions, 
including the culture controls (Figure 5.5A). We also examined the imprinted expression of Lit1 
and found strong imprinted expression (Figure 5.5B). This indicates that loss of imprinting does 
not occur at all imprinted loci. We tested how much time in culture was required to see this 
phenotype and we found loss of imprinting following only 1 hour in culture. This indicates that 
loss of imprinted occurs relatively quickly following being in culture. 
 Our goal for these experiments was to potentially identify a mechanism driving the novel 
gene expression. We were surprised to find that short culture alone was enough to lead to loss of 
imprinting. Importantly, this loss did not effect Lit1, a known imprinted gene regulated by a 
gametic ICR. The transient expression of the novel imprinted genes is likely driven by unstable 130
	  	  
epigenetic marks. Similar to what was found in Chapter 2, we see in vitro culture can lead to loss 
of imprinting. 
A.3 Strain-specific expression and cis-regulation effects 
 Our primary goal in generating and analyzing allele-specific RNA-seq dataset was to 
identify imprinted genes expression, one example of mono-allelic expression. Another example 
of mono-allelic expression occurs in a strain-specific manner (Wittkopp et al. 2009; Goncalves et 
al. 2012; Shen et al. 2014b). This form of mono-allelic expression is caused by divergence in 
regulatory elements between the two strains of mice used. Specifically, polymorphism between 
the divergent strains of mice can mediate differences in allelic expression due to changed in 
regulatory regions (i.e. strain-specific SNP within an enhancer region altering transcription factor 
binding). Additionally, there can be differential expression of genes between strains that can lead 
to an effect in trans (Wray 2007; Goncalves et al. 2012; Shen et al. 2014b).   
 Using our datasets, it is possible for us to characterize the cis-regulatory effects in our F1-
hybrid datasets. We do not have F0 sequencing, which makes identification of trans effects 
limited; trans-regulatory effects happen within the same F1 nucleus. Globally, we find strong 
strain effects in approximately 6% of all expressed genes during gastrulation. This is similar to 
recent work (Goncalves et al. 2012; Shen et al. 2014b). There is additional strain-specific bias, 
which makes up a larger portion of expressed genes, which has also been characterized (Crowley 
et al. 2015). Below will highlight some of the strain-specific effects we have identified. 
A.3.1 Methods 
See Chapter 4 for tissues (Section 4.3.1), generation and sequencing of RNA-seq libraries 
(Section 4.3.2), and RNA-seq analysis (Section 4.3.3). 
A.3.1.1 Strain-specific analysis 
 The mean allelic expression for maternal and paternal SNPs within individual expressed 
genes were calculate. If the log2(FC) between both alleles was greater than 2 and the forward and 
reciprocal cross had biased expression from the same parental strain, the gene was considered 131
	  	  
strain-specific expression. Additionally, there were many genes with a log2(FC)<2, but the 
expression was biased in the same direction. These genes were categorized as having stain-
specific bias. 
A.3.1.2 Validation of strain-specific expression 
Total RNA was isolated using Roche High Pure RNA Isolation Kit (Roche 
11828665001). cDNA synthesis was performed using Bio-Rad iScript synthesis kit (170-8891). 
Primers for strain-specific validation as in Appendix C. RT-PCR were carried out using RubyTaq 
(Affymetrix 71191) for 35 cycles. PCR products were visualized by ethidium bromide 
illumination and imaging.  
A.3.2 Results and summary 
 We found pervasive strain-specific bias for many of the expressed genes analyzed, which 
has been previously identified (Crowley et al. 2015). As mentioned, we also found 6% of 
expressed genes with strong strain-specific expression. This indicated that there are divergent 
regulatory elements between the two strains of mice.  
To characterize the phenomenon further, we validated strain-specific expression in both 
embryos and in adult tissues. To start, we performed RT-PCR to confirm expression during 
gastrulation (Figure A6A). We characterized the expression of Copg2, Dhx58, Dhcr7, Dusp3, 
Atp10d, Ifi27l2b, and Rdm1, which have varying degrees of strain-specific expression. We 
followed the RT-PCR with restriction fragment length polymorphism assays (RFLP) to validate 
the allele-specific expression of the putative strain-specific genes. We found strong mono-allelic 
expression in the gastrulation tissue for Atp10d (not shown), Ifi27l2b, and Rdm1 (Figure A6B). 
We further characterized the mono-allelic expression of Atp10d, Ifi27l2b, and Rdm1 on 
an adult tissue panel. Interestingly, we found tissue-specific maintenance of  strain-specific 
expression (Figure A6C). Atp10d has variable PWD bias, with strong mono-allelic expression in 
the testis. Ifi27l2b has clear biallelic expression in the intestines and stomach; however, we find 
maintenance of PWD-specific expression in the kidney, liver, lung, skeletal muscle, and thymus 132
	  	  
(tongue and uterus expression is too weak to call). This indicated that there might be tissue-
specific regulatory elements. Interestingly, the tissues that maintain mono-allelic expression are 
not from a single lineage (both mesoderm and endoderm). Lastly, Rdm1 is largely biallelic in all 
expressed adult tissues. This suggests that the strain-specific expression is restricted to 
development and possibly a less differentiated state. 
Another interesting strain-specific phenomenon includes differential expression in the 
two parental strains (F0, B6 and PWD) that persists in the F1 generation. The gene Ccnb1ip1 is 
expressed in the PWD strain but not in the B6 strain (Figure A7A). We performed RT-PCR for 
Ccnb1ip1 for 35 and 45 cycles. Even at 45 cycles, we do not see appreciable levels of expression 
in the B6 tissue compared to PWD (equal loading, compared to ActB). The locus is present in 
both strain, as confirmed by genomic DNA PCR (Figure A7A, gDNA). Expression of Ccnb1ip1 
is present in the F1 embryo and in F1 adult tissues and this expression comes solely from the 
PWD allele (Figure A7B,C). 
 These data highlight the necessity of performing both the forward and reciprocal cross 
when performing allele-specific sequencing. They also provide more insight on the cis-regulatory 
differences between the two strains of mice. 
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Figure A.1. Initial ICR embryo culture troubleshooting. A). Culture control and DMSO 
control embryos following 48 hours of in vitro culture. Red asterisk indicated embryo shown in 
(C). B). Trichostatin A (TSA) and 5-aza-2’deoxycytidine (5’aza) drug treated embryos at 5nM 
and 500 pM concentrations. C). Detailed developmental morphology of a culture control embryo. 
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Figure A.2. Development of ICR embryos at 20 hours following augmented culture 
conditions. A). Culture control and DMSO control embryos following 20 hours of in vitro 
culture. B). Trichostatin A (TSA) and 5-aza-2’deoxycytidine (5’aza) drug treated embryos at 5nM 
and 500 pM concentrations (No embryos were cultured in 500 pM TSA due to litter size/embryo 
numbers). Following imaging, embryos were placed into fresh media and were returned to 
culture. 
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Figure A.3. Development of ICR embryos at 42 hours following augmented culture 
conditions. A). Culture control and DMSO control embryos following 42 hours of in vitro 
culture. Red asterisk indicated embryos shown in (C).  B). Trichostatin A (TSA) and 5-aza-
2’deoxycytidine (5’aza) drug treated embryos at 5nM and 500 pM concentrations (No embryos 
were cultured in 500 pM TSA due to litter size/embryo numbers). C). Detailed developmental 
morphology of a culture control embryo. 
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Figure A.4. Development and drug treatment of BxP-F1 embryos in culture. A). Culture 
control following 26 and 46 hours of in vitro culture. Note there was only one embryo in the 
litter. B). Experimental embryo set including culture control, DMSO control, as well as 
Trichostatin A (TSA) and 5-aza-2’deoxycytidine (5’aza) drug treated embryos at 5nM cultured 
for 16 hours. These embryos were used for allele-specific analysis shown in Figure A.5. 
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Figure A.5 Allele-specific analysis of BxP-F1 culture embryos.  A) Sanger sequencing 
electropherograms for A2m, Col3a1, Des, and Dmkn in BxP-F1 tissues at E6.5+16 hours. We see 
loss of imprinted expression, even in the control culture conditions for our novel imprinted genes. 
B). Sanger sequencing electropherograms for the known imprinted gene Lit1 in BxP-F1 tissues at 
E6.5+16 hours. Expression is comparable to in vivo developed E7.5 embryonic tissue. 
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Figure A.6. Validation of strain-specific genes identified in our RNA-seq screen. A). RT-
PCR for strain-specific genes in E6.5 epiblast (EPI) and visceral endoderm (VE), and E7.5 
embryonic (EM) and extra-embryonic (EX) BxP-F1 tissues. ActB serves as a loading control. B). 
Restriction fragment length polymorphism (RFLP) assay for the strain-specific genes in (A). 
Parental controls include maternal C57Bl/6J (B), paternal PWD/PhJ (P), and adult BxP-F1 
tissues. Ifi27l2b and Rdm1 both have mono-allelic expression. C). Adult panel of genes with 
mono-allelic expression. Note that Atp10d is expressed from the PWD/PhJ allele in the testis. 
Ifi27l2b has variable mono-allelic expression (compare intestines to kidney, liver, lung, thymus, 
and uterus). Rdm1 does not retain mono-allelic expression identified during gastrulation (B). 
Reciprocal cross datasets indicate these genes are not imprinted and that they are strain-specific. 
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Figure A.7. Example of differential expression in the F0 generation that leads to strain-
specific expression in the F1-hyrid embryos. A). RT-PCR for Ccnb1ip1 carried out for 35 and 
45 cycles relives PWD/PhJ-specific expression. Genomic PCR for Ccnb1ip1 indicated that the 
genomic sequence is present in both strain. ActB serves as a loading control. B). RT-PCR for 
Ccnb1ip1 in E6.5 epiblast (EPI) and visceral endoderm (VE), and E7.5 embryonic (EM) and 
extra-embryonic (EX) BxP-F1 tissues shows expression, similar to PWD/PhJ control. C). RT-
PCR for Ccnb1ip1 in adult F1 tissues. 
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APPENDIX B 
PROTOCOLS 	  
B.1 Forward  
 Many of the protocols used to perform my thesis work are widely used or transferable 
from one lab to the next; setting up a PCR should be effective regardless of the specifics of 
assembling and running a reaction. In some cases, however, my thesis work involved me 
tweaking protocols to suit my needs. In this section, I will outline those protocols and include 
annotations when necessary to provide supplemental information not included in other chapters. 
Hopefully this will serve as a reference to aid in reproducibility and to help others avoid 
frustration. 
B.2 Homebrew bisulfite mutagenesis 
 Starting DNA should be in 30ul of TE or nuclease free water. This protocol works for 
both high and low input reactions. If the starting DNA is of high quality, this protocol is effective 
for conversion of an individual E6.5 epiblast equivalent of DNA.  
B.2.1 Denaturing the DNA 
 Into a 1.5ml microcentrifuge tube, add 3ul of freshly prepared 3N NaOH to 30ul of DNA 
and mix thoroughly (see B2.5 solution preparation). Incubate at 42°C for 30 minutes. 
B.2.2 Mutagenize the DNA 
 Following incubation to denature the DNA is bisulfite mutagenesis. To the same tube 
now containing 33ul of denatured DNA, add 340ul of 3.6M sodium bisulfite, 20ul of 10mM 
hydroquinone, and 33ul water (see B2.5 solution preparation). Gently mix and then quickly spin 
down the sample to ensure that there are no droplets on the sides or lid of the tube. If there is, this 
can lead to incomplete conversion of that DNA. Overlay the sample with enough clean mineral 
oil to completely cover the sample. Incubate the sample at 55°C for 4-5 hours in the dark. For low 
input, 4 hours is sufficient for complete conversion. For higher input, 5 hours is sufficient. 
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Anything longer than 5 hours leads to degradation. Higher concentrations might not be 
deleteriously effected by degradation, but for embryos, longer incubations lead to poor quality 
DNA following conversion (Grunau et al. 2001).  
B.2.3 Purification of DNA using the GeneClean Turbo kit (MP Bio #111102-400) 
 Once the DNA is converted, carefully transfer the sample to a clean 2ml tube. The goal is 
to avoid carryover of the mineral oil but still transfer the majority of the sample. Expect to be able 
to transfer at least 400ul total. Add 1.5ml of turbo salt and mix well. The final volume of the 
sample and turbo salt will be close to the maximum capacity of the 2ml tube, so take care to avoid 
spilling. Add 600ul of the sample/salt mixture, spin down at maximum speed for the bench top 
centrifuge for 5 seconds, and then discard the flow through. Continue until the entire volume has 
been added to the column. At this point, the manufacture’s protocol is followed until the final 
elution step. Elute in a fresh 1.5ml tube with 35ul elution buffer following a 5-minute incubation 
of the buffer on the column. Repeat this step again. The goal is to have a final volume of 70ul. 
B.2.4 Desulfination and precipitation of the converted DNA 
 Add 10ul of freshly prepared 3N NaOH to the sample and incubate at 37°C for 15 
minutes. Then precipitate the DNA by adding 300ul of 100% ethanol, 40ul 3M sodium acetate, 
and 1ul of glycogen. Mix well and incubate at -20°C or -80°C degrees until chilled down. 
Usually, an hour to overnight works for -20°C, where 10-15 minutes works well for -80°C. 
Following the incubation, spin down the samples for 20 minutes at the maximum speed for the 
bench top centrifuge and then remove the supernatant. Ideally, this is done at 4°C, but room 
temperature also works. Gently wash the pellet, which should be visible, with approximately 
100ul 70% ethanol and spin down again at the maximum speed for 5 minutes. Remove the 
supernatant and allow the pellet to dry. Avoid over drying the pellet, but make sure that all of the 
ethanol is gone. Resuspend the pellet in 5-30ul of water or TE. The volume depends on the 
original input and the downstream application.  
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B.2.5 Solution preparation 
To prepare the 3N NaOH, simply combine 1.2g of NaOH pellets to 10ml of water. Mix 
until fully dissolved. For the 10mM hydroquinone, add 55mg hydroquinone powder to 50ml 
water. for the 3.6M sodium bisulfite solution, add 8.1g sodium bisulfite to 16ml water. Adjust the 
pH to 5.0 with 10N NaOH and then bring the volume up to 20ml. Note that the pH starts around 
3.65 and requires approximately 20 drops with a glass Pasteur pipette. Both the hydroquinone and 
sodium bisulfite solution should be stored on ice, wrapped in foil and protected from light. All 
reagents should be made fresh. 
B.3 EZ DNA Methylation-lightning (D5030) protocol 
 The homebrew protocol for bisulfite conversion works well. It produces consistent results 
with a range of input; however, it is laborious and time-consuming compared to commercially 
available kits. We have successfully used Zymo conversion reagents for multiple projects in the 
lab and have primarily moved away from our homebrew protocol. Importantly, Illumina 
recommends using Zymo reagents for whole genome bisulfite sequencing, specifically the EZ 
DNA Methylation-lightning kit. When we initially sequenced DNA converted with this kit, we 
ended up with poor quality results. In some samples, the percent of bases with 10x or greater 
coverage was less than 1%. We also tried sequencing using our homebrew protocol to convert the 
DNA, but found over 70% duplicate reads. 
I discovered one of the major problems was incomplete conversion or degradation when 
the protocol was followed as written (Figure B.1). Using the recommended reaction volume of 
130ul lead to sample being above the heat block in the thermocycler we use (BioRad). In order to 
have complete conversion, the reaction should be cut in half. Specifically, 65ul of the lightning 
conversion reagent should be added to 10ul of sample in a PCR tube (Figure B.1C). This is 
compared to the 130ul lightning conversion reagent and 20ul sample recommendation. We started 
with the sample amount of DNA input, but simply adjusted the concentration to suit the new 10ul 143
	  	  
requirement. The rest of the manufacture’s protocol was followed, with the exception of adding 
300ul M-binding buffer to the sample following conversion and eluting in 9ul. Using this method 
allows for robust amplification via site-specific bisulfite PCR, as well as improves sequencing 
results (Figure B.1C).  
B.4 Bisulfite PCR and cloning 
 Following bisulfite PCR, the product needs to be cloned so that individual strands of 
DNA can be analyzed by sequencing. I used a standard protocol for cloning PCR products to be 
sequenced. Cloned cells were plated and incubated overnight. Normally after growing overnight, 
colonies would be selected and a mini preparation of plasmid DNA (mini-prep) would be 
performed. I found this to be laborious, especially at times when I wanted to sequences 50+ 
clones. I realized that I could pick colonies directly into a PCR reaction specific to my cloned 
amplicon and amplify insert directly. The key is to make sure the initial denaturation step is long 
enough to lyse the cells. I found that 10 minutes at  95°C was sufficient. After PCR, the products 
should be run out to ensure the appropriate insert has been amplified. The PCR products can then 
be sent out for Sanger sequencing. When compared side-by-side to mini-prep samples, I found no 
difference in the efficacy or fidelity of either method.  
B.5 cDNA synthesis and RT-PCR for Sanger sequencing validation 
 To validate the novel allele-specific expression we identified via RNAseq, I spent time 
troubleshooting cDNA synthesis protocols to replicate the conditions during library preparation. 
The protocol that was the most effective involved using both oligo(dT) and random hexamer 
priming as part of the SuperScript II protocol.  
 Briefly, 1ul of oligo(dT) and 1ul of random hexamer primers were added to 1ul of dNTP 
mix (10mM) and up to 9ul of RNA. If the volume of RNA was less than 9ul, the rest of the 
volume should be made up with water. This mixture is then incubated for 5 minutes at 65°C and 
quickly transferred to ice. Then, 4ul of 5X first-strand buffer, 2ul 0.1M DTT, and 1ul water is 
added. Mix well and then incubate for 42°C for 2 minutes. Add 1ul of SuperScript II reverse 144
	  	  
transcriptase and gently mix. Incubate the reaction at 25°C for 10 minutes, 42°C for 50 minutes, 
70°C for 15 minutes, and then hold at 4°C.  
 Following cDNA synthesis, RT-PCR was carried out in 25ul reaction volumes. This 
allowed for enough PCR product (5ul) to be run out on an agarose gel to ensure appropriate 
amplification of the target transcript. The remaining 20ul can then be sent out for sequencing or 
other downstream applications. 
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Figure B.1. Troubleshooting the Zymo Lightning kit used for WGBS. A,A’). Bisulfite PCR 
for Igf2r DMR2, which is used as a control locus for troubleshooting. Input in (A) is 1ul, which is 
standard. A total of  3ul and 5ul were used in (A’). In all cases, there is little to no amplification 
of converted DNA when the protocol is used as written. B). Non-bisulfite specific genomic PCR 
of converted and non-converted (genomic) DNA. Weak amplification is found in the PWD 
converted control, indicating incomplete conversion. C). Robust bisulfite PCR amplification of 
Igf2r in samples following the modified protocol (75ul total starting volume).  
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APPENDEX C 
SUPPLEMENTAL TABLES 
	  
Table C.1 Primers used for data generated in this thesis 
 
Gene$ID Forward Reverse
Sox4_WT GAAGGAGGCGGAGAGTA+ACGG CATAGCTCAACACA+ATGCCAACGC
Sox4_null TAGAGACGATGTCGCTTTCCTGAG CATAGCTCAACACA+ATGCCAACGC
Plg GATGAATTATTCCACAACC TTTCTGGTGTCCTGTTGTGC
Slc22a3 AGAGAAAGCCTTGCAGATCC CAGTGACCAGACACGACACC
Slc22a2 CCAGTGCATGAGGTATGAGG GGCATAGTTGGGTGAAATCG
Slc22a1 TAACCTGGTGTGTGGAGACG CTGGTACAAGATGGCTGTCG
Igf2r+(SSCP) TTCGACCTATAAGAAGCCTT GGGTACTTTGCTTTTGGGTA
Airn+(RFLP) GGGTGGAGCCTTATGATGAA TGAAGCCTGGGTTTCATTTC
Mas1 TGGCAAAGGCAGGATCTATT TGTTACCAGACGGCAGGAAT
Airn_1 ATTCAGCCCTGCATACTTGG GACGGGGTCTAGAATCACCA
Airn_2 TCCAGACCAGTCAAGGGTTT ATAAGAAAGCAGGCCAAGCA
Airn_3 CAACAGGGACACCAGGAGTT CCTGAAGTGGACACAGGTGA
Airn_4 CCCTCTACAAAGGCAGCAAG CCCATCAGTCTTGGCAGAAT
Airn_5 GCACGAGCGCCAGGTACCTACTCGA AGGTGGTGGTACACGCTTCT
Airn_6 GGAGTAGGGAGAACCTGCAA AGAATGGGCTGTGTGTTTCC
Airn_7 CTAGGGTTCAGCGCAAATCT CCCAAGATGTACCAGCCAGT
DMR1+(Yamaski+2005) GGGATTTTAGAAAGATTGATTTT AAACCTAACAACCCCAAAATTACTCAC
BS_Igf2r_4 GGGTTGTGATTTTGGTTATGTTAAG ACAAAACCCTCTAAATCCTCCTATC
BS_Igf2r_2 TTAAGGGTGAAAAGTTGTATAAGGAG ACTTAACATAACCAAAATCACAACC
Chip1L2+(Yamaski+2005) GACTGACCTCTTAACCCTGC TTCAACCGAGACCAGTACG
ChIP_DMR2 TGATGAGAACTGGTGGGTTG AGAGGGCTCTGCACTATCCA
ChIP_Slc22a3 CCTTCCTCAGTGCCTGGTC GGAGCTGGAGGAATGTGATG
A2m GACTCACGTTCTGCCTGTGA GACTCACGTTCTGCCTGTGA
Col3a1 GGGCCATAGCTGAACTGAAA GGGCCATAGCTGAACTGAAA
Des TGGAGCGTGACAACCTGATA TGGAGCGTGACAACCTGATA
Dmkn CTCACGAATGCACACAGGTC CTCACGAATGCACACAGGTC
Rgs2 GTGTGTGTGATGGACCGAAT GTGTGTGTGATGGACCGAAT
Sbsn GCTGCCTCTTAGTGCTCCTG GCTGCCTCTTAGTGCTCCTG
Dio3 AGCATTTCACAGCTCGGACT AGCATTTCACAGCTCGGACT
Dlk1 AACCTGCGCTACAACCACAT AACCTGCGCTACAACCACAT
Meg3 CACGGACACAGACACCTG CACGGACACAGACACCTG
Rian ATGCCTTCCTCACTGGTCAC ATGCCTTCCTCACTGGTCAC
Rtl1 GAGCTTGTGACCCCACCTTA GAGCTTGTGACCCCACCTTA
Ifi27l2b CATTGCAGCTGGGTCCATAG CATTGCAGCTGGGTCCATAG
Ccnb1ip1 CCCACCAGGGAATAACTCAA CCCACCAGGGAATAACTCAA
Dhx58 GAGACCTGGAGGAACCATCA GAGACCTGGAGGAACCATCA
Atp10d GGGAATCTCCGAGGCTCTTA GGGAATCTCCGAGGCTCTTA
Dusp3 TCTGTGGCTCAGGACATCAC TCTGTGGCTCAGGACATCAC
Dhcr7 CGCTCCCAAAGTCAAGAGTC CGCTCCCAAAGTCAAGAGTC
Copg2 TTCCAGGCAAGACATTTTCC TTCCAGGCAAGACATTTTCC
Rdm1 TTTACCATGGCGGAGTTGAT TTTACCATGGCGGAGTTGAT
ActB GGCCCAGAGCAAGAGAGGTATCC GGCCCAGAGCAAGAGAGGTATCC
147
	  	  
 
 
 
Table C.2. Known imprinted genes in the mouse genome 
Symbol Expression Symbol Expression Symbol Expression Symbol Expression Symbol Expression
1110014L15RIK MAT Cdh15 PAT Herc3 MAT Mirg MAT Slc22a3 MAT
1700006F04Rik PAT Cdh26 PAT Hnrnpk PAT Mkrn1>ps1 PAT Slc38a1 PAT
1700017J07Rik PAT Cdk5r1 PAT Htr2a MAT Mkrn3 PAT Slc38a2 PAT
1700025C18Rik PAT Cdkn1c MAT Htra3 MAT Mkrn3os PAT Slc38a4 PAT
1700067G17Rik PAT Chrac1 MAT Hunk PAT Mst1r MAT Slc6a1 PAT
1700084F23Rik PAT Chst1 PAT Hymai PAT Musd2 Suggested Slurp2 PAT
1700095B10Rik PAT Clcn6 PAT Ifitm10 MAT Myb PAT Smim17 MAT
1700110K17Rik PAT Clic6 PAT Igf2 PAT Myoz2 PAT Smoc1 PAT
1700121N20Rik PAT Cmah MAT Igf2os PAT Nap1l4 MAT Snhg14N MAT
1700125H03Rik PAT Cntn3 MAT Igf2r MAT Nap1l5 PAT Snrpn PAT
2400006E01Rik PAT Cobl MAT Igsf21 PAT Nctc1 PAT Snurf PAT
4930404H11Rik PAT Commd1 MAT Il6 Suggested Ndn PAT Snx14 PAT
4930465M20Rik PAT Copg2 MAT Impact PAT Ndufs1 PAT Sox21 PAT
4930524O08Rik PAT Ctsd MAT Inhbb PAT Nespas PAT Stx16 MAT
4931430N09Rik PAT Ctsh PAT Inpp5f PAT Nhlrc1 PAT Syt13 PAT
9630028H03Rik PAT D0Kist6 Suggested Ins1 PAT Nnat PAT Syt4 PAT
A230006K03Rik PAT Dact2 MAT Ins2 PAT Npepl1 MAT Tbc1d12 PAT
A330076H08Rik PAT Dclk1 PAT Ipw PAT Ntm PAT Tfpi2 MAT
Adam23 PAT Dcn MAT Jade1 PAT Otog PAT Tgfb1i1 MAT
Adamts2 PAT Ddc PAT Jpx PAT Otx2 PAT Th MAT
Adcy1 PAT Ddx39b PAT Kcnk9 MAT Otx2os1 PAT Tial1 MAT
AF313042 MAT Dhcr7 MAT Kcnq1 MAT Pcdhb10 MAT Tle3 PAT
AF357341 MAT Dio3 PAT Kcnq1ot1 PAT Pde10a MAT Tmem106a MAT
AF357355 MAT Dlk1 PAT Khdrbs3 MAT Peg10 PAT Tmem209 MAT
AF357359 MAT Dlx5 MAT Klf14 MAT Peg12 PAT Tnfrsf22 MAT
AF357425 MAT Dnase2b PAT Klf4 MAT Peg13 PAT Tnfrsf23 MAT
AF357426 MAT Drd1 MAT Klhdc10 MAT Peg3 PAT Tnfrsf26 MAT
AF357428 MAT E230032D23Rik MAT Klhdc7a PAT Peg3os MAT Tnk1 PAT
Ago2 MAT E2f3 PAT Lars2 PAT Phlda2 MAT Trappc9 PAT
Ahi1 PAT Edn3 MAT Lin28a Pkm Suggested Trem1 MAT
Airn PAT Eef1b2 PAT Lpar3 PAT Plagl1 PAT Try4 PAT
Ajap1 PAT Enc1 PAT Lrig3 PAT Platr20 PAT Tshz2 PAT
Ampd3 MAT Epas1 PAT Magel2 PAT Platr4 PAT Tsix MAT
Ano1 MAT Epgn PAT Magi2 Vary Pon1 Suggested Tspan32 MAT
Apbb1ip PAT Etv6 PAT Mapt MAT Pon2 MAT Tssc4 MAT
Apoc2 Suggested Fam135b MAT Mas1 PAT Pon3 MAT Ttyh1 PAT
Apoe Suggested Fam13a MAT Matn1 PAT Ppp1r9a MAT Tusc2 PAT
Aqp1 MAT Fam198b PAT Mbnl2 PAT Ppp3ca PAT Ube2m PAT
Art5 MAT Fbxo40 MAT Mcts2 PAT Prdm11 PAT Ube3a MAT
Asb4 MAT Fkbp6 PAT Meg3 MAT Prox1 PAT UC008IHS.1 PAT
Ascl2 MAT Flt1 PAT Mest PAT Prss33 MAT Usp29 PAT
Atp10a MAT Foxl1 PAT Mir127 MAT Ptms PAT Vapb MAT
Atp5e PAT Ftx PAT Mir134 MAT Qpct MAT Wars MAT
Axl MAT G730013B05Rik PAT Mir136 MAT Rasgrf1 PAT Wdr25 PAT
B830012L14Rik MAT Gaa PAT Mir154 MAT Rbms1 PAT Wt1 PAT
Bag3 MAT Gab1 PAT Mir184 PAT Rbp2 PAT Xist PAT
Bbx PAT Gabbr2 PAT Mir296 PAT Rftn1 PAT Xlr3b MAT
BC049762 PAT Gabra5 PAT Mir298 PAT Rhox5 Vary Xlr4b MAT
Bcl2l1 PAT Gabrb3 PAT Mir335 PAT Rian MAT Xlr4c MAT
Begain Vary Gabrg3 Suggested Mir337 MAT Rtl1 PAT Ywhae PAT
Blcap MAT Gadl1 PAT Mir370 MAT Rtn3 PAT Ywhaz PAT
Bmp7 PAT Gas7 PAT Mir376b MAT Runx1 PAT Zcchc13 MAT
Cacng8 PAT Gatm MAT Mir380 MAT Sall3 PAT Zdbf2 PAT
Calcr MAT Gm5086 PAT Mir410 MAT Scin MAT Zfp264 PAT
Calm1 PAT Gm9801 PAT Mir411 MAT Sfmbt2 PAT Zfp64 PAT
Camk2n1 MAT Gnas Vary Mir431 MAT Sgce PAT Zim1 MAT
Casd1 MAT Gpr1 PAT Mir433 MAT Sh3gl3 PAT Zim2 MAT
Ccdc40 PAT Gramd1b PAT Mir434 MAT Six3os1 PAT Zim3 MAT
Cct4 MAT Grb10 Vary Mir6239 PAT Slc17a7 PAT Zrsr1 PAT
Cd44 PAT H13 MAT Mir6241 PAT Slc22a18 MAT
Cd81 MAT H19 MAT Mir692>2b PAT Slc22a2 MAT
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Table C.3. Known DMRs/ICRs in the mouse genome 
Gene$Locus Chr Start End Germline? Methylated$Allele
Gpr1/Zdbf2 chr1 63250283 63280525 Y Paternal
Mcts2/H13 chr2 152686274 152686927 Y Maternal
H139DMR29 chr2 152707764 152708164 - Maternal
Nesp chr2 174283509 174287894 N Paternal
Nespas/Gnasxl chr2 174292903 174299786 Y Maternal
Gnas1a chr2 174327110 174328002 Y Maternal
Peg10/Sgce chr6 4746303 4749370 Y Maternal
Vwde9 chr6 13224720 13224854 - Paternal
Mest9(Peg1) chr6 30735840 30739965 Y Maternal
Herc3/Nap1l5 chr6 58907401 58907794 Y Maternal
Casc1 chr6 145187692 145187815 - Maternal
Peg3/Usp29 chr7 6727356 6733209 Y Maternal
6330408a02Rik9 chr7 13261078 13261561 - Maternal
Snurf/Snrpn chr7 60003140 60005283 Y Maternal
Snrpn chr7 60140302 60140364 - Maternal
U80893 chr7 60939460 60940304 - Maternal
mir344b chr7 61790265 61790917 - Maternal
mir344c chr7 61837481 61837481 - Maternal
mir344 chr7 61877556 61877971 - Maternal
mir344O2 chr7 61939764 61939992 - Maternal
mir344g chr7 61980348 61981280 - Maternal
AK086712 chr7 62209255 62209564 - Maternal
Ndn chr7 62348214 62348295 N Maternal
Magel2 chr7 62376421 62377281 NA Maternal
Magel2/Mrkn39 chr7 62406399 62407144 - Maternal
Mkrn3 chr7 62419126 62420854 N Maternal
Peg12 chr7 62463585 62464133 NA Maternal
Inpp5f chr7 128688124 128688233 Y Maternal
H199 chr7 142577578 142579325 N Paternal
H199ICR chr7 142579886 142582026 Y Paternal
Kcnq1ot1 chr7 143294831 143296101 Y Maternal
Cdkn1c chr7 143459335 143461476 N Paternal
Cdkn1c9 chr7 143463662 143463978 - Paternal
Rasgrf1 chr9 89877107 89885234 Y Paternal
Plagl1 chr10 13090122 13092339 Y Maternal
Neurog39 chr10 62127958 62128001 - Maternal
Grb10 chr11 12023322 12026797 Y Maternal
Grb109DMR29 chr11 12035415 12035541 - Maternal
Zrsr1/Commd1 chr11 22971545 22974145 Y Maternal
Commd19DMR29 chr11 22980151 22980300 - Maternal
FR1494549 chr11 119258403 119259321 - Maternal
FR0855849 chr12 80168173 80168997 - Maternal
Dlk1 chr12 109459709 109462033 N Paternal
Dlk1/Gtl29 chr12 109525755 109530399 Y Paternal
Gtl29 chr12 109539603 109543039 N Paternal
Gtl2/Mirg9 chr12 109544978 109751123 - Paternal
Nhlrc1 chr13 47010810 47010929 - Maternal
Myo109 chr15 25713824 25714163 - Maternal
Pvt19 chr15 62037170 62037330 - Maternal
Peg13/Trappc9 chr15 72801815 72811184 Y Maternal
Eif2c29 chr15 73097359 73179401 - Paternal
Slc38a4 chr15 97054000 97055741 Y Maternal
Airn/Igf2r chr17 12741760 12742949 Y Maternal
Igf2r chr17 12769777 12769830 N Paternal
Impact chr18 12972847 12974748 Y Maternal
DMR$Window
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Abstract
Background: Appropriate epigenetic regulation of gene expression during lineage allocation and tissue differentiation is
required for normal development. One example is genomic imprinting, which is defined as parent-of-origin mono-allelic
gene expression. Imprinting is established largely due to epigenetic differences arriving in the zygote from sperm and
egg haploid genomes. In the mouse, there are approximately 150 known imprinted genes, many of which occur in
imprinted gene clusters that are regulated together. One imprinted cluster includes the maternally expressed Igf2r,
Slc22a2, and Slc22a3 genes and the paternally expressed long non-coding RNA (lncRNA) Airn. Although it is known that
Igf2r and Airn are reciprocally imprinted, the timing of imprinted expression and accompanying epigenetic changes have
not been well characterized in vivo.
Results: Here we show lineage- and temporal-specific regulation of DNA methylation and histone modifications at the
Igf2r/Airn locus correlating with differential establishment of imprinted expression during gastrulation. Our results show
that Igf2r is expressed from both alleles in the E6.5 epiblast. After gastrulation commences, the locus becomes imprinted
in the embryonic lineage with the lncRNA Airn expressed from the paternal allele and Igf2r restricted to maternal allele
expression. We document differentially enriched allele-specific histone modifications in extraembryonic and embryonic
tissues. We also document for the first time allele-specific spreading of DNA methylation during gastrulation
concurrent with establishment of imprinted expression of Igf2r. Importantly, we show that imprinted expression
does not change in the extraembryonic lineage even though maternal DMR2 methylation spreading does occur,
suggesting distinct mechanisms at play in embryonic and extraembryonic lineages.
Conclusions: These results indicate that similar to preimplantation, gastrulation represents a window of dynamic
lineage-specific epigenetic regulation in vivo.
Background
Genomic imprinting is an epigenetic phenomenon that re-
sults in mono-allelic gene expression in a parent-of-origin
manner. Imprinted expression has been identified at ap-
proximately 150 mouse genes, which often occurs in clusters
containing multiple imprinted transcripts [1,2]. Expression
of imprinted genes is thought to be established in cis by
allele-specific DNA methylation established at imprinting
control regions (ICRs) in the gametes, thus arriving in
the zygote as maternal and paternal specific information. A
regulatory theme has emerged at many imprinted clusters in
which a single long non-coding RNA (lncRNA) is thought
to repressively regulate genes in cis through direct transcrip-
tional blocking and/or recruitment of repressive chromatin
remodeling complexes such as G9a and PRC2, resulting in
differential allele-specific histone modifications [3,4].
One cluster on mouse chromosome 17 includes the ma-
ternally expressed Igf2r, Slc22a2, and Slc22a3 genes and
the paternally expressed lncRNA Airn [5], and several
non-imprinted genes (Slc22a1, Mas, and Plg). The Airn
promoter lies in the second intron of Igf2r, and Airn
transcription occurs from the opposite strand overlapping
Igf2r exons 1 and 2 [5-7]. Paternal Airn expression may
participate in imprinting of the maternally expressed genes
by blocking access of the transcriptional machinery to the
Igf2r start site [8], and transcription of Airn has been
shown to be required for silencing of Igf2r [8,9]. Paternal
allele silencing of the other imprinted genes in the cluster
only occurs in extraembryonic lineages and may be a re-
sult of Airn recruitment of repressive complexes such as
G9a to their promoters [4]. Biallelic expression of Igf2r is
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observed in ES cells and only becomes imprinted upon dif-
ferentiation in vitro [4]. Although the expression of Igf2r
and Airn has been documented in preimplantation and late
stage embryos [10-12], lineage-specific expression dynam-
ics have not been observed during gastrulation. Recent
studies have focused on mechanisms in ES cell models
[4,8,13], but the precise timing and mechanisms respon-
sible for imprinting at Igf2r/Airn in vivo remain unknown.
Here we characterize tissue-specific dynamics of expres-
sion and epigenetic modifications that occur at Igf2r/Airn
during normal gastrulation. We show that significant epi-
genetic regulation occurs at imprinted loci during epiblast
differentiation in vivo.
Results and discussion
Imprinted expression of Igf2r and Airn during gastrulation
The Igf2r/Airn imprinted cluster contains the maternally
expressed Igf2r, Slc22a2, and Slc22a3, the paternally
expressed Airn, and the non-imprinted Plg, Slc22a1, and
Mas1 genes (Figure 1A). We determined the expression
of the genes within the cluster in embryonic and extra-
embryonic tissues from C57BL/6JxPWD/PhJ-F1 embryos
at embryonic days E6.5 and E7.5 by RT-PCR (Figure 1B).
Of the genes in the cluster, Igf2r is expressed in both the
epiblast (EPI) and visceral endoderm (VE) at E6.5 and
the embryonic (EM) and extraembryonic (EX) tissues of
E7.5 embryos (Figure 1B). Airn is expressed in the VE at
E6.5 and in both tissues at E7.5. However, no Airn was
detected in the epiblast at E6.5 (Figure 1B).
To further understand the imprinted expression of Igf2r
and Airn during gastrulation, we carried out allele-specific
expression analysis of C57BL/6JxPWD/PhJ-F1 and C57BL/
6J-Chr 17PWD/Ph/ForeJxC57BL/6J-F1 embryos (hereafter re-
ferred to as B × P and P × B F1 embryos, respectively).
Single-strand confirmation polymorphism (SSCP) revealed
that Igf2r is expressed from both alleles in the EPI of E6.5
embryos (Figure 1C, red box). In E6.5 VE, Igf2r is mater-
nally expressed and paternally imprinted (Figure 1C). At
E7.5, Igf2r is imprinted in both tissues (Figure 1C). Our
results show that in the multipotent epiblast, Igf2r is
Figure 1 Expression analysis. (A) Schematic of gene locations at the mouse Igf2r/Airn locus: transcription start sites (bent arrows), Igf2r (light grey),
and Airn (dark grey). (B) RT-PCR analysis of genes in the cluster shows expression of Igf2r at E6.5 and E7.5, as well as Airn expression in the E6.5 VE and
E7.5 EM and EX. The other genes in the cluster are not expressed at appreciable levels during gastrulation. (C) SSCP analysis of Igf2r expression shows
biallelic expression in the E6.5 EPI, while the paternal allele is silent (imprinted) in all other tissues and stages examined. (D) RT-PCR demonstrates that
Airn is not expressed in epiblast but is paternally expressed (E) in all other samples. Two embryos (one per lane) shown for each tissue/stage for each
assay. EPI, epiblast; VE, visceral endoderm; EM, embryonic portion of E7.5 embryo; EX, extraembryonic portion of E7.5 embryo. Red box highlights the
non-imprinted status of Igf2r and lack of Airn expression in the E6.5 EPI. B, B6 allele; P, PWD allele. +, pooled adult kidney, liver, brain, and heart cDNA.
Parental tissue used in (C-E) is adult kidney.
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expressed from both alleles, but once embryonic cells have
adopted defined lineages at E7.5, Igf2r expression becomes
imprinted. This correlation suggests a relationship between
relative differentiation state in vivo and imprinted expres-
sion at the locus - consistent with ES cell models.
Since Airn is thought to establish imprinting of Igf2r [8],
we also examined allele-specific Airn expression. In E6.5
EPI, Airn is not expressed (Figure 1B,D, red box), corre-
sponding with biallelic Igf2r expression (Figure 1C). In the
VE at E6.5, where Igf2r is imprinted, we observe reciprocal
imprinting (paternal expression) of Airn (Figure 1E). At
E7.5, Igf2r and Airn are imprinted in both embryonic and
extraembryonic tissue (Figure 1E). This change in imprinted
expression between EPI and EM also occurs in the recipro-
cal cross (P×B, Figure 1C,D,E), ruling out background-
specific genetic differences. Airn has also been shown to
regulate imprinting of Slc22a2 and Slc22a3 in extraembry-
onic lineages [5]; however, we could not detect these tran-
scripts at appreciable levels during gastrulation (Figure 1B).
The change in Igf2r and Airn expression indicate a lineage-
and stage-specific establishment of imprinted expression
during normal development. We therefore examined allele-
specific epigenetic modifications at the locus.
DNA methylation spreads at DMR 2
Allele-specific DNA methylation at ICRs or differentially
methylated regions (DMRs) are required for imprinted ex-
pression at many loci [14-16]. The Igf2r/Airn locus has
two known differentially methylated regions (Figure 2A,
[15]). Methylation at DMR1 has been shown to occur late
in development in a tissue-specific manner after imprint-
ing is established and is thought to be a consequence of
Airn expression [17]. In all tissues that we examined dur-
ing gastrulation, DNA methylation at DMR1 is not signifi-
cantly different than methylation in the adult brain [12]
(Additional file 1: Figure S1), suggesting that DMR1 DNA
methylation does not regulate the silencing of the paternal
Igf2r allele that we observe at E7.5.
DMR2 methylation has been shown to be present in
oocytes [17], defining DMR2 as an ICR. Previous reports
documented DMR2 by methylation-sensitive restriction
enzymes, presenting the analysis of two specific CpG di-
nucleotides [13,17]. To gain a more comprehensive un-
derstanding of the methylation status, we designed two
overlapping PCR amplicons for bisulfite sequencing at
DMR2 (Figure 2A). With this approach, we fortuitously
identified the precise 3′ boundary of ICR methylation
present in oocytes [CpG at Chr17:12,742,488-12,742,489
(Figure 2A, red asterisk)]. In E6.5 EPI and VE, the pre-
cise ICR border was maintained on the maternal allele
(Figure 2B). However, by E7.5 DNA methylation had
spread in the 3′ direction in both embryonic and extra-
embryonic tissues (Figure 2B). These results indicate
that although ICR methylation at DMR2 is established
in the female germline [17], maternal allele-specific
methylation increases/spreads in cells of all lineages
Figure 2 DNA methylation at DMR2. (A) Schematic of the mouse Igf2r/Airn locus: transcription start sites (bent arrows), Igf2r exons (solid boxes), and
location of DMR1 and DMR2. Two amplicons (F2R2 and F4R4) spanning 20 CpG dinucleotides were analyzed. Methylation in oocytes confirmed that
DMR2 is an ICR and defined the methylation boundary (red asterisk in A). (B) ICR methylation is maintained in EPI and VE, but spreading of maternal
DMR2 methylation occurs in EM and EX (compare EPI to EM, and VE to EX). Filled circles =methylated cytosine, Open = unmethylated cytosine. Asterisk
denotes ICR border. Arrows indicate bisulfite-sequencing primer locations in (A). Parental SNP indicated on each bisulfite strand. Pat, paternal;
Mat, maternal.
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coincident with the onset of gastrulation. It is particu-
larly intriguing that the methylation spreading occurs in
the extraembryonic tissue given that reciprocal imprinting
of Igf2r and Airn is already established. It is also evident
that the increase in DNA methylation is coincident with
initiation of Airn expression in the epiblast, suggesting a
tissue-specific mechanistic relationship. It may be of inter-
est in the future to determine how far DNA methylation
continues, if the spreading also occurs in the 5′ direction,
and if the spreading is required for paternal silencing of
Igf2r and activation of Airn.
Airn is progressively expressed during development
To more closely examine the timing of Airn expression,
paternal Igf2r silencing, and the spread of DNA methyla-
tion at DMR2, we carefully assessed litters of late-streak
stage embryos at approximately E7.0 to establish relative
developmental age within each litter (Figure 3A). The
spreading of maternal methylation at DMR2 has already
occurred in all embryos examined at approximately E7.0
(Figure 3A shows four embryos from the same litter). Sur-
prisingly, Igf2r is expressed from both alleles in these same
embryos (Figure 3B). However, Airn is only expressed in
slightly older embryos (3 and 4 (Figure 3C)). Hypermethyla-
tion of maternal DMR2 (Figure 3D) clearly precedes pater-
nal Airn expression in embryos 1 and 2. Hypermethlyation
of maternal DMR2 also precedes silencing of paternal Igf2r
in embryonic lineages (embryos 3 and 4). Importantly, the
epiblast of embryos 3 and 4 express both alleles of Igf2r and
paternal Airn, suggesting that transcription from both loci
can occur on opposite strands of the same paternal chromo-
some. Analysis with single cell-resolution will be important
to support this finding.
Since the Airn transcript is 108 kb, we designed ampli-
cons along its length to assess if the entire lncRNA is
detectable in embryonic lineages at various developmen-
tal stages (Figure 3E). Qualitative RT-PCR indicates that
Airn transcripts increase in length with developmental
progress (Figure 3F). At E7.0, only the 5′-most ampli-
cons are detected while the 3′-most amplicons are also
detected in older embryos (Figure 3F). By E9.5, all but
the very 3’-most amplicon is detected, and the entire
lncRNA is detectable in adult tissue (Figure 3F, +). Al-
though qualitative, these results also suggest that total
levels of Airn transcripts increase as development pro-
ceeds (Figure 3F, compare to ActB control).
These findings raise the possibility that maternal DNA
methylation spreading is required to inhibit maternal Airn
transcription. This could explain activation of only the pa-
ternal unmethylated allele in the embryo. Furthermore,
the difference in Igf2r and Airn expression between EPI
(biallelic Igf2r and no Airn) and VE (reciprocal imprinting)
indicate a distinct mechanism during epiblast differenti-
ation that activates Airn (since Airn is already expressed in
Figure 3 Mid-gastrulation expression and DNA methylation.
(A) Four approximately E7.0 embryos from a single litter shown in
age order - analyzed for Igf2r (B), Airn and ActB (C) expression as
well as DMR2 DNA methylation (D). Igf2r is expressed from both
alleles in all four embryos but Airn is detected only in the two older
embryos (3 and 4). DNA methylation has already spread across DMR2
(D) independent of Airn expression. Filled circles =methylated cytosine,
Open = unmethylated cytosine. (E) Schematic of Airn illustrating Igf2r
start site and locations of primer pairs used in (F). (F) RT-PCR expression
analysis from approximately E7.0 embryos 1, 3, 4, as well as other
stages and adult kidney RNA highlight progressive expression of
Airn coordinated with development. Pat, paternal; Mat, maternal; +,
kidney cDNA.
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VE but the methylation dynamics are the same in EPI-EM
and VE-EX). Alternatively, there may be regulation on the
paternal allele that initially inhibits Airn transcription
in epiblast. Either scenario indicates that neither DNA
methylation nor Airn expression is responsible for si-
lencing paternal Igf2r in the epiblast. Taken together,
the observation that DNA methylation dynamics are
the same in embryonic and extraembryonic tissues but
that allelic expression patterns are different, require an
embryonic lineage-specific mechanism responsible for
establishment of imprinted expression.
Ctcf binding at DMR2
The methylation-sensitive insulator Ctcf participates in chro-
matin looping at imprinted loci [18-20]. At Igf2/H19, Ctcf
binds to the unmethylated maternal ICR preventing Igf2-en-
hancer interactions [19,21]. We therefore examined Ctcf ex-
pression and binding to DMR2 to determine if it may be
involved in regulation of Igf2r/Airn. At E6.5, very little Ctcf
transcript is detectable in EPI or VE (Figure 4A), but expres-
sion is evident at E7.5 in both lineages. Consistent with the
absence of transcripts, immunofluorescence showed no/
trace nuclear signal at E6.5, while robust nuclear Ctcf is ob-
served at E7.5 (Additional file 2: Figure S2). We confirmed
earlier reports of Ctcf expression in blastocysts (both mRNA
and protein, Additional file 2: Figure S2), indicating that the
locus undergoes dramatic transcriptional regulation during
normal development. This dramatic change in Ctcf expres-
sion and localization was unexpected and may reflect the
important role that the protein plays in maintaining epigen-
etic regulatory domains. Perhaps Ctcf is required during
preimplantation to establish and/or maintain chromatin dy-
namics established during the first cell lineage decisions
(ICM/TE) but is dispensable until the next major lineage
decisions are made during gastrulation. This possibility sup-
ports the idea that genome-wide epigenetic alterations are
required during gastrulation lineage decisions, similar to
preimplantation. In the future, conditional deletion strat-
egies may make it feasible to functionally test the require-
ment of Ctcf in specific tissues during gastrulation.
Ctcf chromatin immunoprecipitation (ChIP) indicates
Ctcf binds to DMR2 in both embryonic and extraem-
bryonic E8.5 tissues (Figure 4B). Sequencing of ChIP-
PCR products clearly shows allele-specific binding of
Ctcf at DMR2 to the unmethylated paternal allele in ex-
traembryonic tissues (Figure 4B). Surprisingly, both al-
leles are bound by Ctcf in embryonic lineage - although
there is a detectable shift toward the paternal allele
(compare input and ChIP, Figure 4B). Together, the lack
of Ctcf in the epiblast at E6.5 and the biallelic binding
of Ctcf at E8.5 suggest that while Ctcf may play a role
in maintaining imprinted expression at later stages, it is
not involved in the initiation of paternal Igf2r silencing
or Airn activation in the embryonic lineage during
gastrulation.
Differential histone enrichment at DMR2
Allele-specific histone modifications (HMODs) have
been shown to correlate with Igf2r imprinting in the
central nervous system [12,22]. We therefore performed
ChIP to examine enrichment of H3K4me3, H3K9me3,
and H3K27me3 at DMR1 and DMR2 (Figure 4C). In the
embryonic tissue at DMR1, we observe maternal allele-
specific enrichment of H3K4me3, as well as paternally
biased H3K9me3 and H3K27me3. In the extraembryonic
tissues, there is no allele-specific enrichment of H3K4me3
and a weak paternal bias of H3K9me3 and H3K27me3
(Figure 4D).
Similar to binding of Ctcf, we observe allele-specific
enrichment of HMODs at DMR2 in extraembryonic tis-
sues but not in chromatin derived from the embryo
(Figure 4E). In extraembryonic tissues, the active H3K4me3
mark is greatly enriched on the paternal allele (which ex-
presses Airn), and H3K9me3 is enriched on the maternal
allele (where Airn is silent, Figure 4E). Surprisingly, PRC2-
mediated H3K27me3 which has been shown to be required
for imprinting at other loci [23] is not enriched on the si-
lent Igf2r allele, suggesting that PRC2 does not participate
in regulation of the Airn locus in extraembryonic cells. In
the embryonic tissue however, we find maternal bias of re-
pressive H3K9me3 and H3K27me3 (although not as highly
enriched as extraembryonic cells).
Together these data indicate distinct lineage- and
allele-specific enrichment of HMODs occur at DMR1
and DMR2. Strikingly, there is limited allele-specific en-
richment in the extraembryonic tissue at DMR1 at E8.5,
even though Igf2r is imprinted at least 2 days prior.
This indicates differential methylation (Additional file
1: Figure S1), and HMODs at DMR1 (Figure 4D) may
play a secondary role in the imprinting of Igf2r.
Dramatic allele-specific binding/enrichment of Ctcf,
H3K4me3, and H3K9me3 is present at DMR2 in extra-
embryonic tissues suggesting that these chromatin modi-
fications are established at an earlier stage. Although
biased, DMR2 allele-specific chromatin modifications
are not fully established in embryonic lineages by E8.5.
While it is possible that multiple cell types of the E8.5
embryo contain distinct allele-specific enrichment, it is
more likely that the allele-specific modifications are
not yet fully established - particularly since imprinted
expression of Igf2r and Airn is initiated only 24 h prior
at E7.5.
Conclusions
Our results indicate lineage-specific regulation of Igf2r/
Airn imprinted expression during gastrulation. We iden-
tify the precise ICR boundary as well as spreading of
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Figure 4 Chromatin modification at DMR2. (A) Ctcf RT-PCR indicates no/trace expression of Ctcf in both EPI and VE at E6.5. Ctcf is expressed in both
lineages at E7.5. (B) Ctcf ChIP at DMR2 with E8.5 chromatin shows binding in both embryonic and extraembryonic tissues. Sequencing of ChIP-PCR
products indicates allele-specific Ctcf enrichment of the paternal allele in the extraembryonic tissue, but both alleles are bound in embryonic
tissue (although biased toward the paternal allele). (C) Illustration of DMR1 and DMR2 in relation to the start sites of Igf2r and Airn. (D-E)
H3K4me3, H3K9me3, and H3K27me3 ChIP-PCR of DMR1 and DMR2 on E8.5 chromatin. Sequencing of ChIP-PCR products shows allele-specific
enrichment in embryonic tissues at DMR1 and extraembryonic tissue at DMR2. The position of the polymorphism is boxed in red on each
electropherogram. DMR1 (A, maternal; G, paternal). DMR2 (G, maternal B6; C, paternal PWD).
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DNA methylation at Igf2r DMR2 during gastrulation
(summarized in Figure 5). At E6.5, both EPI and VE lin-
eages maintain maternal ICR methylation. However, the
epiblast expresses biallelic Igf2r and no Airn. In contrast,
both genes are imprinted in visceral endoderm of the
same embryos. Therefore, there must exist mechanistic
distinctions that result in imprinted expression in VE but
not in EPI at E6.5 - possibly lineage-specific expression of
chromatin binding/modifying genes established during
preimplantation inner cell mass/trophectoderm differen-
tiation. Our data also show locus-specific methylation
spreading occurs during gastrulation in both lineages.
While spreading of ICR methylation is known to occur
during preimplantation, it has not been previously shown
during gastrulation at imprinted loci, indicating that
DNMTs are targeted to the locus specifically during these
stages. The lineage differences in imprinted expression
documented herein are remarkably similar to patterns of
X-inactivation. Imprinted X-inactivation is established in
extraembryonic cells during preimplantation, while sto-
chastic X-inactivation occurs in the embryo only after gas-
trulation commences. Furthermore, non-coding RNAs
help induce silencing in cis of the inactive X chromosome
(reviewed in [24]) suggesting that Airn may function in a
similar fashion at the Igf2r locus. The results presented
here support the possibility that regulation of Igf2r/Airn
(and other imprinted loci) and X-inactivation may utilize a
common mechanism. Identification of the lineage-specific
machinery that enables epigenetic changes specifically in
the embryo will lead to a more complete understanding of
the events underlying normal gastrulation and epigenetic
reprogramming.
Methods
Tissues
All procedures were approved by the University of
Massachusetts Amherst Institutional Animal Care and
Use Committee. Embryos were derived from C57BL/6J
Figure 5 Summary schematic depiction showing dynamic regulation of Igf2r and Airn in the embryonic lineage. In the EPI, Igf2r is
biallelic and Airn is not expressed. During gastrulation, maternal methylation at DMR2 spreads, followed by initiation of paternal Airn expression
and then silencing of paternal Igf2r. In the extraembryonic lineage (right side), reciprocal imprinting of Igf2r and Airn is already established in VE
at E6.5. DMR2 methylation spreads but does not correlate with changes in allelic expression in extraembryonic lineage. Paternal specific binding
of Ctcf occurs at DMR2 in the extraembyronic lineage, but not in the embryo. Additionally, lineage- and allele-specific histone modifications are
present at DMR1 and DMR2 suggesting an epiblast-specific mechanism required to establish imprinted expression.
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(JAX 000664) and PWD/PhJ (JAX004660). Reciprocal
F1 embryos were derived from female C75BL6/J
Chr17PWD/PhJ/ForeJ (JAX 005267) and C57BL/6J (JAX
000664) males. Embryos were microdissected for DNA
and mRNA extraction. MII oocytes were collected
from superovulated B6D2F1 females to confirm ICR
methylation.
Imprinted expression analysis
Total RNA was isolated using the Roche High Pure
RNA Isolation Kit (Roche 11828665001, Roche, Basel,
Switzerland). cDNA synthesis was performed using Bio-
Rad iScript cDNA synthesis kit (170-8891) (Bio-Rad La-
boratories, Inc., Hercules, USA). Primers for allele-specific
expression and full-length Airn RT-PCR are shown in
Additional file 3: Table S1. Airn restriction fragment length
polymorphism (RFLP) was performed with AvaI. SSCP was
performed on Igf2r PCR products with MDE polyacryl-
amide gel electrophoresis (Lonza 50620, Lonza Group,
Basel, Switzerland). PCR products were visualized by
ethidium bromide illumination and imaging.
Bisulfite sequencing
Bisulfite sequencing was performed as previously de-
scribed [25] with the primers provided in Additional file
3: Table S1.
Chromatin immunoprecipitation
E8.5 C75BL/6JxPWD/PhJ-F1 embryos were dissected,
and embryonic and extraembryonic tissues were sepa-
rated and immediately processed using instructions in
either ChIP-IT High Sensitivity kit (Active Motif 53040,
Active Motif, Carlsbad, USA) or Zymo-Spin ChIP kit
(Zymo D5210, Zymo Research, Irvine, USA). Samples
were kept on ice and either sonicated twice for 20 s
with the Heat Systems Sonicator/Ultra Processor (out-
put 3) or sonicated for 30 s on/20 s off for 3 min using
a cup horn adaptor for the QSonica A500 (QSonica,
Newtown, USA). After sonication, 1% of each sample
was removed for input control. Immunoprecipitation
was carried out using Active Motif Protein G agarose
beads or magnetic Protein G Dynabeads (10003D, Life
Technologies, Carlsbad, USA) and either anti-Ctcf
(Santa Cruz sc-28198, Santa Cruz Biotechnology, Inc.,
Dallas, USA), anti-H3K4me3 (Abcam ab8580, Abcam,
Cambridge, UK), anti-H3K9me3 (Abcam ab8898), or
H3K27me3 (Millipore 07-449, Millipore, Billerica, USA)
along with normal rabbit IgG. After antibody incuba-
tion, beads were washed and DNA was collected using
manufacturer’s protocol. ChIP-PCR primers found in
Additional file 3: Table S1 (Additional file 4: Supplemental
Methods).
Additional files
Additional file 1: Figure S1. DMR1 methylation. (A) Schematic of the
mouse Igf2r/Airn locus: transcription start sites (bent arrows), Igf2r exons
(boxes), and location for DMR1 and DMR2. One amplicon spanning 12
CpG dinucleotides were analyzed. (B) Methylation of adult F1 brain and
liver. Note DMR1 methylation levels are variable in a tissue specific
context. (C) Embryo DMR1 methylation at E6.5, E7.0, and E7.5. Levels of
DMR1 methylation are comparable to the adult brain. Maternal = A,
Paternal = G.
Additional file 2: Figure S2. CTCF immunoflourescence. (A, A’) No/
trace nuclear CTCF signal is detectable in EPI or VE in E6.5 embryos.
Decidual cells show robust nuclear CTCF (FITC) serving as a positive
control. (B, B’) Robust nuclear CTCF is observed at E7.5 in all cells. (C, C’)
Nuclear staining is observed in the blastocyst at E3.5. CTCF shown in
FITC/green, nuclear counterstain DAPI shown in blue. Scale = 100 μm.
Additional file 3: Table S1. Primers for allele-specific expression and
full-length Airn RT-PCR.
Additional file 4: Supplemental Methods.
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Abstract
Successful mammalian development requires descendants of single-cell zygotes to differentiate into diverse cell types even though
they contain the same genetic material. Preimplantation dynamics are first driven by the necessity of reprogramming haploid parental
epigenomes to reach a totipotent state. This process requires extensive erasure of epigenetic marks shortly after fertilization. During the
few short days after formation of the zygote, epigenetic programs are established and are essential for the first lineage decisions and
differentiation. Here we review the current understanding of DNA methylation and histone modification dynamics responsible for these
early changes during mammalian preimplantation development. In particular, we highlight insights that have been gained through
next-generation sequencing technologies comparing human embryos to other models as well as the recent discoveries of active DNA
demethylation mechanisms at play during preimplantation.
Reproduction (2015) 150 R109–R120
From zygote to blastocyst
Mammalian preimplantation development is a time of
dynamic change in which the fertilized egg undergoes
cleavage divisions developing into a morula and then a
blastocyst with the first two distinct cell lineages (inner
cell mass (ICM) and trophectoderm (TE)). This develop-
mental period is characterized by three major tran-
sitions, each of which entails pronounced changes in
the pattern of gene expression. The first transition is the
maternal-to-zygotic transition (MZT), which serves three
functions: i) to destroy oocyte-specific transcripts (e.g.,
H1oo (Tanaka et al. 2001)), ii) to replace maternal
transcripts that are common to the oocyte and early
embryo with zygotic transcripts and iii) to facilitate the
reprogramming of the early embryo by generating novel
transcripts that are not expressed in the oocyte (Latham
et al. 1991). In mice, zygotic gene activation initiates
during the 1-cell stage, and is clearly evident by the
2-cell stage (Latham et al. 1991, Schultz et al. 1993).
Coincident with genome activation is the implemen-
tation of a chromatin-based transcriptionally-repressive
state (Nothias et al. 1995, Schultz 2002) and more
efficient use of TATA-less promoters (Majumder &
DePamphilis 1994), which are likely to play a major
role in establishing the appropriate pattern of gene
expression required for successful development.
The second developmental transition is compaction,
which occurs during the 8-cell stage, when the first
morphological differentiation occurs due to adhesive
interactions between the blastomeres generating a
tightly organized and less distinct mass of cells (Fleming
et al. 2001). Accompanying compaction are pronounced
biochemical changes through which blastomeres
acquire characteristics resembling somatic cells,
reflected in such features as ion transport, metabolism,
cellular architecture and gene expression pattern
(Fleming et al. 2001, Kidder & Winterhager 2001).
Following compaction, cleavage divisions allocate cells
to the inside of the developing morula. These inner cells
are set aside between the 8-cell and 16-cell stage, and
then again between the 16-cell stage and the 32-cell
stage (Pedersen et al. 1986). The inner cells of the morula
give rise to the ICM cells from which the embryo proper
is derived, whereas the outer cells differentiate
exclusively into the TE, which gives rise to extraem-
bryonic tissues (Yamanaka et al. 2006). The TE is a fluid-
transporting epithelium that is responsible for forming
the blastocoel cavity and is essential for continued
development and differentiation of the ICM (Biggers
et al. 1988, Watson et al. 1990). Distinct differentiation
first occurs in the blastocyst and is characterized by
differences in gene expression between the ICM and
q 2015 Society for Reproduction and Fertility DOI: 10.1530/REP-15-0180
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TE cells (Nichols & Gardner 1984, Pesce & Scholer
2001). Additionally, by the time of implantation the
primitive endoderm has differentiated from the ICM/
epiblast and resides as a single-cell layer on the
blastocoel cavity side of the ICM/EPI (reviewed in
Schrode et al. (2013)).
These dynamic morphological, cellular and molecular
events are driven by gene expression changes facilitated
by epigenetic phenomenon, including DNAmethylation
and histone modifications at sites throughout the
genome. Below we review the current understanding
of the mechanisms responsible for regulation of
epigenetic programming and re-programming that
occur during mammalian preimplantation.
DNA methylation dynamics in the preimplantation
mouse embryo
In mammalian cells, the predominant form of DNA
methylation occurs at CpG dinucleotides. Throughout
the genome, non-promoter associated CpGs are
generally found methylated. However, the majority of
protein coding genes have regions of high-density CpG
dinucleotides termed CpG islands. In most cell types the
methylation status at these promoter associated CpG
islands correlate with the transcriptional activity of the
locus – actively transcribed genes generally are not
methylated while silenced genes are often found to be
heavily methylated in the promoter island. Additionally,
there is growing evidence that CpG islands found outside
of transcription start sites play functional roles (Saxonov
et al. 2006, Illingworth et al. 2010, Maunakea et al.
2010). While DNA methylation at gene promoters is
traditionally thought to act as a binary switch (methyl-
ated, silent; unmethylated, active), it appears that CpG
density, not just presence of methylation alone, also
contributes to regulation of expression. For example,
methylation at low CpG dense promoters still allows for
transcriptional activity (Fouse et al. 2008). Furthermore,
there are numerous examples, particularly of non-coding
RNAs, that are transcribed, although the allele is heavily
methylated (Bartolomei et al. 1993, Takada et al. 2002,
Sleutels et al. 2003). These examples highlight that while
there are general correlations of methylation status and
gene activity, individual loci vary greatly.
In mammals, the molecular machinery responsible for
adding a methyl group to cytosine residues (resulting
5-methylcytosine (5mC)) has been identified as a family
of DNA methyltransferases (Dnmt1, Dnmt3a,
Dnmt3b,and Dnmt3l). Dnmt3a and Dnmt3b are respon-
sible for de novo methylation and play partially
redundant but independently essential roles during
early development. This includes methylation of repeat
regions, imprinted loci, as well as genes involved in
lineage decisions (Okano et al. 1999, Bourc’his et al.
2001, Kaneda et al. 2004). More specifically, Dnmt3a
and Dnmt3b help to establish de novomethylation in the
blastocyst, allowing global 5mC levels to increase to that
of somatic cells following implantation (Smith et al.
2012). Dnmt3a is maternally loaded in the oocyte and is
the predominate methyltransferase in the oocyte and
zygote (Kaneda et al. 2004, Kato et al. 2007), whereas
Dnmt3b is transcribed upon zygotic genome activation
(Watanabe et al. 2002) and is the primary mediator of
de novo methylation during implantation (Borgel et al.
2010). Knockout studies in mice show that each of the
Dnmts is required for viability (Li et al. 1992, Okano
et al. 1999), highlighting the essential nature of de novo
and maintenance methylation during development.
Dnmt1 has two functional transcripts that are expressed
during development – Dnmt1s is expressed in somatic
cells while Dnmt1o is specifically expressed as an oocyte
specific form (Rouleau et al. 1992, Gaudet et al. 1998,
Mertineit et al. 1998). Unlike Dnmt3a and Dnmt3b,
Dnmt1 maintains CpG methylation by recognizing
hemimethylated DNA and methlyating the unmethlyated
strand, ensuring 5mC is maintained through DNA
synthesis (Leonhardt et al. 1992, Arand et al. 2012).
Targeting of Dnmt1 to replication foci occurs in most
proliferating cells (Kishikawa et al. 2003, Bostick et al.
2007), however, Dnmt1o/s is largely excluded from the
nucleus during early preimplantation stages (Howell et al.
2001), likely to allow for the large-scale demethylation
that occurs to both haploid genomes (Figs 1 and 2).
Both sperm and oocytes contain parent- of- origin
specific 5mC patterns. Therefore, at the time of fertiliza-
tion the two haploid genomes arrive with diverse
epigenomic signatures. Both parental pronuclei undergo
dramatic global demethylation, presumably to ensure
similar epigenetic information at the two parental alleles
of the majority of genes (imprinted loci being one
exception) aswell as to program the newly formed zygote
to a totipotent state. The male haploid genome is heavily
methylated in sperm, where between 80 and 90% of all
CpG dinucleotides are methylated (Mayer et al. 2000,
Oswald et al. 2000, Santos et al. 2002). Global DNA
methylation levels in the maternal haploid genome are
approximately half that of the sperm (Howlett & Reik
1991, Smallwood et al. 2011, Peat et al. 2014). Shortly
after fertilization, the two parental genomes undergo
distinct but equally dramatic waves of DNA demethyl-
ation. The paternal genome undergoes active, replica-
tion-independent demethylation within the first several
hours post-fertilization. In contrast, the maternal genome
largely undergoes passive, cell division-dependent diffu-
sion of methylation, resulting in demethylation over the
course of preimplantation development.
Active DNA demethylation during preimplantation
development by Tet3 oxidation of 5mC
Demethylation begins immediately in the newly formed
embryo, prior to the first cell division. By the time the
R110 C Marcho, W Cui and others
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embryo reaches the morula stage, the genome is almost
completely devoid of DNA methylation (Santos et al.
2002). Despite wide-spread global demethylation, a few
regions of the genome are protected, including
imprinted loci and active retrotransposons like intracis-
ternal A particle (IAP) elements (Lane et al. 2003). The
large-scale demethylation begins with the rapid, active
demethylation of the paternal haploid genome.
The differences between demethylation dynamics
within the maternal and paternal pronuclei are thought
to arise from their distinct architecture. The paternal
genome is packed mostly around protamines, which are
disassembled after fertilization and re-organized with
histone-containing nucleosomes (Braun 2001, Balhorn
2007). The maternal genome is largely assembled
around H3K9me2-rich histones. These structural distinc-
tions between the two haploid genomes at pronuclear
stage 0 (PN0) is thought to greatly influence the timing of
bulk genome-wide demethylation (Santos et al. 2005),
the kinetics of which are different between the maternal
and paternal pronuclei (Fig. 1). Examination of global
DNA methylation by immunofluorescence showed that
the paternal pronucleus undergoes division-independent
demethylation (Santos et al. 2002). When the zygote
reaches the PN3 stage (w4 h after fertilization), there is
already a dramatic loss of 5mC observed in the paternal
pronucleus but little change in the maternal pronucleus
(Mayer et al. 2000, Oswald et al. 2000). By the time of
the first cell division (24 h after fertilization), there is no
5mC signal detected in the paternal PN, indicating near-
complete loss of 5mC methylation. Even though the two
parental genomes occupy the same nucleus after PN
fusion, the differences in 5mC levels are apparent
beyond the 4-cell stage (Santos et al. 2002).
Early studies of demethylation dynamics in mice based
on immunofluorescence conflicted somewhat with
bisulfite DNA sequencing data sets, which did not
show as dramatic a loss of 5mC (Oswald et al. 2000). It
was not until the realization that the 5mC oxidation
product 5-hydroxymethylcytosine (5hmC) is present
in vivo that this discrepancy was resolved. Traditional
bisulfite treatment does not distinguish between 5mC
and 5hmC (Huang et al. 2010), while the antibodies used
for immunofluorescence specifically (and only) detect
5mC. It has been subsequently shown that TET enzymes
mediate the oxidation of 5mC to 5hmC (as well as
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC))
in vivo and that TET proteins are expressed and
differentially localized during preimplantation develop-
ment (Gu et al. 2011, He et al. 2011, Iqbal et al. 2011,
Wossidlo et al. 2011). Specifically, TET3 primarily
localizes to the paternal pronucleus (Fig. 1) and is
thought to be responsible for the observed rapid
demethylation. Importantly, Gu et al. (2011) showed
that the loss of 5mC corresponds with a concomitant
gain in 5hmC. In both pronuclei, 5mC is present until
PN3, and by late PN3, there is a detectable decrease in
5mC and an increase in 5hmC (Fig. 1; Gu et al. 2011,
Iqbal et al. 2011, Wossidlo et al. 2011). It was also
shown that Tet proteins convert 5mC to 5fC and 5caC as
well, suggesting that Tet-mediated oxidation results in
three oxidative forms for cytosine in vivo (Inoue 2011),
ultimately resulting in replacement of the oxidized base
with unmethylated cytosine by base excision repair or
replication-dependent diffusion. Additionally, oxidation
of 5mC has been shown in other mammalian zygotes,
indicating a conserved mechanism of demethylation
(Wossidlo et al. 2011).
Surprisingly, deletion of Tet3 activity results in retention
of 5mC in the paternal pronucleus and inappropriate gene
activation at many loci, but only mild global phenotype
(reduced viability (Gu et al. 2011)). Tet3 mediated
Sperm Oocyte PN1 PN2 PN3 PN4 PN5
PPN
~40% methylation
H3K9me2-rich
80–90% methylation
protamine-rich
PGC7
5mC
MPN
Tet3
5hmC,
5fC, 5caC
PN
PN
Figure 1 DNA demethylation in the zygote. Distinct demethylation dynamics occur in the maternal (pink) and paternal (blue) pronuclei prior to
fusion. At fertilization, the maternal haploid genome hasw40%methylation compared to nearly 90%methylation in the paternal haploid genome.
Upon fertilization and continuing through pronuclear stage PN2, the paternal genome undergoes Tet3-dependent demethylation. PGC7, which
preferentially binds to H3K9me2-rich chromatin, protects the maternal genome from Tet3 activity during PN stages. By PN5 stage, the bulk of
paternal 5mC is gone and little change has occurred to maternal methylation. PPN, paternal pronucleus; MPN, maternal pronucleus.
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hydrolysis of 5mC also occurs during reprogramming after
SCNTcloning – Tet3 localizes to the pseudo-pronucleus in
recombined zygotes. In SCNT embryos made with Tet3-
null host oocytes, there is no 5hmC present in the pseudo-
pronucleus, further indicating the role of Tet3 in active
demethylation (Wossidlo et al. 2011, Gu et al. 2011).
These recent studies offered the prevailing idea that
demethylation during preimplantation development
occurred via i) active DNA demethylation of the paternal
pronuclei mediated by Tet3 and thymine DNA glycosy-
lase (TDG)-mediated base excision repair (reviewed in
Kohli & Zhang (2013)) and ii) passive, replication-
dependent dilution loss of methylation of the maternal
genome due to lack of Dnmt1 in the nucleus (Howell
et al. 2001).
However, recent work is shifting the hypotheses about
the mechanisms responsible in vivo. Using whole
genome approaches to assess cytosine methylation
patterns, it has been shown that Tet3-mediated
demethylation is only partially responsible for paternal
demethylation and that active demethylation also occurs
in the maternal PN (Guo et al. 2014a, Shen et al. 2014).
Furthermore, although Tet3-mediated oxidation is
required for active demethylation, TDG-mediated base
excision repair is not (Guo et al. 2014a). Additionally,
it appears that there is conflicting evidence regarding the
Fertilization Preimplantation Post-implantation
Zygote 4-cell 8-cell Blastocyst
E6.5
Paternal genome
Maternal genome
5hmC, 5fC, 5caC
E7.5
Active
demethylation
Passive
demethylation
Differentiation
remethylation
5m
C 
lev
e
ls
Figure 2 DNA methylation dynamics from fertilization through gastrulation. The three main phases of methylation change are illustrated. During
zygotic stages, the paternal genome undergoes active demethylation (blue line). This active demethylation is evident by sharply increased levels of
oxidative products (5mC to 5hmC, 5fC and 5caC) in the paternal pronucleus. Passive replication-dependent demethylation (predominantly in the
maternal pronucleus) occurs though exclusion of DNMTs from the nucleus during early preimplantation (red line). Lowest levels of methylation are
reached between the morula to blastocyst stage, when methylation levels begin to rise. During blastocyst formation and gastrulation, the genome
becomes re-methylated to levels consistent with somatic cells (black line).
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role that replication-dependent demethylation plays
in removing methylation from the paternal genome.
By blocking replication of the paternal pronucleus, Shen
et al. (2014) showed diminished demethylation in the
paternal pronucleus even though Tet3 activity is present,
indicating that replication is also involved in the
demethylation of the paternal PN. Adding additional
ambiguity is the fact that that Tet3-mediated demethyl-
ation is largely dispensable for successful development
(Peat et al. 2014, Shen et al. 2014, Inoue et al. 2015).
Taken together the mechanisms that reprogram sperm
and oocyte specific DNA methylation are not mutually
exclusive as once predicted, and these recent stories
indicate that there are likely unknown mechanisms also
contributing to DNA methylation dynamics during
preimplantation. With these advances, there are three
main modes of DNA demethylation: i) active
Tet3-mediated oxidation (predominantly in the paternal
pronucleus); ii) replication-dependent dilution of
Tet3-oxidative products, which plays a major role in
demethylation of the paternal pronucleus and
iii) replication-dependent (Tet3-independent) dilution
of 5mC (predominantly in the maternal pronucleus).
As our technical abilities evolve, it will be interesting to
determine the interplay of these mechanisms within the
same cells in vivo, define the specific loci at which each
occurs and identify whether there are differing roles
influencing cell fate decisions.
If Tet3 is present in the oocyte but only acts primarily
on the paternal genome, there must be a protective
mechanism to prevent conversion of maternal 5mC. One
candidate for this maternal genome protection is
PGC7/Stella, a DNA-binding protein expressed during
germ cell specification and in gonads and oocytes
(Saitou et al. 2002, Sato et al. 2002). PGC7 null embryos
fail to complete preimplantation and there is a loss of
5mC in both pronuclei, indicating a protective role in
the maternal pronucleus. Additionally, PGC7/Stella is
targeted to differentially methylated regions (DMRs) of
imprinted genes in the early embryo (Nakamura et al.
2007), supporting a functional role in blocking
Tet3-mediated demethylation.
PGC7/Stella is able to protect the maternal pronucleus
by binding to H3K9me2, which is a distinguishing feature
of the maternal pronucleus. Loss of H3K9me2 by ectopic
Jndm2a, a H3K9 methylation/dimethylation-specific
demethylase, leads to loss of 5mC in both the maternal
and parental pronuclei. PGC7/Stella also binds to
H3K9me2 regions of the paternal pronucleus, including
DMRs, which are not subject to protamine replacement.
Tet3 is inhibited by PGC7/Stella, thus offering protection
from active demethylation (Nakamura et al. 2012).
Imprinted loci are protected from demethylation
While most of the genome undergoes global DNA
demethylation, imprinted loci are protected and retain
parent of origin DMRs (Branco 2008, Cirio 2008,
Hirasawa 2008). It is clear that Dnmt1 is required for
the maintenance of these imprinted sites (Bourc’his et al.
2001), even though it is largely excluded from the nucleus
(Hirasawa 2008). Stella is also known to protect these
loci, including some imprinted sites of the paternal
genome. Additionally, Zfp57, a KRAB zinc finger protein,
and Trim28 have also been shown to be required for
integrity of ICRs in the early embryo. Trim28 interacts
with Zfp57 to target it to specific imprinted sites, resulting
in recruitment of repressive complexes including NuRD,
SETDB1 and DMNTs (Iyengar et al. 2011, Quenneville
et al. 2011, Zuo et al. 2012).While loss ofmaternal Zfp57
can be rescued by paternal expression, loss of maternal
Trim28 is lethal (Li et al. 2008, Messerschmidt et al.
2012), due in part to the variation in loss of imprinted
expression (Messerschmidt et al. 2012).
Early DNA demethylation dynamics in other
mammalian species
Preimplantation DNA demethylation dynamics are
largely the same in mouse and human embryos.
However, this is not the case in all mammals, indicating
distinct epigenetic reprogramming in different species.
During the PN stages and in the first cell divisions,
human, mouse and rat zygotes lose the majority of their
paternal 5mC (Dean et al. 2001, Zaitseva et al. 2007).
In contrast, both bovine and goat embryos retain an
intermediate level of 5mC in the paternal pronuclei (Park
et al. 2010, Wossidlo et al. 2010). Strikingly, sheep, pig
and rabbit embryos retain 5mC during the PN stages and
throughout preimplantation development (Beaujean
et al. 2004, Jeong et al. 2007, Reis e Silva et al. 2012).
In sheep, levels of 5mC drop during the 2-cell stage, but
then increase at the 16-cell stage, and the ICMmaintains
levels of DNA methylation but the TE levels decrease
dramatically (Young & Beaujean 2004).
These comparative studies illustrate the differences in
timing and degree of 5mC loss during preimplantation
among different mammalian species. These differences
may be due in part to variation in zygotic genome
activation, but they may also hint at differences in
methylation reprogramming requirements needed to
reach a totipotent state. These data also support the
idea that active, Tet3-mediated demethylation in mice is
not required for normal preimplantation development
(Peat et al. 2014, Shen et al. 2014).
Next-generation sequencing to assess global DNA
methylation dynamics during preimplantation
development
Next-generation sequencing, including reduced
representation bisulfite sequencing (RRBS) and whole-
genome bisulfite sequencing (WGBS) now allow
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assessment of global DNA methylation reprogramming
with high resolution even from limited numbers of cells.
Confirming earlier work, methylation across the genome
is observed at relatively low levels in oocytes and early
preimplantation stages, while sperm and post-
implantation embryos have methylation similar to that
of somatic cells (Smith et al. 2012, Guo et al. 2014a,b,
Peat et al. 2014). These newer technologies have
allowed for refined assessment of methylation changes
across the genome during precise developmental stages,
examination of specific classes of DNA sequence
elements and comparison of mouse and human
preimplantation embryos.
DNA methylation dynamics in human
preimplantation embryos
Two groups recently examined genome-wide DNA
methylation changes in human oocyte, sperm, zygote,
pre- andpost-implantation stages, using RRBS andWGBS
(Smith et al. 2012, Guo et al. 2014a). Similar to mouse,
both groups found that human sperm is highlymethylated
(although less than mouse sperm) and human oocytes
have intermediate levels of methylation. The post-
fertilization demethylation kinetics are also similar in
the human zygote (Smith et al. 2012). Guo et al. (2014a)
note that the greatest loss of DNA methylation occurred
between the 1- to 2-cell stage in human embryos, rather
than during PN stages (as is the case in the mouse). This
could indicate that differences in the rate of active
demethylation also correlates with the timing of zygotic
genome activation, which occurs later in humans
(Beaujean et al. 2004). Because bisulfite sequencing
used in these studies did not distinguish between 5mC
and the oxidative products of Tet-mediated demethyl-
ation, the distinct timing in mouse and human embryos
may reflect a difference in the oxidation rates of 5mC or
Tet activity between species. Paternal genome demethyl-
ation in humans is similar to observations in mouse
zygotes, in that the majority of methylation is rapidly lost
and only low levels of methylation remain during
preimplantation. Levels of methylation in the maternal
pronucleus are similar to mice, but the genomic regions
that are demethylated are divergent. Additionally, unlike
in mice, the majority of sperm and oocyte-specific DMRs
regain their full methylation following implantation
(Smith et al. 2012, Guo et al. 2014a).
Comparison of genome-wide methylation with single-
cell RNA sequencing data (Yan et al. 2013) confirmed
the previously observed negative correlation between
promoter methylation and gene expression and high-
lighted that this inverse relationship strengthens after the
MZT in human embryos (Smith et al. 2012, Guo et al.
2014b). Genes that had increased promoter methylation
after the blastocyst stage showed a predicted decrease in
expression in post-implantation-stage embryos (Guo
et al. 2014b). Also as expected, changes in DNA
methylation during preimplantation influence the repres-
sion of transposable elements. SINE/variable number of
tandem repeat/Alu elements (SVAs) expression increases
after the 2-cell stage, when rapid demethylation occurs.
This expression is maintained until the morula stage,
when expression decreases, presumably as the genome
is re-methylated – a trend which continues post-
implantation (Smith et al. 2012, Guo et al. 2014b).
While many repeat elements undergo loss of DNA
methylation and increased expression, the evolutionary
age of the transposable element appears to influence the
retention of methylation during preimplantation
development. Evolutionarily younger elements, which
are still capable of transposition are relatively resistant to
demethylation while their evolutionarily older counter-
parts that have lost the ability to jump are readily
demethylated along with coding genes. This might hint
at the evolutionary origins of methylation/demethylation
dynamics in mammalian preimplantation development
(Wang et al. 2014).
Histone modifications during preimplantation
In addition to DNA methylation changes, chromatin
organization and histone modifications play a critical
role in establishing a totipotent embryo, as well as
directing the first lineage decisions. Chromatin is a
highly organized and dynamic nuclear structure
containing DNA, histones and many other proteins.
Nucleosomes, the basic building block of chromatin are
comprised of two each of histone H2A, H2B, H3 and H4.
It is well established that the N-terminal tails of these
core histones are subject to post-translational modifi-
cations (PTMs), which play a fundamental role in
influencing gene expression patterns among disparate
cell types (Fischle et al. 2003). Histone PTMs include
acetylation, methylation, phosphorylation, ubiquitina-
tion and others, which occur at specific amino acid
residues catalyzed by specific enzymes (Strahl & Allis
2000, Tan et al. 2011). Additional complexity arises in
that methylation at lysines or arginines may exist in
distinct forms: mono-, di-, or trimethyl for lysines and
mono- or dimethyl on arginine residues (Kouzarides
2007). A general theme has emerged in which PTMs are
catalyzed by opposite functional pairs of enzymes.
Many studies have revealed functional themes where
histone PTMs correlate with gene expression patterns. For
example, lysine acetylation is commonly considered to be
an activemark that correlateswith chromatin accessibility
and active transcription, whereas histone lysine methyl-
ation can be either active or repressive depending on the
particular lysine residue that is modified (Tsukada et al.
2006, Bernstein et al. 2007). Recent large-scale efforts
supported by the Roadmap Epigenomics Project are
defining ‘chromatin states’ in many diverse tissues – that
is, combinations of histone modifications, DNA methyl-
ation and transcription factor binding that correlate with
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functional property of a particular locus (http://www.
roadmapepigenomics.org/publications/).
Histone modification during preimplantation
embryo development
Studies of early embryonic development have shown
that shortly after fertilization, many histone modifi-
cations are observed asymmetrically in the parental
haploid genomes prior to PN fusion (summarized in
Fig. 3). For example, in mice, H3K27ac, H4K5ac and
H4K16ac are only detectable in the paternal PN of early
zygotes (Adenot et al. 1997, Stein et al. 1997,
Hayashi-Takanaka et al. 2011). Conversely, all forms of
H3K4 methylation (me1, me2 and me3) are observed in
maternal PN (Lepikhov & Walter 2004, Santenard et al.
2010), and H3K9me2 and me3 are also significantly
higher in the maternal PN (Lepikhov & Walter 2004,
Wongtawan et al. 2011, Beaujean 2014). H3K27me1 is
present in both PNs, but H3K27me2 and -me3 occur
extensively in the maternal PN (Erhardt et al. 2003,
Santos et al. 2005, Santenard et al. 2010). Additionally,
H3K9me3S10P, H3K36me3 and H4K20me3 are also
found exclusively in the maternal PN at early post-
fertilization stages (Boskovic et al. 2012, Ribeiro-Mason
et al. 2012, Beaujean 2014). Although the functional
significance of these asymmetric PTMs remains largely
unknown, it highlights the distinct reprogramming that is
required for the paternal and maternal PN for proper
embryonic genome activation and embryo development
(Ribeiro-Mason et al. 2012, Beaujean 2014).
Histone PTMs also play key roles in remodeling of
chromatin configuration and DNA methylation. In mice,
the increase of H3K79me by forced expression of DOT1L
causes premature chromocenter formation and develop-
mental arrest of 2-cell embryos (Ooga et al. 2013).
Additionally, deletion of the methyltransferase Setdb1 in
mouse embryonic stem cells leads to the reduction of
H3K9me3 and an overall decrease of DNA methylation
levels at specific loci (Leung et al. 2014). In porcine
embryos, disturbed H3K4me3-H3K27me3 balance after
knockdown of demethylase Kdm5b can cause increased
expressions of Tet family members (Huang et al. 2015),
which are found to be crucial for the interactions between
histone modification and DNA methylation in mouse
embryonic stem cells (Sui et al. 2012).
Functional studies of the roles of specific modifi-
cations are just beginning, using genetic strategies to add
or remove specific enzymatic activities to embryos. For
example in mice, hyperacetylation of histone H4
mediated by knockdown of HDAC1 causes develop-
mental delay (Ma & Schultz 2008). Knockdown of either
Ing2 (H3K4me3 methyltransferase activity) or RNF20
(histone H2B monoubiquitination) results in arrest at
the morula stage (Ooga et al. 2015, Zhou et al. 2015).
Depletion of H4K20me1 by knockout of the PR-Set7
gene induces early embryonic lethality prior to the 8-cell
stage (Oda et al. 2009), and our lab has shown critical
roles of H3K36me3 during preimplantation develop-
ment by knockdown of CTR9/PAF1 (Zhang et al. 2013a).
Other recent examples include studies in mice showing
that maternal-specific H3K9me3 is enriched at the Xist
promoter region and prevents maternal Xist activation
(Fukuda et al. 2014); increased H3K4me2 results in
abnormal expression of eIF-4C/Oct4 and arrest at the
2-cell stage (Shao et al. 2008); and that PRC1 binding to
H3K27me3 plays an indispensable role in embryonic
genome activation and developmental progression
(Posfai et al. 2012). Although precise in the removal of
specific gene function, these studies highlight the
difficulty in assigning specific function to a particular
modification or enzymatic activity since the phenotype
is often developmental failure and misregulation of
many genes. It is only very recently that next-generation
technologies allow for very low input such that
ICM: H3K27me3; H3R26me
Expression: Oct4, Sox2, NanogBoth: H3K9me1; H3K27me1
H3K27me2,3; H3K9me3S10P;
H3K36me3; H4K20me3
PN: H3K27ac; H4K5ac; H4K16ac
PN
?
PN
PN: H3K4me; H3K9me2,3;
TE: H4/H2AS1P
Expression: Cdx2, Eomes
Figure 3 Differential histone modification during preimplantation development. After fertilization, the parental pronuclei are differentially enriched
with many distinct histone modifications (left side: list of PTMs). Little data is available regarding the timing and mechanisms resulting after
pronuclear fusion that result in largely homogenous PTMs during cleavage stages (indicated by the question mark). By the time ICM and TE begin to
differentiate, these cell lineages have acquired distinct epigenetic signatures and gene expression patterns (right side).
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investigators can determine which loci across the
genome are altered in these knockout/knockdown
embryos (Brind’Amour et al. 2015).
Relevant to artificial reproductive technologies,
histone modifications are sensitive to manipulations
during preimplantation, potentially altering epigenomic
patterns (Feil & Fraga 2012, Dupont et al. 2012). For
example, in the mouse, H3K4me3 is significantly lower
in the in vitro fertilized embryos compared with in vivo
fertilized embryos (Wu et al. 2012). Similarly lower
levels of H3K27me3 are found in the ICM of heated-
sperm-derived blastocysts when compared to untreated-
sperm-derived blastocysts (Chao et al. 2012), and
cryopreservation can alter H4K12ac patterns in both
oocytes and zygotes (Suo et al. 2010). Despite these
observations, it remains unclear if altered PTM levels
persist in offspring or if surviving individuals contain
appropriate epigenomic information – possibly correct-
ing the epigenome during cell lineage differentiation at
post-implantation stages.
Histone modifications in ICM and TE lineage
specification
In mouse embryos, transcription factors such as Oct4,
Sox2 and Nanog are enriched in cells of the ICM and
function to both promote pluripotency and resist
differentiation. Conversely, in TE, transcription factors
such as Cdx2 and Eomes become upregulated, promoting
differentiation. In contrast to the mouse, Oct4 and Cdx2
are co-expressed in the ICMand TE of bovine and porcine
embryos, and the mechanisms of molecular differen-
tiation remain largely unknown (Kirchhof et al. 2000).
This first lineage specification is critical for implan-
tation and successful development.DNAmethylation has
been shown to be dispensable for growth and differen-
tiation of the extraembryonic lineages (Sakaue et al.
2010), suggesting that appropriate histone modifications
may provide key epigenetic information directing gene
expression and lineage specification. Once the TE and
ICMbecomedistinct, theyexhibit asymmetries in specific
histone PTMs. For example, in the mouse, H4- and
H2AS1P are increased in the TE cells (Sarmento et al.
2004), while H3K27me3 is enriched in the ICM (Erhardt
et al. 2003). At the 4-cell stage, blastomeres have
different levels of methylated H3R26me and those cells
with higherH3R26me aremore likely to result in ICMcell
fate. Overexpression of the H3R26 methyltransferase
CARM1 results in increased expression Nanog and Sox2,
suggesting that pluripotency factor expression is influ-
enced by locus-specific H3R26me (Torres-Padilla et al.
2007). Other examples include studies showing that
repressive H3K9me3 at the Cdx2 promoter is important
for maintaining pluripotency and loss of associated
methyltransferase ESET in early embryos results in ICM
failure (Yeap et al. 2009). However, in TE lineage, Suv39h
methyltransferase mediates repressive H3K9me3 at ICM-
specific gene promoters in the TE lineage (Alder et al.
2010, Rugg-Gunn et al. 2010). These studies highlight
that even the same histone modification can be finely
tuned by distinct enzymes to influence lineage specifi-
cation in different cell populations.
There are ever growing observations of locus specific
enrichment of histone modifications correlating with
lineage decisions during preimplantation development.
For example, H3K4me3 and H3K27me3 are enriched
at promoters of genes exclusively expressed in ICM or TE
in both murine and bovine embryos (Dahl et al. 2010,
Herrmann et al. 2013). It was also recently shown that
loss of repressive H3K27me3 participation at TE-specific
genes is essential for TE lineage development and
embryo implantation (Saha et al. 2013, Paul & Knott
2014). In addition to methylation of histone H3 residues,
acetylation of histone H4 (H4K8ac and H4K12ac) has
also been implicated in early lineage specification
(VerMilyea et al. 2009, Zhang et al. 2013b).
A handful of histone-modifying proteins thought to be
central to epigenetic programing during development
have knock-out phenotypes only apparent after preim-
plantation. These include members of Polycomb Repres-
siveComplex2 (Eed, Ezh2 andSuz12) aswell as theH3K9
methyltransferases G9a and Eset. It remains unclear if the
timing of null phenotypes is due to functional redundancy
with other genes ormaternal loading of RNA/protein, or if
the modifications they perform are in fact not required
until gastrulation (or later). There are a few histone-
modifying enzyme knock-out phenotypes inmice that do
result in lethality during preimplantation, some of which
show lineage-specific defects. Loss of the histone H3K9
demethylase Jmjd2C results in morula arrest and null
embryos show reduced levels of ICM-specific gene
transcription, suggesting a failure to maintain pluripo-
tency (Wang et al. 2010). Similarly, null embryos of
several members of the NuRD complex (Sin3A, Suds3,
Arid4b (McDonel et al. 2009)) and PAF1 complex (Ctr9
and Rtf1 (Ding et al. 2009, Zhang et al. 2013a)) do form
blastocysts but show defects in ICM proliferation as a
major cause of developmental lethality and failure. It is
perhaps not so surprising that knockout of genes with
distinct functions (such as Sin3AandCtr9) result in similar
defects in maintenance of ICM potency, which is of the
utmost importance for continued development and
requires myriad proteins to accomplish.
Moving forward
As described above, a wide array of covalent histone
modifications are now recognized to occur in vivo and
correlate with distinct transcriptional states and/or
chromatin conformation. However, knowledge about
the role of histone modifications during development is
mostly limited to reports of changes in global patterns –
apparent by immunofluorescence with antibodies
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directed against specific modifications (reviewed in
Beaujean (2014)). While these descriptive studies are
an essential beginning, little is known about the
functional importance of these modifications. In vivo
analysis of the role of histone modifications at specific
loci during early development is only just beginning, and
the relative lack of functional data is due to several factors
including: i) limitations in our ability to efficiently
generate maternal and zygote null embryos at the same
time, ii) limitations in our ability to assess histone
modifications at specific loci from very small numbers
of cells and iii) an inability to alter specific modifications
at specific loci. Due to the combinatorial nature of the
histone code and the difficulty in functionally preventing
one particular modification at one locus in vivo, it is
currently not feasible to simply ask, ‘What is the role of a
specific histone modification at a specific genomic locus
during development’. Fortunately, this type of epigenetic
engineering has come to the fore and many groups
are currently working to develop in vivo epigenetic
targeting tools.
With greatly enhanced access to next-generation
sequencing technologies, there is ever-growing oppor-
tunity to probe genome-wide methylation patterns at
single-base/nucleosome resolution in diverse cell popu-
lations, and improved techniques are pushing WGBS
towards single-cell sequencing. Additionally, multiple
methods are now readily available for the discrimination
of 5mC and 5hmC at a single base resolution. Combining
DNA methylation analysis with ChIP-seq and RNA-seq
during preimplantation development will allow for a
comprehensive cataloguing of early epigenetic repro-
gramming dynamics. Cross-species comparison of these
dynamics at specific loci and the capability to function-
ally test the importance of specific modifications will
allow for deeper understanding of how epigenetic
dynamics influence preimplantation development, the
transition from gametes to totipotency and the require-
ments of lineage differentiation.
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RLIM is dispensable for X-chromosome inactivation
in the mouse embryonic epiblast
JongDae Shin1, Mary C. Wallingford2, Judith Gallant3, Chelsea Marcho2, Baowei Jiao1{, Meg Byron3, Michael Bossenz4,
Jeanne B. Lawrence3, Stephen N. Jones3, Jesse Mager2 & Ingolf Bach1,5
In femalemice, two formsofX-chromosome inactivation (XCI) ensure
theselective silencingof femalesexchromosomesduringmouseembryo-
genesis.Beginning at the four-cell stage, imprintedXCI (iXCI) exclu-
sively silences thepaternalXchromosome.Later, around implantation,
epiblast cells of the inner cell mass that give rise to the embryo reac-
tivate the paternal X chromosome and undergo a random form of
XCI (rXCI)1,2. Xist, a long non-coding RNA crucial for both forms
of XCI, is activated by the ubiquitin ligase RLIM (also known as
Rnf12)3–5. Although RLIM is required for triggering iXCI in mice,
its importance for rXCI has been controversial. Here we show that
RLIM levels are downregulated in embryonic cells undergoing rXCI.
Usingmouse geneticswedemonstrate that female cells lackingRLIM
frompre-implantation stages onwards showhallmarks ofXCI, includ-
ingXist clouds andH3K27me3 foci, and have full embryogenic poten-
tial. These results provide evidence thatRLIM is dispensable for rXCI,
indicating that inmice anRLIM-independentmechanism activates
Xist in the embryo proper.
The X-linked gene Rlim encodes the RING-finger ubiquitin ligase
RLIM6,7, which functions as a sex-specific epigenetic regulator of nur-
turing tissues in female mice. In the mammary glands of pregnant and
lactating females, RLIM expressed from the paternal X chromosome
(Xp) serves as a survival factor formilk-producingalveolar cells8,9. In con-
trast, female embryos with a maternal deletion of Rlim in the germ line
(Dm) show defectiveXist cloud formation and subsequent Xp silencing
during iXCI, and die between embryonic day (E)5.5 and E10.5 due to a
lack of extraembryonic trophoblast tissues in the placenta5. Using an
embryonic stem (ES)-cellmodel, evidencehas beenprovided thatRLIM
can serve as a dose-dependent activator of XCI: the overexpression of
RLIM induces ectopic Xist clouds in male and female ES cells4, and, in
this system, homozygous disruption of Rlim results in a failure to ini-
tiate Xist transcription during rXCI3,10. Thus, current models of rXCI
present RLIM as a crucial activator ofXist11,12, although some evidence
suggests that it has a less important role in mice5.
Duringmousedevelopment,RLIM-encodingmessengerRNA isubiq-
uitously expressed, whereas its protein expression profile seems more
restricted6,13. Thus, to investigate in vivo functions of RLIM for rXCI,
we first analysed its protein expression and co-stained early embryos
with antibodies against RLIM and the pluripotency factorOct4, which
identifies undifferentiated cells in the inner cell mass (ICM) undergo-
ing rXCI.WhereasRLIMseemed to be uniformly expressed in the cells
of E3.5 embryos (Fig. 1a), at E4.5 andE5.5 only low levelswere detected
inOct4-positive cells, in contrast to extraembryonic cell types (Fig. 1b, c
and ExtendedData Fig. 1a; data not shown). Likewise, at E6.5 and E7–
7.5 we detected low levels of RLIM in embryonic epiblast tissues and
amnion tissues,whereas levelswerehigh inmanyextraembryonic tissues,
including cells of the ectoplacental cone, extraembryonic ectodermand
visceral endoderm (Fig. 1d and ExtendedData Fig. 1b; data not shown).
Indeed, owing to low levelsofRLIM, itwasdifficult todistinguishwild-type
embryos fromthose lackingRLIMinembryonic tissuesby immunostaining
(Extended Data Fig. 1b). Although we did not genotype E5.5 embryos
for technical reasons, in all tenwild-type embryos analysedwedetected
no/very low levelsofRLIMinOct4-positivenuclei.Moreover,weobserved
similarly low RLIM levels in genotyped males and female embryos at
E4.5 and E7–7.5 of various genetic backgrounds (Fig. 1 and Extended
Data Fig. 1; data not shown). As rXCI occurs aroundE5–E5.5, our data
indicate that levels of RLIM are downregulated in mouse epiblast cells
before rXCI.
To induce the conditional knockout ofRlim (cKO) in female embryos
after the occurrence of iXCI but before induction of rXCI, we used Sox2-
Cre (SC) transgenicmice14,15, as Sox2 is specifically expressed in embry-
onic epiblast cells of E3.5 blastocysts16, and a paternally transmitted
SC transgene is robustly transcribed in ICM cells of pre-implantation
blastocysts14. Indeed, froma fl/fl3WT/Y-SC (where fl indicates floxed,
WT indicates wild type, andY-SC indicates amale that carries both a Y
chromosome and the SC transgene) cross, female andmale pupswith a
maternal cKO (cKOm) are born in Mendelian sex ratios, and the per-
centages of male and female pups carrying cKOmwere similar (Fig. 2a),
confirming normal iXCI. Importantly, female pups carrying a cKOm
and a paternal germline deletion of Rlim (cKOm/Dp) generated via a fl/
fl3 cKO/Y-SC cross are born at Mendelian ratios (Fig. 2b), and, except
for amammary phenotype, adult cKOm/Dp females appear normal and
are fertile (data not shown). In genotyping these animals using poly-
merase chain reaction (PCR) we detected only the knockout allele but
no longer the floxed allele (Fig. 2c), andRLIMproteinwas undetectable
in somatic tissues (Fig. 2d).Moreover, inmatingsusing cKO/Y-SCmales
we never observed the transmission of an unrecombined floxed allele
(data not shown). Consistent with published data14,15, these results indi-
cate complete penetrance of the SC-mediated cKO. Analysing embryos
from fl3WT/Y-SC crosses, the recombination of the floxed allele was
robustly detectable using PCR in blastocysts as early as E3.75 (Fig. 2e),
well before initiation of rXCI.
To testwhether an essential functionofRLIMin rXCImightbemasked
by the C57BL/6mouse background, we generated first filial generation
(F1) parents inmixedC57BL/6–SV129 andC57BL/6–FVBhybrid back-
grounds suitable for generating SC-mediated cKOmoffspring.Although
thenumbers of cKOmF2pupswere slightlyunderrepresented compared
with maternal wild type (WTm) pups, there was no difference between
thenumbers ofmale and female cKOmpups (ExtendedData Fig. 2a, b),
indicating that this effect is XCI independent. Sequencing analyses of
cKOm/Dp pups inmixedC57BL/6–SV129 backgrounds using 156 strain-
specific single nucleotide polymorphisms (SNPs) distributed among all
chromosomes revealednogeneral bias towards theC57BL/6 background
(Extended Data Fig. 2c). Together with strain-independent low RLIM
protein levels in the embryonic epiblast (Fig. 1 andExtendedData Fig. 1),
these data indicate that the genetic background has little or no influence
on pup numbers.
1Program in Gene Function and Expression, University of Massachusetts Medical School (UMMS), Worcester, Massachusetts 01605, USA. 2Veterinary & Animal Sciences, University of Massachusetts
Amherst, Amherst, Massachusetts 01003, USA. 3Department of Cell andDevelopmental Biology, UMMS,Worcester, Massachusetts 01605, USA. 4OrtenauKlinikumLahr-Ettenheim, Institut fu¨r Pathologie,
77933 Lahr, Germany. 5Program in Molecular Medicine, UMMS, Worcester, Massachusetts 01605, USA. {Present address: Kunming Institute of Zoology, Chinese Academy of Science, Kunming 650223,
China.
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We next examined XCI using RNA fluorescence in situ hybridiza-
tion (RNA-FISH) inmouse embryonic fibroblasts (MEFs) isolated from
E12.5 embryos, co-hybridizingwith probes specific forXist17 andRlim5.
As expected,maleWT/YMEFs only showedRlim transcription foci but
no Xist clouds (Fig. 3a). In contrast, the majority of female WT/WT,
cKOm/WT,WT/cKOpandcKOm/DpMEFs showedmonoallelic expres-
sion of both genes, with Xist painting the inactive X and foci of Rlim
transcriptionmarking the activeX (Xi andXa, respectively) (Fig. 3a, b).
XCI in cKOm/DpMEFs was verified by co-staining cells with antibodies
directed against RLIMandH3K27me3, anXCImarker downstreamof
Xist18 (Extended Data Fig. 3). We observed a similar pattern for prim-
arymammary epithelial cells isolated from3-month-old adult females
(Fig. 3c, d; data not shown). We also examined X skewing in MEFs
isolated from female embryos with either a maternal or paternal cKO
allele, using transgenic mice containing an X-linked green fluorescent
protein (XGFP) transgene19 on the wild-type X chromosome.MEFs of
both cKOm/XGFPp andXGFPm/cKOp embryos showedapproximately
1:1 ratios of GFP-positive:GFP-negative cells (Extended Data Fig. 4).
These results indicate normal rXCI in somatic tissues.
Focusing our analyses on embryonic stages E5.5–E7.5, when rXCI
occurs in vivo1,2, we dissected epiblast tissue of E6–6.5 WT/WT and
cKOm/Dp embryos andmeasuredmRNAlevels ofRlim andXistbyquan-
titative PCRwith reverse transcription (RT–qPCR). Although levels of
Rlimwere greatly diminished in cKOm/Dp embryos, those ofXistwere
only slightly reduced (Fig. 4a). The residual levels of Rlim in cKOm/Dp
embryos are probably due to minor amounts of contaminating extra-
embryonic tissue in epiblast dissections. Consistent with the kinetics of
developingH3K27me3marks on theXi18, we first detectedH3K27me3
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Figure 1 | Downregulation of RLIM levels in early embryonic tissues before
and after implantation. a, b, Co-stainings of wholeWT/WTpre-implantation
embryos at E3.5 (a) and E4.5 (b) (n5 5 and 8, respectively) using antibodies
against RLIM (red) and Oct4 (green). Embryos were first photographed
and then processed for genotyping. DAPI, 49,6-diamidino-2-phenylindole.
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n5 10) within placental tissues. Note the lack of RLIM staining (red) in nuclei
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embryos (n5 5) within decidual tissues using antibodies against RLIM (red)
and H3K27me3 (green). Boxed regions are shown in bottom panels. d1,
ectoplacental cone region; d2, amnion region; d3, embryonic epiblast region.
Note the low RLIM staining intensity in cells in the amnion and epiblast
regions. Scale bars, 15mm (a, b), 30mm (c) and 75mm (d).
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foci in WT/WT embryonic tissues at stages E7–E7.5 but not in earlier
post-implantationembryos (Fig. 4b;datanot shown). These signalswere
indistinguishable from those of E7–7.5 cKOm/Dp embryos, indicating
similar XCI kinetics in the absence of RLIM.Moreover, cKOm/Dp and
WT/WT embryos were similar in size, and in immunostainings using
antibodies directed against cleaved caspase 3, no increase in cells under-
going apoptosis was detected in cKOm/Dp embryos (data not shown).
To obtain definitive evidence that rXCI does not require the presence
of RLIM in cells, we performed tetraploid complementation assays in
which tetraploid WT/WT embryos were aggregated with low-passage
Rlim D/D (ES-cell line IB8 or IB11), and control flm/Dp (IB6) or male
Dm/Y ES cells (and IB13), freshly isolated from blastocysts. These ES-
cell lineswere generatedby a flm/Dp3D/Y-SC cross, and are capable of
developing H3K27me3 foci upon differentiation in culture, indicating
XCI (Extended Data Fig. 5a, b). In tetraploid injections, the develop-
ment of embryos derived fromD/DES cells was indistinguishable from
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control ES cells at E9–9.5 (Fig. 4c), and no significant differences in
complementation efficiencies between these ES-cell lineswere detected
(ExtendedData Fig. 5c). Examining rXCI inMEFs isolated from E10.5
embryos generated fromD/D IB11 cells revealed thatmore than 75%of
D/DMEFs developed H3K27me3 foci andXist clouds (Fig. 4d and Ex-
tended Data Fig. 5d, e). Combined with the presence of a single Rlim
transcription focus in cells, this indicated that ES cells lackingRLIMare
capable of undergoingXCI in vivo. Together, our results provide strong
evidence that RLIM is dispensable for rXCI inmice.Moreover, because
maternal Rlim is crucial for iXCI and the D/D ES-cell line IB11 is SC
negative (Extended Data Fig. 5a)—therefore containing maternal and
paternal D alleles—these data indicate that the process of iXCI is not
required in pre-implantation embryos for the epiblast precursor-cell
lineage that will give rise to the embryo proper.
Clearly, RLIM can serve as an activator ofXist in some systems3–5,10.
The fact that in cKOm/Dp embryos, Xist levels are only mildly affected
andH3K27me3 signals are establishedwith kinetics similar toWT/WT
(Figs 4a, b), combined with the finding that RLIM levels are down-
regulated in wild-type embryos (Fig. 1, ExtendedData Fig. 1), suggests
that in femalemouse embryos anRLIM-independentmechanism is used
to activate/upregulate Xist transcription during rXCI. This is further
underscored by our results that outgrowths of E4.5 blastocyst-stage
female embryos with amaternal and paternal germlineRlim knockout
can develop Xist clouds in cells of the ICM5. Because rXCI occurred
with low frequency in theRlim-knockout ES-cell system3, it seems likely
that two independentmechanisms forXist activation exist inmice: one
that is independent of RLIM and may be inactive or downregulated in
certain ES-cell systems in culture, and another that is RLIMdependent.
Such a model is consistent with the presence of Xist activators other
than RLIM, such as JpxRNA20,21, and would explain why RLIM is nec-
essary for XCI in specific ES cells but not in embryos. A similar case in
which ES-cell systems do not accurately reflect the in vivo situation has
been reported for Nanog: although Nanog is required for the main-
tenance of pluripotency in the mouse epiblast22, it is dispensable for
somatic pluripotency inES cells23.Moreover, a specific downregulation
ofRLIMinmicemay alsoprovide an explanation for reporteddifferences
in its embryonic functions, as phenotypes inmorphogenesis uponRlim
mutation have been observed in zebrafish24 but not in mice5.
Our results suggest important functions of parental germline imprint-
ing onRLIMexpression and the rXCI process. In addition, differences in
Rlimmutant allelesmay exert some effect on the discrepancies reported,
because from theRlim-knockout locus, a protein containing 83 amino
acids is predicted to be expressed inmice5 compared to 340 amino acids
in theES-cell system3,4. Thus,we cannot exclude thepossibility that trun-
cated RLIM produced from the respective Rlim-knockout loci may dif-
ferentially influence the rXCI process. In summary, although there is no
doubt about the crucial function of Rlim forXist function during iXCI,
we propose that Rlim is dispensable for rXCI in mice.
METHODS SUMMARY
To investigate the functions of RLIM during rXCI in mice, the conditional Rlim
knockout5 was targeted to the ICM in pre-implantation blastocysts using a patern-
ally transmitted Sox2-Cre transgene14,15 as a driver. Analyses of cells and embryos
at pre- and post-implantation stages was carried out as described previously using
RNA-FISH25, immunological stainingmethods5,26, western blotting27 and RT–qPCR5.
Rlim D/D ES-cell lines were newly generated28 and used for tetraploid injections.
MEFs were prepared as described29.
Online Content Any additional Methods, ExtendedData display items and Source
Data are available in the online version of the paper; references unique to these
sections appear only in the online paper.
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METHODS
Mice. Mice used in this study and genotyping have been previously described:
Rlimfl/fl (ref. 5), Sox2-Cre14, XGFP19. Sox2-Cre, XGFP, wild-type SV129 and FVB
micewere purchased from the JacksonLaboratories.Rlimmicewere generally bred
in a congenic C57BL/6 background. However, to examine background effects on
XCI, the floxed Rlim and Sox2-Cre alleles were introduced into C57BL/6–SV129
and C57BL/6–FVB hybrid backgrounds. The extent of C57BL/6 versus SV129
background of hybrid F2 cKOm/Dp newborn females was determined on genomic
DNA using the Genome Scanning Services provided by The Jackson Laboratories.
All mice were housed in the animal facility of the University of Massachusetts
Medical School according to National Institutes of Health guidelines, enforced by
the Institute of Animal Care and Usage Committee.
Generation of ES cells and tetraploid injection experiments. ES cell lines Rlim
D/D (IB8 and IB11), flm/Dp (IB6) and D/Y (IB13) were generated as described28.
Briefly, E3.5 blastocyst-stage embryos from a flm/Dp3 D/Y-SC cross were recov-
ered and cultured onto mitotically inactivated SNL-76 feeder cells in DMEM plus
antibiotics and 15% FBS supplemented with b-mercaptoethanol, non-essential
amino acids and nucleosides. Five days after hatching and expansion, each blas-
tocyst culture was rinsed with PBS and the ICM collected bymanual pipetting and
placed into trypsin. After disaggregation, the cells were plated into an individual
well of a 96-well feeder dish and expanded appropriately for genotyping and freez-
ing. ES cellswere scored by genotyping and further expanded formycoplasma test-
ing, ability to undergo XCI and for use in tetraploid injection experiments.
For tetraploid complementation, ES cells weremicroinjected into eight-cell stage
embryos that had undergone tetraploid fusion at the two-cell stage using aCF-150B
Electrofusion Instrument (BLSLaboratory). ES cells were harvested from feeder cell
layers, rinsed, and placed intoDMEMplus 20% fetal bovine serum. Approximately
8–10EScellsweremicroinjected into the tetraploid-fusedembryos, and the injected
embryos then surgically placed into the oviducts of pseudo-pregnant female (E0.5)
mice. The recipient female mice were killed 9 days later, and embryos were recovered
and assessed for proper embryonic development and formation of structures derived
from the three germ-cell layers before genotyping.MEFswere prepared as described29.
Preparation of embryos andRT–qPCR.Apart fromembryos generated via tetra-
ploid injection, all blastocysts and embryoswere generated by naturallymating 8–14-
week-old female mice withmales. Embryos were collected at stages E3.5 to E12.5 for
further processing. Genotyping of embryos was carried out as described5. Analyses of
dissected epiblast tissuesof E6.5 embryosusingRT–qPCR includingprimer sequences
have previously been described5. Values obtained from three independent biological
samples were normalized against actin and standard deviation was calculated.
Blastocyst outgrowths and culturing of primary mammary cells. Blastocysts
were obtained at E4.5 and cultured for 24 h before immunocytochemical stainings
as described5. Embryos were genotyped after image recording. Primarymammary
epithelial cells were isolated from adult virgin female mice (12 weeks), cultured as
described8 and then processed for RNA-FISH or immunostainings.
RNA-FISH. RNA-FISH experiments on MEFs and primary mammary epithelial
cells were performed as described previously5,8,25. For the synthesis of specific Xist
probes,weusedplasmids containingmouseXist exon1 and6 that recognizeXist and
Tsix17. For the Rlim probe, we used a plasmid containing genomic Rlim sequences
upstream of the knockout site that detects specific RlimmRNAs transcribed from
both wild-type and knockout alleles5.
Antibodies and western blots. Primary antibodies used for immunostainings
were rabbit RLIM7, guinea pig RLIM13, Oct4 (Santa Cruz, sc5279; Abcam, ab27985),
H3K27me3 (Abcam, ab6002; Millipore, 07-447), GFP (Rockland, 600-101-215),
cleaved caspase 3 (Cell Signaling, 5A1E) and actin (Sigma, A 4700). Secondary anti-
bodies were Alexa Fluor-488 donkey anti-rabbit IgG (Invitrogen, A21206), Alexa
Fluor-488 goat anti-mouse IgG (Invitrogen, A11029), Alexa Fluor-546 goat anti-
guinea pig IgG (Invitrogen A11074), Alexa Fluor-568 goat anti-rabbit IgG (Invi-
trogen, A11011). Western blots were carried out as reported27.
Immunohistochemistry. Immunohistochemical staining of embryonic sections
was carried out essentially as described26. After dissection and removal of the ecto-
placental cone for genotyping, embryos were gently placed into a small section of
uterus, in order to facilitate the embedding protocol and maintain orientation for
sectioning. Embryos/uteri were fixed for histology in 4% paraformaldehyde (PFA)
for 2 h at room temperature or overnight at 4 uC.Embryos in uteriwere dehydrated
in methanol washes; 20min at 25%, 50%, 75%methanol in PBS/0.01% Tween-20
(PBT), followedby two100%methanolwashes. After overnight incubation in100%
Xylenes, embryoswere incubated for 2 h inmolten paraffin, before embedding and
sectioning26. Sections were mounted and dried on superfrost plus slides. Wax was
removed through three 10min xylene washes and rehydrated with three 5min
washes in 100% ethanol, followed by successive washes in 90%, 80%, 70% ethanol
and finally water (1min each). Antigen retrieval consisted of boiling for 5min in
0.01M Tris Base pH 10.0 with 0.05% Tween-20. After cooling to room temper-
ature, slides were washed twice in PBT for 2min before blockingwith 0.5%milk in
PBT (2 h at room temperature) in a humidified chamber. Primary antibodies were
incubated in 0.05% milk/PBT overnight at 4 uC. Three 15min PBT washes were
done before 1 h secondary antibody incubation (also in 0.05%milk/PBT) in a humid
chamber at room temperature. Slideswerewashed twice in PBT for 15min andonce
in PBS. Nuclei were stained using DAPI (Roche or Molecular Probes) 1:10,000 in
PBS for 2min and rinsed once with PBS. Prolong Gold (Invitrogen) was used to
seal and coverslip the slides. Images of sectioned embryos were takenwith aNikon
Eclipse TE2000-S inverted fluorescencemicroscope andQImaging Retiga Exi Fast
1394 camera using NIS-Elements BR Software.
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Extended Data Figure 1 | Strain-independent downregulation of RLIM in
the mouse embryonic epiblast. a, Test of specificity of the RLIM antibody
(comparewith Fig. 1b). Shown is anE4.5D/Y blastocyst outgrowth stainedwith
RLIM (red). Increasing the general signal levels (RLIM9) reveals augmented
unspecific staining mainly in the cytoplasm of cells. b, Co-stainings of sections
of E7–7.5 embryos within decidual tissues using antibodies directed against
RLIM (red) and H3K27me3 (green). Representative C57BL/6 and SV129
embryos are shown (out of at least three that were stained). Scale bars, 75mm.
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Extended Data Figure 2 | Genetic background has little or no influence
on RLIM dispensability during rXCI. a, b, C57BL/6–SV129 (a) and
C57BL/6–FVB (b) hybrid F1 parents were generated by crossings of fl/Y
(C57BL/6) males with WT/WT (SV129 or FVB) females and WT/Y (SV129
or FVB) males with cKO/D-SC (C57BL/6) females. F1 WT/fl females and
cKO/Y-SC males were then backcrossed to generate F2 cKOm offspring.
Percentages of offspring (grouped into female and male) and their genotypes
with respect to Rlim and SC are indicated in the abscissa and ordinate,
respectively, and the total number (n) of born and genotyped F2 pups is shown.
Maternally transmitted cKO alleles are indicated in black. c, No discrimination
against SV129 in born cKOm/Dp pups with a mixed C57BL/6–SV129
background. Sequencing analyses of genomic DNA isolated from eight
hybrid cKOm/Dp pups using 156 strain-specific SNPs distributed among all
chromosomes (blue/red) or ten SNPs distributed on the X chromosome
(green/orange). Note that the SV129 contribution in born cKOm/Dp pups is up
to 70% (total) and 80% (on the X).
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ExtendedData Figure 3 | Co-stainings ofMEFs isolated from cKOm/Dp and
WT/WT embryos using antibodies directed against H3K27me3 (green) and
RLIM (red). a, Representative images are shown. b, Summary graph of cells
showing H3K27me3 foci is shown on the right. Numbers of counted cells
from independent biological duplicates are 111/112 (WT/WT) and 110/104
(cKOm/Dp).
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Extended Data Figure 4 | RandomXCI in female mice heterozygous for the
Sox2-Cre-mediated deletion of Rlim. Female mice were generated carrying
either a paternal or maternal Rlim deletion and aGFP transgene on the other X
chromosome (XGFP). Mating schemes to generate these females are indicated.
Female littermates without the Sox2-Cre transgene were used as controls.
Numbers of cells counted from independent biological duplicates are indicated.
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Extended Data Figure 5 | Female ES cells lacking RLIM are able to undergo
rXCI in vivo. a, Parental cross used for the generation of ES-cell lines is
indicated on top. Newly generated ES-cell lines were genotyped using PCR for
the presence of wild-type, floxed or knockout Rlim alleles, as well as Cre driver
(SC) and Y chromosome (Zfy2). b, Newly isolated female ES cells were
differentiated for 5 days in culture and stained with the H3K27me3 antibody.
c, Summary of the tetraploid complementation assays showing the injected
ES-cell lines, genotypes, number of deciduas and embryos obtained (see also
Fig. 4c). All embryos generated via tetraploid complementationwere genotyped
for the presence of wild-type, floxed and knockout Rlim alleles as well as
Zfy2. d, Left, MEFs isolated from an E10.5 embryo generated via tetraploid
injection of D/D line IB11 ES cells were cultured for 24 h before staining with
antibodies against H3K27me3. Right, summary of H3K27me3 stainings.
Numbers of counted cells from independent biological duplicates are 60/62
(WT/WT) and 78/75 (cKOm/Dp). e, Summary of RNA-FISH experiments on
MEFs isolated from embryos generated via tetraploid injection ofD/D line IB11
ES cells (n5 109) (see Fig. 4d). MEFs isolated from WT/WT embryos
(n5 106) served as control.
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Towards Functional Annotation of 
the Preimplantation Transcriptome: 
An RNAi Screen in Mammalian 
Embryos
Wei Cui1, Xiangpeng Dai2, Chelsea Marcho1, Zhengbin Han1,3, Kun Zhang4, 
Kimberly D. Tremblay1 & Jesse Mager1
With readily available transcriptome-wide data, understanding the role of each expressed gene is an 
essential next step. Although RNAi technologies allow for genome-wide screens in cell culture, these 
approaches cannot replace strategies for discovery in the embryo. Here we present, for the first time, a 
knockdown screen in mouse preimplantation embryos. Early mammalian development encompasses 
dynamic cellular, molecular and epigenetic events that are largely conserved from mouse to man. 
We assayed 712 genes for requirements during preimplantation. We identified 59 genes required for 
successful development or outgrowth and implantation. We have characterized each phenotype and 
revealed cellular, molecular, and lineage specific defects following knockdown of transcript. Induced 
network analyses demonstrate this as a valid approach to identify networks of genes that play 
important roles during preimplantation. Our approach provides a robust and efficient strategy towards 
identification of novel phenotypes during mouse preimplantation and facilitates functional annotation 
of the mammalian transcriptome.
Preimplantation development refers to the period from fertilization to implantation. The fertilized oocyte pro-
gresses through a number of cleavage divisions and three major transcriptional and morphogenetic events that 
lead to the first cell fate decision and development into a blastocyst stage embryo capable of implantation. The 
first of these dynamic events is the maternal-to-zygotic transition (MZT), which includes degradation of mater-
nal mRNAs and replacement with zygotic transcripts, a dramatic reprogramming of gene expression which is 
required for successful embryo development1,2. In the mouse, zygotic genome activation (ZGA) is detectable in 
1-cell stage embryos but occurs mostly at the 2-cell stage. MZT and ZGA are essential for continued development 
and establishment of totipotency3,4. The second event is embryo compaction, which initiates at 8-cell stage in 
mouse embryos. During compaction, blastomere morphology becomes flattened and biochemical changes to 
cellular metabolism, ion transport and cell-cell contacts result in early embryonic cells first resembling somatic 
cells5. Compaction is essential for developmental progression and segregation of the initial embryonic lineages6. 
Following compaction, the third critical event is blastomere allocation and cell fate determination. The blasto-
meres located inside of the morula give rise to the inner cell mass (ICM) from which the embryo proper is derived 
(Fig. 1A), whereas the outer blastomeres differentiate exclusively into the trophectoderm (TE) from which 
extra-embryonic tissues are derived7,8. Well-defined gene expression patterns occur within these two distinct 
lineages. For example, in the mouse embryo, the transcription factor Oct4 (also known as Pou5f1) is enriched 
in ICM and functions to promote pluripotency and inhibit differentiation, while the transcription factor Cdx2 
becomes highly expressed in TE and influences epithelial differentiation9–11. Appropriate regulation and mutually 
exclusive localization of Oct4 and Cdx2 is critical for successful ICM/TE lineage separation and formation of a 
competent blastocyst12–15.
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With the advent of large-scale transcriptome profiling and sequencing efforts that reveal gene expression 
dynamics during distinct developmental stages, tissues and in different species, understanding the role of 
each expressed gene is the next frontier. Although current RNA interference (RNAi) technologies allow for 
genome-wide knockdown studies in tissue culture models, these approaches cannot replace strategies for dis-
covery in the embryo. Several studies have described transcriptome dynamics in preimplantation embryos16–19, 
however a large-scale functional annotation has not been reported.
Towards this goal, we established a robust and reliable RNAi based system in mouse embryos to study preim-
plantation development. All embryos in this study were cultured in 5% (low) oxygen to decrease oxidative stress 
and more faithfully recapitulate development in utero20. Under our conditions, control embryos after microin-
jection and culture show precisely the same morphological and developmental progression as embryos in utero 
(Fig. 1A) and the rate of blastocyst formation is greater than 90%21,22.
After knockdown (KD) by microinjection, embryos were assayed in several ways to maximize the identifi-
cation of gene function (Fig. 1A). Embryos were first assessed for morphological development to blastocysts in 
order to determine if KD caused developmental failure. If KD embryos developed into blastocysts, then blastocyst 
potential was functionally assessed in a 3-day outgrowth (OG) assay, which has been used as a model of implan-
tation23,24. OG assays can be used to ascertain the potential of both TE growth and ICM/ES colony formation. 
Under our conditions, approximately 60% of control blastocysts hatch from the zona pellucida, and attach to the 
culture plate forming a distinct ICM colony (Fig. 1A, far right, yellow dashed line) surrounded by robustly prolif-
erating trophoblast cells (Fig. 1A, far right, green dashed line).
Results
Microinjection of long double-stranded RNA (dsRNA) designed against specific transcripts has been used as a 
robust and specific approach to achieve gene silencing during preimplantation stages25–28 as there is no interferon 
response or significant off-target effect29. Since mammalian zygotes are available in relatively small numbers and 
microinjection is labor intensive, we sought to establish efficient screening strategies to overcome these technical 
challenges.
We first established an efficient dsRNA production protocol. dsRNAs were produced using an bacteria-free 
method (Fig. 1B). Briefly, PCR primers were designed to generate a 300–500 base pair amplicon – usually in the 
longest exon of each targeted gene allowing genomic DNA to be used as template for initial amplification. T7 
promoter sequence was added to both forward and reverse primers. Following PCR amplification, in vitro tran-
scription with T7 polymerase produced high quality, highly concentrated dsRNA suitable for microinjection (see 
methods for details).
We next determined a pooling strategy that allowed for reliable knockdown of multiple genes simultaneously 
(Figs 1C and 2). As shown in Fig. 1C, 3–5 different dsRNAs were injected together to knockdown multiple genes 
within the same embryo. Each pool of dsRNAs was injected into ~20 zygotes, and resulting embryos were assayed 
in multiple ways (developmental potential, morphology, and outgrowth). Pooled dsRNAs that were identified 
with phenotypes were then injected one at a time to determine the gene responsible, and to reproduce and vali-
date each phenotype (Fig. 1C).
We used two strategies in order to compile a large list of candidate genes – both of which utilized available and 
published transcriptome studies. First, we took advantage of preimplantation microarray data (raw data)17–19 and 
extracted genes that were found to have at least a 5-fold change in mRNA expression during any two specific pre-
implantation stages. This analysis yielded 1995 candidates. We also mined available RNA-seq analyses for genes 
enriched in specific lineages – being highly expressed in epiblast (EPI), primitive endoderm (PE) or trophecto-
derm (TE)16. This approach added another 925 candidates. We then filtered these 2920 genes in multiple ways – 
largely to enhance the novelty of our candidates. Genes with known developmental functions and/or documented 
Figure 1. RNAi screen in preimplantation embryos. (A) Work flow and developmental progression of 
preimplantation embryos. (B) High efficiency bacterial cloning-free method to make dsRNA. (C) Candidates 
selection and pooling strategy to identify genes essential for preimplantation embryo development.
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early lethal phenotypes during embryo development (Mouse Genome Informatics) were removed from the list. 
We also removed genes known or likely to be cell-lethal phenotypes base on documented functions (GeneCards 
Database www.genecards.org and PubMed Database), which accounted for a large number of our pre-selected 
candidates. These filtering steps left us with 748 candidate genes of which 712 were successfully screened by RNAi 
in preimplantation embryos (Fig. 1C, full lists in Supplementary Tables S1 and S2).
Efficient KD after microinjection of pooled dsRNA. Figure 2 illustrates 4 different dsRNAs sin-
gly injected - each resulting in robust and specific knockdown of the target endogenous mRNA (examined by 
RT-PCR, Fig. 2A). As expected, KD of one gene does not disturb the expression of other transcripts, indicating 
the specificity of dsRNA mediated RNAi as previously reported. When these 4 dsRNAs are microinjected simul-
taneously, a similarly robust knockdown of each gene occurs (Fig. 2B). For all data presented, we use embryos 
injected with dsGFP as the negative control in order to stimulate the RNAi machinery and ensure identified 
phenotypes are specific for gene functions.
Despite mRNA knockdown of these 4 genes, embryos developed normally into blastocysts without obvious 
defects in morphology, developmental dynamics or blastocyst formation rate (Fig. 2C). Blastocysts were further 
assessed by three-day outgrowth (OG) assay. As shown in Fig. 2D, KD blastocysts hatched out of the zona pellu-
cida by 24 hours, attached to the culture plate by 48 hours and formed ICM colonies with surrounding trophoblast 
cells at 72 hours. These results suggest these 4 transcripts are not functionally required during preimplantation 
and illustrate the efficacy of our approach. With confidence that our system would allow for identification of 
phenotypes specifically due to knockdown of individual genes, we injected dsRNAs designed against 712 genes 
in 198 experimental pools. As described below, we have identified 59 novel phenotypes during preimplantation 
development.
Genes required for morula formation. Likely due to our removal of cell lethal genes from the candi-
date list, we identified only 4 phenotypes that resulted in cleavage stage embryo arrest. These phenotypes were 
observed after microinjection of dsRNA designed against Dck, Itgae, Hist1h2a and Hist1h2b. Each of these tran-
scripts was found to be essential for morula formation. The majority of these KD embryos were arrested at 4–8 
cell stage exhibiting morula failure after depletion of each transcript (Supplementary Figs S1 and S2), suggesting 
involvement of these genes in basic cellular events. Dck encodes deoxycytidine kinase which catalyzes phospho-
rylation of all four deoxynucleosides - essential for DNA replication. One recent study showed DCK plays a key 
role in cell proliferation30. Hist1h2a and Hist1h2b belong to histone cluster 1, the major histone gene locus also 
Figure 2. Efficient mRNA depletion after microinjection of dsRNA. (A) RT-PCR shows robust and specific 
transcript degradation after individual dsRNA injection. (B) RT-PCR results indicate simultaneous and efficient 
KD of 4 genes after pooled dsRNA injection. (C) No obvious developmental phenotypes after KD of these 
4 genes – indicating a reliable screening system. (D) Similarly, knockdown of these genes does not inhibit 
blastocyst outgrowth when assayed. Scale bars, 50 µ m.
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essential for DNA replication31. Itgae encodes the epithelial-cell-specific integrin alpha E, which mediates cell 
adhesion. Both Hist1h2a and Hist1h2b are members of gene families that are very well conserved. Therefore the 
dsRNAs target other family members as well suggesting that the morula failure phenotype is due to functional 
KD of many family members. As we are largely focused on lineage specification and blastocyst formation, we did 
not pursue these novel phenotypes further.
Identification of 20 genes essential for blastocyst formation. We identified twenty genes that are 
required for successful blastocyst formation. These genes are Actl6a, Gabpa, Hist1h3, Matr3, Mfng, Mxi1, Nop2, 
Pbrm1, Pnldc1, Ptpn18, Rpl7l1, Rrp7a, Rtn4, Sf3b1, Sf3b6, Supt6, Tm4sf1, Txnrd3, Uspl1, and Wdr74 (gene spe-
cific details provided in Supplementary Table S2). After depletion of each of these 20 transcripts, the majority 
of embryos were able to compact and develop into morphologically normal morulae with only a few arrested 
or delayed (Fig. 3A, arrowheads). However these KD morulae failed to progress into morphologically apparent 
blastocysts and remained as morulae or were visibly necrotic at 96 hours post-fertilization (when control embryos 
had formed expanded blastocysts, Fig. 3A; Supplementary Fig. S1). Four of these phenotypes are shown in Fig. 3 
(others available in Supplementary Fig. S3). Since these KD phenotypes fail to form blastocysts, we examined 
morula stage embryos from each KD to investigate possible reasons for blastocyst failure. We performed immu-
nofluorescence (IF) to examine localization and relative expression of Oct4 and Cdx2 critical determinants of 
ICM and TE, respectively. We also assayed for active Trp53 (p53) to reveal apoptotic blastomeres. Additionally we 
carefully counted the number of cells in all embryos to assess cleavage/development potential. The four gene KD 
shown in Fig. 3A,B are representatives of the range of results within this class of 20 phenotypes. Control dsGFP 
morula embryos showed robust and specific Oct4 and Cdx2 protein with most cells expressing either Oct4 or 
Cdx2 but not both at high levels (Fig. 3B, Oct4 shown as green, Cdx2 shown as white). Virtually no active p53 was 
detected in control embryos (Fig. 3B, red).
Tm4sf1-KD embryos (hereafter referred to as dsTm4sf1 embryos) exhibited globally reduced Oct4 and Cdx2, 
suggesting defects in both ICM and TE lineage specification, and a few apoptotic cells were observed in all 
dsTm4sf1 embryos. Although blastomeres of dsTm4sf1 morulae were able to compact without obvious abnor-
malities, blastomere number per embryo was significantly reduced compared to controls (Fig. 3B right column, 
dsGFP = 28.8 ± 0.9 cells/embryo, dsTm4sf1 = 13.3 ± 0.8 cells/embryo, P < 0.05). Combined, the absence of Oct4 
and Cdx2 plus the reduction in cell number and only a few apoptotic cells suggest cell cycle arrest and possible 
block in global transcription or translation in the absence of Tm4sf1. Tm4sf1 is a member of transmembrane 4 
superfamily of proteins – which have not been thoroughly characterized. One recent study in human breast can-
cer cells revealed that TM4SF1 stimulates cancer cell migration and invasion as well as inhibit apoptosis through 
PI3K/AKT/mTOR pathway32, offering the possibility that Tm4sf1 is required for blastomere growth and commu-
nication between blastomeres during preimplantation.
In contrast, dsTxnrd3 embryos maintained appropriate cell number with normal Oct4 positive blastomeres. 
However, no Cdx2 high blastomeres are observed in dsTxnrd3, with the majority of cells expressing low levels 
of Cdx2 (and high Oct4). Additionally, the majority of blastomeres in dsTxnrd3 embryos were p53 positive. 
Txnrd3 has not been shown previously to have a role in early development. Our results are consistent with a 
previous study in intestinal epithelium revealing that the gene product thioredoxin reductase 3 is involved in 
Figure 3. Twenty genes were identified essential for blastocyst formation. (A) KD Embryos were able 
to compact and develop into morulae while they failed to form blastocysts. Some embryos showed early 
phenotypes at morula stage (arrowheads). (B) KD morula embryos were characterized by IF. Arrows indicate 
the blastomeres lack of Oct4 and Cdx2 while with increased apoptosis. Arrowheads indicate the blastomeres 
arrested at earlier stage with bigger size nuclei and increased apoptosis. (C) 66 cellular/molecular defects were 
identified after characterizing these 20 genes involved in blastocyst failure. Scale bars, 50 µ m.
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defense against oxidative stress and has been implicated in cell proliferation and differentiation33. Together, these 
results suggest that in the absence of Txnrd3 function, blastomeres succumb to oxidative damage and undergo 
programmed cell death.
Whereas dsTxnrd3 embryos only showed globally increased apoptosis, dsPtpn18 and dsUspl1 embryos exhib-
ited similar phenotypes with reduced total cell number, reduced number of Oct4 positive cells (Fig. 3B, arrows), 
an absence of Cdx2 high cells, and increased apoptosis (but only in a few cells). Intriguingly, both KD result 
in some blastomeres that were neither Oct4 nor Cdx2 positive – which does not normally occur. Notably, in 
dsPtpn18 embryos, blastomeres with nuclei of bigger size were apparent (Fig. 3B, arrowheads), suggesting defects 
during synthesis and/or mitosis. Ptpn18 belongs to the protein tyrosine phosphatase (PTP) family that regulates 
multiple cellular processes including cell growth, differentiation, and mitosis. PTPN18 was recently found essen-
tial for HER2 (human epidermal growth factor receptor-2) activity34 which is broadly involved in both normal 
cell growth and tumorigenesis, suggesting Ptpn18 participates in a variety of cellular events required for embryo 
cleavage and blastomere growth.
Very little is known about Uspl1, which encodes ubiquitin specific peptidase like 1. Recent studies have 
demonstrated that human USPL1 is a cysteine protease belonging to ubiquitin-specific protease (USP) family that 
plays a key role in snRNA transcription, telomere integrity and cell proliferation35,36. A role in such fundamental 
cell viability requirements is consistent with an early developmental failure and suggests either that maternal 
protein allows dsUspl1 embryos to progress until morula stage or that other genes are redundant until blastocyst 
formation.
In this way we characterized all 20 blastocyst failure phenotypes with careful morphological assess-
ment, cell counting and the presence of Oct4, Cdx2, and active p53 protein by IF (Supplementary Fig. S3, and 
Supplementary Table S3). For each phenotype we scored 5 characteristics based on the IF results: 1. ICM defect 
(reduced Oct4); 2. TE defect (reduced Cdx2); 3. Increased apoptosis; 4. Irregular morphology or cell location; 
5. Reduced cell number per embryo. For example, dsTm4sf1 was scored with defects in ICM, TE, cell number and 
apoptosis, while dsTxnrd3 was scored only defective in p53+ cells. We analyzed all of the phenotypes together 
to ascertain if specific phenotypic features/defects were more prevalent than others. The most common defect 
observed was reduced total cell number (18/20 phenotypes), as well as increased apoptosis (17/20) and TE defect 
(reduced Cdx2 in 17/20). This summary analysis indicates that the genes we have identified with blastocyst failure 
phenotypes are likely involved in basic cellular events resulting in cell death and a defective TE lineage specifi-
cation. Although this conclusion is not in itself surprising, identification of 20 new genes required for blasto-
cyst formation greatly adds to our understanding of the molecular requirements for successful preimplantation 
development.
Identification of 35 genes required for hatching and outgrowth. For all pooled dsRNA microinjec-
tions for which KD embryos developed into morphologically obvious blastocysts (with a visible blastocoel cavity), 
we subjected embryos to an additional 72-hour OG assay. OG assays have been used as a model for implantation, 
allowing for functional assessment of blastocysts37. Mouse blastocysts become expanded and hatch from the zona 
pellucida, attaining adhesion competence during the first 24 hours of OG culture. During the following 24 hours, 
hatched blastocysts attach to the culture dish and trophoblast cells begin to grow outward with surrounding 
primary trophoblast giant cells. Concurrently, as ICM cells proliferate, they pile up on one another creating a 
rudimentary ICM “stalk” like colony that is obvious by light microscopy. During the third 24 hours of OG cul-
ture, the ICM colony is taller and more obvious, surrounded by a monolayer of trophoblast that proliferates and 
expands in area23,24,38,39. Establishment of the ICM colony is essential for embryonic stem cell (ESC) derivation. 
Approximately 60% of control dsGFP blastocysts formed successful outgrowths with embryos hatching from the 
zona, attaching on the plate and establishing evident TE and ICM/ES lineages. This rate is similar to blastocysts 
isolated following in utero development. Pooled dsRNA injection blastocysts for which less than 30% of embryos 
performed as expected at each 24-hour period of OG assay were scored as positive for an OG phenotype.
Each individual dsRNA from pooled dsRNA that resulted in a phenotype was re-injected to determine which 
specific gene was responsible for the observed phenotype. In this way, 35 genes (Supplementary Table S2) were 
identified as indispensable for normal hatching and outgrowth. These genes include: 9130008F23Rik, Akap3, 
Ankrd7, Arhgdig, Asf1b, Bcor, Ccdc24, Ccdc62, Cmtm3, Coprs, Crxos, Ctr9, Fbll1, Hcfc1, Hs3st6, Lpar6, Ndufa2, 
Necab1, Pemt, Phf6, Plpp4, Ppp4r4, Slc25a34, Slc35e2, Smim14, St8sia6, Stmn3, Suds3, Suv39h1, Tbl1xr1, Tuba1, 
Ube2a, Zbed6, Zfp14, Zfp420.
Presented in Fig. 4 are a few examples of these phenotypes (complete results shown in Supplementary Figs S1 and S4). 
For example, dsFbll1 blastocysts failed to hatch out of the zona pellucida after 24 hours, and were visibly dis-
organized and/or proliferating but were trapped inside of the zona at 48 and 72 hours. This suggests that Fbll1 
function is required for trophoblast-meditated hatching. Similarly, many dsSmim14 embryos failed to hatch, and 
those that did hatch failed to form an obvious ICM colony (Fig. 4A, asterisk). dsCoprs embryos exhibited delayed 
hatching and only did so after 48 hrs (as opposed to 24 hrs). dsCoprs ICM colonies were observed (Fig. 4A, yellow 
line) but these outgrowths had visibly smaller trophoblast outgrowth with very few TE cells (Fig. 4A, green line), 
suggesting TE was more severely affected than ICM after depletion of Coprs. Yet another phenotype observed was 
severely degrading/dying embryos of dsStmn3 embryos during the outgrowth assay (Fig. 4A, arrows), suggesting 
Stmn3 is essential for cell survival – but only after blastocyst formation.
To explore the possible reasons for outgrowth failure and examine cell lineage allocation and organization, we 
analyzed Oct4, Cdx2, and Sox2 protein localization in KD blastocysts. We scored each of the 35 OG phenotypes 
as normal or defective for 6 characteristics: 1. ICM defect (reduced Oct4 or Sox2); 2. TE defect (reduced Cdx2); 
3. Irregular ICM morphology/location; 4. Irregular TE morphology/location; 5. Molecular lineage defect (Oct4 
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and Cdx2 double positive cells); and 6. Lineage allocation defect (abnormal ratio of Oct4 positive and Cdx2 pos-
itive cells).
As shown in Fig. 4B, dsFbll1 blastocysts exhibited an obvious Sox2 reduction, suggestive of ICM defects. 
Additionally, ICM cells (Oct4 positive) were loosely associated and not aggregated together as in controls (Fig. 4B, 
circled). Furthermore, Cdx2 positive TE cells were not located uniformly on the outside of blastocysts and many 
cells remained Oct4 and Cdx2 positive. Combined, the lack of Sox2, the irregular location of both Oct4 and Cdx2 
suggest that dsFbll1 blastocysts have both ICM and TE lineages defects.
The ICM of dsSmim14 embryos appears normal and appropriately organized with a tight cluster of Oct4/Sox2 
double positive cells. However, the majority of outer blastomeres in dsSmim14 blastocysts were also Oct4 posi-
tive with very few Cdx2 positive cells. Combined with a failure to hatch from the zona pellucida (Fig. 4A), these 
results indicate a failure to specify functional TE lineage.
In dsCoprs embryo, Oct4 protein was found in numerous outer layer blastomeres that were also Cdx2 positive 
(Fig. 4B, arrowheads), indicating a failure to down regulate ICM transcriptional program in the TE cells and 
impaired molecular lineage specification. Additionally, only a small number of blastomeres were allocated to TE 
(Cdx2 positive) and these were not located regularly or uniformly, further supporting the notion of defective TE 
specification in the absence of Coprs function.
In dsStmn3 embryos, both Sox2 and Cdx2 were present in very few blastomeres, suggesting defects in both 
ICM and TE. Additionally, Oct4 signal was present in outer layer cells (Fig. 4B, arrows), indicating irregular ICM 
location or defective TE specification. This resulted in a much higher ratio of blastomeres being scored as ICM 
lineage (Oct4 positive) with scant TE cells (Cdx2 positive) scattered irregularly on the outer edge of dsStmn3 
blastocysts.
Based on the scored criteria for each OG phenotype (Supplementary Fig. S4, Supplementary Table S4), 104 
cellular/molecular defects were identified (Fig. 4C). The most common observation was defective ICM mor-
phology/location (27/35 phenotypes), followed by ICM defect (reduced Oct4 or Sox2 in 23/35), suggesting that 
most of the genes identified are indispensible for ICM development and/or function. This is consistent with 
well-established studies showing that specification of TE is intimately linked to proper ICM allocation and 
function9,40.
Expression patterns of the 59 genes essential for preimplantation. As presented above, 712 candi-
date genes were functionally assessed and 59 were identified essential for pre- or peri-implantation development. 
4, 20 and 35 are functionally indispensable for proper formation of morula, blastocyst and outgrowth, respectively 
Figure 4. Thirty-five genes were identified essential for blastocyst outgrowth, 4 of 35 phenotypes are 
shown. (A) Blastocyst quality was functionally assessed by 3 days of OG. dsGFP control blastocysts hatch and 
attach to the plate after 24 hrs and 48 hrs culture, respectively; and finally form obvious ICM colony (yellow line) 
with proliferating trophoblast cells (green line) by 72 hrs. Examples shown are dsFbll1, dsSmim14, dsCoprs 
and dsStmn3 embryos. dsFbll1 blastocysts failed to hatch and were trapped inside of the zona (arrowheads). 
Most dsSmim14 embryos did not hatch and those that did hatch failed to form ICM colony (asterisk). dsCoprs 
embryos had delayed hatching and formed ICM colonies (yellow line) but with much smaller trophoblast OG 
areas (green line). dsStmn3 embryos degraded severely during the OG culture failing to hatch or proliferate 
(arrows). (B) KD blastocysts were characterized by IF. ICM cells (circled) in dsGFP control blastocysts are 
tightly arranged with robust expression of Oct4 and Sox2, and TE cells are uniformly arranged with specific 
expression of Cdx2. Arrowheads in dsCoprs point to Cdx2 positive cells in the outer layer that inappropriately 
remain Oct4 positive. Arrows in dsStmn3 indicate those outer layer cells possessing Oct4 high/Cdx2 low 
signals, which is opposite to control. Oct4 (green), Cdx2 (white), Sox2 (red), DAPI (blue). (C) Summary of 104 
cellular/molecular defects that were identified among the 35 genes OG phenotypes. Scale bars, 50 µ m.
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(Fig. 5A). In order to determine if the transcriptional profile of each gene might correlate with the observed 
phenotype, we characterized the normal expression pattern of each gene during preimplantation (Fig. 5B, and 
refs 21, 22, 27, 28, 41). Overall, we found no correlation of expression profile and phenotype. Although there are 
some genes with specific developmental windows of expression matching the timing of phenotype (Itgae, Mfng, 
9130008F23Rik, Hs3st6, Ndufa2), many are expressed at all stages examined, and there are several whose mRNA 
expression is incongruous with the observed phenotype. For example Mxi1 and Supt6 are not expressed in blas-
tocysts – even though that is when they are functionally required. Similarly, Akap3, Ankrd7, Fbll1, Ppp4r4, St8sia6 
and Ube2a are not expressed in later stages but are required for successful OG. These discrepancies could be due 
to stable proteins with slow molecular turnover within cells42 or due to rapid transcriptional activation precisely 
when they are required43,44. Alternatively, these protein functions may be required for events temporally down-
stream in stages after their expression occurs as we have shown for other genes (Suds322 and Ctr927), which would 
suggest control of signaling cascades, transcriptional regulation or epigenetic functions.
Gene ontology and network analysis. One major goal of the work presented was to screen a large set 
of genes that we did not select based on a molecular function of interest in order to identify unknown mRNAs 
and proteins involved in preimplantation development. We therefore sought to assess if there were particular GO 
terms associated with the 59 genes we identified. We also asked if we could infer novel pathways or gene networks 
that are required for successful preimplantation development based on the 59 genes that we did identify.
We first compared enrichment of molecular function GO terms between the full 712-gene list (Fig. 6A) and 
the 59 genes with preimplantation phenotypes (Fig. 6B). Only the smallest of the GO categories present in the 
initial list was absent in 59 phenotype genes (0.5% translation regulator activity) – likely due to the very small 
percentage representation. In other words, all categories of GO terms were still represented in the phenotypes at 
roughly similar representation. Among these terms/functions, the biggest change in percentage was “binding”, 
which increased from 36.0% in the initial list to 48.9% in the phenotype genes. Further analysis of sub-categories 
of binding revealed that similarly, all principal binding functions in large list are present in the phenotype list and 
that the increase in percentage of binding is largely due to an increase in “nucleic acid binding” (compare grey 
pie segments, right side of Fig. 6A and B), suggesting an enrichment for transcriptional regulators in genes with 
phenotypes. In summary, GO term analysis offered no striking outliers in functional categories within our screen 
results and suggests that preimplantation development equally requires all aspects of cellular and molecular func-
tion for success. Supporting this notion, previous studies have found essential roles during preimplantation for 
genes within each of these functional categories (including DNA/RNA/protein binding45,46, catalytic activity47,48, 
various transporter activity49–51).
Although the screen presented herein is not comprehensive, it provides clear pathway forwards towards 
assessment of all expressed genes during preimplantation which has not yet been accomplished. While our phe-
notype list of genes is small, we performed an “induced network module analysis”52 on the 59 genes we identified. 
As shown in Fig. 6C, this analysis revealed one major gene network stemming from 10 genes (seed nodes, grey 
squares) from our phenotype list (gene names in black, Fig. 6C). These nodes connect with each other by docu-
mented protein-protein interactions and also with 9 intermediate nodes that were not included in our screen list 
(blue gene names/squares, Fig. 6C). Importantly, each of these other genes (intermediate nodes) is also required 
for early embryonic development or neonatal survival53–62.
This analysis indicates the identification of a network of essential mammalian genes and suggests that even 
a limited screen can identify novel networks required during early development. Notably, due to the relatively 
Figure 5. Total 59 genes identified as essential for preimplantation development. (A) Summary of these 59 
phenotypes. (B) Expression patterns of each transcript in wild-type preimplantation embryos. MII, metaphase 
II oocyte; Zy, Zygote; 2c, 2-cell embryo; 4/8c, mix of 4- and 8-cell stage embryos; Mo, Morula; Bl, Blastocyst.
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un-annotated/unstudied bias of our gene lists, 49 of our genes with phenotypes were not found to have network 
amongst themselves using the current statistics in CPDB-mouse database52. With ever evolving annotation data-
bases, our finding of so many novel phenotypes will contribute to these analyses in the future.
Discussion
Since mammalian embryos lack interferon response29 and long dsRNAs are generally more efficient than single 
small interfering RNAs (siRNAs)63,64, dsRNA has been widely accepted as a robust and specific RNAi reagent to 
achieve gene silencing during early mammalian development25,26. dsRNAs are particularly useful when validated 
siRNAs are not available, since in our lab ~98% of dsRNAs result in KD greater than 80%. An additional benefit 
of dsRNAs is that they allow for rapid analysis of gene family members with similar sequence since one dsRNA 
can KD many closely related genes when designed appropriately. For example, in the screen presented herein, 4 
of the dsRNAs intentionally result in KD of entire families of transcripts. Hist1h2a, Hist1h2b, Hist1h3 and Tuba1 
were identified as essential for preimplantation development in our screen. When we designed RT-PCR assays 
that would intentionally amplify all of the family member transcripts (primers bind to conserved sequences), we 
observed consistent KD of all mRNAs simultaneously due to the single dsRNA injection (Supplementary Fig. S5).
To further confirm the specificity of dsRNA mediated RNAi, we microinjected commercial siRNAs against 
6 genes with phenotypes from our screen (2 from each phenotypic category). Results showed that for each gene, 
two independent siRNAs that target different locations of same mRNA (Supplementary Table S5) resulted in 
identical developmental phenotype (Supplementary Fig. S6). Additionally, our previous experiments using 
dsRNA resistant mRNA22 and different siRNAs targeting separate locations of same mRNA21 also support the 
specificity of dsRNA mediated RNAi as a screening tool. Importantly, recent reports of gene knockout phenotypes 
are consistent with our screen induced phenotypes (Actl6a65, Bcor66, Ctr953, Gabpa67, Pbrm168, Rtn469, Supt670 and 
Ube2a71). Taken together these results all indicate that dsRNA mediated RNAi is a robust and specific approach 
for gene abrogation in early mammalian embryos.
Although the practical mechanics of microinjection and culture of mouse zygotes/preimplantation embryos 
are reproducible and robust, limited screens of early mammalian embryos have been performed. Generally, dsRNA 
is used to assess specific gene function after a gene of family has been identified for study. The major challenge of 
a large scale screen in embryos is the fact that mammalian zygotes are only available in relatively small numbers 
and microinjection is labor intensive. For these reasons, many groups defer to cell culture models where genome 
wide-screens are feasible due to the availability of robust tissue culture systems with automated processes. Here we 
have established a dsRNA pooling strategy suitable for preimplantation developmental studies (Fig. 1C), which 
allows for faithful KD of multiple genes within the same embryos. A similar method has recently been reported 
in mammalian oocytes72. While there are ongoing genome wide knockout efforts (https://www.komp.org), 
generation of null alleles will not adequately address functions during preimplantation due to retention of mater-
nal RNA and protein that have accumulated during oocyte growth73. Although gene knockouts provide definitive 
functional assessment – the financial and temporal investment remains very large for each knockout allele.
Figure 6. Gene Ontology (GO) and induced network modules analysis of screened genes. GO analysis was 
performed on 712 screen candidates (A) and 59 genes with phenotypes (B). Induced network modules analysis 
(C) was conducted with the 59 genes to assess relationships among them.
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The dsRNA approach described herein will complement ongoing knockout mouse consortium efforts and 
may offer important selection criteria for genes to be knocked out (preimplantation studies are not a priority 
of the KOMP). Rapid identification of genes required for preimplantation may also guide investigators to gen-
erate conditional knock-out alleles in order to study gene function in tissues/stages beyond preimplantation. 
Therefore we have made our complete screen results and gene lists available and searchable at http://blogs.umass.
edu/jmager/.
Importantly, here we present results focused on obvious phenotypes that we identified during the screen (mor-
ula and blastocyst rate lower than 50% and OG rate lower than 30%). For blastocyst formation assessment, we 
adopted the visible blastocoel cavity as an unbiased standard but not the ratio of blastocoel cavity or the size of 
blastocyst. This may in part explain why more than half of the phenotype genes (35/59) are identified as OG 
failure genes (since small or shrunken blastocysts were still scored as “blastocysts”). Regardless, our analysis 
revealed defects in location and molecular identity of ICM and TE in each gene specific KD (Figs 3B and 4B, 
Supplementary Figs S3 and S4).
In summary, we present an efficient functional screening strategy in mammalian embryos and identify of 59 
genes required for preimplantation development. Forty of these genes do not currently have published functional 
studies and nearly all have no documented role during early development. The wealth of novel results presented 
here highlights the importance of expanding this approach towards functional annotation of the mammalian 
genome.
Methods
Embryo recovery and culture. All animal experimental protocols were approved by the Institutional 
Animal Care and Use Committee of the University of Massachusetts, Amherst (approval No. 2013-009; 2016-
0010). All procedures and methods were carried out in accordance with the approved guidelines and regulations. 
B6D2F1 female mice 8 to 10 weeks old were induced to superovulate with 5 IU pregnant mare serum gonad-
otropin (PMSG, Sigma-Aldrich, St. Louis, MO), followed 48 hr later by 5 IU human chorionic gonadotropin 
(hCG, Sigma-Aldrich, St. Louis, MO). Females were mated with B6D2F1 males and euthanized at 20 hr post-hCG 
injection for zygotes collection from the oviducts. Oviductal ampullae were dissected to release zygotes, and 
cumulus cells were removed by pipetting in M2 medium containing hyaluronidase (EMD Millipore, Billerica, 
MA). Zygotes were then washed in M2 medium (EMD Millipore, Billerica, MA) and cultured in KSOM medium 
(EMD Millipore, Billerica, MA) at 37 °C in a humidified atmosphere of 5% CO2/5% O2 balanced in N2. All cul-
tured embryos were observed daily.
Outgrowth assay. Blastocysts were collected and transferred gently into culture plate coated with 0.1% 
Gelatin (Sigma-Aldrich, St. Louis, MO) and cultured in DMEM (Lonza, Allendale, NJ) containing 10% fetal calf 
serum (Atlanta Biologicals, Flowery Branch, GA) and 1X GlutaMAX (Thermo Fisher, Agawam, MA). Outgrowth 
assay was conducted at 37 °C in a humidified atmosphere of 5% CO2 for 3 days and was observed daily.
Batch primer design for T7 amplicons. FASTA files of cDNA sequences for genes of interest were acquired 
using Ensembl BioMart (GRCm38, Filters = Ensembl gene ID, Attributes = Sequences, cDNA sequences; Header 
information = Ensembl gene ID, Ensembl transcript ID). The longest exon for all genes of interest was identified 
using an in house perl script. Genes were then randomly assigned to pool groups. BatchPrimer374 was used to 
design primers within the longest exon of each interest gene (minimum length = 250, optimum length = 350, 
longest length = 600). Genes with exons that did not meet primer requirements were designed individually using 
Primer3. T7 amplicons were BLASTed with Ensembl mouse cDNA database75 to make sure the overlap with other 
known transcripts is less than 20 bp. All T7 primer information is listed in Supplementary Table S1 and S2.
Double-stranded RNA (dsRNA) preparation. DNA templates for T7-RNA polymerase mediated dsRNA 
production were amplified from genomic DNA or preimplantation embryo cDNA using primers containing 
T7 binding sequences followed by gene specific sequences for dsGFP (5′ -TAATACGACTCACTATAGGGCACAT 
GAAGCAGCACGACTT and 5′ -TAATACGACTCACTATAGGGTGCTCAGGTAGTGGTTGTCG) or other 
dsRNAs (T7 primer information listed in Supplementary Table S1 and S2). PCR products were purified by 
QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). In vitro transcription (IVT) was performed using a 
MEGAscript T7 Kit (Ambion, Waltham, MA) following the manufacturer’s instructions and TURBO RNase-free 
DNase was added to IVT product to degrade the DNA template. The in vitro transcribed sense and antisense 
single-stranded RNAs anneal during IVT (which is performed at 37 °C) to form dsRNA. dsRNA was then passed 
through NucAway Spin Columns (Ambion, Waltham, MA) to remove salt and unincorporated nucleotides. 
dsRNA was extracted with phenol/chloroform (Sigma-Aldrich, St. Louis, MO) and precipitated with 70% etha-
nol and resuspended in RNase-free water (Integrated DNA Technologies, Coralville, IA). The quality of dsRNA 
was confirmed by electrophoresis both after IVT and after final precipitation. The dsRNA concentration was 
measured using NanoDrop (Thermo Scientific, Waltham, MA) and dsRNA was diluted to around 3 µ g/µ l and 
stored at − 80 °C until use.
siRNA production and sequences. Both the scrambled control siRNA and gene specific siRNAs were 
purchased from Qiagen (Valencia, CA, USA). The sequences, target locations and catalog numbers of all siRNAs 
are listed in Supplementary Table S5. siRNAs were resuspended in RNase-free water to 100 µ M solutions.
Microinjection. Microinjection was performed in M2 medium using a Nikon inverted microscope equipped 
with a piezo-driven (Prime Tech, Japan) micromanipulator (TransferMan NK2, Eppendorf, Hamburg, Germany). 
A volume of 5–10 pl dsRNA (3 µ g/µ l) was microinjected into the cytoplasm of zygotes using a blunt-ended pipette 
of 6–7 µ m in diameter. The same concentration and volume of dsGFP was injected as control in all experiments. 
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For siRNA experiment, 5–10 pl (100 µ M) of control or gene specific siRNA was microinjected into the cytoplasm 
of zygotes using same method as described above. After microinjection, zygotes were washed with M2 medium 
and cultured in KSOM medium at 37 °C in a humidified atmosphere of 5% CO2/5% O2 balanced in N2.
RNA extraction and Reverse Transcription PCR (RT-PCR). Total RNA extraction was performed with 
a Roche High Pure RNA Isolation Kit (#11828665001, Basel, Switzerland). cDNA was synthesized using iScript 
cDNA synthesis kit (Bio-Rad Laboratories, 170-8891, Hercules, CA). Specific primers were used for standard 
RT-PCR (Actb: 5′ -GGCCCAGAGCAAGAGAGGTATCC and 5′ -ACGCACGATTTCCCTCTCAGC; genes in 
Fig. 2: same as for the preparation of dsRNA T7 template; genes in final list: listed in Supplementary Table S2).
Immunofluorescence (IF). Embryos were fixed in 4% paraformaldehyde in PBS for 30 min, washed three 
times in washing buffer (PBS containing 0.1% Triton X-100), and permeabilized with PBS containing 0.5% Triton 
X-100 for 15 min. Embryos were then blocked for 1 hr in blocking buffer (PBS containing 10% fetal calf serum 
and 0.1% Triton X-100), and incubated overnight at 4 °C with primary antibodies diluted in blocking buffer. After 
three rinses with washing buffer, embryos were incubated for 1 hr with secondary antibodies (Alexa Fluor, Life 
Technologies, Carlsbad, CA) diluted 1:600 in blocking buffer. DAPI was used to stain nuclear DNA for morula 
blastomere counting. Embryos were washed three times with washing buffer and then mounted and observed 
with the Eclipse-Ti microscope (Nikon, Tokyo, Japan). Identical image capture settings were maintained for 
imaging same batch embryos. Primary antibodies used included: rabbit anti-Sox2, Abcam, ab97959, 1:200; goat 
anti-Oct4, Santa Cruz Biotechnology, sc-8628, 1:100; mouse anti-Cdx2, BioGenex, AM392-5M, 1:200; rabbit 
anti-Trp53, Cell Signaling Technology, #9284, 1:100.
Gene Ontology analysis and induced network modules analysis. Molecular function of Gene 
Ontology analysis was performed using the PANTHER Classification System76. Induced network modules anal-
ysis was performed using CPDB-mouse database52 and Z value was set as 15.
Phenotype scoring and reproducibility. After identification of dsRNA pools resulting in a phenotype, 
each single dsRNA microinjection experiment was repeated twice to validate the identified genes and develop-
mental phenotypes. The number of injected embryos and percentage of embryos showing defects at different 
stages are listed in Supplementary Fig. S1. Through the RNAi screen, dsRNA injected embryos possessing mor-
ula/blastocyst rate lower than 50% and OG rate lower than 30% (approximately half the rate of the control group) 
were considered as phenotypes. Due to the nature of the screen, we pursued only the most robust phenotypes 
(those with at least 50% developmental failure – most with more than 80%), knowing that there may be subtle 
phenotypes that we did not analyze in detail. Therefore our complete screen results are available at http://blogs.
umass.edu/jmager/.
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SUMMARY
Nucleolar protein 2 (NOP2) is evolutionarily conserved from yeast to human, and has
been found to play an important role in accelerating cell proliferation, cell-cycle
progression, and tumor aggressiveness. The expression pattern and function of
Nop2 during early mammalian embryo development, however, has not been investi-
gated.We identifiedNop2asanessential gene fordevelopment to theblastocyststage
while performing anRNA interference (RNAi)-based screen inmouse preimplantation
embryos. Nop2 is expressed throughout preimplantation development, with highest
mRNA and protein accumulation at the 8-cell and morula stages, respectively. RNAi-
mediatedknockdownofNop2 results inembryos that arrest asmorula.NOP2-deficient
embryos exhibit reduced blastomere numbers, greatly increased apoptosis, and
impaired cell-lineage specification. Furthermore, knockdown ofNop2 results in global
reductionofallRNAspecies, including rRNA,small nuclearRNA,small nucleolarRNA,
and mRNA. Taken together, our results demonstrate that Nop2 is an essential gene
for blastocyst formation, and is required for RNA processing and/or stability in vivo
during preimplantation embryo development in the mouse.
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INTRODUCTION
The fertilized egg progresses through three major tran-
scriptional and morphogenetic events during preimplanta-
tion embryo development, resulting in the first cell-lineage
decision and formation of a blastocyst-stage embryo capa-
ble of implantation. The first event is the maternal-to-
zygotic transition, which includes the degradation of ma-
ternal transcripts in favor of zygotic transcripts; this process
initiates the dramatic reprogramming required for success-
ful embryo development (Latham et al., 1991). In mice,
zygotic genome activation begins in 1-cell stage embryos,
but becomes obvious at the 2-cell stage (Schultz, 2002).
The second major event is embryo compaction, which
involves the flattening of blastomeres against each other
starting at the 8-cell stage in the mouse. Compaction is
accompanied by biochemical changes involving cellular
metabolism and ion transport, and results in early
Abbreviations: dsRNA, double-stranded RNA; Nop2, nucleolar protein 2;
RNAi, RNA interference
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embryonic cells first resembling somatic cells (Fleming
et al., 2001; Zeng et al., 2004). The third major event is
blastomere allocation and the first cell-fate determination,
where blastomeres of the morula give rise to the inner cell
mass, from which the embryo proper is derived, versus
the trophectoderm, fromwhich extra-embryonic tissues are
derived (Yamanaka et al., 2006). Overt, detectable gene
expression patterns occurwithin these two distinct lineages
in the compacted morula. For example, the transcription
factor POU5F1 (OCT4) is enriched in the inner cell mass,
where it promotes pluripotency and inhibits differentiation,
although the transcription factor CDX2 becomes highly
upregulated in the trophectoderm, where it influences epi-
thelial differentiation. Appropriate regulation of POU5F1
and CDX2 are necessary for successful blastocyst forma-
tion (Cockburn and Rossant, 2010; Marcho et al., 2015).
We are currently performing an RNA interference
(RNAi)-based screen, using the mouse preimplantation
embryo, to understand which genes are functionally re-
quired for early embryo development (Maserati et al., 2011;
Zhang et al., 2013a,b). Microinjection of long, double-
stranded RNA (dsRNA) against specific transcripts into
fertilized 1-cell zygotes is a robust approach to achieve
gene-specific silencing (Svoboda et al., 2000; Wianny and
Zernicka-Goetz, 2000) without an interferon response or
significant off-target effects (Stein et al., 2005). One goal of
our screen was to identify genes with previously unknown
functions during preimplantation development. One of
these genes encodes nucleolar protein 2 (NOP2).
Murine NOP2 is homologous to yeast protein NOP2p
and human NOP2 (also named NSUN1 or P120) (de Beus
et al., 1994; Mitrecic et al., 2008). NOP2 belongs to the
NOP2/SUN (NSUN) RNA-methyltransferase family, which
includes six other members: NSUN2 through NSUN7
(Blanco and Frye, 2014). NOP2 promotesmouse fibroblast
growth and tumor formation (Perlaky et al., 1992), and is
highly expressed in diverse tumor types but not in normal
cells. Therefore, NOP2 is being pursued as a prognostic
marker for cancer aggressiveness (Saijo et al., 2001;
Bantis et al., 2004). Limited studies in mammals have
demonstrated expression of Nop2 in brain tissue and fetal
liver (Wang et al., 2014; Kosi et al., 2015), but the expres-
sion pattern and function of Nop2 during preimplantation
development have not yet been investigated.
Here we show that Nop2 is expressed throughout pre-
implantation development, with highest transcription and
protein accumulation at the 8-cell and morula stages,
respectively. We further demonstrate that NOP2 is neces-
sary for successful preimplantation embryo development,
as NOP2-deficient embryos cannot form blastocysts, ar-
resting at the morula stage with severe cell death, impaired
lineage specification, and a global reduction in RNA.
RESULTS
Expression of Nop2 During Preimplantation
Immunofluorescence analysis during all stages of pre-
implantation development revealed that NOP2 protein
abundance was low during the oocyte-to-2-cell embryo
development period, with no obvious difference between
the cytoplasm and nucleus (Fig. 1A). NOP2 abundance
increased significantly from the 4- to 8-cell stage, mostly
concentrated in the nucleus, specifically around the nucle-
olus. NOP2 protein accumulation peaked at the morula
stage, with a slight qualitative decrease in nuclear intensity
in blastocyst embryos.
Quantitative and reverse-transcription PCR revealed
that Nop2 mRNA is expressed at relatively low levels
in oocytes and zygotes, increased through subsequent
cleavage stage divisions, peaked at the 8-cell stage,
and dramatically declined in morula and blastocysts
(Fig. 1B andC). ThismRNAexpression profile is consistent
with the dynamic protein levels that we detected, although
there was a slight delay between peak mRNA and protein
levels, which may reflect timing of translation within each
cell.
Efficient Knockdown of NOP2 by dsNop2 RNA
Microinjection
dsNop2 RNAwas injected into the cytoplasm of zygotes
to deplete NOP2 activity. In all experiments presented,
control embryos were injected with dsGFP to stimulate
the RNAi machinery. Injection of specific dsNop2 RNA
resulted in a drastic degradation of Nop2 mRNA in all
stages examined (Fig. 1D). Similarly, immunofluorescence
analysis revealed obvious protein reduction in NOP2-
knockdown embryos (hereafter referred to as dsNop2
embryos) at themorula stage (Fig. 1E), indicating success-
ful functional loss of NOP2.
NOP2 is Required for Blastocyst Formation
We next evaluated the impact of dsNop2 microinjection
on developmental progression at 24 hr (2-cell stage), 48 hr
(4/8-cell stage), 72 hr (morula stage), and 96 hr (blastocyst
stage) post-fertilization. In these time-course experiments,
dsNop2 embryos develop to themorula stage and compact
without obvious differences in morphology or rate of devel-
opment compared to control dsGFP embryos (Fig. 2A).
At 96 hr, 95% (103/108) of control embryos reach the
blastocyst stage whereas nearly all dsNOP2 embryos!!
1.5% (2/105)!!failed to reach the blastocyst stage
(Fig. 2A and B). Some dsNop2 embryos also exhibited
visible signs of degeneration at 96 hr, specifically display-
ing morphological irregularities (Fig. 2A, arrows).
As dsNop2embryos cannot develop into blastocysts,we
performed more-detailed analyses at the morula stage,
when they still appear morphologically normal. dsNop2
embryo blastomeres appeared to compact, although we
observed a reduction in the blastomere number per
embryo compared to that of control embryos at 72 hr
(28.2# 0.7 cells per dsGFP embryo; 14.9# 0.2 cells per
dsNop2 embryo) (Fig. 2C).
We also injected a control and six distinct commercial
siRNAs designed against NOP2 (Fig. 2G) in order to
confirm that the observed phenotype is specifically due
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to the loss of NOP2 function. siRNA controls elicited no
phenotype!!92% (11/12) of injected zygotes form blasto-
cysts (left most image) (Fig. 2H)!!whereas none (0/69) of
the Nop2 siRNA-injected embryos formed blastocysts,
regardless of which siRNA was used. Thus, the arrested-
development phenotype canbeattributed specifically to the
loss of NOP2 function.
NOP2 Deficiency Results in Apoptosis and
Impaired Lineage Specification
Markers of apoptosis (active tumor protein p53 (TP53))
and lineage specification (POU5F1, for the inner cell mass,
and CDX2, for the trophectoderm) were examined by
immunofluorescence to understand howNOP2knockdown
related to blastocyst failure. Compared with dsGFPmorula
at 72 hr, POU5F1 and CDX2 were greatly decreased
whereas active TP53 was present in many blastomeres
of dsNop2 morula (Fig. 2D). dsGFP embryos formed blas-
tocysts with clear lineage-specific POU5F1/CDX2 localiza-
tion and no detectable active TP53 after 96 hr in culture
(Fig. 2E). dsNop2 embryos, on the other hand, remained
arrested at the morula stage, with no lineage-specific
segregation of POU5F1 or CDX2: POU5F1 was present
at low levels inmost blastomeres, and fewblastomeres had
detectable CDX2. Apoptotic cells were alsomore abundant
and many more cells contained apoptotic bodies (Fig. 2E,
arrow). An extra 12 hr of culture (108 hr total) resulted
in even lower POU5F1 and CDX2 protein as well as
severe aggregation of apoptotic bodies in dsNop2 embryos
(Fig. 2F, arrows), indicating the death of blastomere.
NOP2 Deficiency Results in Global Reduction of
RNA
NOP2 plays a role in RNA stability (Hong et al., 1997;
Gustafson et al., 1998; Castello et al., 2012; Blanco and
Frye, 2014), so we assessed global levels of different types
of RNA in control and dsNOP2 embryos. Total RNA was
isolated from identical numbers of dsGFP and dsNop2
morulae (10 each), and then assessed by bioanalyzer.
Electropherograms showed that normal representative
peaks of tRNA/5S/5.8S, 18S, and 28S are clearly visible
in dsGFP control embryos, but were drastically decreased
or entirely absent in dsNop2 embryos (Fig. 3A), suggesting
a global RNA reduction following NOP2 knockdown.
Figure 1. Expression profile of Nop2 during preimplantation development, and efficient knockdown of Nop2 by dsNop2 RNA microinjection.
A: Immunofluorescence analysis of NOP2 protein from themetaphase II (MII) oocyte to the blastocyst stage. Peak accumulation occurs at morula
stage. B and C: Quantitative (B) and reverse-transcription (C) PCR for Nop2 mRNA abundance in wild-type embryos during preimplantation
development. D: Quantitative analysis of Nop2 mRNA degradation following dsNop2 microinjection at the developmental stages examined.
",P<0.05.Mean# standard error is shown.E: DepletionofNOP2protein in dsNop2morula.Oo,MII oocyte; Zy, zygote;Mo,morula;Bl, blastocyst.
Scale bar, 50mm.
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Figure 2. Characterization of NOP2-deficient embryos. A: Developmental progression of dsNop2 embryos. Arrows indicate morphological
abnormalities suggestive of degeneration. B and C: Blastocyst formation rate (B) and blastomere cell number (C) in the absence of NOP2.
", P<0.05. Mean# standard error is shown; ‘‘n’’ indicates the number of embryos examined. D!F: Immunofluorescence analysis of morula (D)
and blastocysts (E) for the lineage-specific markers POU5F1 and CDX2 and the apoptotic marker activated TP53 in treated embryos at the
expected times (D and E) or after extended culture (F). Cells with apoptotic bodies (arrows) can be found in dsNop2 embryos. G: Schematic of
Nop2mRNA (orange UTRs and grey CDs), with the target locations for the dsRNA (dark blue) and six distinct commercial siRNAs (red, Ambion;
light blue, Qiagen) used to knockdown NOP2. H: Phenotype of siRNA-injected embryos. Most embryos injected with scrambled siRNA
developed into blastocysts (11/12), whereas none of the embryos injected with one of the Nop2 siRNAs developed into blastocysts (0/69)
(between 11 and 13 embryos were injected with each siRNA). Scale bar, 50mm.
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Pyronin Y, a fluorescent RNA dye that binds to both RNA
and DNA, was also used to evaluate global RNA levels in
morula. Consistent with the bioanlyzer data, an obvious
decrease in Pyronin Y signal was observed in dsNop2
embryos compared with dsGFP controls (Fig. 3B).
We also performed quantitative PCR to assess the
changes to several different classes of RNAs, and con-
firmed that rRNA (18S), small nuclear RNA (Rnu6), small
nucleolar RNA (Snord65), and mRNAs (Actb, Gapdh,
Pou5f1,Cdx2, and Bax) were all significantly reduced after
NOP2 knockdown. Conversely, Tp53 abundance was
much higher, which is consistent with the active apoptosis
resulting from the depletion of NOP2.
DISCUSSION
In the present study, we tracked the expression of the
mammalianNop2geneduringpreimplantationdevelopment,
and demonstrated its indispensible role in early embryos.
Nop2 mRNA abundance increases at the 2-cell stage and
peaks at the 8-cell stage (Fig. 1B and C), indicating that
the embryonic source is the zygotic genome rather than
maternal stores from the oocyte. The dynamic decline of
Nop2mRNA after the 8-cell stage (Fig. 1B and C) suggests
there is a tightly regulated mechanism that restricts its
accumulation at later stages.
NOP2 promotes cell proliferation and ribosome assem-
bly, and high NOP2 expression leads to tumor aggres-
siveness (Perlaky et al., 1992; Saijo et al., 2001; Bantis
et al., 2004). We therefore speculate that the preimplanta-
tion expression pattern of Nop2 is orchestrated with the
dynamics of preimplantation development: For example, its
levels are highest when cleavage is required, but the gene
is silenced when lineage differentiation occurs. Although,
we detected the majority of NOP2 protein around the
nucleolus, a cytoplasmic form was also detectable. Careful
observation of dsNop2 embryos (Fig. 1E) indicates that this
Figure 3. Global RNA reduction in dsNop2 embryos. A and B: Bioanalyzer electropherograms (A) and Pyronin Y staining (B) of RNA after Nop2
knockdown. Scale bar, 50mm. C: Relative levels of different classes of RNA in injected embryos, representing rRNA (18S), small nuclear RNA
(Rnu6), small nucleolar RNA (Snord65), and mRNAs (Actb, Gapdh, Oct4, Cdx2, Bax). ", P<0.05. Mean# standard error is shown.
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cytoplasmic signal is not due to non-specific background;
indeed, similar cytoplasmic localization has been reported
in yeast (de Beus et al., 1994), suggesting that NOP2
participates in cytoplasmic events in addition to its reported
role in rRNA synthesis and methylation.
dsRNA-mediated knockdown of NOP2 was used to
define its function during early embryo development
(Fig. 1D and E). dsNop2 embryos do not develop past
the morula stage (Fig. 2A and B), indicating an indispens-
able role for NOP2 during blastocyst development. Blasto-
mere numberwas significantly reduced in dsNop2embryos
that reach the morula stage, extending the role for NOP2 in
cell proliferation and cell-cycle progression that has been
reported in yeast (Hong et al., 1997) and human cancer cells
(Saijo et al., 2001; Bantis et al., 2004; Wang et al., 2014) to
mammalian preimplantation embryos. Blastomere number
can limit blastocyst formation (Yamanaka et al., 2006;
Marikawa and Alarcon, 2009), so the fewer blastomeres
surviving in morulae may be one source of the lower blasto-
cyst rates. But dsNOP2 embryos also fail to activate and
properly partition the transcription factors required for inner
cell mass (POU5F1) and trophectoderm (CDX2) differentia-
tion (Figs.2and3).SinceCdx2 isessential for trophectoderm
formation (Biggers et al., 1988; Watson et al., 1990), we
speculate that failure to specify this lineage is another major
contributor to the dsNop2 failed-blastocyst phenotype.
NOP2 in HeLa cells has also been identified as a RNA-
binding protein that regulates both rRNA (Gustafson et al.,
1998) and mRNA (Castello et al., 2012). We therefore
analyzed global RNA levels, and found a significant reduc-
tion in all RNA types in embryos lacking NOP2 using global
and gene-specific assessments (Fig. 3). The direct con-
sequences of NOP2 loss on global levels of cellular RNAs
are difficult to identify since dsNOP2 embryos are stalled or
dying. Even though dsNOP2 morula appear morphologi-
cally normal, it is possible that its blastomeres are already
severely compromised and thus the global RNA reduction
is not specific to the loss of NOP2. On the other hand, our
results are consistent with a recent study demonstrating
that NOP2 interacts with and stabilizes lncRNA-hPVT1 in
human liver cancers (Wang et al., 2014).
In sum, Nop2 is expressed during mouse preimplanta-
tion, with highest mRNA and protein accumulation at 8-cell
and morula stages, respectively; is essential for blastocyst
formation, as NOP2-deficient embryos arrest at the morula
stage with severe apoptosis and impaired cell-lineage
specification; and plays an important role in RNA process-
ing and/or stability during early embryogenesis, as Nop2
knockdown leads to a global reduction of diverse RNA
species. Thus, NOP2 production in early cleavage stages
is required for blastocyst formation.
MATERIALS AND METHODS
Embryo Recovery and Culture
Use of vertebrate animals for embryo production was
approved by the Institutional Animal Care and Use Com-
mittee of the University of Massachusetts, Amherst.
B6D2F1 female mice 8!10 weeks old were induced to
superovulate with 5 IU pregnant mare serum gonadotropin
(Sigma-Aldrich, St. Louis, MO), followed 48 hr later by 5 IU
human chorionic gonadotropin (hCG) (Sigma-Aldrich, St.
Louis, MO). Superovulated females were mated with
B6D2F1males, and euthanized at 20 hr post-hCG injection
for zygote collection from the oviducts. Oviductal ampullae
were dissected to release zygotes, and cumulus cells were
removed by pipetting in M2 medium containing hyaluroni-
dase (EMD Millipore, Billerica, MA). Zygotes were then
washed in M2 medium (EMD Millipore, Billerica, MA) and
cultured in KSOM medium (EMD Millipore, Billerica, MA)
at 378C in a humidified atmosphere of 5% CO2/5% O2
balanced with N2.
Preparation of dsRNA
DNA templates for T7 RNA polymerase-mediated
dsRNA production were amplified from genomic DNA or
preimplantation embryo cDNA using primers containing T7
binding sequences followedby gene-specific sequences for
dsGFP (50-TAATACGACTCACTATAGGGCACATGAAG-
CAGCACGACTT and 50-TAATACGACTCACTATAGGG-
TGCTCAGGTAGTGGTTGTCG) or dsNop2 (50-TAATAC-
GACTCACTATAGGGGGAGCATGAGCGGATCTTAG and
50-TAATACGACTCACTATAGGGTCCACCGTAATGGA-
ACAGGT).
PCR products were purified using a QIAquick PCR
Purification Kit (Qiagen, Hilden, Germany). In vitro tran-
scription was performed using a MEGAscript T7 Kit (Am-
bion, Waltham, MA), followed by the addition of TURBO
RNase-free DNase to degrade the DNA template. dsRNA
was then passed through NucAway Spin Columns (Am-
bion, Waltham, MA) to remove salt and unincorporated
nucleotides. dsRNA was extracted with phenol/chloroform
(Sigma-Aldrich, St. Louis, MO), precipitated with 70% eth-
anol, and resuspended in RNase-free water (Integrated
DNA Technologies, Coralville, IA). The quality of dsRNA
was confirmed by electrophoresis both after in vitro tran-
scription and after final precipitation. The dsRNA concen-
tration was measured using a NanoDrop (Thermo
Scientific, Waltham, MA). Each dsRNA was diluted to
2mg/ml, and stored at !808C until use.
siRNA Production and Sequences
The sources and sequences of all siRNAs are listed in
Table 1. Five to ten picoliters of 100mM control or Nop2
siRNA were microinjected into the cytoplasm of zygotes.
Microinjection
Microinjection was performed in M2 medium using a
Nikon inverted microscope equipped with a piezo-driven
(Sutter Instrument, Novato, CA) micromanipulator (Trans-
ferMan NK2, Eppendorf, Hamburg, Germany). A volume of
5!10 pl of dsNop2 (2mg/ml) or Nop2 siRNA (100mM)
was microinjected into the cytoplasm of zygotes using a
blunt-ended pipette of 6!7mm in diameter. The same
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concentration and volume of dsGFP or scrambled siRNA
was injected as a control in all experiments. After microin-
jection, zygotes were washed with M2 and cultured in
KSOM medium at 378C in a humidified atmosphere of
5% CO2/5% O2 balanced with N2.
RNA Extraction, Reverse Transcription PCR, and
Quantitative PCR
TotalRNAextractionwasperformedwithaHighPureRNA
Isolation Kit (# 11828665001, Roche, Basel, Switzerland).
cDNA was synthesized using an iScript cDNA synthesis kit
(Bio-Rad Laboratories, Hercules, CA, 170-8891). Specific
reverse-transcription primers forRnu6 andSnord65, accom-
panied with TaqMan probes (Life Technologies, Carlsbad,
CA), were used during cDNA synthesis.
Intron-spanning primers were used for standard
reverse-transcription PCR (Actb: 50-GGCCCAGAGCAA-
GAGAGGTATCCand50-ACGCACGATTTCCCTCTCAGC;
Nop2: same as for the preparation of dsNop2 T7 template,
listed above). Quantitative PCR was performed on a
Stratagene MX3005p using TaqMan Gene Expression
Assays (Life Technologies, Carlsbad, CA) and PerfeCTa
qPCR Mix with low ROX (Quanta Biosciences, Gaithers-
burg, MD)-based reactions. Nop2 expression in different
embryo stages was normalized to Gapdh. Quantification
of gene expression differences between control and
NOP2-knockdown groups was achieve using one-
embryo-equivalent of cDNA per reaction since the knock-
down of NOP2 can induce global RNA, including those
encoding housekeeping genes.
All PCR reactions were run with a minimum of three
replicates under the following conditions: 1 cycle of 508C
for 30 sec; 1 cycle of 958C for 2min; then 40 cycles of 15sec
at 958C and 30sec at 608C. The TaqMan probes used
included: Nop2, Mm00663137_g1; Gapdh, 4352339E;
Actb, 4352341E; Pou5f1, Mm00658129_gH; Cdx2,
Mm01212280_m1; 18S, Hs99999901_s1; Rnu6 (U6 small
nuclear RNA, also named U6 snRNA), TM1973; Snord65
(smallnucleolarRNA65,alsonamedsnoRNA135),TM1230,
Trp53 Mm01731287_m1; and Bax, Mm00432050_m1.
Pyronin Y RNA Staining
Embryos were fixed in 4% paraformaldehyde in phos-
phate-buffered saline (PBS) for 20min at 258C, washed
three times in PBS containing 0.3% polyvinylpyrrolidone
(PBS/PVP), and stained with 40,6-diamidino-2-phenylindole
(DAPI). Embryos were then transferred to PBS/PVP con-
taining 5mM Pyronin Y (Thermo Scientific, Waltham, MA)
for 10min. Stained embryos were washed three times in
PBS/PVP before mounting and observation by epifluores-
cence illumination on an Eclipse-Ti microscope (Nikon,
Tokyo, Japan).
Immunofluorescence
Embryos were fixed in 4% paraformaldehyde in PBS for
30min, washed three times in wash buffer (PBS containing
0.1%Triton X-100), and permeabilized with PBS containing
0.5% TritonX-100 for 15min. Embryos were then blocked
for 1 hr in blocking buffer (PBS containing 10% fetal calf
serum and 0.1%Triton X-100), and then incubated over-
night at 48C with primary antibodies diluted in blocking
buffer. After three rinses with wash buffer, embryos were
incubated for 1 hr with secondary antibodies (Alexa Fluor,
Life Technologies, Carlsbad, CA) diluted 1:600 in blocking
buffer. DAPI was used to stain nuclear DNA for blastomere
counting. Embryos were washed three times with wash
buffer, and then mounted and observed with the Eclipse-Ti
microscope (Nikon, Tokyo, Japan). Identical image-
capture settings were maintained for imaging all embryos.
Negative-control embryos were processed without primary
antibodies, but with secondary antibodies.
The primary antibodies used included: rabbit anti-NOP2
(sc-292098, 1:100 dilution; Santa Cruz Biotechnology,
Dallas, TX); goat anti-POU5F1/OCT4 (sc-8628, 1:200 di-
lution; Santa Cruz Biotechnology, Dallas, TX); mouse anti-
CDX2 (AM392-5M, 1:200 dilution; BioGenex, Fremont,
CA); and rabbit anti-TP53 (#9284, 1:100 dilution; Cell
Signaling Technology, Danvers, MA).
Statistical Analysis
All experiments were repeated at least three times.
Student’s t-test was used to evaluate the difference be-
tween groups, and a value of P< 0.05 was considered
statistically significant. Data are expressed as mean#
standard error of the mean.
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TABLE 1. siRNA Sequences
Name Sequence Target location Source Catalog number
Scrambled 50-CAGGGTATCGACGATTACAAA n/a Qiagen 1027280
Nop2 siRNA1 50-GGACAGTGATGAAGATATG 460:478 Ambion 88181
Nop2 siRNA2 50-CGAGTGGGTGGTAGACTAT 1627:1645 Ambion 173114
Nop2 siRNA3 50-GGCTTGTCCACTGAACCTT 2027:2045 Ambion 173115
Nop2 siRNA4 50-CAGGAGCATGAGCGGATCTTA 1202:1222 Qiagen SI01328978
Nop2 siRNA5 50-AAGACGAACAAGGATGAGAAA 1481:1501 Qiagen SI01328992
Nop2 siRNA6 50-AAGGAGGAAATCAATGACAAA 2437:2457 Qiagen SI01328971
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SUMMARY
LongnoncodingRNAs (lncRNAs) exhibit diverse func-
tions, including regulation of development. Here, we
combine genome-wide mapping of SMAD3 occu-
pancy with expression analysis to identify lncRNAs
induced by activin signaling during endoderm differ-
entiation of human embryonic stem cells (hESCs).
We find that DIGIT is divergent to Goosecoid (GSC)
andexpressedduringendodermdifferentiation. Dele-
tion of the SMAD3-occupied enhancer proximal to
DIGIT inhibits DIGIT and GSC expression and defini-
tive endoderm differentiation. Disruption of the gene
encoding DIGIT and depletion of the DIGIT transcript
reveal that DIGIT is required for definitive endoderm
differentiation. In addition, we identify the mouse or-
tholog of DIGIT and show that it is expressed during
development and promotes definitive endoderm dif-
ferentiation of mouse ESCs. DIGIT regulates GSC in
trans, and activation of endogenous GSC expression
is sufficient to rescue definitive endoderm differentia-
tion in DIGIT-deficient hESCs. Our study defines
DIGITasaconservednoncodingdevelopmental regu-
lator of definitive endoderm.
INTRODUCTION
Definitive endoderm (DE) differentiation is one of the earliest
steps in lineage commitment, leading to development of the
gastrointestinal organs, lungs, and thymus (Zorn and Wells,
2009). Activin or Nodal signaling, through the transforming
growth factor b (TGF-b) receptors, is the primary event initiating
DEdifferentiation of embryonic stem cells (ESCs) (D’Amour et al.,
2005; Kubo et al., 2004). Activation of the TGF-b receptors leads
to phosphorylation of the transcription factors SMAD2 and
SMAD3, which translocate from the cytoplasm to the nucleus
to regulate gene expression (Massague´ et al., 2005). SMAD2/3
tend to occupy unique enhancers in different cell types by asso-
ciating with key transcription factors that determine cell identity
(Mullen et al., 2011). As a result, SMAD2 and SMAD3 switch lo-
cations to occupy many new enhancers during DE differentiation
(Brown et al., 2011; Kim et al., 2011). Key mesendoderm and
endoderm transcriptional regulators including EOMES, MIXL1,
SOX17, and FOXA2 are each direct targets of the activin/
SMAD2/3 pathway during differentiation (Brown et al., 2011;
D’Amour et al., 2005; Kim et al., 2011).
Long noncoding RNAs (lncRNAs) are increasingly recognized
as regulators of development and differentiation. lncRNAs are
greater than 200 nt in length, are often polyadenylated, have
the same features as mRNAs (Guttman et al., 2009), and can
localize to the nucleus or cytoplasm without being translated
into proteins (Cabili et al., 2015). Recent studies have identified
lncRNAs as key contributors to the specification of lineages
derived from all three germ layers, including neural (Sauvageau
et al., 2013), epidermal (Kretz et al., 2012), cardiovascular (Grote
et al., 2013; Klattenhoff et al., 2013), dendritic (Wang et al., 2014),
skeletal muscle (Gong et al., 2015), and lung (Herriges et al.,
2014).
Althoughmany lncRNAs have been identified and cataloged in
human cells (Derrien et al., 2012; Xie et al., 2014), in most cases,
their functions have yet to be defined. Two studies have identi-
fied lncRNAs induced in human endoderm differentiation (Jiang
et al., 2015; Sigova et al., 2013). However, the lncRNAs directly
targeted by activin signaling that contribute to regulation of DE
differentiation remain unknown. We mapped the genome-wide
occupancy of SMAD3 during endoderm differentiation and
identified DIGIT (Divergent to GSC, Induced by TGF-b family
signaling) as an lncRNA regulated by an enhancer bound by
SMAD3 following activin signaling. We found that DIGIT is
required for productive DE differentiation of both human and
mouse ESCs. DIGIT is divergently transcribed from the mes-
endoderm regulator Goosecoid (GSC), and DIGIT and GSC
transcripts are induced coordinately in the same cells during dif-
ferentiation. GSC expression is regulated by DIGIT in trans, and
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the defect in DE differentiation present in DIGIT-deficient human
ESCs (hESCs) can be rescued by the induction of GSC. These
results identify DIGIT as an early regulator of DE differentiation
for both human and mouse ESCs.
RESULTS
DIGIT Is Induced by Activin Signaling
First, we defined the lncRNAs that were induced by activin
signaling during endoderm differentiation. Chromatin immuno-
precipitation sequencing (ChIP-seq) identified 252 SMAD3 en-
hancers activated with the induction of endoderm (Figures 1A
and 1B) (Table S1). Steady-state levels of 1,387 lncRNAs
were elevated at least 2-fold (Sigova et al., 2013) with endo-
derm differentiation, and 14 of these lncRNAs were in close
proximity to SMAD3 enhancers, suggesting that they may be
direct targets of activin signaling. Of these 14 candidates, four
showed transcriptional activation during endoderm differentia-
tion, as measured by global run on sequencing (GRO-seq;
p < 0.01) (Sigova et al., 2013). Only one lncRNA had an ortholog
annotated in the mouse genome (GRCm38/mm10), suggesting
possible functional conservation. Transcription of this lncRNA
was activated during endoderm differentiation as measured
by GRO-seq, together with the divergently transcribed develop-
mental transcription factor GSC (Figure 1C). Formaldehyde-as-
sisted isolation of regulatory elements (FAIRE) (Giresi et al.,
2007; Simon et al., 2012) showed that DIGIT and GSC are tran-
scribed from bidirectional promoters (Scruggs et al., 2015),
characterized by nucleosome depletion between the two tran-
scription start sites (TSSs) during endoderm differentiation
(Figure S1A).
To validate the genomic features of DIGIT, we generated
cDNA using poly(A) (polyadenylated) RNA isolated from differen-
tiating hESCs and performed rapid amplification of cDNA ends
(RACE) to define the location of the 50 cap and the 30 terminus
of the DIGIT transcript (Figure S1B; the full sequence is con-
tained in the Supplemental Experimental Procedures). We
then cloned the full-length transcript from poly(A) RNA to
confirm expression during endoderm differentiation. This anal-
ysis showed that DIGIT is encoded by two exons, as predicted
by RNA sequencing (RNA-seq) (Sigova et al., 2013), and defined
the 30 end of exon 2 to be downstream of the 30 end predicted by
RNA-seq (Figure 1C, cloned). We then analyzed DIGIT expres-
sion during endoderm differentiation using qRT-PCR. Both
DIGIT and GSC are induced during the first 4 days of endoderm
differentiation (Figure 1D), and both DIGIT and GSC are highly
restricted to endoderm compared to other human tissues (Fig-
ures S1C–S1E).
We performed single-molecule RNA-fluorescence in situ hy-
bridization (FISH) and found that DIGIT transcripts are primarily
retained in the nucleus, while GSC mRNA transcripts are most
abundant in the cytoplasm (Figure 1E). Quantification of this dis-
tribution across 50 cells revealed that about 90% of DIGIT tran-
scripts are retained in the nucleus compared to 15% of GSC
transcripts. Nuclear localization of DIGIT provides further sup-
port that DIGIT is not an mRNA, and this analysis also revealed
that DIGIT and GSC are induced in the same cells during
differentiation.
DIGIT andGSC are coordinately induced during endoderm dif-
ferentiation, and we asked whether the proximal enhancer occu-
pied by SMAD3 (Figures 1B and S1F), which is located 5 kb
downstream of the DIGIT TSS, regulates DIGIT and GSC activa-
tion. We used the CRISPR (clustered regularly interspaced short
palindromic repeats) system (Cong et al., 2013) to delete both
copies of the enhancer occupied by SMAD3 during hESC differ-
entiation (Figure 1F). hESCs in which this enhancer was deleted
maintain expression of the ESCmarkersOCT4 andNANOG (Fig-
ures 1G and 1H) but show a defect in activation of DIGIT and
GSC upon endoderm differentiation (Figures 1I and S1G).
Furthermore, deletion of the enhancer occupied by SMAD3
was also associated with a significant reduction in mRNA and
protein expression of SOX17, FOXA2, and CXCR4 (Figures 1I,
1J, S1G, and S1H), which together identify DE (D’Amour et al.,
2005; Green et al., 2011; Loh et al., 2014; Ogawa et al., 2013).
Passage-matched hESCs and hESCs containing a GFP expres-
sion system (Sim et al., 2016) were used as controls.We used the
CRISPR system to insert the components of the GFP expression
system into the AAVS1 loci to create a control that had under-
gone the same manipulations used to create the SMAD3
enhancer deletions. These findings show that the enhancer
newly occupied by SMAD3 during endoderm differentiation reg-
ulates DIGIT and GSC expression and suggest that depletion of
DIGIT may inhibit DE differentiation.
DIGIT Is a Regulator of DE Differentiation
IfDIGIT is required for DE differentiation, wewould expect deple-
tion of the DIGIT transcript to inhibit expression of genes that
mark the DE fate. We used the CRISPR system to create hESC
lines with constitutive expression of short hairpin RNAs (shRNAs)
against DIGIT by inserting the shRNA expression cassette along
with a drug resistance cassette into the AAVS1 locus. Knock-
down of DIGIT expression resulted in a defect in the induction
of SOX17, FOXA2, and CXCR4 after 4 days of differentiation
compared to controls (Figure 2A), indicating that DE differentia-
tion is compromised. In addition, depletion ofDIGIT using locked
nucleic acids (LNAs) demonstrated a similar defect in endoderm
differentiation (Figure S2A). The LNA experiments were per-
formed on day 2 of endoderm differentiation using two LNA con-
structs that targeted DIGIT. Transient transfection with LNAs
was less effective in depletingDIGIT compared to stable integra-
tion of shRNAs, but still showed that reduction in the DIGIT tran-
script was associated with decreased expression of SOX17 and
FOXA2. CXCR4 expression was not assessed because it is not
induced on day 2 of endoderm differentiation.
To further investigate the role ofDIGIT in DE differentiation, we
asked how disruption of the gene encoding DIGIT affects differ-
entiation. We used the CRISPR system to insert a sequence en-
codingGFP followed by a poly(A) signal 44 bp downstream of the
DIGIT TSS (Figure 2B). This sequence was inserted without de-
leting endogenous DNA to avoid inadvertently removing regula-
tory elements thatmight affect nearby genes. Two drug selection
markers were used to identify colonies with GFP-poly(A) inser-
tions in both DIGIT alleles. hESC lines were expanded from sin-
gle colonies and then transfected with a plasmid expressing Cre
recombinase to remove the drug resistance cassettes (Figures
S2B and S2C). Single cells were sorted and expanded to
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Figure 1. DIGIT Is Divergently Transcribed
from GSC and Is Activated by an Enhancer
Bound by SMAD3 during Endoderm Differen-
tiation
(A) Schematic showing the identification of DIGIT
as a candidate lncRNA that regulates endoderm
differentiation (diff). ChIP-seq, RNA-seq, and
GRO-seq analyses were combined to identify four
lncRNAs that were directly targeted by activin
signaling, and only one lncRNA had a mouse or-
tholog.
(B) ChIP-seq was performed to identify sites of
SMAD3 occupancy in hESCs and after 48 hr of
endoderm differentiation. The x axis represents the
linear sequence of genomic DNA, and the y axis
represents the relative number of mapped reads.
The genomic scale in kilobases (kb) is indicated
above the tracks. The site of SMAD3 occupancy
is located 5 kb upstream of the DIGIT TSS. The
SMAD3 site is enriched for H3K27ac (Tsankov et al.,
2015; Figure S1F), which marks active enhancers.
The locations of GSC and DIGIT are shown at the
bottom of (C).
(C) GRO-seq was analyzed from Sigova et al. (2013)
for hESCs (day 0, top) and hESCs differentiated
toward endoderm for 48 hr (bottom). Transcription
of the Watson (+) strand is indicated in red, and
transcription of the Crick (-) strand is indicated in
green. Arrows show the direction of transcription.
The structure of the GSC gene and the predicted
structure of theDIGIT gene (labeled polyA RNA-seq)
are shown below the tracks. DIGIT was cloned after
RACE-PCR to define the 50 and 30 ends of the DIGIT
transcript (Figure S1B), and the structure of the gene
encoding this transcript is shown in black (labeled
cloned). The cloned DIGIT transcript is shown for
the remainder of the article.
(D) DIGIT (red) and GSC expression (green) were
analyzed by qRT-PCR in hESCs (Day 0) and for
the first 4 days of endoderm differentiation. Fold
enrichment is indicated on the y axis, and error bars
represent SD.
(E) Single-molecule RNA-FISH was performed for
hESCs (Day 0, left) and on day 4 of endoderm
differentiation (center). Red probes identify DIGIT
and green probes identify GSC mRNA. Nuclei are
stained with Hoechst (blue). Each dot represents
a transcript, and white arrows indicate two foci of
overlapping dots at sites of transcription (Levesque and Raj, 2013). The percentage of transcripts (y axis) in the nucleus (black) and cytoplasm (white) is shown for
DIGIT and GSC (far right).
(F) The positions of two gRNAs flanking the enhancer occupied by SMAD3 (black box) are shown. The TSSs of DIGIT (red) and GSC (green) are indicated on the
left. Arrows connected by dotted lines indicate the location of PCR primers. Following deletion of the region occupied by SMAD3, the PCR product decreases
from 580 bp to 130 bp (bottom). Genomic PCR was performed on two independent hESC lines with deletion of the SMAD3 enhancer (EnDel1 and EnDel2) and is
compared to wild-type hESCs.
(G) OCT4 and NANOG are markers of undifferentiated hESCs, while SOX17, FOXA2, and CXCR4 together are markers of DE.
(H) Expression of OCT4 (gray) and NANOG (white) was quantified in two hESC controls (Ctrl and AAVS1) and two SMAD3 enhancer deletions (EnDel1 and
EnDel2). Wild-type hESCs are shown as the first control. hESCs that have undergone genome editing to insert a GFP construct into theAAVS1 locus were used as
a second control. Tukey’s multiple comparison statistical test showed no significant difference between the means of any pair.
(I) hESCs were differentiated toward endoderm for 4 days. RNA levels (y axis) were quantified for the indicated genes (x axis) in the AAVS1 control cells and in
hESCs in which the SMAD3 enhancer is deleted (EnDel1). *p < 0.05. Analysis of EnDel2 is shown in Figure S1G.
(J) Flow cytometry was performed to quantify protein expression of SOX17 (x axis), FOXA2, and CXCR4 (y axis) in AAVS1 control hESCs and hESCs containing
the SMAD3 enhancer deletion (EnDel1) after 4 days of endoderm differentiation. The percentage of double-positive cells is indicated in the gated areas. The
percentage of cells expressing all three markers is quantified for control hESCs and hESCs with the SMAD3 enhancer deletion on the right. *p < 0.05. Analysis of
EnDel2 is shown in Figure S1H.
See also Figure S1.
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Figure 2. Loss of DIGIT Expression Inhibits DE Differentiation
(A) The CRISPR system was used to insert a vector into the AAVS1 locus that expresses an shRNA targeting LacZ (control KD) or an shRNA targeting DIGIT
(DIGIT KD). hESCs lines were established from single colonies. Control and DIGIT KD hESCs were differentiated toward endoderm for 4 days prior to RNA
analysis. *p < 0.05. KD, knockdown.
(B) Insertion of a GFP-polyA (pA) sequence into the gene encodingDIGIT allows transcription at theDIGIT locus while inhbiting production of theDIGIT transcript.
Genomic PCR was performed (lower right) using wild-type hESCs (Ctrl) and cells with the GFP cassette knocked into both copies of DIGIT (gfp/gfp) and
(legend continued on next page)
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establish DIGIT-deficient (DIGITgfp/gfp) hESC lines. The insertion
of GFP-poly(A) allows activation of transcription of GFP at the
DIGIT locus during endoderm differentiation but leads to termi-
nation at the poly(A) signal, preventing expression of the full-
length DIGIT transcript. Analysis of RNA expression by PCR
and RNA-FISH demonstrates that GFP transcripts are induced
during endoderm differentiation (Figures 2C and 2D) and are
translated into protein (Figure 2E). The presence of GFP tran-
scripts and the dramatic reduction of DIGIT (Figure 2D) indicate
that transcription is activated at the DIGIT locus with little pro-
duction of the DIGIT transcript.
DIGITgfp/gfp hESC lines maintain expression of hESC master
regulators (Figure S2D) (Boyer et al., 2005). However, these cells
show significantly reduced levels of DIGIT when differentiated
toward endoderm and also demonstrate a defect in the induction
of SOX17, FOXA2, and CXCR4 mRNA (Figure 2F). Reduced
DIGIT expression also inhibited activation of DEANR1, an
lncRNA recently described to regulate FOXA2 expression (Fig-
ure S2E) (Jiang et al., 2015). The primers detecting the DIGIT
transcript are located downstream of the GFP-poly(A) insertion,
and the low level of DIGIT still detected in DIGITgfp/gfp cells (Fig-
ure 2F) is likely the result of a low frequency of readthrough of the
poly(A) sequence.
hESCs were also analyzed by flow cytometry after 4 days of
endoderm differentiation (Figure 2G). Forty-eight percent of
wild-type hESCs expressed SOX17, FOXA2, and CXCR4, which
together identify DE. In contrast, only 4% and 27% of two inde-
pendent DIGITgfp/gfp cell lines co-express the DE markers (Fig-
ure 2G, right). DIGITgfp/gfp hESCs that do differentiate into DE
maintain expression of SOX17 and FOXA2 at levels comparable
to those of wild-type cells (Figure S2F). Thus, DIGIT appears to
regulate the fraction of cells differentiating into DE but not the
levels of FOXA2 and SOX17 proteins in DE cells. We also quan-
tified DE by another set of markers and found that reduced
expression of DIGIT led to reduced expression of DE (58%–
64% reduced to 3%–7%), as quantified by cell co-expression
of c-KIT and CXCR4 (Figure S2G) (Green et al., 2011; Jiang
et al., 2013; Nostro et al., 2011; Ogawa et al., 2013). In contrast
to genes that together identify DE, reduced DIGIT levels did not
have a significant effect on expression of SOX7, a marker of
primitive and visceral endoderm (Kanai-Azuma et al., 2002),
PLAT(T-PA), a marker of parietal endoderm (Cheng and Grabel,
1997), or MEOX1, a marker of mesoderm (Candia et al., 1992)
(Figure S2H), suggesting that the activity of DIGIT is specific
for DE.
We performed RNA-seq to determine the effect of depletion of
DIGIT on the transcriptome during endoderm differentiation.
Compared to wild-type controls, 225 genes were repressed
and 45 genes were induced in DIGITgfp/gfp cells after 4 days of
differentiation (Figure 2H; Table S1). Sequencing was performed
in duplicate for DIGITgfp/gfp 1 and DIGITgfp/gfp 2 cells and
compared to control hESCs. The genes that were repressed
with the depletion of DIGIT tend to be induced in endoderm
differentiation compared to differentiation into ectoderm or
mesoderm lineages (Figure 2I, top). The small number of genes
induced with the loss ofDIGITwere enriched in neural progenitor
cells (NPCs) (Figure 2I, bottom; p < 0.0018).
To assess the role of DIGIT in non-directed differentiation
(Osafune et al., 2008), we created embryoid bodies (EBs) (Fig-
ure S2I) using DIGITgfp/gfp 1 and DIGITgfp/gfp 2 hESC lines and
one control hESC line matched to the same passage number.
EBs were allowed to spontaneously differentiate for 12 days.
OCT4 expression was similar between all groups on day 0 and
decreased dramatically by day 12. The endoderm markers
SOX17 and Albumin are induced in wild-type cells on day 12,
but this induction was inhibited in DIGITgfp/gfp hESCs (Figure 2J).
Expression of PAX6 and MEOX1, which mark ectoderm and
mesoderm, respectively, were unchanged between all groups
(Figure S2J). Overall, these results reveal that the DIGIT tran-
script is required for both directed and spontaneous differentia-
tion of hESCs toward DE.
DE Differentiation Is Regulated by an Ortholog of DIGIT
in Mice
Next, we asked whether DIGIT is conserved in mammalian
development. We identified a 3,002-nt mouse transcript
divergent to Gsc that was isolated from day-9.5 embryos
(Gm10000) and annotated to contain a 357-nt open reading
demonstrates loss of the 180-bp wild-type product and insertion of the GFP-pA cassette (1.3 kb). The red line (bottom left) indicates that transcription is
terminated after the GFP-pA sequence. Please see Figures S2B and S2C for additional details.
(C) GFP mRNA levels (y axis) were quantified in wild-type hESCs (Ctrl) and DIGITgfp/gfp (gfp/gfp) hESCs prior to endoderm differentiation (d0) and after 4 days of
differentiation (d4). *p < 0.05.
(D) RNA-FISH was performed after 4 days of endoderm differentiation for wild-type hESCs (Ctrl, top) andDIGITgfp/gfp hESCs (bottom). Cells were probed for RNA
encoding GFP (green) and DIGIT (red). Nuclei were stained with Hoechst (blue).
(E) GFP expression was quantified by flow cytometry in DIGITgfp/gfp hESCs prior to endoderm differentiation (Day 0, top) and after 4 days of differentiation (Day 4,
bottom). Green fluorescence is shown on the y axis, and forward scatter (FSC) is shown on the x axis. The percentage of GFP+ cells in each condition is indicated.
(F) Wild-type hESCs (Ctrl) and two independently derived DIGITgfp/gfp lines were differentiated toward endoderm for 4 days prior to RNA analysis. RNA levels
(y axis) are shown for the indicated genes (x axis). *p < 0.05.
(G) Wild-type (Control),DIGITgfp/gfp 1, and DIGITgfp/gfp 2 cells were differentiated toward endoderm for 4 days prior to analysis by flow cytometry. The percentage
of double-positive cells is indicated for each condition. The percentage of cells expressing all three endoderm markers is shown on the far right. *p < 0.05.
(H) Wild-type hESCs, DIGITgfp/gfp 1 and DIGITgfp/gfp 2 hESCs were differentiated toward endoderm for 4 days prior to preparation of RNA-seq libraries. Two
replicates for each condition were analyzed. Heatmaps display genes that change in expression by at least 2-fold (false discovery rate [FDR] < 0.05).
(I) RNA-seq data were analyzed to quantify expression of the genes repressed (top) and activated (bottom) with loss of DIGIT expression (Figure 2H). RNA-seq
datasets from hESCs, hESCs undergoing endoderm differentiation, hESCs differentiated toward cardiomyocytes, and hESCs differentiated toward neural
progenitor cells (NPCs) are displayed (Jiang et al., 2015; Loh et al., 2014; Palpant et al., 2015; Schwartz et al., 2015).
(J) hESCs were harvested after EB formation (day 0) and 12 days later. RNA levels (y axis) were quantified for OCT4 (marker of pluripotency) and for SOX17 and
Albumin (markers of endoderm). hESCs that underwent CRISPR targeting to insert a GFP cassette into the AAVS1 locus were used as controls. *p < 0.05.
See also Figure S2.
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Figure 3. An Ortholog of DIGIT Is Expressed in Mouse and Regulates DE Differentiation
(A)Digit (Gm10000) is divergent toGsc in mouse. The 50 and 30 ends of theDigit transcript were defined by RACE-PCR, and the sequences of the 50 and 30 ends of
the transcript are shown below. The full-length transcript cloned from differentiating mESCs using poly(A) RNA is shown in black.
(B) Digit levels were quantified in mESCs (day 0) and mESCs that were differentiated toward endoderm for 5 days.
(C) BLAST alignment of the sequences from the human and mouse DIGIT orthologs was performed. Yellow areas mark the region of homology in which 294 of
335 nt in DIGIT are conserved with Digit.
(legend continued on next page)
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frame (ORF). We performed RACE-PCR and then cloned the full-
length lncRNA from poly(A) RNA harvested from mouse ESCs
(mESCs) that were differentiated toward endoderm for 5 days.
This analysis confirmed a single exon transcript that contained
a 50 cap and 30 poly(A) signal (Figure 3A; the full sequence is
contained in Supplemental Experimental Procedures).
It was unclear whether this transcript was induced during
endoderm differentiation, whether it was a coding or noncoding
transcript, or whether it shared conserved function with DIGIT.
We found that mouse Digit was induced after 5 days of endo-
derm differentiation compared to mESCs (day 0) (Figure 3B).
Similar to human transcripts, mouseDigit andGsc are also highly
restricted in expression to endoderm compared to other tissues
(Figures S3A and S3B). Analysis of nucleic acid sequence con-
servation between the human and mouse orthologs also re-
vealed a 335-nt sequence with 88% identity (Figure 3C). These
results show that both DIGIT and GSC are induced during endo-
dermdifferentiation of hESCs andmESCs.We then isolated RNA
from mouse embryos from embryonic day (E) 5.5 to E8.5 (Fig-
ure S3C) to quantify Digit and Gsc expression during in vivo
development. RT-PCR results show that both Digit and Gsc
are induced on E6.5, which corresponds to the formation of
the anterior primitive streak (Lawson et al., 1991). The highest
levels of Digit expression are reached on E7.5, corresponding
to the formation of DE (TamandBeddington, 1987), and continue
to be expressed on E8.5 (Figure 3D).
We then asked whether the Digit transcript encoded a protein.
First, we prepared nuclear and cytoplasmic extracts from
mESCs differentiated toward endoderm for 5 days and found
thatDigitwas retained in the nucleus (Figure 3E), which suggests
that Digit is not an mRNA, despite containing an annotated ORF.
Next, we assessed the coding potency of the annotated ORF.
CPAT (Coding Potential Assessment Tool) analysis (Wang
et al., 2013) provided further evidence that Digit is not a pro-
tein-coding transcript (p < 0.08). Finally, we tried to detect pro-
tein encoded by the annotated ORF. We generated a transgene
in which a sequence encoding a hemagglutinin (HA) tag was in-
serted in frame within the annotated ORF immediately upstream
of the annotated stop codon. As a control, a transgene was
created in which a sequence encoding an HA tag was inserted
at the 30 end of mouse hemoglobin (Hb) cDNA immediately up-
stream of the stop codon. The Hb cDNA was chosen because
it encodes a protein of similar molecular weight to that predicted
for Digit. Ectopic expression of these transgenes in HEK293T
cells resulted in the production of RNA for both transgenes (Fig-
ure S3D), but western blot analysis detected the HA tag only in
cells expressing the Hb transgene and not in cells expressing
the Digit transgene (Figure 3F). It is possible that HEK293T cells
may not express all the factors necessary to promote translation
of a mouse transcript, so we transfected mESCs with the same
constructs. We could detect the Hb-HA protein by immunofluo-
rescence (IF) microscopy but not the digit-HA product (Fig-
ure 3G). These results establish Digit as an lncRNA that shares
a conserved genomic location and pattern of expression with
DIGIT.
We applied the GFP-poly(A) knockin strategy previously used
for premature termination of DIGIT transcription in hESCs to
determine whether Digit is required for DE differentiation in
mESCs (Figure S3E). MouseDigitwas also required for DE differ-
entiation, as Digitgfp/gfp mESCs were deficient in induction of
Sox17, Foxa2, and Cxcr4 compared to controls (Figures 3H
and 3I). Thus, DIGIT is an lncRNA with conserved function in
differentiation of mammalian ESCs.
DIGIT Contributes to DE Differentiation through
Regulation of GSC Expression
Divergent lncRNAs can positively and negatively regulate neigh-
boring protein-coding genes (Guil and Esteller, 2012), and
we asked whether GSC expression is dependent on DIGIT. We
quantified the expression ofGSC in hESCs during endoderm dif-
ferentiation with the depletion ofDIGIT by shRNAs and LNAs and
found that the depletion of DIGIT was also associated with
reduced GSC expression (Figure 4A, left; Figure S4A). Further-
more, DIGITgfp/gfp hESCs (Figure 4A, right) and Digitgfp/gfp
mESCs (Figure S4B) also showed reduced induction of GSC
during endoderm differentiation.
GSC is a homeobox gene induced by activin/Nodal signaling
in early gastrulation in Xenopus and the primitive streak in mam-
mals (Blum et al., 1992; Cho et al., 1991), but its role in hESC dif-
ferentiation is not fully understood.We used an shRNA to deplete
GSC (Figure 4B) and determine how depletion of GSC affected
differentiation of DE. Depletion of GSC expression inhibited
SOX17, as previously described (Kalisz et al., 2012), as well
as FOXA2 and CXCR4, which together mark DE. The results
(D) RNAwas extracted frommouse embryos at the indicated developmental stage. PCRwas performedwith (+) andwithout (-) reverse transcription (RT) to detect
Gsc and Digit. ActB was used as a loading control. A water blank, serving as a negative control, is on the far right.
(E) RNA was extracted from nuclear (gray) and cytoplasmic fractions (white) on day 5 of differentiation. Digit expression in each fraction was quantified in
comparison to Gapdh mRNA.
(F) Digit is annotated with a 357-nt ORF. A sequence encoding hemagglutinin (HA) was inserted in frame in the annotated Digit and hemoglobin (Hb) ORFs.
Plasmids containing the HA-tagged transgenes were transiently transfected into HEK293T cells. HA expression was quantified by western blot. TheDigit product
is predicted to be 17 kDa. ACTIN is shown as a loading control. RNA levels of Digit and Hb were comparable after transfection (Figure S3D).
(G) Plasmids encoding Digit-HA and Hb-HA were transfected into mESCs 48 hr prior to analysis by IF microscopy. HA is shown in red, and nuclear staining is
shown in blue (Hoechst).
(H) Wild-type (control mESC) and Digitgfp/gfp mESCs were differentiated toward endoderm for 5 days prior to analysis by IF microscopy. Images show nuclear
staining (Hoechst, top) and expression of Foxa2 (middle) and Sox17 (bottom). Digitgfp/gfp mESCs were created by inserting a GFP-pA sequence to disrupt Digit
transcription, and these experiments were performed before drug selection markers were removed (Figure S3E). The scale bars represent 200 mm.
(I)Wild-typemESCs (Ctrl) and two independently derivedDigitgfp/gfp lineswere differentiated toward endoderm for 5 days prior to RNA analysis. RNA levels (y axis)
are shown for the indicated genes (x axis). These experiments were performed after transient transfection with a plasmid expressing Cre recombinase to remove
the drug resistance cassettes. *p < 0.05.
See also Figure S3.
Cell Reports 17, 353–365, October 4, 2016 359
210
GSC
dCas9-
VPR
R
N
A 
le
ve
ls
A
B
C
DIGIT
gRNA
TS
S 
(+
1)
(-1
02
)
0.0
0.5
1.0
1.5
C
trl
sh
R
N
A
G
SC
 R
N
A 
le
ve
ls gRNA2gRNA1
Day 4 (Endoderm)
0.0
0.5
1.0
1.5
C
trl
D
IG
IT
gf
p/
gf
p 
1
D
IG
IT
gf
p/
gf
p 
2
*
*
F
0.0
0.5
1.0
1.5
4RCXCCSG SOX17FOXA2
Ctrl shRNA
0.0
0.5
1.0
1.5
R
N
A 
le
ve
ls
Day 2 (Endoderm)
E
G
D
IG
IT
sh
R
N
A
2.0
G
SC
SO
X1
7
FO
XA
2
Ctrl
DIGIT-/-
DIGIT
gRNA + Cas9
+ donor vectors*
*
GSC shRNA
* * *
***
G
SC
FO
XA
2
SO
X1
7
R
N
A 
le
ve
ls
R
N
A 
le
ve
ls
Hoechst DIGIT
DIGITScramble
Day 2 (Endoderm)
D
0
50
100
150
0
2
4
6
8
*
*
*
0
10
20
30
40
50
0
50
100
150
200
250
0
2
4
6
 G
SC
 R
N
A 
le
ve
ls
 D
IG
IT
 R
N
A 
le
ve
ls
LacZ gRNA GSC gRNA
 %
 F
O
XA
2+
, S
O
X1
7+
 a
nd
 
C
XC
R
4 
+
C
on
tro
l
D
IG
IT
-/-
Day 4 (Endoderm)
DIGIT
TS
S 
(-4
78
)
H
D
IG
IT
0
5
10
15
20
GSC FOXA2 SOX17
LacZ gRNA
GSC gRNA
R
N
A 
le
ve
ls
* *
*
I
*
Hoechst DIGIT
15 9 24
18 11 29
33 20 53
Control
DIGIT het
Total
Si
ng
le
D
ou
bl
e
To
ta
l
GSC
KJ
*
Figure 4. DIGIT Regulates DE Differentiation through Control of GSC in hESCs
(A) GSC mRNA levels were quantified in hESCs expressing shRNA targeting GFP (Ctrl shRNA) and shRNA targeting DIGIT (DIGIT shRNA) after 4 days of
endoderm differentiation (left). DIGIT expression is shown in Figure 2A. GSC mRNA levels were quantified in DIGITgfp/gfp 1 and DIGITgfp/gfp 2 hESC lines and
compared to expression in wild-type hESCs after 4 days of differentiation (right). DIGIT expression is shown in Figure 2F. *p < 0.05.
(B) RNA levels were quantified for the indicated genes after 4 days of endoderm differentiation in hESCs containing an shRNA recognizing LacZ inserted into the
AAVS1 locus (Ctrl shRNA) and hESCs containing an shRNA targeting GSC inserted into the AAVS1 locus (GSC shRNA). *p < 0.05.
(C) The location of the gRNA used to induce GSC expression with dCas9-VPR.
(legend continued on next page)
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suggest that GSC is required for formation of DE during hESC
differentiation.
The DIGITgfp/gfp Phenotype Is Rescued by Induction of
Endogenous GSC
IfDIGIT contributes to DE differentiation by regulatingGSC, then
induction of GSC in DIGIT-deficient hESCs should rescue the
defect observed during endoderm differentiation. We first trans-
fected hESCs with a plasmid encoding a dead Cas9 fused to
the VP64-P65-Rta transcription activation domain (dCas9-VPR)
(Chavez et al., 2015) and a plasmid encoding a guide RNA
(gRNA) that directs dCas9-VPR to theGSC promoter (Figure 4C)
to determine whether recruiting dCas9-VPR to the GSC pro-
moter could activate GSC expression. hESCs transfected with
both plasmids showed a nearly 200-fold induction of GSC after
48 hr (Figure 4D, left). dCas9-VPR was directed to bind 102 bp
upstream of the GSC TSS, but this was also 376 bp upstream
of the DIGIT TSS (Figure 4C), and targeting dCas9-VPR to this
location also increased DIGIT expression, but to a lower extent
(Figure 4D, right). These results showed that dCas9-VPR primar-
ily activated GSC but also increased the expression of DIGIT.
DIGITgfp/gfp hESCs rely on a poly(A) signal to terminate transcrip-
tion and prevent production of DIGIT. We were concerned that
increased transcription at the DIGIT locus in DIGITgfp/gfp cells
would lead to a proportional increase in the small number of tran-
scripts reading through the poly(A) and complicate interpretation
of the experiment. To avoid this effect, we used the CRISPR
system to generate hESC lines with homozygous deletion of
the second exon of the DIGIT (Figures 4E and S4C). We then
confirmed that these DIGIT!/! hESCs do not express DIGIT dur-
ing endoderm differentiation (Figure S4D) and are also deficient
in DE differentiation (Figure 4F). Next, we transiently transfected
DIGIT!/! hESCs with plasmids expressing dCas9-VPR andGSC
gRNA. We cultured cells in hESCs media for 2 days to allow
expression of GSC prior to induction of differentiation. Because
thesewere transient transfections, we analyzed gene expression
after 2 days of endoderm differentiation and found that the DE
markers SOX17 and FOXA2 were induced in DIGIT!/! cells
with activation of GSC (Figure 4G). We repeated the experiments
in DIGITgfp/gfp hESCs with the same results (Figures S4E and
S4F). These findings demonstrate that activation of endogenous
GSC can rescue the defect in DE differentiation created by the
loss of DIGIT expression and suggest that DIGIT controls DE dif-
ferentiation of hESCs, at least in part, through regulation ofGSC.
DIGIT Regulates GSC in Trans
Depletion ofDIGIT by shRNAs, LNAs, and the insertion of poly(A)
termination sequences shows that it is the DIGIT transcript and
not transcription at the DIGIT locus that is required to regulate
GSC expression. To provide further evidence that theDIGIT tran-
script regulates GSC expression, we asked whether ectopic
expression of DIGIT could induce GSC expression in DIGIT-
deficient cells. First, we transfected hESCs with a plasmid
expressing DIGIT behind a PGK promoter and performed
RNA-FISH to confirm that DIGIT expressed from the plasmid is
localized to the nucleus (Figure 4H). Next, we transiently trans-
fected DIGIT!/! hESCs with a plasmid expressing DIGIT or a
scrambled DIGIT sequence along with GFP. One day after trans-
fection, hESCs were differentiated toward endoderm, and GFP+
cells were sorted after 2 days of differentiation. We found
that DIGIT!/! hESCs expressing ectopic DIGIT (Figure 4I, left)
showed increased expression of GSC as well as FOXA2 and
SOX17 (Figure 4I, right). DIGIT!/! cells were used for this exper-
iment instead ofDIGITgfp/gfp hESCs because they did not already
express GFP, and expression analysis was performed on day 2
of differentiation because these were transient transfections.
CXCR4 expression was not assessed, as it is not induced on
day 2 of endoderm differentiation. These results show that DIGIT
does not need to be transcribed adjacent to GSC to promote
GSC expression and provides further evidence that DIGIT regu-
lates GSC expression.
The results from ectopic expression of DIGIT suggest that the
DIGIT transcript may function in trans to regulateGSC. To further
evaluate this possibility, we created DIGIT heterozygous (+/gfp)
hESCs and asked whetherGSCwas expressed from both alleles
or only the allele adjacent to thewild-type copy ofDIGIT. We per-
formed RNA-FISH to analyze GSC expression in wild-type and
DIGIT+/gfp hESCs undergoing endoderm differentiation (Fig-
ure 4J). Sites of GSC transcription are identified by bright foci
of GSC RNA (Figure 1E) (Levesque and Raj, 2013) and can be
(D) hESCs were transfected with a plasmid expressing the gRNA (in C) or a control gRNA recognizing LacZ along with a second plasmid expressing dCas9-VPR.
GSC (left) and DIGIT expression (right) was quantified by qRT-PCR after 48 hr. *p < 0.05.
(E) The positions of two gRNAs flanking the second exon of DIGIT and used to create DIGIT!/! hESCs are shown.
(F) Control (gray) and DIGIT!/! hESCs (white) were differentiated toward endoderm for 4 days, and DE differentiation is quantified by co-expression of FOXA2,
SOX17, and CXCR4 by flow cytometry (left). Control and DIGIT!/! hESCs were differentiated toward endoderm for 2 days prior to analysis of RNA expression
(right). *p < 0.05.
(G) DIGIT!/! hESCs were transiently transfected with dCas9-VPR and the gRNA targeting the GSC promoter (white) or a LacZ gRNA, which does not target the
GSC promoter (gray). hESCs were maintained in mTeSR1 for 2 days and then differentiated toward endoderm for 2 days before analysis of RNA expression.
*p < 0.05.
(H) hESCs were transfected with a plasmid encoding DIGIT. RNA-FISH was performed after 2 days and shows nuclear localization (Hoechst, blue) of DIGIT (red)
with transient transfection.
(I)DIGIT!/! hESCswere transfected with a plasmid expressingGFP and eitherDIGIT or a scrambled sequence ofDIGIT (Scramble). hESCswere transfected, and
GFP+ cells were sorted after 2 days of endoderm differentiation. RNA expression was analyzed for the indicated genes. *p < 0.05.
(J) RNA-FISH was performed after 4 days of endoderm differentiation for wild-type hESCs (control) and DIGIT+/gfp hESCs (DIGIT het). Cells were probed for RNA
encoding GSC. The transcription sites of GSC were counted in nuclei with either single or double sites of transcription for both wild-type and DIGIT+/gfp hESCs.
Fisher’s exact test showed no significant difference between the ratio of single to double transcription sites between the two genotypes (p value = 1).
(K) RNA-FISH was performed after 4 days of endoderm differentiation for DIGIT+/gfp hESCs. Cells were probed for RNA encoding GSC (green) and DIGIT (red).
Nuclei were stained with Hoechst (blue).
See also Figure S4.
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observed at one or two sites in differentiating cells. The distribu-
tions of cells demonstrating one or two foci to mark active GSC
transcription are not statistically different between wild-type and
DIGIT+/gfp cells, and DIGIT+/gfp cells show a similar frequency of
cells expressing GSC from two alleles compared to wild-type
cells (Figure 4J). These results suggest that transcription can
occur at bothGSC alleles, even when one allele is no longer pro-
ducing DIGIT (Figure 4K). Together, the results from the ectopic
expression of DIGIT in DIGIT!/! cells and the expression ofGSC
from both alleles in DIGIT heterozygous cells suggest that
the DIGIT transcript can function in trans to regulate GSC
expression.
DISCUSSION
In this study, we performed genome-wide analysis of SMAD3 oc-
cupancy to identify enhancers targeted by activin signaling dur-
ing endoderm differentiation. This approach, combinedwith pre-
vious analysis of transcriptional responses (Sigova et al., 2013),
allowed us to identify DIGIT out of over 1,000 lncRNAs induced
during endoderm differentiation. Deletion of the SMAD3-occu-
pied enhancer proximal to DIGIT showed a profound reduction
in DIGIT andGSC expression and inhibition of DE differentiation.
These results show that the enhancer is required for normal acti-
vation of DIGIT and GSC, but targeted disruption of SMAD3
binding elements within this enhancer will be required to deter-
mine whether SMAD3 occupancy is required for activation. Our
analysis defined 252 sites activated for SMAD3 binding within
48 hr of endoderm differentiation, and it is likely that investigation
of these sites will identify additional enhancers that are also
required for endoderm differentiation. Applying this concept
more broadly suggests that focusing on lncRNAs that are direct
targets of the signaling pathways that control differentiation will
identify the lncRNAs that are likely to regulate development.
DIGIT is expressed divergently from GSC and is coordi-
nately induced with GSC during endoderm differentiation when
analyzed at the population level by RNA expression (Figure 1D)
(Sigova et al., 2013), and expression of both genes are highly
restricted to endoderm differentiation (Figures S1C–S1E, S3A,
and S3B). We also observe both DIGIT and GSC transcripts
in the same cells during differentiation (Figure 1E). In other
cell types, divergent genes are not always associated with co-
expression (Cabili et al., 2015). This coordinated induction of
divergent lncRNA and coding gene pairs may be more common
with activation of loci during differentiation (Lepoivre et al., 2013;
Ponjavic et al., 2009; Sigova et al., 2013) where sets of genes are
turned on in a coordinated fashion to regulate changes in cell
identity and may be less fixed in cells maintaining homeostasis.
Not only isDIGIT divergently transcribed from the gene encod-
ing GSC, but it also regulates GSC expression. Depletion of the
DIGIT transcript inhibited induction ofGSC during endoderm dif-
ferentiation of both hESCs and mouse ESCs (Figures 4A, S4A,
and S4B), and ectopic expression of DIGIT in DIGIT!/! cells
was also sufficient to induce GSC expression (Figure 4I). These
findings, coupled with the observation that GSC can be ex-
pressed from both alleles in DIGIT heterozygous cells, show
that DIGIT regulates GSC in trans rather than by being tran-
scribed in close proximity to GSC.
GSC is a homeobox gene that is induced in early gastrulation
with the formation of the dorsal lip of the blastopore in Xenopus
and the primitive streak in mammals and is activated as a target
of activin/Nodal signaling (Blum et al., 1992; Cho et al., 1991).
Surprisingly, GSC!/! mice do not show a defect in gastrulation
and survive to gestation with craniofacial defects (Rivera-Pe´rez
et al., 1995). Loss of GSC expression in hESCs was previ-
ously shown to be associated with the significant reduction of
SOX17 (Kalisz et al., 2012), which is expressed in both definitive
and visceral endoderm (Shimoda et al., 2007). By quantifying the
effects of GSC on additional genes, our results provide more
convincing data that GSC is required for DE differentiation of
hESCs. Thus, while loss of GSC does not appear to be required
for in vivo gastrulation in mice, we demonstrate that GSC is
required for DE of ESCs. Furthermore, the defect in DE differen-
tiation that occurs with loss of DIGIT expression can be rescued
by the induction ofGSC (Figure 4G), showing that DIGIT controls
DE differentiation by promoting expression of GSC. Further
experiments will be required to determine the function of Digit
during in vivo development.
There are increasing examples of lncRNAs that positively
regulate proximal protein-coding genes, including those diver-
gently transcribed from developmental genes (Arnes et al.,
2016; Herriges et al., 2014; Jiang et al., 2015; Luo et al., 2016),
making it necessary to have genomic tools to disrupt lncRNAs
without genomic deletions that could affect the regulatory ele-
ments of neighboring genes. We have established a method
for efficient loss of lncRNA function via insertion of a GFP-poly(A)
sequence into the lncRNA gene. Whether transcription initiation
at divergently transcribed genes is mediated through bidirec-
tional or adjacent unidirectional promoters (Core et al., 2014;
Duttke et al., 2015; Grzechnik et al., 2014), the ability to allow
transcription initiation and elongation at the endogenous lncRNA
TSS while preventing production of the lncRNA transcript pro-
vides an essential tool to dissect lncRNA function. This system
can be applied tomany divergently transcribed lncRNAs or those
in close proximity to protein-coding genes and allows preserva-
tion of transcriptional activation at the lncRNA locus while pre-
venting production of the lncRNA product. It also avoids the
need to delete any endogenous sequences that might act as a
regulatory element of nearby genes. This approach has led to
the identification of DIGIT as a key regulator of human and
mouse DE differentiation and can be applied to investigate the
function of lncRNAs in any developmental system.
EXPERIMENTAL PROCEDURES
ESC Culture and Differentiation
hESCs were cultured and differentiated as previously described (Sigova et al.,
2013). mESCs were cultured on irradiated mouse embryonic fibroblasts
(MEFs) and differentiated with 100 ng/mL activin A. Please see the Supple-
mental Experimental Procedures for additional details.
Sequencing Analysis
ChIP-seq libraries were prepared and analyzed as described previously
(Mullen et al., 2011). GRO-seq (Sigova et al., 2013) analysis was performed us-
ing HTseq (Anders et al., 2015) and DESeq2 (Love et al., 2014). RNA-seq anal-
ysis of wild-type and DIGITgfp/gfp hESCs and comparison to other datasets of
hESCdifferentiation were performed using HTseq andDESeq2. Please see the
Supplemental Experimental Procedures for additional details.
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Genome Editing
Genome editing was performed by transfecting cells with the px330 plasmid
(Cong et al., 2013) containing the indicated gRNAs alongwith the indicated ho-
mology plasmids. The sequences of all gRNAs are listed in Table S2. Please
see the Supplemental Experimental Procedures for additional information,
including maps of the homology plasmids.
RNA In Situ Hybridization
Custom Stellaris FISH probes (Biosearch Technologies) were designed
against DIGIT, GSC, and GFP using the Stellaris FISH Probe Designer
(www.biosearchtech.com/stellarisdesigner) (Table S2). The samples were
hybridized with Stellaris FISH Probe sets labeled with Quasar 570 or
Quasar 670.
Cell Sorting and Flow Cytometry Analysis
hESCs and differentiated cells were separated into single cells by Accutase
treatment prior to cell sorting using the FACSAria II (BD Biosciences) or flow
cytometry using the Accuri C6 (BD Biosciences). Antibodies used for FACS
were as follows: SOX17-PerCP (BD Biosciences, 562387), FOXA2-PE anti-
body (BD Biosciences, 561589), and CXCR4-APC antibody (R&D Systems,
FAB173A). Please see the Supplemental Experimental Procedures for addi-
tional details.
Analysis of RNA Expression in Developing Embryos
Female CD1 mice were mated with male CD1 mice and checked daily for
vaginal plugs indicating E0. Pregnant mice were euthanized 5–8 days later,
and embryos were dissected, carefully staged, and imaged (stages are indi-
cated in Figure S3C).
Total RNA was isolated using the Roche High Pure RNA Isolation Kit
(Roche, 11828665001), following themanufacturer’s protocol with the addition
of a second DNase treatment following the first wash. cDNA synthesis
was performed using SuperScript II reverse transcriptase (Invitrogen,
18064014) with both oligo(dT) primers (Promega C1181) and random primers
(Promega C1101). RT-PCR was performed though 35 cycles at 94"C for 30 s,
60"C for 30 s, and 72"C for 30 s. Products were electrophoresed on 2%
agarose gel.
IF Microscopy
IF was performed using the following antibodies: FoxA2 (Abcam, ab40874),
Sox17 (R&D, AF1924), and HA (Abcam, ab9110). Please see the Supplemental
Experimental Procedures for additional details.
Induction of Endogenous GSC Expression
A plasmid expressing dCas9-VPR (Chavez et al., 2015) was transiently trans-
fected along with a plasmid expressing either a gRNA specific to LacZ or a
gRNA specific to a promoter of GSC. Cells were maintained in mTESR1 for
48 hr after transfection and were then differentiated for an additional 48 hr.
Previously Published RNA Datasets Used in This Study
Human tissue datasets from GTEx (GTEx Consortium, 2013) were obtained
through dbGAP (Table S3). Additional datasets of differentiating hESCs were
obtained from GSE63935, GSE52657, and GSE44875. GRO-seq data for
hESCs and endoderm differentiation were obtained from GSE41009. Mouse
tissue datasets were obtained fromGSE36025, and datasets for differentiating
mESCs were from GSE36114.
ACCESSION NUMBERS
The accession number for the RNA-seq data for differentiation of DIGITgfp/gfp
hESCs and the ChIP-seq data for SMAD3 reported in this paper is GEO:
GSE75297.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three supplemental tables and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2016.09.017.
AUTHOR CONTRIBUTIONS
K.D. and A.C.M. conceived the study and designed the experiments. K.D.,
J.V.P., B.-M.K., S.R.Y., J.A.M., A.A., B.T., C.M., K.D.T., J.M., and M.Y.C. per-
formed and analyzed the experiments. C.Z. and J.V.P. performed the compu-
tational analysis. K.D. and A.C.M. wrote the manuscript, with input from A.A.S.
ACKNOWLEDGMENTS
We would like to thank the MGH/HSCI Flow Cytometry Core Facility and Mer-
edith Weglarz for technical support; the MGH/PBM microscopy core, Bio-
search Technologies, and Marc Beal for assistance with RNA-FISH; and
Kate Jeffrey, Konrad Hochedlinger, Igor Ulitsky, Cosmas Giallourakis, Abid
Khan, and Jennifer Chen for helpful discussion. This work was supported by
NIH grants DK090122 and DK104009 and MGH startup funds (A.C.M.).
Received: December 3, 2015
Revised: August 12, 2016
Accepted: September 3, 2016
Published: October 4, 2016
REFERENCES
Anders, S., Pyl, P.T., and Huber, W. (2015). HTSeq–a Python framework to
work with high-throughput sequencing data. Bioinformatics 31, 166–169.
Arnes, L., Akerman, I., Balderes, D.A., Ferrer, J., and Sussel, L. (2016). blinc1
encodes a long noncoding RNA that regulates islet b-cell formation and func-
tion. Genes Dev. 30, 502–507.
Blum, M., Gaunt, S.J., Cho, K.W., Steinbeisser, H., Blumberg, B., Bittner, D.,
and De Robertis, E.M. (1992). Gastrulation in themouse: the role of the homeo-
box gene goosecoid. Cell 69, 1097–1106.
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P.,
Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005). Core
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122,
947–956.
Brown, S., Teo, A., Pauklin, S., Hannan, N., Cho, C.H.-H., Lim, B., Vardy, L.,
Dunn, N.R., Trotter, M., Pedersen, R., and Vallier, L. (2011). Activin/Nodal
signaling controls divergent transcriptional networks in human embryonic
stem cells and in endoderm progenitors. Stem Cells 29, 1176–1185.
Cabili, M.N., Dunagin, M.C., McClanahan, P.D., Biaesch, A., Padovan-Merhar,
O., Regev, A., Rinn, J.L., and Raj, A. (2015). Localization and abundance anal-
ysis of human lncRNAs at single-cell and single-molecule resolution. Genome
Biol. 16, 20.
Candia, A.F., Hu, J., Crosby, J., Lalley, P.A., Noden, D., Nadeau, J.H., and
Wright, C.V. (1992). Mox-1 andMox-2 define a novel homeobox gene subfam-
ily and are differentially expressed during early mesodermal patterning in
mouse embryos. Development 116, 1123–1136.
Chavez, A., Scheiman, J., Vora, S., Pruitt, B.W., Tuttle, M., Iyer, E., Lin, S.,
Kiani, S., Guzman, C.D., Wiegand, D.J., et al. (2015). Highly efficient Cas9-
mediated transcriptional programming. Nat. Methods 12, 326–328.
Cheng, L., and Grabel, L.B. (1997). The involvement of tissue-type plasmin-
ogen activator in parietal endoderm outgrowth. Exp. Cell Res. 230, 187–196.
Cho, K.W., Blumberg, B., Steinbeisser, H., and De Robertis, E.M. (1991). Mo-
lecular nature of Spemann’s organizer: the role of the Xenopus homeobox
gene goosecoid. Cell 67, 1111–1120.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X.,
Jiang, W., Marraffini, L.A., and Zhang, F. (2013). Multiplex genome engineering
using CRISPR/Cas systems. Science 339, 819–823.
Cell Reports 17, 353–365, October 4, 2016 363
214
Core, L.J., Martins, A.L., Danko, C.G., Waters, C.T., Siepel, A., and Lis, J.T.
(2014). Analysis of nascent RNA identifies a unified architecture of initiation re-
gions at mammalian promoters and enhancers. Nat. Genet. 46, 1311–1320.
D’Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E., and Baetge,
E.E. (2005). Efficient differentiation of human embryonic stem cells to definitive
endoderm. Nat. Biotechnol. 23, 1534–1541.
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guer-
nec, G., Martin, D., Merkel, A., Knowles, D.G., et al. (2012). The GENCODE v7
catalog of human long noncoding RNAs: analysis of their gene structure, evo-
lution, and expression. Genome Res. 22, 1775–1789.
Duttke, S.H.C., Lacadie, S.A., Ibrahim,M.M., Glass, C.K., Corcoran, D.L., Ben-
ner, C., Heinz, S., Kadonaga, J.T., and Ohler, U. (2015). Human promoters are
intrinsically directional. Mol. Cell 57, 674–684.
Giresi, P.G., Kim, J., Mcdaniell, R.M., Giresi, P.G., Kim, J., Mcdaniell, R.M.,
Iyer, V.R., and Lieb, J.D. (2007). FAIRE (Formaldehyde-Assisted Isolation of
Regulatory Elements) isolates active regulatory elements from human chro-
matin. Genome Res. 17, 877–885.
Gong, C., Li, Z., Ramanujan, K., Clay, I., Zhang, Y., Lemire-Brachat, S., and
Glass, D.J. (2015). A long non-coding RNA, LncMyoD, regulates skeletal mus-
cle differentiation by blocking IMP2-mediated mRNA translation. Dev. Cell 34,
181–191.
Green, M.D., Chen, A., Nostro, M.-C., d’Souza, S.L., Schaniel, C., Lemischka,
I.R., Gouon-Evans, V., Keller, G., and Snoeck, H.-W. (2011). Generation of
anterior foregut endoderm from human embryonic and induced pluripotent
stem cells. Nat. Biotechnol. 29, 267–272.
Grote, P., Wittler, L., Hendrix, D., Koch, F., Wa¨hrisch, S., Beisaw, A., Macura,
K., Bla¨ss, G., Kellis, M., Werber, M., and Herrmann, B.G. (2013). The tissue-
specific lncRNA Fendrr is an essential regulator of heart and body wall devel-
opment in the mouse. Dev. Cell 24, 206–214.
Grzechnik, P., Tan-Wong, S.M., and Proudfoot, N.J. (2014). Terminate and
make a loop: regulation of transcriptional directionality. Trends Biochem.
Sci. 39, 319–327.
GTEx Consortium (2013). The Genotype-Tissue Expression (GTEx) project.
Nat. Genet. 45, 580–585.
Guil, S., and Esteller, M. (2012). Cis-acting noncoding RNAs: friends and foes.
Nat. Struct. Mol. Biol. 19, 1068–1075.
Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M.,
Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals
over a thousand highly conserved large non-coding RNAs inmammals. Nature
458, 223–227.
Herriges, M.J., Swarr, D.T., Morley, M.P., Rathi, K.S., Peng, T., Stewart, K.M.,
and Morrisey, E.E. (2014). Long noncoding RNAs are spatially correlated with
transcription factors and regulate lung development. Genes Dev. 28, 1363–
1379.
Jiang, W., Zhang, D., Bursac, N., and Zhang, Y. (2013). WNT3 is a biomarker
capable of predicting the definitive endoderm differentiation potential of
hESCs. Stem Cell Reports 1, 46–52.
Jiang, W., Liu, Y., Liu, R., Zhang, K., and Zhang, Y. (2015). The lncRNA
DEANR1 facilitates human endoderm differentiation by activating FOXA2
expression. Cell Rep. 11, 137–148.
Kalisz, M., Winzi, M., Bisgaard, H.C., and Serup, P. (2012). EVEN-SKIPPED
HOMEOBOX 1 controls human ES cell differentiation by directly repressing
GOOSECOID expression. Dev. Biol. 362, 94–103.
Kanai-Azuma, M., Kanai, Y., Gad, J.M., Tajima, Y., Taya, C., Kurohmaru, M.,
Sanai, Y., Yonekawa, H., Yazaki, K., Tam, P.P.L., and Hayashi, Y. (2002).
Depletion of definitive gut endoderm in Sox17-null mutant mice. Development
129, 2367–2379.
Kim, S.W., Yoon, S.-J., Chuong, E., Oyolu, C., Wills, A.E., Gupta, R., and
Baker, J. (2011). Chromatin and transcriptional signatures for Nodal signaling
during endoderm formation in hESCs. Dev. Biol. 357, 492–504.
Klattenhoff, C.A., Scheuermann, J.C., Surface, L.E., Bradley, R.K., Fields, P.A.,
Steinhauser, M.L., Ding, H., Butty, V.L., Torrey, L., Haas, S., et al. (2013).
Braveheart, a long noncoding RNA required for cardiovascular lineage
commitment. Cell 152, 570–583.
Kretz, M., Webster, D.E., Flockhart, R.J., Lee, C.S., Zehnder, A., Lopez-Pa-
jares, V., Qu, K., Zheng, G.X.Y., Chow, J., Kim, G.E., et al. (2012). Suppression
of progenitor differentiation requires the long noncoding RNA ANCR. Genes
Dev. 26, 338–343.
Kubo, A., Shinozaki, K., Shannon, J.M., Kouskoff, V., Kennedy, M., Woo, S.,
Fehling, H.J., and Keller, G. (2004). Development of definitive endoderm
from embryonic stem cells in culture. Development 131, 1651–1662.
Lawson, K.A., Meneses, J.J., and Pedersen, R.A. (1991). Clonal analysis of
epiblast fate during germ layer formation in the mouse embryo. Development
113, 891–911.
Lepoivre, C., Belhocine, M., Bergon, A., Griffon, A., Yammine, M., Vanhille, L.,
Zacarias-Cabeza, J., Garibal, M.-A., Koch, F., Maqbool, M.A., et al. (2013).
Divergent transcription is associated with promoters of transcriptional regula-
tors. BMC Genomics 14, 914.
Levesque, M.J., and Raj, A. (2013). Single-chromosome transcriptional
profiling reveals chromosomal gene expression regulation. Nat. Methods 10,
246–248.
Loh, K.M., Ang, L.T., Zhang, J., Kumar, V., Ang, J., Auyeong, J.Q., Lee, K.L.,
Choo, S.H., Lim, C.Y.Y., Nichane, M., et al. (2014). Efficient endoderm induc-
tion from human pluripotent stem cells by logically directing signals controlling
lineage bifurcations. Cell Stem Cell 14, 237–252.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550.
Luo, S., Lu, J.Y., Liu, L., Yin, Y., Chen, C., Han, X., Wu, B., Xu, R., Liu, W., Yan,
P., et al. (2016). Divergent lncRNAs regulate gene expression and lineage
differentiation in pluripotent cells. Cell Stem Cell 18, 637–652.
Massague´, J., Seoane, J., and Wotton, D. (2005). Smad transcription factors.
Genes Dev. 19, 2783–2810.
Mullen, A.C., Orlando, D.A., Newman, J.J., Love´n, J., Kumar, R.M., Bilodeau,
S., Reddy, J., Guenther, M.G., DeKoter, R.P., and Young, R.A. (2011).
Master transcription factors determine cell-type-specific responses to
TGF-b signaling. Cell 147, 565–576.
Nostro, M.C., Sarangi, F., Ogawa, S., Holtzinger, A., Corneo, B., Li, X., Micallef,
S.J., Park, I.-H., Basford, C., Wheeler, M.B., et al. (2011). Stage-specific
signaling through TGFb family members and WNT regulates patterning and
pancreatic specification of human pluripotent stem cells. Development 138,
861–871.
Ogawa, S., Surapisitchat, J., Virtanen, C., Ogawa, M., Niapour, M., Sugamori,
K.S., Wang, S., Tamblyn, L., Guillemette, C., Hoffmann, E., et al. (2013). Three-
dimensional culture and cAMP signaling promote the maturation of human
pluripotent stem cell-derived hepatocytes. Development 140, 3285–3296.
Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato,
Y., Cowan, C.A., Chien, K.R., and Melton, D.A. (2008). Marked differences in
differentiation propensity among human embryonic stem cell lines. Nat. Bio-
technol. 26, 313–315.
Palpant, N.J., Pabon, L., Roberts, M., Hadland, B., Jones, D., Jones, C., Moon,
R.T., Ruzzo, W.L., Bernstein, I., Zheng, Y., et al. (2015). Inhibition of b-catenin
signaling respecifies anterior-like endothelium into beating human cardiomyo-
cytes. Development 142, 3198–3209.
Ponjavic, J., Oliver, P.L., Lunter, G., and Ponting, C.P. (2009). Genomic and
transcriptional co-localization of protein-coding and long non-coding RNA
pairs in the developing brain. PLoS Genet. 5, e1000617.
Rivera-Pe´rez, J.A., Mallo, M., Gendron-Maguire, M., Gridley, T., and Beh-
ringer, R.R. (1995). Goosecoid is not an essential component of the mouse
gastrula organizer but is required for craniofacial and rib development. Devel-
opment 121, 3005–3012.
Sauvageau, M., Goff, L.A., Lodato, S., Bonev, B., Groff, A.F., Gerhardinger, C.,
Sanchez-Gomez, D.B., Hacisuleyman, E., Li, E., Spence, M., et al. (2013). Mul-
tiple knockout mouse models reveal lincRNAs are required for life and brain
development. eLife 2, e01749.
364 Cell Reports 17, 353–365, October 4, 2016
215
Schwartz, M.P., Hou, Z., Propson, N.E., Zhang, J., Engstrom, C.J., and San-
tos, V. (2015). Human pluripotent stem cell-derived neural constructs for
predicting neural toxicity. Proc Natl Acad Sci USA 112, 12516–12521.
Scruggs, B.S., Gilchrist, D.A., Nechaev, S., Muse, G.W., Burkholder, A., Fargo,
D.C., and Adelman, K. (2015). Bidirectional transcription arises from two
distinct hubs of transcription factor binding and active chromatin. Mol. Cell
58, 1101–1112.
Shimoda, M., Kanai-Azuma, M., Hara, K., Miyazaki, S., Kanai, Y., Monden, M.,
and Miyazaki, J. (2007). Sox17 plays a substantial role in late-stage differenti-
ation of the extraembryonic endoderm in vitro. J. Cell Sci. 120, 3859–3869.
Sigova, A.A., Mullen, A.C., Molinie, B., Gupta, S., Orlando, D.A., Guenther,
M.G., Almada, A.E., Lin, C., Sharp, P.A., Giallourakis, C.C., and Young, R.A.
(2013). Divergent transcription of long noncoding RNA/mRNA gene pairs in
embryonic stem cells. Proc. Natl. Acad. Sci. USA 110, 2876–2881.
Sim, X., Cardenas-Diaz, F.L., French, D.L., and Gadue, P. (2016). A Doxycy-
cline-Inducible System for Genetic Correction of iPSC Disease Models.
Methods Mol. Biol. 1353, 13–23.
Simon, J.M., Giresi, P.G., Davis, I.J., and Lieb, J.D. (2012). Using formalde-
hyde-assisted isolation of regulatory elements (FAIRE) to isolate active regula-
tory DNA. Nat. Protoc. 7, 256–267.
Tam, P.P., and Beddington, R.S. (1987). The formation of mesodermal tissues
in the mouse embryo during gastrulation and early organogenesis. Develop-
ment 99, 109–126.
Tsankov, A.M., Gu, H., Akopian, V., Ziller, M.J., Donaghey, J., Amit, I., Gnirke,
A., and Meissner, A. (2015). Transcription factor binding dynamics during hu-
man ES cell differentiation. Nature 518, 344–349.
Wang, L., Park, H.J., Dasari, S., Wang, S., Kocher, J.-P., and Li, W. (2013).
CPAT: Coding-Potential Assessment Tool using an alignment-free logistic
regression model. Nucleic Acids Res. 41, e74.
Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., and
Cao, X. (2014). The STAT3-binding long noncoding RNA lnc-DC controls hu-
man dendritic cell differentiation. Science 344, 310–313.
Xie, C., Yuan, J., Li, H., Li, M., Zhao, G., Bu, D., Zhu, W., Wu, W., Chen, R., and
Zhao, Y. (2014). NONCODEv4: exploring the world of long non-coding RNA
genes. Nucleic Acids Res. 42, D98–D103.
Zorn, A.M., and Wells, J.M. (2009). Vertebrate endoderm development and
organ formation. Annu. Rev. Cell Dev. Biol. 25, 221–251.
Cell Reports 17, 353–365, October 4, 2016 365
216
BIBLIOGRAPHY 
Adenot PG, Mercier Y, Renard JP, Thompson EM. 1997. Differential H4 acetylation of 
paternal and maternal chromatin precedes DNA replication and differential 
transcriptional activity in pronuclei of 1-cell mouse embryos. Development 124: 
4615-4625. 
Ahmed K, Dehghani H, Rugg-Gunn P, Fussner E, Rossant J, Bazett-Jones DP. 2010. 
Global chromatin architecture reflects pluripotency and lineage commitment in 
the early mouse embryo. PLoS One 5: e10531. 
Ajduk A, Biswas Shivhare S, Zernicka-Goetz M. 2014. The basal position of nuclei is 
one pre-requisite for asymmetric cell divisions in the early mouse embryo. Dev 
Biol 392: 133-140. 
Anani S, Bhat S, Honma-Yamanaka N, Krawchuk D, Yamanaka Y. 2014. Initiation of 
Hippo signaling is linked to polarity rather than to cell position in the pre-
implantation mouse embryo. Development 141: 2813-2824. 
Andergassen D, Dotter CP, Wenzel D, Sigl V, Bammer PC, Muckenhuber M, Mayer D, 
Kulinski TM, Theussl HC, Penninger JM et al. 2017. Mapping the mouse 
Allelome reveals tissue-specific regulation of allelic expression. Elife 6. 
Aplin JD. 2006. Embryo implantation: the molecular mechanism remains elusive. Reprod 
Biomed Online 13: 833-839. 
Aplin JD, Kimber SJ. 2004. Trophoblast-uterine interactions at implantation. Reprod Biol 
Endocrinol 2: 48. 
Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meissner A, Jenuwein T, Xu G, 
Leonhardt H, Wolf V et al. 2012. In vivo control of CpG and non-CpG DNA 
methylation by DNA methyltransferases. PLoS genetics 8: e1002750. 
Auclair G, Guibert S, Bender A, Weber M. 2014. Ontogeny of CpG island methylation 
and specificity of DNMT3 methyltransferases during embryonic development in 
the mouse. Genome Biol 15: 545. 
Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, 
Dymecki S, Eppig JT et al. 2004. The knockout mouse project. Nat Genet 36: 
921-924. 
217
Babak T, Deveale B, Armour C, Raymond C, Cleary MA, van der Kooy D, Johnson JM, 
Lim LP. 2008. Global survey of genomic imprinting by transcriptome sequencing. 
Curr Biol 18: 1735-1741. 
Babak T, DeVeale B, Tsang EK, Zhou Y, Li X, Smith KS, Kukurba KR, Zhang R, Li JB, 
van der Kooy D et al. 2015. Genetic conflict reflected in tissue-specific maps of 
genomic imprinting in human and mouse. Nat Genet 47: 544-549. 
Balhorn R. 2007. The protamine family of sperm nuclear proteins. Genome Biol 8: 227. 
Baran Y, Subramaniam M, Biton A, Tukiainen T, Tsang EK, Rivas MA, Pirinen M, 
Gutierrez-Arcelus M, Smith KS, Kukurba KR et al. 2015. The landscape of 
genomic imprinting across diverse adult human tissues. Genome Res 25: 927-936. 
Barlow DP. 2011. Genomic imprinting: a mammalian epigenetic discovery model. 
Annual review of genetics 45: 379-403. 
Barlow DP, Bartolomei MS. 2014. Genomic imprinting in mammals. Cold Spring Harb 
Perspect Biol 6. 
Barlow DP, Stoger R, Herrmann BG, Saito K, Schweifer N. 1991. The mouse insulin-like 
growth factor type-2 receptor is imprinted and closely linked to the Tme locus. 
Nature 349: 84-87. 
Bartolomei MS. 2009. Genomic imprinting: employing and avoiding epigenetic 
processes. Genes & development 23: 2124-2133. 
Bartolomei MS, Ferguson-Smith AC. 2011. Mammalian genomic imprinting. Cold 
Spring Harb Perspect Biol 3. 
Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM. 1993. Epigenetic mechanisms 
underlying the imprinting of the mouse H19 gene. Genes & development 7: 1663-
1673. 
Bartolomei MS, Zemel S, Tilghman SM. 1991. Parental imprinting of the mouse H19 
gene. Nature 351: 153-155. 
218
Barton SC, Surani MA, Norris ML. 1984. Role of paternal and maternal genomes in 
mouse development. Nature 311: 374-376. 
Bazzi H, Fantauzzo KA, Richardson GD, Jahoda CA, Christiano AM. 2007. 
Transcriptional profiling of developing mouse epidermis reveals novel patterns of 
coordinated gene expression. Dev Dyn 236: 961-970. 
Beaujean N. 2014. Histone post-translational modifications in preimplantation mouse 
embryos and their role in nuclear architecture. Molecular reproduction and 
development 81: 100-112. 
Beaujean N, Hartshorne G, Cavilla J, Taylor J, Gardner J, Wilmut I, Meehan R, Young L. 
2004. Non-conservation of mammalian preimplantation methylation dynamics. 
Current biology : CB 14: R266-267. 
Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, 
Kellis M, Marra MA, Beaudet AL, Ecker JR et al. 2010. The NIH Roadmap 
Epigenomics Mapping Consortium. Nat Biotechnol 28: 1045-1048. 
Biase FH, Cao X, Zhong S. 2014. Cell fate inclination within 2-cell and 4-cell mouse 
embryos revealed by single-cell RNA sequencing. Genome Res 24: 1787-1796. 
Biggins JS, Royer C, Watanabe T, Srinivas S. 2015. Towards understanding the roles of 
position and geometry on cell fate decisions during preimplantation development. 
Semin Cell Dev Biol 47-48: 74-79. 
Bjornsson HT, Albert TJ, Ladd-Acosta CM, Green RD, Rongione MA, Middle CM, 
Irizarry RA, Broman KW, Feinberg AP. 2008. SNP-specific array-based allele-
specific expression analysis. Genome Res 18: 771-779. 
Blakeley P, Fogarty NM, del Valle I, Wamaitha SE, Hu TX, Elder K, Snell P, Christie L, 
Robson P, Niakan KK. 2015. Defining the three cell lineages of the human 
blastocyst by single-cell RNA-seq. Development 142: 3151-3165. 
Bonthuis PJ, Huang WC, Stacher Horndli CN, Ferris E, Cheng T, Gregg C. 2015. 
Noncanonical Genomic Imprinting Effects in Offspring. Cell Rep 12: 979-991. 
219
Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE. 2007. UHRF1 plays a 
role in maintaining DNA methylation in mammalian cells. Science 317: 1760-
1764. 
Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH. 2001. Dnmt3L and the 
establishment of maternal genomic imprints. Science 294: 2536-2539. 
Branco MR, Oda M, Reik W. 2008. Safeguarding parental identity: Dnmt1 maintains 
imprints during epigenetic reprogramming in early embryogenesis. Genes Dev 22: 
1567-1571. 
Braun RE. 2001. Packaging paternal chromosomes with protamine. Nature genetics 28: 
10-12. 
Burton A, Muller J, Tu S, Padilla-Longoria P, Guccione E, Torres-Padilla ME. 2013. 
Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of 
cell fate in the mammalian embryo. Cell Rep 5: 687-701. 
Campbell KH, McWhir J, Ritchie WA, Wilmut I. 1996. Sheep cloned by nuclear transfer 
from a cultured cell line. Nature 380: 64-66. 
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. 
2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. 
Science 298: 1039-1043. 
Carr MS, Yevtodiyenko A, Schmidt CL, Schmidt JV. 2007. Allele-specific histone 
modifications regulate expression of the Dlk1-Gtl2 imprinted domain. Genomics 
89: 280-290. 
Cattanach BM, Kirk M. 1985. Differential activity of maternally and paternally derived 
chromosome regions in mice. Nature 315: 496-498. 
Chazaud C, Rossant J. 2006. Disruption of early proximodistal patterning and AVE 
formation in Apc mutants. Development 133: 3379-3387. 
Chazaud C, Yamanaka Y, Pawson T, Rossant J. 2006. Early lineage segregation between 
epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK 
pathway. Dev Cell 10: 615-624. 
220
Cheung M, Abu-Elmagd M, Clevers H, Scotting PJ. 2000. Roles of Sox4 in central 
nervous system development. Brain Res Mol Brain Res 79: 180-191. 
Cirio MC, Ratnam S, Ding F, Reinhart B, Navara C, Chaillet JR. 2008. Preimplantation 
expression of the somatic form of Dnmt1 suggests a role in the inheritance of 
genomic imprints. BMC Dev Biol 8: 9. 
Consortium EP. 2012. An integrated encyclopedia of DNA elements in the human 
genome. Nature 489: 57-74. 
Cooper TK, Zhong Q, Krawczyk M, Tae HJ, Muller GA, Schubert R, Myers LA, Dietz 
HC, Talan MI, Briest W. 2010. The haploinsufficient Col3a1 mouse as a model 
for vascular Ehlers-Danlos syndrome. Vet Pathol 47: 1028-1039. 
Court F, Tayama C, Romanelli V, Martin-Trujillo A, Iglesias-Platas I, Okamura K, 
Sugahara N, Simon C, Moore H, Harness JV et al. 2014. Genome-wide parent-of-
origin DNA methylation analysis reveals the intricacies of human imprinting and 
suggests a germline methylation-independent mechanism of establishment. 
Genome Res 24: 554-569. 
Cowley M, Wood AJ, Bohm S, Schulz R, Oakey RJ. 2012. Epigenetic control of 
alternative mRNA processing at the imprinted Herc3/Nap1l5 locus. Nucleic Acids 
Res 40: 8917-8926. 
Crowley JJ, Zhabotynsky V, Sun W, Huang S, Pakatci IK, Kim Y, Wang JR, Morgan AP, 
Calaway JD, Aylor DL et al. 2015. Analyses of allele-specific gene expression in 
highly divergent mouse crosses identifies pervasive allelic imbalance. Nat Genet 
47: 353-360. 
Cui W, Dai X, Marcho C, Han Z, Zhang K, Tremblay KD, Mager J. 2016a. Towards 
Functional Annotation of the Preimplantation Transcriptome: An RNAi Screen in 
Mammalian Embryos. Sci Rep 6: 37396. 
Cui W, Pizzollo J, Han Z, Marcho C, Zhang K, Mager J. 2016b. Nop2 is required for 
mammalian preimplantation development. Mol Reprod Dev 83: 124-131. 
da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. 2008. Genomic 
imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet 24: 306-316. 
221
Dahl JA, Jung I, Aanes H, Greggains GD, Manaf A, Lerdrup M, Li G, Kuan S, Li B, Lee 
AY et al. 2016. Broad histone H3K4me3 domains in mouse oocytes modulate 
maternal-to-zygotic transition. Nature 537: 548-552. 
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. 2001. High-resolution 
haplotype structure in the human genome. Nat Genet 29: 229-232. 
Dean W, Santos F, Stojkovic M, Zakhartchenko V, Walter J, Wolf E, Reik W. 2001. 
Conservation of methylation reprogramming in mammalian development: 
aberrant reprogramming in cloned embryos. Proc Natl Acad Sci U S A 98: 13734-
13738. 
DeChiara TM, Robertson EJ, Efstratiadis A. 1991. Parental imprinting of the mouse 
insulin-like growth factor II gene. Cell 64: 849-859. 
Delaval K, Govin J, Cerqueira F, Rousseaux S, Khochbin S, Feil R. 2007. Differential 
histone modifications mark mouse imprinting control regions during 
spermatogenesis. EMBO J 26: 720-729. 
DeVeale B, van der Kooy D, Babak T. 2012. Critical evaluation of imprinted gene 
expression by RNA-Seq: a new perspective. PLoS Genet 8: e1002600. 
Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, 
Rajagopal N, Xie W et al. 2015. Chromatin architecture reorganization during 
stem cell differentiation. Nature 518: 331-336. 
Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B. 2012. 
Topological domains in mammalian genomes identified by analysis of chromatin 
interactions. Nature 485: 376-380. 
Doherty AS, Mann MR, Tremblay KD, Bartolomei MS, Schultz RM. 2000. Differential 
effects of culture on imprinted H19 expression in the preimplantation mouse 
embryo. Biol Reprod 62: 1526-1535. 
Donnison M, Beaton A, Davey HW, Broadhurst R, L'Huillier P, Pfeffer PL. 2005. Loss 
of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic 
patterning. Development 132: 2299-2308. 
222
Du Z, Zheng H, Huang B, Ma R, Wu J, Zhang X, He J, Xiang Y, Wang Q, Li Y et al. 
2017. Allelic reprogramming of 3D chromatin architecture during early 
mammalian development. Nature 547: 232-235. 
El-Hashash AH, Warburton D, Kimber SJ. 2010. Genes and signals regulating murine 
trophoblast cell development. Mech Dev 127: 1-20. 
Engel N, Thorvaldsen JL, Bartolomei MS. 2006. CTCF binding sites promote 
transcription initiation and prevent DNA methylation on the maternal allele at the 
imprinted H19/Igf2 locus. Human molecular genetics 15: 2945-2954. 
Erhardt S, Su IH, Schneider R, Barton S, Bannister AJ, Perez-Burgos L, Jenuwein T, 
Kouzarides T, Tarakhovsky A, Surani MA. 2003. Consequences of the depletion 
of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse 
development. Development 130: 4235-4248. 
Ferguson-Smith AC, Cattanach BM, Barton SC, Beechey CV, Surani MA. 1991. 
Embryological and molecular investigations of parental imprinting on mouse 
chromosome 7. Nature 351: 667-670. 
Fierro-Gonzalez JC, White MD, Silva JC, Plachta N. 2013. Cadherin-dependent filopodia 
control preimplantation embryo compaction. Nat Cell Biol 15: 1424-1433. 
Fitzpatrick GV, Pugacheva EM, Shin JY, Abdullaev Z, Yang Y, Khatod K, Lobanenkov 
VV, Higgins MJ. 2007. Allele-specific binding of CTCF to the multipartite 
imprinting control region KvDMR1. Mol Cell Biol 27: 2636-2647. 
Fitzpatrick GV, Soloway PD, Higgins MJ. 2002. Regional loss of imprinting and growth 
deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 32: 426-431. 
Fleming TP. 1987. A quantitative analysis of cell allocation to trophectoderm and inner 
cell mass in the mouse blastocyst. Dev Biol 119: 520-531. 
Fleming TP, Sheth B, Fesenko I. 2001. Cell adhesion in the preimplantation mammalian 
embryo and its role in trophectoderm differentiation and blastocyst 
morphogenesis. Front Biosci 6: D1000-1007. 
223
Flyamer IM, Gassler J, Imakaev M, Brandao HB, Ulianov SV, Abdennur N, Razin SV, 
Mirny LA, Tachibana-Konwalski K. 2017. Single-nucleus Hi-C reveals unique 
chromatin reorganization at oocyte-to-zygote transition. Nature 544: 110-114. 
Fournier C, Goto Y, Ballestar E, Delaval K, Hever AM, Esteller M, Feil R. 2002. Allele-
specific histone lysine methylation marks regulatory regions at imprinted mouse 
genes. Embo J 21: 6560-6570. 
Fouse SD, Shen Y, Pellegrini M, Cole S, Meissner A, Van Neste L, Jaenisch R, Fan G. 
2008. Promoter CpG methylation contributes to ES cell gene regulation in parallel 
with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell 
stem cell 2: 160-169. 
Gardner RL. 2001. Specification of embryonic axes begins before cleavage in normal 
mouse development. Development 128: 839-847. 
Gaudet F, Talbot D, Leonhardt H, Jaenisch R. 1998. A short DNA methyltransferase 
isoform restores methylation in vivo. J Biol Chem 273: 32725-32729. 
Goncalves A, Leigh-Brown S, Thybert D, Stefflova K, Turro E, Flicek P, Brazma A, 
Odom DT, Marioni JC. 2012. Extensive compensatory cis-trans regulation in the 
evolution of mouse gene expression. Genome Res 22: 2376-2384. 
Grabarek JB, Zyzynska K, Saiz N, Piliszek A, Frankenberg S, Nichols J, Hadjantonakis 
AK, Plusa B. 2012. Differential plasticity of epiblast and primitive endoderm 
precursors within the ICM of the early mouse embryo. Development 139: 129-139. 
Graham JD, Hunt SM, Tran N, Clarke CL. 1999. Regulation of the expression and 
activity by progestins of a member of the SOX gene family of transcriptional 
modulators. J Mol Endocrinol 22: 295-304. 
Granier C, Gurchenkov V, Perea-Gomez A, Camus A, Ott S, Papanayotou C, Iranzo J, 
Moreau A, Reid J, Koentges G et al. 2011. Nodal cis-regulatory elements reveal 
epiblast and primitive endoderm heterogeneity in the peri-implantation mouse 
embryo. Dev Biol 349: 350-362. 
Gregg C, Zhang J, Butler JE, Haig D, Dulac C. 2010a. Sex-specific parent-of-origin 
allelic expression in the mouse brain. Science 329: 682-685. 
224
Gregg C, Zhang J, Weissbourd B, Luo S, Schroth GP, Haig D, Dulac C. 2010b. High-
resolution analysis of parent-of-origin allelic expression in the mouse brain. 
Science 329: 643-648. 
Gregory RI, Randall TE, Johnson CA, Khosla S, Hatada I, O'Neill LP, Turner BM, Feil R. 
2001. DNA methylation is linked to deacetylation of histone H3, but not H4, on 
the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol 21: 5426-5436. 
Grunau C, Clark SJ, Rosenthal A. 2001. Bisulfite genomic sequencing: systematic 
investigation of critical experimental parameters. Nucleic Acids Res 29: E65-65. 
Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, Xie ZG, Shi L, He X, Jin SG et al. 2011. 
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. 
Nature 477: 606-610. 
Guo F, Li X, Liang D, Li T, Zhu P, Guo H, Wu X, Wen L, Gu TP, Hu B et al. 2014a. 
Active and passive demethylation of male and female pronuclear DNA in the 
Mammalian zygote. Cell stem cell 15: 447-458. 
Guo H, Zhu P, Yan L, Li R, Hu B, Lian Y, Yan J, Ren X, Lin S, Li J et al. 2014b. The 
DNA methylation landscape of human early embryos. Nature 511: 606-610. 
Gurdon JB, Byrne JA. 2003. The first half-century of nuclear transplantation. Proc Natl 
Acad Sci U S A 100: 8048-8052. 
Gurdon JB, Byrne JA, Simonsson S. 2003. Nuclear reprogramming and stem cell creation. 
Proc Natl Acad Sci U S A 100 Suppl 1: 11819-11822. 
Haig D. 2000a. Genomic imprinting, sex-biased dispersal, and social behavior. Ann N Y 
Acad Sci 907: 149-163. 
Haig D. 2000b. The Kinship Theory of Genomic Imprinting. Annual Review of Ecology 
and Systematics 31: 9-32. 
Haig D. 2014. Coadaptation and conflict, misconception and muddle, in the evolution of 
genomic imprinting. Heredity (Edinb) 113: 96-103. 
225
Hall JG. 1990. Genomic imprinting: review and relevance to human diseases. Am J Hum 
Genet 46: 857-873. 
Hayashi-Takanaka Y, Yamagata K, Wakayama T, Stasevich TJ, Kainuma T, Tsurimoto T, 
Tachibana M, Shinkai Y, Kurumizaka H, Nozaki N et al. 2011. Tracking 
epigenetic histone modifications in single cells using Fab-based live endogenous 
modification labeling. Nucleic acids research 39: 6475-6488. 
He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L et al. 2011. Tet-
mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian 
DNA. Science 333: 1303-1307. 
Hikichi T, Kohda T, Kaneko-Ishino T, Ishino F. 2003. Imprinting regulation of the 
murine Meg1/Grb10 and human GRB10 genes; roles of brain-specific promoters 
and mouse-specific CTCF-binding sites. Nucleic Acids Res 31: 1398-1406. 
Hirasawa R, Chiba H, Kaneda M, Tajima S, Li E, Jaenisch R, Sasaki H. 2008. Maternal 
and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA 
methylation imprints during preimplantation development. Genes Dev 22: 1607-
1616. 
Hiura H, Sugawara A, Ogawa H, John RM, Miyauchi N, Miyanari Y, Horiike T, Li Y, 
Yaegashi N, Sasaki H et al. 2010. A tripartite paternally methylated region within 
the Gpr1-Zdbf2 imprinted domain on mouse chromosome 1 identified by meDIP-
on-chip. Nucleic Acids Res 38: 4929-4945. 
Hoppe PC, Illmensee K. 1982. Full-term development after transplantation of 
parthenogenetic embryonic nuclei into fertilized mouse eggs. Proc Natl Acad Sci 
U S A 79: 1912-1916. 
Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, Chaillet JR. 2001. 
Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. 
Cell 104: 829-838. 
Howlett SK, Reik W. 1991. Methylation levels of maternal and paternal genomes during 
preimplantation development. Development 113: 119-127. 
Hu JF, Oruganti H, Vu TH, Hoffman AR. 1998. Tissue-specific imprinting of the mouse 
insulin-like growth factor II receptor gene correlates with differential allele-
specific DNA methylation. Mol Endocrinol 12: 220-232. 
226
Huang W, Cao X, Biase FH, Yu P, Zhong S. 2014. Time-variant clustering model for 
understanding cell fate decisions. Proc Natl Acad Sci U S A 111: E4797-4806. 
Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. 2010. The behaviour of 5-
hydroxymethylcytosine in bisulfite sequencing. PloS one 5: e8888. 
Hudson QJ, Kulinski TM, Huetter SP, Barlow DP. 2010. Genomic imprinting 
mechanisms in embryonic and extraembryonic mouse tissues. Heredity (Edinb) 
105: 45-56. 
Hudson QJ, Seidl CI, Kulinski TM, Huang R, Warczok KE, Bittner R, Bartolomei MS, 
Barlow DP. 2011. Extra-embryonic-specific imprinted expression is restricted to 
defined lineages in the post-implantation embryo. Dev Biol 353: 420-431. 
Hug CB, Grimaldi AG, Kruse K, Vaquerizas JM. 2017. Chromatin Architecture Emerges 
during Zygotic Genome Activation Independent of Transcription. Cell 169: 216-
228 e219. 
Huntriss JD, Hemmings KE, Hinkins M, Rutherford AJ, Sturmey RG, Elder K, Picton 
HM. 2013. Variable imprinting of the MEST gene in human preimplantation 
embryos. Eur J Hum Genet 21: 40-47. 
Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr AR, James KD, Turner DJ, 
Smith C, Harrison DJ, Andrews R, Bird AP. 2010. Orphan CpG islands identify 
numerous conserved promoters in the mammalian genome. PLoS genetics 6: 
e1001134. 
Inoue A, Jiang L, Lu F, Suzuki T, Zhang Y. 2017. Maternal H3K27me3 controls DNA 
methylation-independent imprinting. Nature 547: 419-424. 
Inoue A, Shen L, Dai Q, He C, Zhang Y. 2011. Generation and replication-dependent 
dilution of 5fC and 5caC during mouse preimplantation development. Cell Res 21: 
1670-1676. 
Inoue A, Shen L, Matoba S, Zhang Y. 2015. Haploinsufficiency, but Not Defective 
Paternal 5mC Oxidation, Accounts for the Developmental Defects of Maternal 
Tet3 Knockouts. Cell reports doi:10.1016/j.celrep.2014.12.049. 
227
Inoue A, Zhang Y. 2011. Replication-dependent loss of 5-hydroxymethylcytosine in 
mouse preimplantation embryos. Science 334: 194. 
Iqbal K, Jin SG, Pfeifer GP, Szabo PE. 2011. Reprogramming of the paternal genome 
upon fertilization involves genome-wide oxidation of 5-methylcytosine. 
Proceedings of the National Academy of Sciences of the United States of America 
108: 3642-3647. 
Iyengar S, Ivanov AV, Jin VX, Rauscher FJ, 3rd, Farnham PJ. 2011. Functional analysis 
of KAP1 genomic recruitment. Molecular and cellular biology 31: 1833-1847. 
Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B, Zhang X, Chavez L, 
Wang H, Hannah R et al. 2014. Large conserved domains of low DNA 
methylation maintained by Dnmt3a. Nat Genet 46: 17-23. 
Johnson DR. 1974. Hairpin-tail: a case of post-reductional gene action in the mouse egg. 
Genetics 76: 795-805. 
Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, Sanai Y, 
Yonekawa H, Yazaki K, Tam PP et al. 2002. Depletion of definitive gut 
endoderm in Sox17-null mutant mice. Development 129: 2367-2379. 
Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E, Sasaki H. 2004. Essential role 
for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. 
Nature 429: 900-903. 
Kato Y, Kaneda M, Hata K, Kumaki K, Hisano M, Kohara Y, Okano M, Li E, Nozaki M, 
Sasaki H. 2007. Role of the Dnmt3 family in de novo methylation of imprinted 
and repetitive sequences during male germ cell development in the mouse. 
Human molecular genetics 16: 2272-2280. 
Kemp CR, Willems E, Wawrzak D, Hendrickx M, Agbor Agbor T, Leyns L. 2007. 
Expression of Frizzled5, Frizzled7, and Frizzled10 during early mouse 
development and interactions with canonical Wnt signaling. Dev Dyn 236: 2011-
2019. 
Kishikawa S, Murata T, Ugai H, Yamazaki T, Yokoyama KK. 2003. Control elements of 
Dnmt1 gene are regulated in cell-cycle dependent manner. Nucleic Acids Res 
Suppl: 307-308. 
228
Kohli RM, Zhang Y. 2013. TET enzymes, TDG and the dynamics of DNA demethylation. 
Nature 502: 472-479. 
Kurotaki Y, Hatta K, Nakao K, Nabeshima Y, Fujimori T. 2007. Blastocyst axis is 
specified independently of early cell lineage but aligns with the ZP shape. Science 
316: 719-723. 
Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z, Lobanenkov V, 
Reik W, Ohlsson R. 2006. CTCF binding at the H19 imprinting control region 
mediates maternally inherited higher-order chromatin conformation to restrict 
enhancer access to Igf2. Proc Natl Acad Sci U S A 103: 10684-10689. 
Kwon GS, Hadjantonakis AK. 2009. Transthyretin mouse transgenes direct RFP 
expression or Cre-mediated recombination throughout the visceral endoderm. 
Genesis 47: 447-455. 
Kwon GS, Viotti M, Hadjantonakis AK. 2008. The endoderm of the mouse embryo arises 
by dynamic widespread intercalation of embryonic and extraembryonic lineages. 
Dev Cell 15: 509-520. 
Lander ES Linton LM Birren B Nusbaum C Zody MC Baldwin J Devon K Dewar K 
Doyle M FitzHugh W et al. 2001. Initial sequencing and analysis of the human 
genome. Nature 409: 860-921. 
Lane N, Dean W, Erhardt S, Hajkova P, Surani A, Walter J, Reik W. 2003. Resistance of 
IAPs to methylation reprogramming may provide a mechanism for epigenetic 
inheritance in the mouse. Genesis 35: 88-93. 
Larue L, Ohsugi M, Hirchenhain J, Kemler R. 1994. E-cadherin null mutant embryos fail 
to form a trophectoderm epithelium. Proc Natl Acad Sci U S A 91: 8263-8267. 
Latos PA, Pauler FM, Koerner MV, Senergin HB, Hudson QJ, Stocsits RR, Allhoff W, 
Stricker SH, Klement RM, Warczok KE et al. 2012. Airn transcriptional overlap, 
but not its lncRNA products, induces imprinted Igf2r silencing. Science 338: 
1469-1472. 
Latos PA, Stricker SH, Steenpass L, Pauler FM, Huang R, Senergin BH, Regha K, 
Koerner MV, Warczok KE, Unger C et al. 2009. An in vitro ES cell imprinting 
model shows that imprinted expression of the Igf2r gene arises from an allele-
specific expression bias. Development 136: 437-448. 
229
Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV, Korving JP, 
Hogan BL. 1999. Bmp4 is required for the generation of primordial germ cells in 
the mouse embryo. Genes Dev 13: 424-436. 
Leclerc EA, Huchenq A, Kezic S, Serre G, Jonca N. 2014. Mice deficient for the 
epidermal dermokine beta and gamma isoforms display transient cornification 
defects. J Cell Sci 127: 2862-2872. 
Lee JH, Park SJ, Nakai K. 2017. Differential landscape of non-CpG methylation in 
embryonic stem cells and neurons caused by DNMT3s. Sci Rep 7: 11295. 
Lee MT, Bonneau AR, Giraldez AJ. 2014. Zygotic genome activation during the 
maternal-to-zygotic transition. Annu Rev Cell Dev Biol 30: 581-613. 
Leonhardt H, Page AW, Weier HU, Bestor TH. 1992. A targeting sequence directs DNA 
methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865-
873. 
Lepikhov K, Walter J. 2004. Differential dynamics of histone H3 methylation at positions 
K4 and K9 in the mouse zygote. BMC developmental biology 4: 12. 
Lerchner W, Barlow DP. 1997. Paternal repression of the imprinted mouse Igf2r locus 
occurs during implantation and is stable in all tissues of the post-implantation 
mouse embryo. Mechanisms of development 61: 141-149. 
Lewis A, Mitsuya K, Umlauf D, Smith P, Dean W, Walter J, Higgins M, Feil R, Reik W. 
2004. Imprinting on distal chromosome 7 in the placenta involves repressive 
histone methylation independent of DNA methylation. Nat Genet 36: 1291-1295. 
Li E, Beard C, Jaenisch R. 1993. Role for DNA methylation in genomic imprinting. 
Nature 366: 362-365. 
Li E, Bestor TH, Jaenisch R. 1992. Targeted mutation of the DNA methyltransferase 
gene results in embryonic lethality. Cell 69: 915-926. 
Li G, Bahn JH, Lee JH, Peng G, Chen Z, Nelson SF, Xiao X. 2012. Identification of 
allele-specific alternative mRNA processing via transcriptome sequencing. 
Nucleic Acids Res 40: e104. 
230
Li L, Lu X, Dean J. 2013. The maternal to zygotic transition in mammals. Mol Aspects 
Med 34: 919-938. 
Li X, Ito M, Zhou F, Youngson N, Zuo X, Leder P, Ferguson-Smith AC. 2008. A 
maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal 
imprints. Dev Cell 15: 547-557. 
Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, 
Amit I, Lajoie BR, Sabo PJ, Dorschner MO et al. 2009. Comprehensive mapping 
of long-range interactions reveals folding principles of the human genome. 
Science 326: 289-293. 
Lindroth AM, Park YJ, McLean CM, Dokshin GA, Persson JM, Herman H, Pasini D, 
Miro X, Donohoe ME, Lee JT et al. 2008. Antagonism between DNA and H3K27 
methylation at the imprinted Rasgrf1 locus. PLoS Genet 4: e1000145. 
Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. 2000. A GNAS1 
imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 106: 1167-
1174. 
Liu P, Wakamiya M, Shea MJ, Albrecht U, Behringer RR, Bradley A. 1999. Requirement 
for Wnt3 in vertebrate axis formation. Nat Genet 22: 361-365. 
Liu X, Wang C, Liu W, Li J, Li C, Kou X, Chen J, Zhao Y, Gao H, Wang H et al. 2016. 
Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-
implantation embryos. Nature 537: 558-562. 
Liu X, Wu H, Byrne M, Krane S, Jaenisch R. 1997. Type III collagen is crucial for 
collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl 
Acad Sci U S A 94: 1852-1856. 
Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP. 2003. Allelic variation 
in gene expression is common in the human genome. Genome Res 13: 1855-1862. 
Lowe LA, Yamada S, Kuehn MR. 2001. Genetic dissection of nodal function in 
patterning the mouse embryo. Development 128: 1831-1843. 
Lu CC, Brennan J, Robertson EJ. 2001. From fertilization to gastrulation: axis formation 
in the mouse embryo. Curr Opin Genet Dev 11: 384-392. 
231
Lu F, Liu Y, Inoue A, Suzuki T, Zhao K, Zhang Y. 2016. Establishing Chromatin 
Regulatory Landscape during Mouse Preimplantation Development. Cell 165: 
1375-1388. 
Luedi PP, Hartemink AJ, Jirtle RL. 2005. Genome-wide prediction of imprinted murine 
genes. Genome Res 15: 875-884. 
Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, 
DePinho RA, Lenz J, van Lohuizen M. 2002. Genome-wide retroviral insertional 
tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 32: 160-
165. 
Ma P, Schultz RM. 2008. Histone deacetylase 1 (HDAC1) regulates histone acetylation, 
development, and gene expression in preimplantation mouse embryos. Dev Biol 
319: 110-120. 
Ma WG, Song H, Das SK, Paria BC, Dey SK. 2003. Estrogen is a critical determinant 
that specifies the duration of the window of uterine receptivity for implantation. 
Proc Natl Acad Sci U S A 100: 2963-2968. 
MacIsaac JL, Bogutz AB, Morrissy AS, Lefebvre L. 2012. Tissue-specific alternative 
polyadenylation at the imprinted gene Mest regulates allelic usage at Copg2. 
Nucleic Acids Res 40: 1523-1535. 
Mager J, Montgomery ND, de Villena FP, Magnuson T. 2003. Genome imprinting 
regulated by the mouse Polycomb group protein Eed. Nat Genet 33: 502-507. 
Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, Schultz RM, Bartolomei MS. 
2004. Selective loss of imprinting in the placenta following preimplantation 
development in culture. Development 131: 3727-3735. 
Marcho C, Bevilacqua A, Tremblay KD, Mager J. 2015. Tissue-specific regulation of 
Igf2r/Airn imprinting during gastrulation. Epigenetics Chromatin 8: 10. 
Market Velker BA, Denomme MM, Mann MR. 2012. Loss of genomic imprinting in 
mouse embryos with fast rates of preimplantation development in culture. Biol 
Reprod 86: 143, 141-116. 
232
Market-Velker BA, Fernandes AD, Mann MR. 2010. Side-by-side comparison of five 
commercial media systems in a mouse model: suboptimal in vitro culture 
interferes with imprint maintenance. Biol Reprod 83: 938-950. 
Maserati M, Dai X, Walentuk M, Mager J. 2014. Identification of four genes required for 
mammalian blastocyst formation. Zygote 22: 331-339. 
Maserati M, Walentuk M, Dai X, Holston O, Adams D, Mager J. 2011. Wdr74 is 
required for blastocyst formation in the mouse. PLoS One 6: e22516. 
Matoba S, Wang H, Jiang L, Lu F, Iwabuchi KA, Wu X, Inoue K, Yang L, Press W, Lee 
JT et al. 2018. Loss of H3K27me3 Imprinting in Somatic Cell Nuclear Transfer 
Embryos Disrupts Post-Implantation Development. Cell Stem Cell 
doi:10.1016/j.stem.2018.06.008. 
Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson 
BE, Hong C, Nielsen C, Zhao Y et al. 2010. Conserved role of intragenic DNA 
methylation in regulating alternative promoters. Nature 466: 253-257. 
Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. 2000. Demethylation of the zygotic 
paternal genome. Nature 403: 501-502. 
McDole K, Xiong Y, Iglesias PA, Zheng Y. 2011. Lineage mapping the pre-implantation 
mouse embryo by two-photon microscopy, new insights into the segregation of 
cell fates. Dev Biol 355: 239-249. 
McEwen KR, Ferguson-Smith AC. 2010. Distinguishing epigenetic marks of 
developmental and imprinting regulation. Epigenetics Chromatin 3: 2. 
McGrath J, Solter D. 1983. Nuclear transplantation in the mouse embryo by microsurgery 
and cell fusion. Science 220: 1300-1302. 
McGrath J, Solter D. 1984a. Completion of mouse embryogenesis requires both the 
maternal and paternal genomes. Cell 37: 179-183. 
McGrath J, Solter D. 1984b. Maternal Thp lethality in the mouse is a nuclear, not 
cytoplasmic, defect. Nature 308: 550-551. 
233
Mertineit C, Yoder JA, Taketo T, Laird DW, Trasler JM, Bestor TH. 1998. Sex-specific 
exons control DNA methyltransferase in mammalian germ cells. Development 
125: 889-897. 
Messerschmidt DM, de Vries W, Ito M, Solter D, Ferguson-Smith A, Knowles BB. 2012. 
Trim28 is required for epigenetic stability during mouse oocyte to embryo 
transition. Science 335: 1499-1502. 
Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, 
Brockman W, Kim TK, Koche RP et al. 2007. Genome-wide maps of chromatin 
state in pluripotent and lineage-committed cells. Nature 448: 553-560. 
Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. 1996. Disruption of muscle 
architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134: 
1255-1270. 
Miura S, Mishina Y. 2007. The DVE changes distal epiblast fate from definitive 
endoderm to neurectoderm by antagonizing nodal signaling. Dev Dyn 236: 1602-
1610. 
Morris SA, Graham SJ, Jedrusik A, Zernicka-Goetz M. 2013. The differential response to 
Fgf signalling in cells internalized at different times influences lineage 
segregation in preimplantation mouse embryos. Open Biol 3: 130104. 
Morris SA, Teo RT, Li H, Robson P, Glover DM, Zernicka-Goetz M. 2010. Origin and 
formation of the first two distinct cell types of the inner cell mass in the mouse 
embryo. Proc Natl Acad Sci U S A 107: 6364-6369. 
Motosugi N, Bauer T, Polanski Z, Solter D, Hiiragi T. 2005. Polarity of the mouse 
embryo is established at blastocyst and is not prepatterned. Genes Dev 19: 1081-
1092. 
Mouse Genome Sequencing C Waterston RH Lindblad-Toh K Birney E Rogers J Abril 
JF Agarwal P Agarwala R Ainscough R Alexandersson M et al. 2002. Initial 
sequencing and comparative analysis of the mouse genome. Nature 420: 520-562. 
Murrell A, Heeson S, Reik W. 2004. Interaction between differentially methylated 
regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin 
loops. Nat Genet 36: 889-893. 
234
Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, Fraser P. 2008. 
The Air noncoding RNA epigenetically silences transcription by targeting G9a to 
chromatin. Science 322: 1717-1720. 
Nakamura T, Arai Y, Umehara H, Masuhara M, Kimura T, Taniguchi H, Sekimoto T, 
Ikawa M, Yoneda Y, Okabe M et al. 2007. PGC7/Stella protects against DNA 
demethylation in early embryogenesis. Nature cell biology 9: 64-71. 
Nakamura T, Liu YJ, Nakashima H, Umehara H, Inoue K, Matoba S, Tachibana M, 
Ogura A, Shinkai Y, Nakano T. 2012. PGC7 binds histone H3K9me2 to protect 
against conversion of 5mC to 5hmC in early embryos. Nature 486: 415-419. 
Nativio R, Wendt KS, Ito Y, Huddleston JE, Uribe-Lewis S, Woodfine K, Krueger C, 
Reik W, Peters JM, Murrell A. 2009. Cohesin is required for higher-order 
chromatin conformation at the imprinted IGF2-H19 locus. PLoS Genet 5: 
e1000739. 
Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. 1989. Genetic imprinting 
suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. 
Nature 342: 281-285. 
Nikaido I, Saito C, Mizuno Y, Meguro M, Bono H, Kadomura M, Kono T, Morris GA, 
Lyons PA, Oshimura M et al. 2003. Discovery of imprinted transcripts in the 
mouse transcriptome using large-scale expression profiling. Genome Res 13: 
1402-1409. 
Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, 
Stephenson RO, Ogonuki N et al. 2009. The Hippo signaling pathway 
components Lats and Yap pattern Tead4 activity to distinguish mouse 
trophectoderm from inner cell mass. Dev Cell 16: 398-410. 
Oda H, Okamoto I, Murphy N, Chu J, Price SM, Shen MM, Torres-Padilla ME, Heard E, 
Reinberg D. 2009. Monomethylation of histone H4-lysine 20 is involved in 
chromosome structure and stability and is essential for mouse development. 
Molecular and cellular biology 29: 2278-2295. 
Okae H, Hiura H, Nishida Y, Funayama R, Tanaka S, Chiba H, Yaegashi N, Nakayama 
K, Sasaki H, Arima T. 2012. Re-investigation and RNA sequencing-based 
identification of genes with placenta-specific imprinted expression. Hum Mol 
Genet 21: 548-558. 
235
Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian development. Cell 
99: 247-257. 
Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced 
pluripotent stem cells. Nature 448: 313-317. 
Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, 
Mariathasan S, Sasaki T, Wakeham A, Ohashi PS et al. 2000. Regulation of T cell 
activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 97: 
12272-12277. 
Ooga M, Suzuki MG, Aoki F. 2015. Involvement of histone H2B monoubiquitination in 
the regulation of mouse preimplantation development. J Reprod Dev 
doi:10.1262/jrd.2014-137. 
Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundele R, Dean W, Reik W, Walter 
J. 2000. Active demethylation of the paternal genome in the mouse zygote. 
Current biology : CB 10: 475-478. 
Oudet P, Gross-Bellard M, Chambon P. 1975. Electron microscopic and biochemical 
evidence that chromatin structure is a repeating unit. Cell 4: 281-300. 
Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R, Thomson JA. 
2007. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in 
human embryonic stem cells. Cell Stem Cell 1: 299-312. 
Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, Nagano T, 
Mancini-Dinardo D, Kanduri C. 2008. Kcnq1ot1 antisense noncoding RNA 
mediates lineage-specific transcriptional silencing through chromatin-level 
regulation. Mol Cell 32: 232-246. 
Pant PV, Tao H, Beilharz EJ, Ballinger DG, Cox DR, Frazer KA. 2006. Analysis of 
allelic differential expression in human white blood cells. Genome Res 16: 331-
339. 
Pant V, Mariano P, Kanduri C, Mattsson A, Lobanenkov V, Heuchel R, Ohlsson R. 2003. 
The nucleotides responsible for the direct physical contact between the chromatin 
insulator protein CTCF and the H19 imprinting control region manifest parent of 
236
origin-specific long-distance insulation and methylation-free domains. Genes & 
development 17: 586-590. 
Parfitt DE, Zernicka-Goetz M. 2010. Epigenetic modification affecting expression of cell 
polarity and cell fate genes to regulate lineage specification in the early mouse 
embryo. Mol Biol Cell 21: 2649-2660. 
Patten MM, Ross L, Curley JP, Queller DC, Bonduriansky R, Wolf JB. 2014. The 
evolution of genomic imprinting: theories, predictions and empirical tests. 
Heredity (Edinb) 113: 119-128. 
Pearce JJ, Evans MJ. 1999. Mml, a mouse Mix-like gene expressed in the primitive 
streak. Mech Dev 87: 189-192. 
Peat JR, Dean W, Clark SJ, Krueger F, Smallwood SA, Ficz G, Kim JK, Marioni JC, 
Hore TA, Reik W. 2014. Genome-wide bisulfite sequencing in zygotes identifies 
demethylation targets and maps the contribution of TET3 oxidation. Cell reports 
9: 1990-2000. 
Penzo-Mendez A, Dy P, Pallavi B, Lefebvre V. 2007. Generation of mice harboring a 
Sox4 conditional null allele. Genesis 45: 776-780. 
Perea-Gomez A, Camus A, Moreau A, Grieve K, Moneron G, Dubois A, Cibert C, 
Collignon J. 2004. Initiation of gastrulation in the mouse embryo is preceded by 
an apparent shift in the orientation of the anterior-posterior axis. Curr Biol 14: 
197-207. 
Pfister S, Steiner KA, Tam PP. 2007. Gene expression pattern and progression of 
embryogenesis in the immediate post-implantation period of mouse development. 
Gene Expr Patterns 7: 558-573. 
Pinter SF, Colognori D, Beliveau BJ, Sadreyev RI, Payer B, Yildirim E, Wu CT, Lee JT. 
2015. Allelic Imbalance Is a Prevalent and Tissue-Specific Feature of the Mouse 
Transcriptome. Genetics 200: 537-549. 
Piotrowska K, Wianny F, Pedersen RA, Zernicka-Goetz M. 2001. Blastomeres arising 
from the first cleavage division have distinguishable fates in normal mouse 
development. Development 128: 3739-3748. 
237
Plachta N, Bollenbach T, Pease S, Fraser SE, Pantazis P. 2011. Oct4 kinetics predict cell 
lineage patterning in the early mammalian embryo. Nat Cell Biol 13: 117-123. 
Plasschaert RN, Bartolomei MS. 2014. Genomic imprinting in development, growth, 
behavior and stem cells. Development 141: 1805-1813. 
Plusa B, Piliszek A, Frankenberg S, Artus J, Hadjantonakis AK. 2008. Distinct sequential 
cell behaviours direct primitive endoderm formation in the mouse blastocyst. 
Development 135: 3081-3091. 
Prickett AR, Barkas N, McCole RB, Hughes S, Amante SM, Schulz R, Oakey RJ. 2013. 
Genome-wide and parental allele-specific analysis of CTCF and cohesin DNA 
binding in mouse brain reveals a tissue-specific binding pattern and an association 
with imprinted differentially methylated regions. Genome Res 23: 1624-1635. 
Proudhon C, Bourc'his D. 2010. Identification and resolution of artifacts in the 
interpretation of imprinted gene expression. Brief Funct Genomics 9: 374-384. 
Quenneville S, Verde G, Corsinotti A, Kapopoulou A, Jakobsson J, Offner S, Baglivo I, 
Pedone PV, Grimaldi G, Riccio A et al. 2011. In embryonic stem cells, 
ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and 
DNA methylation of imprinting control regions. Molecular cell 44: 361-372. 
Ralston A, Rossant J. 2008. Cdx2 acts downstream of cell polarization to cell-
autonomously promote trophectoderm fate in the early mouse embryo. Dev Biol 
313: 614-629. 
Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R. 2000. Non-
CpG methylation is prevalent in embryonic stem cells and may be mediated by 
DNA methyltransferase 3a. Proc Natl Acad Sci U S A 97: 5237-5242. 
Redrup L, Branco MR, Perdeaux ER, Krueger C, Lewis A, Santos F, Nagano T, Cobb BS, 
Fraser P, Reik W. 2009. The long noncoding RNA Kcnq1ot1 organises a lineage-
specific nuclear domain for epigenetic gene silencing. Development 136: 525-530. 
Reichmann J, Nijmeijer B, Hossain MJ, Eguren M, Schneider I, Politi AZ, Roberti MJ, 
Hufnagel L, Hiiragi T, Ellenberg J. 2018. Dual-spindle formation in zygotes 
keeps parental genomes apart in early mammalian embryos. Science 361: 189-193. 
238
Reik W. 1989. Genomic imprinting and genetic disorders in man. Trends Genet 5: 331-
336. 
Renfree MB, Hore TA, Shaw G, Graves JA, Pask AJ. 2009. Evolution of genomic 
imprinting: insights from marsupials and monotremes. Annu Rev Genomics Hum 
Genet 10: 241-262. 
Rivera-Perez JA, Magnuson T. 2005. Primitive streak formation in mice is preceded by 
localized activation of Brachyury and Wnt3. Dev Biol 288: 363-371. 
Robb L, Hartley L, Begley CG, Brodnicki TC, Copeland NG, Gilbert DJ, Jenkins NA, 
Elefanty AG. 2000. Cloning, expression analysis, and chromosomal localization 
of murine and human homologues of a Xenopus mix gene. Dev Dyn 219: 497-504. 
Rouleau J, Tanigawa G, Szyf M. 1992. The mouse DNA methyltransferase 5'-region. A 
unique housekeeping gene promoter. J Biol Chem 267: 7368-7377. 
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, 
Mullikin JC, Mortimore BJ, Willey DL et al. 2001. A map of human genome 
sequence variation containing 1.42 million single nucleotide polymorphisms. 
Nature 409: 928-933. 
Saitou M, Barton SC, Surani MA. 2002. A molecular programme for the specification of 
germ cell fate in mice. Nature 418: 293-300. 
Sandell LL, Guan XJ, Ingram R, Tilghman SM. 2003. Gatm, a creatine synthesis enzyme, 
is imprinted in mouse placenta. Proc Natl Acad Sci U S A 100: 4622-4627. 
Santenard A, Ziegler-Birling C, Koch M, Tora L, Bannister AJ, Torres-Padilla ME. 2010. 
Heterochromatin formation in the mouse embryo requires critical residues of the 
histone variant H3.3. Nature cell biology 12: 853-862. 
Santos F, Hendrich B, Reik W, Dean W. 2002. Dynamic reprogramming of DNA 
methylation in the early mouse embryo. Developmental biology 241: 172-182. 
Santos F, Peters AH, Otte AP, Reik W, Dean W. 2005. Dynamic chromatin modifications 
characterise the first cell cycle in mouse embryos. Developmental biology 280: 
225-236. 
239
Sato M, Kimura T, Kurokawa K, Fujita Y, Abe K, Masuhara M, Yasunaga T, Ryo A, 
Yamamoto M, Nakano T. 2002. Identification of PGC7, a new gene expressed 
specifically in preimplantation embryos and germ cells. Mechanisms of 
development 113: 91-94. 
Saxonov S, Berg P, Brutlag DL. 2006. A genome-wide analysis of CpG dinucleotides in 
the human genome distinguishes two distinct classes of promoters. Proceedings of 
the National Academy of Sciences of the United States of America 103: 1412-1417. 
Schilham MW, Moerer P, Cumano A, Clevers HC. 1997. Sox-4 facilitates thymocyte 
differentiation. Eur J Immunol 27: 1292-1295. 
Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, van de Wetering M, 
Verbeek S, Lamers WH, Kruisbeek AM, Cumano A et al. 1996. Defects in 
cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking 
Sox-4. Nature 380: 711-714. 
Schoenherr CJ, Levorse JM, Tilghman SM. 2003. CTCF maintains differential 
methylation at the Igf2/H19 locus. Nat Genet 33: 66-69. 
Schrode N, Saiz N, Di Talia S, Hadjantonakis AK. 2014. GATA6 levels modulate 
primitive endoderm cell fate choice and timing in the mouse blastocyst. Dev Cell 
29: 454-467. 
Schultz BM, Gallicio GA, Cesaroni M, Lupey LN, Engel N. 2015. Enhancers compete 
with a long non-coding RNA for regulation of the Kcnq1 domain. Nucleic Acids 
Res 43: 745-759. 
Schultz RM. 2002. The molecular foundations of the maternal to zygotic transition in the 
preimplantation embryo. Hum Reprod Update 8: 323-331. 
Schulz R, Woodfine K, Menheniott TR, Bourc'his D, Bestor T, Oakey RJ. 2008. 
WAMIDEX: a web atlas of murine genomic imprinting and differential 
expression. Epigenetics 3: 89-96. 
Schwenk F, Baron U, Rajewsky K. 1995. A cre-transgenic mouse strain for the 
ubiquitous deletion of loxP-flanked gene segments including deletion in germ 
cells. Nucleic Acids Res 23: 5080-5081. 
240
Searle AG, Beechey CV. 1978. Complementation studies with mouse translocations. 
Cytogenet Cell Genet 20: 282-303. 
Shemer R, Birger Y, Riggs AD, Razin A. 1997. Structure of the imprinted mouse Snrpn 
gene and establishment of its parental-specific methylation pattern. Proc Natl 
Acad Sci U S A 94: 10267-10272. 
Shen L, Inoue A, He J, Liu Y, Lu F, Zhang Y. 2014a. Tet3 and DNA replication mediate 
demethylation of both the maternal and paternal genomes in mouse zygotes. Cell 
stem cell 15: 459-470. 
Shen SQ, Turro E, Corbo JC. 2014b. Hybrid mice reveal parent-of-origin and Cis- and 
trans-regulatory effects in the retina. PLoS One 9: e109382. 
Shi J, Chen Q, Li X, Zheng X, Zhang Y, Qiao J, Tang F, Tao Y, Zhou Q, Duan E. 2015. 
Dynamic transcriptional symmetry-breaking in pre-implantation mammalian 
embryo development revealed by single-cell RNA-seq. Development 142: 3468-
3477. 
Shin JY, Fitzpatrick GV, Higgins MJ. 2008. Two distinct mechanisms of silencing by the 
KvDMR1 imprinting control region. EMBO J 27: 168-178. 
Simmons DG, Cross JC. 2005. Determinants of trophoblast lineage and cell subtype 
specification in the mouse placenta. Dev Biol 284: 12-24. 
Simmons DG, Fortier AL, Cross JC. 2007. Diverse subtypes and developmental origins 
of trophoblast giant cells in the mouse placenta. Dev Biol 304: 567-578. 
Sleutels F, Tjon G, Ludwig T, Barlow DP. 2003. Imprinted silencing of Slc22a2 and 
Slc22a3 does not need transcriptional overlap between Igf2r and Air. Embo J 22: 
3696-3704. 
Sleutels F, Zwart R, Barlow DP. 2002. The non-coding Air RNA is required for silencing 
autosomal imprinted genes. Nature 415: 810-813. 
Smallwood SA, Tomizawa S, Krueger F, Ruf N, Carli N, Segonds-Pichon A, Sato S, 
Hata K, Andrews SR, Kelsey G. 2011. Dynamic CpG island methylation 
landscape in oocytes and preimplantation embryos. Nature genetics 43: 811-814. 
241
Smith LB, Hadoke PW, Dyer E, Denvir MA, Brownstein D, Miller E, Nelson N, Wells S, 
Cheeseman M, Greenfield A. 2011. Haploinsufficiency of the murine Col3a1 
locus causes aortic dissection: a novel model of the vascular type of Ehlers-
Danlos syndrome. Cardiovasc Res 90: 182-190. 
Smith ZD, Chan MM, Mikkelsen TS, Gu H, Gnirke A, Regev A, Meissner A. 2012. A 
unique regulatory phase of DNA methylation in the early mammalian embryo. 
Nature 484: 339-344. 
Spencer HG, Clark AG. 2014. Non-conflict theories for the evolution of genomic 
imprinting. Heredity (Edinb) 113: 112-118. 
Spencer HG, Wolf JB. 2014. Genomic imprinting: theories and data. Heredity (Edinb) 
113: 93-95. 
Stein P, Worrad DM, Belyaev ND, Turner BM, Schultz RM. 1997. Stage-dependent 
redistributions of acetylated histones in nuclei of the early preimplantation mouse 
embryo. Molecular reproduction and development 47: 421-429. 
Stephenson RO, Yamanaka Y, Rossant J. 2010. Disorganized epithelial polarity and 
excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. 
Development 137: 3383-3391. 
Stoger R, Kubicka P, Liu CG, Kafri T, Razin A, Cedar H, Barlow DP. 1993. Maternal-
specific methylation of the imprinted mouse Igf2r locus identifies the expressed 
locus as carrying the imprinting signal. Cell 73: 61-71. 
Surani MA, Barton SC, Norris ML. 1984. Development of reconstituted mouse eggs 
suggests imprinting of the genome during gametogenesis. Nature 308: 548-550. 
Sutherland AE, Speed TP, Calarco PG. 1990. Inner cell allocation in the mouse morula: 
the role of oriented division during fourth cleavage. Dev Biol 137: 13-25. 
Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA, Copeland 
NG. 2002. New genes involved in cancer identified by retroviral tagging. Nat 
Genet 32: 166-174. 
242
Szabo PE, Mann JR. 1995. Allele-specific expression and total expression levels of 
imprinted genes during early mouse development: implications for imprinting 
mechanisms. Genes & development 9: 3097-3108. 
Takada S, Paulsen M, Tevendale M, Tsai CE, Kelsey G, Cattanach BM, Ferguson-Smith 
AC. 2002. Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse 
chromosome 12: implications for imprinting control from comparison with Igf2-
H19. Hum Mol Genet 11: 77-86. 
Takaoka K, Yamamoto M, Hamada H. 2011. Origin and role of distal visceral endoderm, 
a group of cells that determines anterior-posterior polarity of the mouse embryo. 
Nat Cell Biol 13: 743-752. 
Takaoka K, Yamamoto M, Shiratori H, Meno C, Rossant J, Saijoh Y, Hamada H. 2006. 
The mouse embryo autonomously acquires anterior-posterior polarity at 
implantation. Dev Cell 10: 451-459. 
Talbert PB, Henikoff S. 2017. Histone variants on the move: substrates for chromatin 
dynamics. Nat Rev Mol Cell Biol 18: 115-126. 
Tam PP, Kanai-Azuma M, Kanai Y. 2003. Early endoderm development in vertebrates: 
lineage differentiation and morphogenetic function. Curr Opin Genet Dev 13: 
393-400. 
Terranova R, Yokobayashi S, Stadler MB, Otte AP, van Lohuizen M, Orkin SH, Peters 
AH. 2008. Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction 
and imprinted repression in early mouse embryos. Dev Cell 15: 668-679. 
Theiler K. 1989. The house mouse : atlas of embryonic development. Springer-Verlag, 
New York. 
Thorvaldsen JL, Duran KL, Bartolomei MS. 1998. Deletion of the H19 differentially 
methylated domain results in loss of imprinted expression of H19 and Igf2. Genes 
& development 12: 3693-3702. 
Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller 
N, Schubeler D, van Nimwegen E, Christofori G. 2013. Sox4 is a master regulator 
of epithelial-mesenchymal transition by controlling Ezh2 expression and 
epigenetic reprogramming. Cancer Cell 23: 768-783. 
243
Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. 2007. Histone arginine 
methylation regulates pluripotency in the early mouse embryo. Nature 445: 214-
218. 
Tremblay KD, Duran KL, Bartolomei MS. 1997. A 5' 2-kilobase-pair region of the 
imprinted mouse H19 gene exhibits exclusive paternal methylation throughout 
development. Mol Cell Biol 17: 4322-4329. 
Tremblay KD, Saam JR, Ingram RS, Tilghman SM, Bartolomei MS. 1995. A paternal-
specific methylation imprint marks the alleles of the mouse H19 gene. Nat Genet 
9: 407-413. 
Tsang S, Woo AY, Zhu W, Xiao RP. 2010. Deregulation of RGS2 in cardiovascular 
diseases. Front Biosci (Schol Ed) 2: 547-557. 
Umans L, Serneels L, Overbergh L, Stas L, Van Leuven F. 1999. alpha2-macroglobulin- 
and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. Am 
J Pathol 155: 983-993. 
Umlauf D, Goto Y, Cao R, Cerqueira F, Wagschal A, Zhang Y, Feil R. 2004. Imprinting 
along the Kcnq1 domain on mouse chromosome 7 involves repressive histone 
methylation and recruitment of Polycomb group complexes. Nat Genet 36: 1296-
1300. 
van de Wetering M, Oosterwegel M, van Norren K, Clevers H. 1993. Sox-4, an Sry-like 
HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 12: 
3847-3854. 
Vincent SD, Dunn NR, Hayashi S, Norris DP, Robertson EJ. 2003. Cell fate decisions 
within the mouse organizer are governed by graded Nodal signals. Genes Dev 17: 
1646-1662. 
Viotti M, Nowotschin S, Hadjantonakis AK. 2011. Afp::mCherry, a red fluorescent 
transgenic reporter of the mouse visceral endoderm. Genesis 49: 124-133. 
Wallingford MC, Angelo JR, Mager J. 2013. Morphogenetic analysis of peri-
implantation development. Dev Dyn 242: 1110-1120. 
244
Walser CB, Lipshitz HD. 2011. Transcript clearance during the maternal-to-zygotic 
transition. Curr Opin Genet Dev 21: 431-443. 
Wang J, Xie G, Singh M, Ghanbarian AT, Rasko T, Szvetnik A, Cai H, Besser D, 
Prigione A, Fuchs NV et al. 2014. Primate-specific endogenous retrovirus-driven 
transcription defines naive-like stem cells. Nature 516: 405-409. 
Wang X, Sun Q, McGrath SD, Mardis ER, Soloway PD, Clark AG. 2008. Transcriptome-
wide identification of novel imprinted genes in neonatal mouse brain. PLoS One 3: 
e3839. 
Watanabe D, Suetake I, Tada T, Tajima S. 2002. Stage- and cell-specific expression of 
Dnmt3a and Dnmt3b during embryogenesis. Mechanisms of development 118: 
187-190. 
Williams M, Burdsal C, Periasamy A, Lewandoski M, Sutherland A. 2012. Mouse 
primitive streak forms in situ by initiation of epithelial to mesenchymal transition 
without migration of a cell population. Dev Dyn 241: 270-283. 
Williamson CM, Ball ST, Dawson C, Mehta S, Beechey CV, Fray M, Teboul L, Dear TN, 
Kelsey G, Peters J. 2011. Uncoupling antisense-mediated silencing and DNA 
methylation in the imprinted Gnas cluster. PLoS Genet 7: e1001347. 
Williamson CM, Turner MD, Ball ST, Nottingham WT, Glenister P, Fray M, Tymowska-
Lalanne Z, Plagge A, Powles-Glover N, Kelsey G et al. 2006. Identification of an 
imprinting control region affecting the expression of all transcripts in the Gnas 
cluster. Nat Genet 38: 350-355. 
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. 1997. Viable offspring 
derived from fetal and adult mammalian cells. Nature 385: 810-813. 
Wilson ME, Yang KY, Kalousova A, Lau J, Kosaka Y, Lynn FC, Wang J, Mrejen C, 
Episkopou V, Clevers HC et al. 2005. The HMG box transcription factor Sox4 
contributes to the development of the endocrine pancreas. Diabetes 54: 3402-
3409. 
Wittkopp PJ, Stewart EE, Arnold LL, Neidert AH, Haerum BK, Thompson EM, Akhras 
S, Smith-Winberry G, Shefner L. 2009. Intraspecific polymorphism to 
interspecific divergence: genetics of pigmentation in Drosophila. Science 326: 
540-544. 
245
Wongtawan T, Taylor JE, Lawson KA, Wilmut I, Pennings S. 2011. Histone H4K20me3 
and HP1alpha are late heterochromatin markers in development, but present in 
undifferentiated embryonic stem cells. Journal of cell science 124: 1878-1890. 
Wood AJ, Schulz R, Woodfine K, Koltowska K, Beechey CV, Peters J, Bourc'his D, 
Oakey RJ. 2008. Regulation of alternative polyadenylation by genomic imprinting. 
Genes Dev 22: 1141-1146. 
Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V, Boiani M, Arand 
J, Nakano T, Reik W, Walter J. 2011. 5-Hydroxymethylcytosine in the 
mammalian zygote is linked with epigenetic reprogramming. Nature 
communications 2: 241. 
Wotton D, Lake RA, Farr CJ, Owen MJ. 1995. The high mobility group transcription 
factor, SOX4, transactivates the human CD2 enhancer. J Biol Chem 270: 7515-
7522. 
Wray GA. 2007. The evolutionary significance of cis-regulatory mutations. Nat Rev 
Genet 8: 206-216. 
Wu J, Huang B, Chen H, Yin Q, Liu Y, Xiang Y, Zhang B, Liu B, Wang Q, Xia W et al. 
2016. The landscape of accessible chromatin in mammalian preimplantation 
embryos. Nature 534: 652-657. 
Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP. 1997. 
Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 
389: 745-749. 
Xie W, Barr CL, Kim A, Yue F, Lee AY, Eubanks J, Dempster EL, Ren B. 2012. Base-
resolution analyses of sequence and parent-of-origin dependent DNA methylation 
in the mouse genome. Cell 148: 816-831. 
Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, 
Hawkins RD, Leung D et al. 2013. Epigenomic analysis of multilineage 
differentiation of human embryonic stem cells. Cell 153: 1134-1148. 
Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H, Lamers WH. 1998. Sox4-
deficiency syndrome in mice is an animal model for common trunk. Circ Res 83: 
986-994. 
246
Yamanaka Y, Lanner F, Rossant J. 2010. FGF signal-dependent segregation of primitive 
endoderm and epiblast in the mouse blastocyst. Development 137: 715-724. 
Yamasaki Y, Kayashima T, Soejima H, Kinoshita A, Yoshiura K, Matsumoto N, Ohta T, 
Urano T, Masuzaki H, Ishimaru T et al. 2005. Neuron-specific relaxation of Igf2r 
imprinting is associated with neuron-specific histone modifications and lack of its 
antisense transcript Air. Hum Mol Genet 14: 2511-2520. 
Yan L, Yang M, Guo H, Yang L, Wu J, Li R, Liu P, Lian Y, Zheng X, Yan J et al. 2013. 
Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic 
stem cells. Nat Struct Mol Biol 20: 1131-1139. 
Yang L, Froberg JE, Lee JT. 2014. Long noncoding RNAs: fresh perspectives into the 
RNA world. Trends in biochemical sciences 39: 35-43. 
Yatsuki H, Joh K, Higashimoto K, Soejima H, Arai Y, Wang Y, Hatada I, Obata Y, 
Morisaki H, Zhang Z et al. 2002. Domain regulation of imprinting cluster in 
Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA 
methylation analysis reveals that DMR-Lit1 is a putative imprinting control 
region. Genome Res 12: 1860-1870. 
Yevtodiyenko A, Carr MS, Patel N, Schmidt JV. 2002. Analysis of candidate imprinted 
genes linked to Dlk1-Gtl2 using a congenic mouse line. Mamm Genome 13: 633-
638. 
Zhang B, Zheng H, Huang B, Li W, Xiang Y, Peng X, Ming J, Wu X, Zhang Y, Xu Q et 
al. 2016. Allelic reprogramming of the histone modification H3K4me3 in early 
mammalian development. Nature 537: 553-557. 
Zhang H, Niu B, Hu JF, Ge S, Wang H, Li T, Ling J, Steelman BN, Qian G, Hoffman AR. 
2011. Interruption of intrachromosomal looping by CCCTC binding factor decoy 
proteins abrogates genomic imprinting of human insulin-like growth factor II. The 
Journal of cell biology 193: 475-487. 
Zhang K, Dai X, Wallingford MC, Mager J. 2013a. Depletion of Suds3 reveals an 
essential role in early lineage specification. Dev Biol 373: 359-372. 
Zhang K, Haversat JM, Mager J. 2013b. CTR9/PAF1c regulates molecular lineage 
identity, histone H3K36 trimethylation and genomic imprinting during 
preimplantation development. Dev Biol 383: 15-27. 
247
Zhang Y, Xiang Y, Yin Q, Du Z, Peng X, Wang Q, Fidalgo M, Xia W, Li Y, Zhao ZA et 
al. 2018. Dynamic epigenomic landscapes during early lineage specification in 
mouse embryos. Nat Genet 50: 96-105. 
Zhao XD, Han X, Chew JL, Liu J, Chiu KP, Choo A, Orlov YL, Sung WK, Shahab A, 
Kuznetsov VA et al. 2007. Whole-genome mapping of histone H3 Lys4 and 27 
trimethylations reveals distinct genomic compartments in human embryonic stem 
cells. Cell Stem Cell 1: 286-298. 
Zheng H, Huang B, Zhang B, Xiang Y, Du Z, Xu Q, Li Y, Wang Q, Ma J, Peng X et al. 
2016. Resetting Epigenetic Memory by Reprogramming of Histone Modifications 
in Mammals. Mol Cell 63: 1066-1079. 
Zhou L, Wang P, Zhang J, Heng BC, Tong GQ. 2015. ING2 (inhibitor of growth protein-
2) plays a crucial role in preimplantation development. Zygote 
doi:10.1017/S0967199414000768: 1-9. 
Zuo X, Sheng J, Lau HT, McDonald CM, Andrade M, Cullen DE, Bell FT, Iacovino M, 
Kyba M, Xu G et al. 2012. Zinc finger protein ZFP57 requires its co-factor to 
recruit DNA methyltransferases and maintains DNA methylation imprint in 
embryonic stem cells via its transcriptional repression domain. J Biol Chem 287: 
2107-2118. 
Zwart R, Sleutels F, Wutz A, Schinkel AH, Barlow DP. 2001. Bidirectional action of the 
Igf2r imprint control element on upstream and downstream imprinted genes. 
Genes & development 15: 2361-2366. 
 
 
 	  
248
